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SUMMARY 
 
Messenger RNAs (mRNAs) are associated with a dynamic set of RNA-binding proteins as well as 
additional proteins whose interaction with the mRNA is bridged by protein-protein interactions. 
These interactions regulate every step of mRNA life cycle from transcription and processing in 
the nucleus to translation and decay in the cytoplasm. The last decade has seen the development 
of many new approaches to study mRNA-protein interactions that have greatly extended our 
knowledge of the mRNA-associated aspects of gene expression regulation. Affinity purification 
of RNA-binding proteins (RBPs) combined with the identification of co-purifying RNAs by 
DNA microarray analysis has shown that mRNAs that encode for proteins with related function 
or sub-cellular location are co-ordinately regulated by specific sets of RBPs (Gerber, Herschlag, 
and Brown 2004; Hogan et al. 2008a; Gerber et al. 2006; Hieronymus and Silver 2003). These 
findings suggest that RBPs play a central role in the post-transcriptional regulation of mRNA 
expression (Hogan et al. 2008a). Proteome-wide screens to identify RNA-protein interactions 
using high-density protein microarrays suggest the existence of novel RBPs among unexpected 
classes of proteins such as enzymes (Tsvetanova et al. 2010; Scherrer et al. 2010). Global analysis 
of mRNA-bound proteome by in vivo UV cross-linking combined with polyadenylated RNA 
purification and quantitative proteomic analysis of the captured proteins has enabled to compile a 
comprehensive list of RBPs in mammalian cells (Baltz et al. 2012; Castello et al. 2012). Methods 
also exist for the creation of a transcriptome-wide high-resolution map of RBP-binding sites 
(reviewed in Ascano et al. 2012). Due to methodological limitations, however, our knowledge of 
the protein composition of mRNPs assembled on distinct cellular mRNAs is very limited. We 
have therefore developed a single-step mRNP affinity purification method that is based on the 
capture of the mRNA component of in vivo-assembled mRNPs from the budding yeast 
Saccharomyces cerevisiae. In order to capture the mRNA of interest we make use of the high affinity 
interaction between the bacteriophage MS2 coat protein and its RNA binding site; integrated 
after the stop codon, MS2 stem-loops serve as an RNA affinity tag for mRNP capture (Haim et 
al. 2007). The protein composition of affinity purified mRNPs is analysed by quantitative 
proteomics. Collectively, our approach should provide an overall picture of the various 
interactions an mRNP is involved in during its life cycle and also reveal the abundance of specific 
interactions.  
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The analysis of the mRNA-bound proteome of two mRNAs encoding for glycolytic 
enzymes, PGK1 and ENO2, indicates that large mRNP subpopulations are engaged in mRNA 
translation and 5′→3′ exoribonucleolytic decay. The latter process seems to be accelerated for the 
analysed mRNAs due to the integration of the RNA tag. The analysis of an mRNA-like transcript 
composed of the RNA tag surrounded by 5′ and 3′ UTR sequences derived from endogenous 
genes revealed an mRNP protein composition largely similar to PGK1 and ENO2. This result 
suggests that the main determinant for recognizing a transcript as an mRNA is not the open 
reading frame but the 5′ and 3′ untranslated regions. The three analysed mRNA-bound 
proteomes contained besides proteins with a well established role in mRNA life cycle also 
multiple unexpected proteins. Our results point to a possible role for ribosome biogenesis 
factors, tRNA-modifying enzymes and some metabolic enzymes in mRNA biology and suggest  
co-translational supramolecular glycolytic enzyme complex formation.  
The established mRNP affinity purification method provides a starting point for further 
analysis of the protein composition of specific in vivo-assembled mRNPs in S. cerevisiae. 
Combining the method with UV cross-linking would enable to determine the proteins that 
directly interact with the mRNA of interest plus the binding sites of these proteins on the 
mRNA. In order to elucidate the molecular mechanisms that regulate the post-transcriptional fate 
of mRNA, future studies should aim at identifying the mRNA-associated proteome on a 
genome-wide scale as well as provide insight into the temporal dynamics of mRNA-protein 
interactions. 
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INTRODUCTION 
 
mRNP – the functional form of mRNA 
 
The physiological and developmental stages of a cell are the outcome of spatially and temporally 
coordinated gene expression. In eukaryotes, gene expression regulation occurs at multiple levels 
from transcription to post-translational protein modifications. In the centre of many of these 
control steps is mRNA. In order to be successfully translated, an mRNA has to undergo proper 
5' capping, splicing, 3' end processing and export. These steps do not only involve pre-mRNA 
modifications but also result in the loading of various factors on the transcript. An mRNA 
together with the associated proteins and non-coding RNAs comprises the messenger 
ribonucleoprotein particle (mRNP). The composition of an mRNP is highly dynamic. The 
changing repertoire of mRNA-interacting factors has a profound influence on the fate and 
function of the mRNA because these factors coordinate and couple the post-transcriptional gene 
expression events.  
The life cycle of an mRNP starts with transcription. As soon as the nascent transcript 
emerges from RNA polymerase II it is bound by RNA-binding proteins. Some RBPs participate 
in gene transcription by promoting elongation and preventing RNA-DNA hybrid formation. 
Other RBPs take part in pre-mRNA processing into 5′ capped, spliced and polyadenylated 
mature transcripts. The interplay between pre-mRNA processing, co-transcriptional mRNA 
export factor recruitment and nuclear mRNP quality control result in the formation of mature, 
export competent mRNPs that are subsequently transported through the nuclear pores to the 
cytoplasm. mRNP export is accompanied by mRNP remodelling which results in the exchange of 
many mRNP proteins. After export, mRNPs can be directly engaged in translation or they can be 
localized to distinct cellular regions. mRNP localization is often mediated by specific mRNA-
binding adaptor proteins that link mRNPs to motor proteins. Transcript-specific translational 
regulation, which, among other processes, is also necessary to prevent protein synthesis during 
mRNA localization, is exerted by RBPs.  Finally, mRNAs are degraded by ribonucleases in 
general cytoplasmic mRNA turnover pathways or in more specialized pathways relying on 
specific cis-acting sequence elements and sequence-specific trans-acting factors.  
Describing the life cycle of an mRNP, however, as a single linear pathway does not 
accurately reflect the reality. In fact, mRNPs are a part of a complex post-transcriptional gene 
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expression regulation system. The importance of post-transcriptional gene expression regulation 
in mRNP life cycle is emphasized by the highly variable correlation between mRNA and protein 
expression levels (Ghaemmaghami et al. 2003; Greenbaum et al. 2003). Hence, it is not possible 
to accurately predict protein abundance based on mRNA expression levels and vice versa. An 
emerging paradigm is the existence of extensive regulatory networks, where mRNAs encoding 
for proteins that are functionally related or localized in same sub-cellular compartments, are 
regulated in a coordinated way by distinct RBPs (reviewed in Keene and Tenenbaum 2002; 
Keene 2007). This concept is supported by evidence provided by several studies (Scherrer et al. 
2010; Gerber, Herschlag, and Brown 2004; Hieronymus and Silver 2003; Tsvetanova et al. 2010; 
Hogan et al. 2008a) and is perhaps best illustrates by the discovery that each of the five members 
of the Puf family of RBPs associates with a distinct set of functionally related mRNAs in the 
budding yeast Saccharomyces cerevisae  (Gerber, Herschlag, and Brown 2004).  
The following overview aims at giving an understanding of the life cycle of an mRNP in 
the context of a complex post-transcriptional regulatory network. In order to provide relevant 
background information for the experimental part of the thesis, which focuses on the protein 
composition analysis of affinity purified mRNPs from S. cerevisiae, mRNA-protein interactions 
involved in different steps of the mRNA life cycle will be discussed. Much of the current 
knowledge about mRNP biogenesis, export and cytoplasmic destiny is based on studies 
performed in S. cerevisiae. Therefore, this overview will focus mostly on this model organism but 
also refer to relevant findings in higher eukaryotes. In addition, experimental methods to study 
mRNA-protein complexes will be reviewed.  
 
 
RNA binding proteins at a glance 
 
RBPs recognize their targets via RNA-binding domains (RBDs). Taken the wide range of 
functions carried out by RBPs one might assume that an equally large number of protein 
structures are involved in RNA recognition. However, this does not appear to be the case. A 
large scale bioinformatics analysis has classified around 40 types of motifs as “non-catalytic” 
RBDs (Anantharaman, Koonin, and Aravind 2002). Some RBDs, such as the RNA-recognition 
motif (RRM), are found in hundreds of proteins within a species, whereas other RBDs can be 
present only in a single proteins (e.g. S6 and L30 ribosomal protein domains) or in proteins with 
a specific functions (e.g. cap-binding domain) (Anantharaman, Koonin, and Aravind 2002). The 
better studied RBDs include the above mentioned RRM plus the heterogeneous nuclear RNP K 
homology (KH) domain, the double-stranded RNA-binding domain (dsRBD), RGG (Arg-Gly-
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Gly) box, DEAD/DEAH box, zinc finger (ZnF), Pumilio/FBF (PUF or Pum-HD) domain and 
the Piwi/Argonaute/Zwiller (PAZ) domain (reviewed in Cléry, Blatter, and Allain 2008; Lunde, 
Moore, and Varani 2007; Auweter, Oberstrass, and Allain 2006). Rather than containing a single 
RBD, RBPs usually harbour multiple copies of a certain RBD or several different RBDs. The 
modular structure of RBPs confers a more specific and higher affinity binding to the cognate 
substrate and ultimately enables RBPs to recognize a wide variety of targets.  
Further functional diversity among RBPs is achieved by combining RBDs with other 
types of domains which can impart catalytic or protein-binding activities. For instance, both 
protein kinase R (PKR) and adenosine deminase 2 (ADAR2) contain two dsRBDs in the N-
terminus, but differ in their catalytic domains and thus in the cellular functions. PKR harbours a 
kinase domain (Dar, Dever, and Sicheri 2005; Lemaire et al. 2008; Meurs et al. 1990), whereas 
ADAR2 contains a deaminase domain catalyzing the conversion of adenosins to inosins (Bass 
2002; Macbeth et al. 2005). PKR activation by double-stranded viral RNA leads to translational 
shut-down, thereby inhibiting viral particle production. ADAR2, on the other hand, can 
modulate biological processes involving sequence- and structure-specific interactions with the 
RNA by changing the primary sequence of the RNA (reviewed in Bass 2002).  
 For some RBPs the ability to form protein-protein interactions can be functionally as 
important as the ability to bind RNA. A good example here is the serine/arginine (SR)-rich 
protein family, whose members are involved in various aspects of mRNA metabolism including 
the regulation of constitutive and alternative splicing (reviewed in Twyffels, Gueydan, and Kruys 
2011). SR proteins interact with RNA via one or two conserved RRMs, whereas protein-protein 
interactions are mediated by a domain enriched in arginine and serine residues (RS domain) (Zuo 
and Maniatis 1996; Kohtz et al. 1994; Amrein, Hedley, and Maniatis 1994). SR proteins can 
greatly enhance splicing activity by recruiting spliceosome components to the regulated splice 
sites and this function is dependent on the protein-binding RS domain (Graveley, Hertel, and 
Maniatis 1998; Kohtz et al. 1994; Zuo and Maniatis 1996). In other RBPs protein-protein 
interactions can be mediated also by atypical RRMs or KH domains and dsRBDs (Ramos et al. 
2002; Irion et al. 2006; Toba and White 2008). For instance, in some heterogenous nuclear 
ribonucleoproteins (hnRNPs), which together with SR proteins play an important role in splicing 
regulation (reviewed in Han, Tang, and Smith 2010), KH domains and RRMs are essential for 
protein-binding (J. H. Kim et al. 2000). 
The versatility of RNA-protein interaction modes among RBPs is further emphasized by 
a group of RBPs whose mRNA recognition specificity is not dependent on RBDs but on guide 
RNAs. Identified guide RNA classes that are involved in post-transcriptional gene silencing 
include microRNAs (reviewed in Bartel 2004), endogenous small interfering RNAs (Tam et al. 
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2008; Kawamura et al. 2008) and Piwi-interacting RNAs (Aravin et al. 2006; Lau et al. 2006). The 
first two types of small non-coding RNAs are found in complex with Argonaut proteins and the 
later with Piwi proteins. Guide RNA function is also provided by small nuclear RNAs during 
splicing (reviewed in Wahl, Will, and Lührmann 2009) and small nucleolar RNAs during RNA-
guided nucleotide modifications (reviewed in Decatur and Fournier 2003). 
3 to 11% of all bacterial, archaeal and eukaryotic proteins are involved in RNA 
metabolism (Anantharaman, Koonin, and Aravind 2002). The list of annotated and predicted 
RBPs in S. cerevisiae comprises over 600 proteins, corresponding to more than 10% of the yeast 
proteome (Hogan et al. 2008a). Astonishingly, most of these proteins lack known RNA-binding 
domains, suggesting that many RBPs remain to be elucidated (Hogan et al. 2008a). The existence 
of RBPs among unexpected classes of proteins, like metabolic enzymes, has been known for 
about two decades (R. Singh and Green 1993; Kennedy et al. 1992; Nagy and Rigby 1995). The 
early findings include the discovery that aconitase, the key player in citric acid cycle that converts 
citrate to isocitrate in mitochondria, also acts as the iron-responsive element-binding protein 1 
(IRP-BP 1) in cytosol (Butt et al. 1996; Kennedy et al. 1992). In response to low cellular iron 
levels IRP-BP 1 binds to the iron-responsive element in its target mRNAs, thereby up- or down-
regulating their expression (Kato et al. 2007). More recent data suggests that the ability to bind 
RNA might be a widespread feature among enzymes (Hogan et al. 2008a; Scherrer et al. 2010; 
Tsvetanova et al. 2010; Hentze and Preiss 2010). These findings point to the possibility that many 
metabolic enzymes could have dual functions which could allow them to fine-tune gene 
expression in response to cell’s metabolic state (reviewed in Hentze and Preiss 2010). The 
question, how proteins without known RBDs bind RNA, remains, in many cases, elusive. One 
possible explanation, which is exemplified by aconitase, is that evolution has selected for RNA 
secondary structures capable of protein-binding to establish these RNA-protein interactions.  
 
 
mRNP life cycle is guided by RNA binding proteins  
 
Transcription elongation and the concomitant pre-mRNA processing events 
The guiding role of RBPs in mRNP life cycle is manifested by tight coupling of different steps in 
mRNP biogenesis. The first important player along this path of interconnected events is RNA 
polymerase II (Pol II), the enzyme transcribing eukaryotic protein-coding genes. The special 
feature of Pol II that enables sequential recruitment of mRNA processing factors is the carboxy-
terminal domain (CTD) of the largest subunit (reviewed in Meinhart et al. 2005). The CTD 
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consists of repeats of an amino acid motif with a consensus sequence Tyr-Ser-Pro-Thr-Ser-Pro-
Ser. Different stages of the transcription cycle are characterized by specific patterns of CTD post-
translational modifications, of which serine phosphorylation has a major impact on transcription 
and mRNA processing factor recruitment (M. Kim et al. 2009; reviewed in Egloff and Murphy 
2008). For instance, the first mRNA processing event – 5′ end capping – is dependent on Ser5 
phosphorylation that directly recruits the capping machinery to Pol II soon after transcription 
initiation (Schroeder et al. 2000; Rodriguez et al. 2000; Yue et al. 1997). Capping not only affects 
mRNA by ensuring mRNA stability (Hsu and Stevens 1993; Walther et al. 1998) and efficient 
translation (Tarun and Sachs 1996a; Wakiyama, Imataka, and Sonenberg 2000), but also 
transcription. Several lines of evidence suggest that capping enzymes play a critical role in the 
transition from abortive early transcription to full elongation (Guiguen et al. 2007; Mandal et al. 
2004). 
The monomethylated cap structure is co-transcriptionally bound by nuclear cap-binding 
complex (CBC) (Wong et al. 2007) that likely comprises the first proteins to assemble on a pre-
mRNA. The evolutionarily conserved CBC in S. cerevisia is composed of Cbc2 (CBP20 in higher 
eukaryotes), the 20 kDa cap-binding subunit (Colot, Stutz, and Rosbash 1996; Visa et al. 1996), 
and Cbc1. Cbc1 homolog in higher eukaryotes, CBP80, is the regulatory subunit that enables 
high affinity binding of CBP20 to cap structure (Mazza et al. 2001; Izaurralde et al. 1994) (Table 
1). Studies in yeast have shown that CBC is important for various steps in mRNP biogenesis, 
further emphasizing the importance of functional coupling in this process. CBC is required for 
co-transcriptional spliceosome assembly (Görnemann et al. 2005) and can stimulate transcription 
pre-initiation complex formation on active genes (Lahudkar et al. 2011). In addition, CBC is 
necessary for proper transcription termination because the complex suppresses the recognition of 
weak polyadenylation sites (Wong et al. 2007; B Das et al. 2000). CBC has also been shown to 
participate in rapid mRNA degradation in the nucleus upon mRNA export block (Biswadip Das, 
Butler, and Sherman 2003; Kuai, Das, and Sherman 2005).  
Splicing is another pre-mRNA processing event that is largely co-transcriptional (G. 
Zhang et al. 1994; J. Singh and Padgett 2009; Lacadie and Rosbash 2005; Görnemann et al. 2005). 
During splicing intron-containing pre-mRNAs interact with one of the most complex eukaryotic 
macromolecular machineries – the spliceosome – that catalysis the excision of intronic sequences 
(reviewed in Will and Lührmann 2011). Spliceosome is assembled from U1, U2, U5 and U4/U6 
small nuclear ribonucleoprotein particles (snRNPs) and a multitude of non-snRNP proteins 
(Fabrizio et al. 2009; Y.-I. G. Chen et al. 2007; Zhou, Licklider, et al. 2002). Each snRNP is 
composed of one (or two in case or U4/U6) uridine-rich small nuclear RNA (U snRNA), a 
common set of seven Sm proteins and a varying number of snRNP specific proteins. Proteomic 
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studies have shown that in total about 90 (Fabrizio et al. 2009) and 170 (reviewed in Jurica and 
Moore 2003) proteins associate with the yeast and human spliceosome, respectively. Spliceosome 
composition is highly dynamic. Different stages of splicing are characterized by changes in 
spliceosome protein composition and extensive remodelling of snRNPs. The large number of 
spliceosome associated proteins, which in humans comprises two-thirds of the spliceosome mass, 
indicates the importance of protein-RNA and protein-protein interactions for proper splicing. 
 
Table 1. Selected yeast proteins and their metazoan homologues cited in the thesis. Description refers to the 
biological function of proteins. Table modified from (Kelly and Corbett 2009) and (Rodríguez-Navarro and Hurt 
2011). 
 
S. cerevisiae protein     Metazoan  Description 
orthologue  
Abbreviation Full name    Abbreviation 
Cbc2/Cbp20 cap-binding protein 20   CBP20  Cap-binding complex with Cbp80 
Cbc1/Cbp80 cap-binding protein 80   CBP80  Cap-binding complex with Cbp20 
Tho2  THO complex subunit 2   THOC2  THO/TREX component  
Hpr1  hyperrecombination protein 1  THOC1  THO/TREX component 
Mft1  mitochondrial fusion target protein 1 -  THO/TREX component 
Thp2  THO complex subunit THP2  -  THO/TREX component 
Sub2  suppressor of BRR1 protein 2  UAP56  RNA helicase, TREX component 
Yra1 RNA annealing protein YRA1  Aly/REF  RNA binding protein,  
TREX component  
Mex67  mRNA export factor 67   TAP/NXF1 mRNA export receptor 
Mtr2  mRNA transport regulator 2  p15/NXT1 mRNA export receptor 
Nab2  nuclear polyadenylated RNA-binding 2 NAB2  RNA binding protein 
Npl3  nuclear protein 3    -  RNA binding protein 
Pcf11  protein 1 of CF I    PCF11  mRNA 3′ end processing factor 
Rna14  mRNA 3′ end processing protein RNA14 CstF77  mRNA 3′ end processing factor 
Rna15  mRNA 3′ end processing protein RNA15 CstF64  mRNA 3′ end processing factor 
Glc7  serine/threonine-protein phosphatase  PP1c  protein phosphatase 
PP1-2  
Pap1  poly(A) polymerase 1   Pap1  poly(A) tail synthesis 
Sac3  nuclear mRNA export protein SAC3 GANP/Xmas-2 TREX-2 component 
Thp1  nuclear mRNA export protein THP1 ENST00000246505 TREX-2 component 
Sus1  protein SUS1    DC6/ENY2  SAGA and TREX-2 component 
Cdc31  cell division control protein 31  CETN3  TREX-2 component 
Nup1  nucleoporin NUP1   -  nucleoporin 
Nup60  nucleoporin NUP60   Nup153  nucleoporin 
Mlp1  myosin-like protein 1   TRP  NPC-associated protein 
Mlp2  myosin-like protein 1   TRP  NPC-associated protein 
Dbp5/Rat8 DEAD-box protein 5   DDX19  RNA helicase 
Gle1  nucleoporin GLE1   hGLE1  nucleoporin 
Dis3/Rrp44 chromosome disjunction 3  hDIS3/hDIS3L exosome component  
Rrp6  ribosomal RNA-processing protein 6 hRRP6  exosome component 
Trf4/Pap2 topoisomerase 1-related protein 4  hTRF4-1  TRAMP component 
Trf5  topoisomerase 1-related protein 5  hTRF4-2  TRAMP component 
Air1  Arg methyltransferase-interacting   ZCCHC7  TRAMP component 
RING-finger 1    
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Table 1. Continued 
 
S. cerevisiae protein     Metazoan  Description 
orthologue  
Abbreviation Full name    Abbreviation 
Air2  Arg methyltransferase-interacting   ZCCHC7  TRAMP component 
RING-finger 2   
Mtr4  mRNA-transport regulator 4  hMTR4  TRAMP component 
Rat1  ribonucleic acid-trafficking 1  XRN2  5′→3′ exoribonuclease 
Rai1  RAT1-interacting protein   DOM3Z  Rat1 co-activator 
 
 
mRNP export factors are recruited during transcription 
Co-transcriptional packaging of Pol II generated transcripts into mRNPs is vital for cells to 
preserve genome integrity. Naked RNA has a tendency to invade the DNA duplex behind the 
elongating Pol II and by base pairing with the non-coding DNA strand force the coding strand 
into single-stranded conformation. Such structures are termed R loops and they are harmful for 
the cell in several ways (reviewed in Aguilera and García-Muse 2012). R loop formation can 
impair transcription elongation as this structure is likely to obstruct the next elongating Pol II.  R 
loops can also induce chromosomal DNA rearrangements by blocking replication fork 
progression (Gómez-González, Felipe-Abrio, and Aguilera 2009; Prado and Aguilera 2005; Gan 
et al. 2011; Huertas and Aguilera 2003). 
A critical role in co-transcriptional mRNA packaging into export competent mRNPs, and 
thus in preventing R-loop formation (Gómez-González et al. 2011), is played by the 
evolutionarily conserved transcription and export (TREX) complex (Katja Strässer et al. 2002; 
Abruzzi, Lacadie, and Rosbash 2004). In S. cerevisiae the TREX complex contains the components 
of the THO complex (Tho2, Hpr1, Mft1, Thp2 and, possibly, Tex1) (Chávez et al. 2000; A. Pena 
et al. 2012) and two RNA export adapters, Sub2 and Yra1, which are necessary for the 
recruitment of the mRNA export receptor (Katja Strässer et al. 2002).  Chromatin 
immunoprecipitation experiments have demonstrated that the THO components and the RNA 
export adapters Sub2 and Yra1 become associated with active chromatin during transcription 
elongation (A. Pena et al. 2012; Zenklusen et al. 2002). THO recruitment is partly mediated by 
the C-terminal nucleic acid-binding domain of Tho2 (A. Pena et al. 2012), whereas Sub2 bridges 
the interaction between THO complex and Yra1 (Zenklusen et al. 2002). A model based on this 
data suggests that upon association with sites of active transcription THO complex, specifically 
Hpr1 (Zenklusen et al. 2002), recruits Sub2 to the nascent transcript that further recruits Yra1 
(reviewed in Kelly and Corbett 2009). Yra1 can then serve as an adaptor for the general S. 
cerevisiae mRNA export receptor, Mex67/Mtr2 heterodimer (Santos-Rosa et al. 1998; Kadowaki et 
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al. 1994; Zenklusen et al. 2001; K Strässer and Hurt 2000). As Mex67 and Sub2 share the same 
binding site on Yra1, Sub2 is likely displaced by Mex67 prior to mRNA export (K Strässer and 
Hurt 2001). However, evidence is accumulating that mRNA export does not follow a single linear 
pathway as suggested by the described model. Some of the most notable findings along these 
lines include the discovery that two shuttling heterogeneous nuclear ribonucleoproteins Npl3 
(Wendy Gilbert and Guthrie 2004) and Nab2 (Iglesias et al. 2010) can serve as adaptors for 
Mex67. The role of Npl3 as an mRNA export adaptor is closely related to 3′ end processing and 
will be therefore discussed in the following chapter. 
Nab2 is a polyadenylated RNA-binding protein (J. T. Anderson et al. 1993) with a well-
established role in poly(A) tail length control (Viphakone, Voisinet-Hakil, and Minvielle-Sebastia 
2008; Hector et al. 2002) and nuclear mRNA export (Fasken, Stewart, and Corbett 2008; 
Vinciguerra et al. 2005; D. M. Green et al. 2003; D. M. Green et al. 2002; Batisse et al. 2009). The 
notion that Nab2 can serve as an adaptor for Mex67 is based on the findings that Nab2, Yra1 
and Mex67 can form a trimeric complex, and that the lethal phenotype of Δyra1 cells can be 
rescued by Nab2 overexpression (Iglesias et al. 2010). Furthermore, in the same study Yra1 was 
shown to stimulate the interaction between Mex67 and Nab2, suggesting that Yra1 may not be a 
bona fide mRNA export adaptor but rather a chaperone facilitating Mex67-Nab2 association 
(Iglesias et al. 2010). 
Besides Yra1, Npl3 and Nab2 also the THO complex has been implicated in Mex67 
recruitment. Interestingly, RNase treatment affects the association of Sub2 (Abruzzi, Lacadie, and 
Rosbash 2004; Dieppois, Iglesias, and Stutz 2006) but not Mex67 (Dieppois, Iglesias, and Stutz 
2006) with actively transcribed genes and hints that Mex67 recruitment is largely mediated by 
adaptors associated with the transcription machinery. One such adaptor can be the THO 
component Hpr1. It has been shown that Mex67 can directly be recruited via its ubiquitin-
associated (UBA) domain to Hpr1 and that this recruitment depends on Hpr1 ubiquitination 
(Gwizdek et al. 2006) (Fig. 1). Hpr1 is ubiquitinated in a transcription-dependent manner leading 
to Mex67 association with active genes (Gwizdek et al. 2005). Mex67-UBA binding in turn 
transiently protects Hpr1 from proteasomal degradation (Gwizdek et al. 2006) and can thereby 
contribute to the coordination of transcription and mRNP assembly.  
Not only mRNA export factors are loaded co-transcriptionally to the nascent mRNA, the 
same holds true for the 3′ end processing machinery. A central role in coupling transcription to 3′ 
end formation is played by Pcf11, a conserved subunit of the yeast cleavage factor 1A (CF1A) 
required for cleavage and polyadenylation steps of 3′ end formation (E. J. Steinmetz and Brow 
1996; Sadowski et al. 2003) (Fig. 1). Pcf11 can bind both Pol II CTD via phospho-Ser2 (Barillà, 
Lee, and Proudfoot 2001; Licatalosi et al. 2002; Hollingworth et al. 2006), a phosphorylation 
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mark coinciding with transcription elongation (Komarnitsky, Cho, and Buratowski 2000; Z. Ni et 
al. 2004), and RNA (Licatalosi et al. 2002; M. Kim et al. 2004), thereby facilitating 3′ end 
processing machinery co-transcriptional recruitment. However, linking transcription and 3′ end 
formation does not seem to be the only coupling event Pcf11 is participating in. A recent study 
showed that Yra1 co-transcriptional recruitment was not dependent on Sub2 as anticipated, but 
on Pcf11 (Johnson, Cubberley, and Bentley 2009). The authors proposed that after the initial 
Yra1 recruitment by Pcf11, Yra1 is transferred to Sub2. This scenario is supported by the finding 
that Pcf11 and Sub2 contact with the same region on Yra1, suggesting mutually exclusive binding 
(Johnson, Cubberley, and Bentley 2009). Yra1 recruitment by 3′ end processing machinery could 
provide an additional mRNP quality control mechanism as export competence, which is acquired 
through Yra1 loading, depends on proper transcription and 3′ end processing.  
 
 
3′ end formation and mRNA export are coupled 
All eukaryotic mRNAs, with the exception of replication-dependent histone mRNAs (Dávila 
López and Samuelsson 2008), carry a homopolymeric tail consisting of adenosyl (poly(A)) 
residues at their 3′ end. These poly(A) tails, which are associated with multiple copies of poly(A)-
binding protein (PABP), have a well defined species specific length of 70-80 nt in S. cerevisiae and 
200-250 nt in mammalian cells (reviewed in Eckmann, Rammelt, and Wahle 2011; Lemay et al. 
2010). The two enzymatic activities required in eukaryotes for mRNA 3′ end formation are site-
specific endonucleolytic cleavage of the pre-mRNA and poly(A) tail addition onto the upstream 
cleavage product. Despite the seemingly simple biochemistry of the reactions, a megadalton-sized 
protein machinery is needed both in yeast and mammals for 3′ end formation (reviewed in 
Mandel, Bai, and Tong 2008). The importance of correct 3′ end polyadenylation for living 
organisms is emphasizes by the fact that most 3′ end processing factors are encoded by essential 
genes in S. cerevisiae (reviewed in Proudfoot 2011).  
The co-transcriptional recruitment of mRNA export factors, jet the nuclear export of 
only mature mRNPs suggests that cells can efficiently discriminate between mRNPs still on the 
“assembly line” and export competent mature mRNPs. Evidence has accumulated from studies 
mainly done on yeast that mRNP export competency is linked to 3′ end processing. Similarly to 
temperature sensitive mex67-5 cells (Segref et al. 1997), temperature sensitive mutants of the yeast 
CF1A subunits Rna14, Rna15 and Pcf11 as well as poly(A) polymerase 1 (Pap1) show poly(A) 
RNA accumulation in the nucleus at restrictive temperature (Hilleren et al. 2001; Hammell et al. 
2002; Brodsky and Silver 2000). Conversely, mex67-5 cells show hyperpolyadenylation of 
INTRODUCTION 
 
18 
 
transcripts at restrictive temperature (T H Jensen, Patricio, et al. 2001; Hammell et al. 2002; 
Hilleren et al. 2001). This phenotype is also observed in cells defective for 3′ end processing 
(Hammell et al. 2002). 
 
 
 
Figure 1. mRNP co-transcriptional assembly. During transcription initiation the C-terminal domain (CTD) of 
RNA polymerase II (RNA Pol II) becomes phosphorylated at Ser5 in the heptad amino acid repeat composing 
the CTD. This results in the recruitment of the capping machinery to the CTD and subsequent capping of the 
nascent transcript, leading to processive transcription elongation. Cap is bound by the cap binding complex 
that likely represents the first proteins to assemble on the nascent transcript (omitted for simplicity).  During 
transcription elongation CTD is phosphorylated at Ser2, which recruits Pcf11 on the transcription machinery. 
Pcf11 is a component of cleavage factor 1A (CF1A), and has been shown to be necessary for initial Yra1 
association with transcription machinery (Johnson, Cubberley, and Bentley 2009). Yra1 is transferred from 
Pcf11 to the mRNA export adaptor Sub2, which liberates Pcf11 for interaction with 3′ end processing complex. 
Phospho-Ser2 is necessary also for the recruitment of shuttling mRNA-binding protein Npl3. Among other 
functions, Npl3 prevents early termination (Bucheli and Buratowski 2005; Bucheli et al. 2007). Npl3 
phosphorylation during transcription gradually leads to the loss of its anti-termination activity, leading to 
cleavage and polyadenylation factor (CPF) association at the 3′ end (Dermody et al. 2008). During 3′ end 
formation, CPF component Glc7 dephosphorylates Npl3 which promotes Npl3 interaction with the mRNA 
export receptor Mex67 and subsequent mRNP export (Wendy Gilbert and Guthrie 2004). The THO complex 
plays a crucial role in co-transcriptional mRNA export factor recruitment and mature mRNP release form 
transcription site, as indicated by the impairment of these processes in tho mutant yeast strains. The first step 
in Mex67 recruitment to mRNA is likely mediated by THO component Hpr1. Ubiquitination of Hpr1 during 
transcription elongation directly recruits Mex67 to the active genes (Gwizdek et al. 2006). Mex67 is loaded 
together with its adaptors onto the mRNP during 3′ end formation. Three proteins – Yra1, Npl3 and Nab2 – 
have been shown to function as Mex67 adaptors. However, at the moment it is not clear if Mex67 would be 
loaded onto mRNA in a complex with all three adaptors or with only a subset of them (Kim Guisbert et al. 2005; 
D. M. Green et al. 2002; Hieronymus and Silver 2003).  CTD – C-terminal domain, NPC – nuclear pore complex, 
RNA Pol II – RNA polymerase II, P – phosphorylation, Pi – dephosphorylation, Ub – ubiquitin. Figure modiefied 
after (Tutucci and Stutz 2011).  
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The SR-like protein Npl3 is an abundant shuttling RBP that plays a role in a wide range 
of processes including mRNA transcription elongation, termination/3′ end processing (Wong et 
al. 2007; Dermody et al. 2008; Bucheli and Buratowski 2005; Bucheli et al. 2007), splicing (Kress, 
Krogan, and Guthrie 2008), export (Windgassen and Krebber 2003; Singleton et al. 1995; M. S. 
Lee, Henry, and Silver 1996) and translation (Windgassen et al. 2004).  Npl3 directly interacts 
with Pol II CTD via phosphorylated Ser2  and promotes both transcription (Dermody et al. 
2008) and co-transcriptional splicing factor recruitment (Kress, Krogan, and Guthrie 2008) (Fig. 
1). During transcription elongation Npl3 also prevents early termination (Bucheli et al. 2007; 
Bucheli and Buratowski 2005) but this activity is gradually lost due to Npl3 phosphorylation, 
which leads to the recruitment of cleavage and polyadenylation factor (CPF) at the 3′ end 
(Dermody et al. 2008). Npl3 dephosphorylation by CPF component Glc7 elegantly links 3′ end 
processing to mRNA export receptor Mex67 loading (Wendy Gilbert and Guthrie 2004). 
Namely, Npl3 dephosphorylation by Glc7 enables Npl3 to act as an mRNA export adapter 
protein by promoting its direct binding to Mex67 and mature mRNP nuclear export. In the 
cytoplasm Npl3 is rephosphorylated, which leads to its release form the mRNP and nuclear re-
import (W Gilbert, Siebel, and Guthrie 2001). 
In addition to Npl3, Sub2 and the THO complex also have a clear role in 3′ end 
processing and mRNP release form the transcription site. In tho/sub2 mutants the 3′ end of the 
HSP104 locus is trapped in a dense chromatin fraction that besides the gene’s 3′ region also 
contains RNA, Pol II, pre-mRNA 3′ end processing machinery and nuclear pore complex (NPC) 
components (Rougemaille et al. 2008). In the same study 3′ regions of nearly 400 yeast genes were 
found to be associated with dense chromatin in tho mutants. These results suggest that THO and 
Sub2 are required to dissociate the 3′ end processing machinery and to release the export 
competent mRNP form the transcription site. Remarkably, transcription site release seems to 
take place in close proximity to NPC that could further facilitate mRNP export (Rougemaille et 
al. 2008). 
 
 
mRNP export form nucleus 
Mature mRNPs are exported through the nuclear pore complexes to the cytoplasm. The yeast 
NPC contains about 30 different proteins termed nucleoporins (Nups).  The central NPC 
transport channel is filled and surrounded with Nups containing domains rich in phenylalanine 
(F) and glycine (G) (FG-Nups), which create a physical barrier for macromolecules larger than 
about 40 kDa (reviewed in Terry and Wente 2009). This barrier is overcome by cargo export 
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receptors by binding to FG-repeats. At the nuclear side of the NPC eight filaments, connected by 
a ring at the end, reach into the nucleoplasm and form a structure termed the nuclear basket 
(Kiseleva et al. 2004; Ris and Malecki 1993). The filaments reaching into the cytoplasm are not 
connected to each other and are therefore highly mobile (Kiseleva et al. 2004).  
mRNP export starts at the nuclear basket where export competent mRNPs can 
concentrate using multiple mechanisms (Fig. 2). In yeast, TREX-2 complex, which is composed 
of Sac3, Thp1, Sus1 and Cdc31(Rodríguez-Navarro et al. 2004; T. Fischer et al. 2002), has been 
shown to mediate the repositioning of actively transcribed GAL genes from the nuclear interior 
to the NPC (Rodríguez-Navarro et al. 2004; Cabal et al. 2006). Subsequent production of mRNA 
in close vicinity to NPC is likely to increase mRNP export efficiency. TREX-2 mediates the 
repositioning of active genes to the nuclear pores through binding to both the nuclear basket and 
to the SAGA transcriptional co-activator complex (Brownell et al. 1996; Grant et al. 1997). 
TREX-2 component Sac3 tethers TREX-2 to the nuclear basked through interactions with 
nucleoporins Nup1 and Nup60 (T. Fischer et al. 2002). Sus1, which is a functional component of 
both the SAGA and TREX-2 complexes, binds to Sac3, thereby anchoring active genes to 
nuclear pores (Cabal et al. 2006; Rodríguez-Navarro et al. 2004; Jani et al. 2009).  However, 
TREX-2 does not seem to comprise the only link between sites of active transcription and 
nuclear pores. Nuclear basket-associated proteins Mlp1 and Mlp2, which, similarly to Sac3, bind 
this structure via Nup60 (Feuerbach et al. 2002), have been shown to physically associate with 
SAGA components on transcriptionally active GAL genes (Luthra et al. 2007). In addition to 
physically linking sites of active transcription to nuclear pore, Mlp1 can also facilitate the docking 
of export competent mRNPs at the nuclear basket. Namely, the protein has been shown to 
interact with Nab2 (Fasken, Stewart, and Corbett 2008). The existence of a complex web of 
protein-protein interactions at the nuclear basket is further emphasized by the finding that Mex67 
can interact with Sac3 both in vivo and in vitro (T. Fischer et al. 2002). 
The phenomenon of actively transcribed gene docking at NPC is thus far well 
documented only for S. cerevisiae. However, the evolutionary conservation of SAGA (Brand et al. 
1999; Martinez et al. 2001), TREX-2 (Jani et al. 2012) and the NPC including the Mlp proteins 
(Mendjan et al. 2006; Strambio-de-Castillia, Blobel, and Rout 1999) suggests that the mechanism 
could exist also in higher eukaryotes. Indeed, SAGA has been shown to function in anchoring of 
a subset of active transcription sites to the nuclear pores in Drosophila melanogaster (Kurshakova et 
al. 2007). 
In vivo imaging of single endogenous mRNPs in mammalian cells has revealed that mRNA 
export contains three basic steps: docking, transport and release (Grünwald and Singer 2010). 
Surprisingly, transport through the NPC central channel is a very rapid process and is completed 
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in less than 20 ms. Most of the about 200 ms needed for export, the mRNP spends equally 
between the docking and the release phase (Schmitt et al. 1999). mRNA export directionality is 
likely achieved by mRNP reorganization at the cytoplasmic face of the NPC. One protein 
implicated in this processed is the conserved RNA helicase Dbp5 (also known as Rat8) (Schmitt 
et al. 1999; Snay-Hodge et al. 1998; Tseng et al. 1998) (Fig. 2). Dbp5 is a shuttling protein 
(Estruch and Cole 2003; Zhao et al. 2002; Hodge et al. 1999) that at steady state locates at the 
cytoplasmic filaments of the NPC (Weirich et al. 2004; Hodge et al. 1999; Schmitt et al. 1999). 
The low intrinsic RNA-dependent ATPase activity of Dbp5 (Tseng et al. 1998) is greatly 
stimulated at the cytoplasmic filaments upon interaction with Gle1. Inositol hexakisphosphate 
binding to Gle1 has been shown to enhance Gle1-mediated stimulation of Dbp5 ATPase activity 
(Weirich et al. 2006; Alcázar-Román et al. 2006). Even though there is no clear consensus about 
how Dbp5 activity results in mRNP remodelling (reviewed in Linder 2008), the protein has been 
shown to facilitate the removal of export factors such as Mex67 (Lund and Guthrie 2005) and 
Nab2 (Tran et al. 2007). 
 
 
 
Figure 2. Anchoring of active genes to nuclear pore complex (NPC) and mRNP remodelling upon export. 
Active genes can be docked at the NPC by a four subunit protein complex termed TREX-2 or by Mlp proteins. 
TREX-2 bridges the interaction between nucleoporins (Nups) of the nuclear basket and the SAGA transcriptional 
co-activator complex (T. Fischer et al. 2002; Jani et al. 2009). Another link between SAGA and NPC is provided 
by NPC-associated proteins Mlp1 and Mlp2 (Luthra et al. 2007) (represented by dotted lines). Export 
competent mRNP docking at the NPC can be mediated by Nab2, which has been shown to interact with Mlp1 
(Fasken, Stewart, and Corbett 2008), and by Sac3, which can bind Mex67 (T. Fischer et al. 2002) (represented 
by dotted line). mRNA export leads to mRNP remodelling. An important player in this process, the RNA helicase 
Dbp5, is loaded onto the mRNP in the nucleus. Dbp5 ATPase activity is greatly stimulated at the cytoplasmic 
face of the NPC by Gle1 bound to inositol hexakisphosphate (IP6) (Weirich et al. 2006; Alcázar-Román et al. 
2006). Dbp5 activation results in mRNP remodelling, leading to the dissociation of mRNA export factors such as 
Mex67 and Nab2 (Lund and Guthrie 2005; Tran et al. 2007). Figure modified after (Iglesias et al. 2010) and 
(Köhler and Hurt 2007). 
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Nuclear mRNP quality control 
Formation of a mature, export-competent mRNP is a multistep process where each mRNP 
maturation reaction is inherently error-prone. Functional coupling of the different mRNP 
biogenesis steps helps cells to monitor the overall accuracy of the process. The crosstalk between 
proteins involved in mRNP maturation and quality control leads to the destruction, nuclear arrest 
or transcriptional downregulation of aberrant transcripts. 
mRNA degradation is the best studied nuclear mRNP quality control mechanism (Fig. 3). 
The first ribonucleolytic activity identified in this cellular compartment belongs to the multi-
subunit exosome complex (P. Mitchell et al. 1997; Bousquet-Antonelli, Presutti, and Tollervey 
2000). The eukaryotic nuclear exosome is composed of 9 core subunits forming a barrel-like 
structure, and two enzymatically active subunits.  3′→5′ exonuclease activity of the exosome in S. 
cerevisiae is provided by Dis3 (also known as Rrp44) (Allmang et al. 1999; Dziembowski et al. 
2007) and Rrp6 (Allmang et al. 1999; Liu, Greimann, and Lima 2006). Dis3 also displays 
endonucleolytic activity (Schaeffer et al. 2009; Schneider et al. 2009; Lebreton et al. 2008). mRNA 
degradation by exosome is stimulated by the TRAMP (Trf4/5-Air1/2-Mtr4) polyadenylation 
complex, which marks aberrant transcripts for degradation by adding a short poly(A) tail that 
facilitates exosome recruitment (LaCava et al. 2005; Wyers et al. 2005). Functional exosome is 
required for the rapid degradation of unspliced pre-mRNAs (Bousquet-Antonelli, Presutti, and 
Tollervey 2000), mRNAs with defective poly(A) tails (Milligan et al. 2005; Burkard and Butler 
2000; Libri et al. 2002)  and nucleus-restricted mRNAs upon mRNA export block (Biswadip Das, 
Butler, and Sherman 2003). In addition, catalytically active exosome is also involved in transcript 
retention at the site of synthesis observed in mRNA export deficient yeast strains (Assenholt et 
al. 2008). Interestingly, this phenotype is not dependent on the exosome co-factor TRAMP, 
indicating a functional difference between the two complexes (Rougemaille et al. 2007). 
The other main ribonucleolytic activity in the cell nucleus is provided by 5′→3′ 
exonuclease Rat1. Together with its co-factor Rai1, Rat1 is implicated in transcription termination 
of RNA Pol II (West, Gromak, and Proudfoot 2004; M. Kim et al. 2004) as well as RNA Pol I 
(Kawauchi et al. 2008; El Hage et al. 2008). According to the “torpedo” model of transcription 
termination, Rat1 attacks the 5′ end formed after pre-mRNA cleavage by the 3′ end processing 
machinery and degrades the RNA produced by Pol II downstream of the polyadenylation site, 
causing Pol II to terminate (Connelly and Manley 1988; Luo, Johnson, and Bentley 2006). In 
nuclear RNA quality control Rat1 is needed for the 5′→3′ exonucleolytic degradation of 
unsuccessfully capped mRNAs (Jiao et al. 2010; Jimeno-González et al. 2010). The substrate for 
Rat1-mediated mRNA decay, 5′-monophosphorylated RNA, is generated by Rat1 co-factor Rai1 
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by removing the unmethylated cap or by hydrolyzing the 5′ end triphosphate of an uncapped 
RNA (Xiang et al. 2009; Jiao et al. 2010).  
 
 
 
Figure 3. mRNA degradation during nuclear mRNA quality control. Defects in pre-mRNA processing to 5′ 
capped, spliced and polyadenylated mature transcripts or in mRNA export result in nuclear retention, 
transcriptional downregulation or degradation of these transcripts. Nuclear mRNA degradation involves 5′→3′ 
and 3′→5′ exonucleolytic, as well as endonucleolytic cleavage. The 5′→3′ degradation pathway is responsible 
for the removal of mRNAs with aberrant 5′ ends. Rai1 removes the non-methylated cap structure or hydrolyzes 
the 5′ triphosphate of an uncapped RNA to leave 5′-monophosphorylated RNA, which can then act as a 
substrate for Rat1 5′→3′ exoribonuclease. The 3′→5′ degradation is involved in the surveillance of proper 
mRNA 3′ end formation. Inefficient plyadenylatation by poly(A) polymerase 1 (Pap1) due to defective splicing 
or 3′ end processing results in the addition of a short poly(A) tail by the non-canonical poly(A) polymerase of 
the TRAMP complex. TRAMP then recruits the nuclear exosome, leading to rapid mRNA degradation form the 
3′ end. The exosome contains nine conserved core subunits plus two 3′→5′ exonucleases, Dis3 and Rrp6. Dis3 
also harbours endonucleolytic activity. CBC – cap binding complex. Figure modified after (Tutucci and Stutz 
2011).  
 
Nuclear mRNA quality control does not reduce the level of aberrant transcripts only by 
mRNA degradation. Non-optimal mRNP formation can have a direct negative effect on 
transcriptional rates. Evidence for that has come both from the analysis of defective splicing and 
mRNA export. In the mammalian system promoter-proximal 5′ splice site mutation has been 
shown to strongly reduce the steady state levels of the mRNA in an mRNA decay-independent 
fashion (Damgaard et al. 2008; Furger et al. 2002). As U1 snRNA can interact both with the 5′ 
splice site (Massimo Caputi et al. 2004; Kammler et al. 2001) and TFIIH (Kwek et al. 2002), it has 
been suggested to stimulate transcription initiation by enhancing pre-initiation complex assembly 
(Damgaard et al. 2008). Transcriptional downregulation upon promoter proximal 5′ splice site 
mutation could therefore be an outcome of this disrupted communication. Similarly to the 
mammalian system, the removal of a promoter proximal intron in yeast reduces transcription 
levels of the gene (Furger et al. 2002). How does a cells profit form transcriptional 
downregulation of aberrant mRNAs? The answer could lie in the observation that artificially 
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reduced transcription rates in tho/sub2 mutants can suppress several associated phenotypes (T H 
Jensen, Boulay, et al. 2001; Torben Heick Jensen et al. 2004). This finding suggests that under 
challenging conditions mRNP assembly efficiency can be increased by reducing the production 
level of aberrant mRNAs. 
 
 
mRNP cytoplasmic destiny 
 
Translation is accompanied by mRNP remodelling 
In rapidly growing S. cerevisiea cells most newly exported mRNPs will be immediately engaged in 
translation in the cytoplasm (Arava et al. 2003). Translation is accompanied by major changes in 
mRNP composition, which involves the dissociation of several nuclear-acquired proteins as well 
as the recruitment of the elongation-competent 80S ribosome. Translation-accompanied changes 
in mRNP composition not only enable bulk protein synthesis but also ensure the quality of gene 
expression through translation-dependent mRNA surveillance pathways (reviewed in Maquat, 
Tarn, and Isken 2010; Isken and Maquat 2007). Nuclear-acquired proteins that travel with the 
mRNA to the cytoplasm include the nuclear cap-binding complex, PABP and, in case of 
mammalian pre-mRNAs subjected to splicing, the exon-junction complex (EJC) deposited ~20-
24 nucleotides (nt) upstream of exon-exon junctions. The newly exported mRNPs seem to 
acquire a set of proteins characteristic for mRNAs involved in steady-state translation 
predominantly by the end of the first or the so-called “pioneer” round of translation (Gehring et 
al. 2009; Sato and Maquat 2009; Hosoda, Lejeune, and Maquat 2006; Ishigaki et al. 2001; S.-Y. 
Chiu et al. 2004). In mammalian cells, where translation-dependent mRNP remodelling has been 
extensively studied, these changes include the replacement of CBP80-CBP20 heterodimer with 
eukaryotic translation initiation factor 4E at the 5′ cap, the exchange of nuclear poly(A) binding 
protein PABPN1 by cytoplasmic PABPC1 and the removal of EJCs (Sato and Maquat 2009; 
Gehring et al. 2009; Dostie and Dreyfuss 2002; Lejeune et al. 2002).   
 
 
mRNP interactions in cap-dependent translation 
Besides the 79 proteins that are loaded onto the mRNA as part of the yeast 80S ribosome 
(reviewed in D. N. Wilson and Cate 2012), mRNA translation involves numerous accessory 
factors that participate in translation initiation, elongation, termination and ribosome recycling 
and interact with the mRNA either directly or indirectly through protein-protein interactions with 
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other components of the translation machinery (reviewed in R. J. Jackson, Hellen, and Pestova 
2010; Hinnebusch 2011; Dever and Green 2012). The largest number of accessory factors, at 
least 10, participate in translation initiation (reviewed in R. J. Jackson, Hellen, and Pestova 2010). 
Eukaryotic initiation factors (eIFs) help to separate the ribosomal subunits after translation 
termination, prepare the mRNA and the small (40S) ribosomal subunit for binding with each 
other and participate in locating the start codon and in subsequent large (60S) subunit joining 
with 40S, after which translation elongation can proceed (reviewed in R. J. Jackson, Hellen, and 
Pestova 2010; Hinnebusch 2011).  
The “end product” of translation initiation step is an elongation-competent 80S 
ribosome, which is defined by base-pairing between the mRNA’s start codon and the anticodon 
loop of the initiator methionyl tRNA (Met-tRNAi
Met) occupying the ribosomal peptidyl (P) site. 
The molecular events enabling elongation-competent 80S formation start with post-termination 
ribosome separation into free 40S and 60S subunits. After translation termination, the 80S 
ribosome remains bound to at least three factors: mRNA, P-site deacylated tRNA, and eukaryotic 
release factor (eRF) 1 and, possibly, eRF3 (Pisarev, Hellen, and Pestova 2007) (Fig. 4). At a low (1 
mM) free Mg2+ concentration, which enables greater flexibility of the ribosomal subunits (Shenvi 
et al. 2005), eIF3, eIF1 and eIF1A are sufficient to mediate ribosome recycling into free 40S and 
60S subunits (Pisarev, Hellen, and Pestova 2007; Pisarev et al. 2010). In vivo, however, efficient 
ribosome recycling likely needs an additional factor, ABCE1, which is an essential (Z.-Q. Chen et 
al. 2006; Dong et al. 2004) and highly conserved protein of the ATP-binding cassette (ABC) 
transporter superfamily (reviewed in Dean and Annilo 2005). Importantly, ABCE1 can mediate 
the separation of post-termination ribosomes into free 60S and mRNA- and tRNA-bound 40S 
subunits in a wide range of Mg2+ concentrations (Pisarev et al. 2010). The subsequent release of 
mRNA and deacylated tRNA from the 40S subunit is promoted by eIF3, eIF1 and eIF1A 
(Pisarev, Hellen, and Pestova 2007), which are recruited to the 40S subunit during ribosome 
recycling (reviewed in R. J. Jackson, Hellen, and Pestova 2010). All three eIFs remain associated 
with the released 40S subunit and participate in the following steps of translation initiation.  
The binding of eIF1 and eIF1A triggers a conformational change in 40S subunit that 
opens the mRNA binding channel – a change that is proposed to convert the “closed”, scanning-
incompetent 40S structure into an “open”, scanning-competent 43S pre-initiation complex (PIC) 
(Passmore et al. 2007). 43S pre-initiation complex contains besides the 40S subunit and the eIFs 
3, 1 and 1A also the eIF2-GTP- Met-tRNAi
Met ternary complex (TC), which delivers the initiator 
tRNA to the ribosomal P-site (Shin et al. 2011), and eIF5 (reviewed in R. J. Jackson, Hellen, and 
Pestova 2010; Hinnebusch 2011). Biochemical data indicate that eIF1- and eIF1A-induced 
conformational change enhances the rate of eIF2-GTP- Met-tRNAi
Met ternary complex binding to 
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40S, producing a 43S PIC capable of directly docking the mRNA into the mRNA binding 
channel during translation initiation (Passmore et al. 2007). It should be noted that in addition to 
the step-by-step association of eIFs with the 40S subunit, there is evidence for an alternative 
pathway for 43S PIC formation where eIFs 1, 3, 5, and the TC associate into a large multifactor 
complex (MFC) prior to binding to 40S subunit (K Asano et al. 2000; Sokabe, Fraser, and 
Hershey 2012; Dennis, Person, and Browning 2009). 
The 43S PIC is loaded onto the mRNA at the 5′ cap-proximal region and subsequently 
scans downstream the 5′ untranslated region (UTR) to locate the initiation codon (reviewed in R. 
J. Jackson, Hellen, and Pestova 2010; Hinnebusch 2011). 43S PIC is able to attach to an scan 
along an unstructured 5′ UTR (Tatyana V Pestova and Kolupaeva 2002; S. F. Mitchell et al. 
2010). However, attachment to an even weakly structured 5′ UTR depends on eIF4F and eIF4B 
or eIF4H that cooperate to unwind the 5′ cap-proximal region for 43S PIC loading and assist 43S 
PIC in scanning (Tatyana V Pestova and Kolupaeva 2002; S. F. Mitchell et al. 2010; Rogers et al. 
2001; Marintchev et al. 2009). eIF4F is composed of three proteins: (1) eIF4E, the cap-binding 
protein; (2) eIF4A, a DEAD-box RNA helicase; and (3) eIF4G, a large modular protein acting as 
a scaffold for the assembly of highly stable eIF4F at the mRNA’s 5′ end (reviewed in Prévôt, 
Darlix, and Ohlmann 2003; Hinnebusch 2011). eIF4G directly interacts with both eIF4E and 
eIF4A, thereby directing the RNA helicase to the cap-proximal region (J. D. Gross et al. 2003; 
Volpon et al. 2006; S. F. Mitchell et al. 2010; P. Schütz et al. 2008). Furthermore, the ATPase 
activity of eIF4A is stimulated upon binding to eIF4G (P. Schütz et al. 2008). The affinity of 
eIF4E for the cap structure is also enhances by eIF4G-eIF4E interaction (J. D. Gross et al. 
2003).  
Besides interacting with mRNA’s 5′ end, eIF4G also contacts the 3′ poly(A) tail via PABP, 
thereby physically linking the mRNA termini (E.-H. Park et al. 2011; Svitkin et al. 2009; Tarun et 
al. 1997; Craig et al. 1998; Le et al. 1997; AMRANI et al. 2008). The formation of a “closed-loop” 
structure is not absolutely required for translation in vivo as indicated by genetic analysis in S. 
cerevisiae (E.-H. Park et al. 2011; Tarun et al. 1997). However, eIF4G-PABP interaction is thought 
to promote 43S PIC attachment, and thus translation initiation, because it contributes to the 
stability of mRNA binding by eIF4F (reviewed in Hinnebusch 2011). In addition to participating 
in a network of interactions that stabilize eIF4F binding, eIF4G can promote translation 
initiation by directly recruiting 43S PIC to the mRNA. Namely, in mammalian cells eIF4G 
interacts with the 43S PIC component eIF3 (LeFebvre et al. 2006; Morino et al. 2000; Lamphear 
et al. 1995; Korneeva et al. 2000). In yeast, the interaction between the aforementioned proteins 
is bridged by eIF5 or eIF1, which simultaneously interact with both eIF4G and eIF3 (H. He et al. 
2003; Katsura Asano et al. 2001; S. F. Mitchell et al. 2010). 
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Figure 4. Model of eukaryotic translation initiation by ribosomal scanning. Translation initiation is a multitep 
process (single steps in blue type) that starts with the separation of post-termination ribosomal complexes into 
free 40S and 60S ribosomal subunits (shapes depicting ribosomal subunits correspond to crystal structures of 
bacterial 70S and 30S ribosomal species). Association of a subset of eukaryotic translation initiation factors 
(eIFs, dipicted as numbered shapes) and the eIF2-GTP- Met-tRNAi
Met  
ternary complex (TC) with 40S subunit 
results in the formation of 43S pre-initiation complex (PIC). eIFs and TC may be recruited to 40S subunit in a 
sequential manner or as a pre-formed multifactor complex. Association of eIF4F (eIF4E/eIF4G/eIF4A) with m
7
G 
cap and poly(A)-binding protein (PABP) with poly(A) tail activates mRNA for translation initiation – the DEAD-
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box RNA helicase eIF4A with eIF4B unwinds the mRNA to generate a single-stranded region at mRNA’s 5′ end, 
which is bound by 43S PIC. 43S PIC scans the 5′ UTR until initiation codon recognition and 48S PIC formation, 
which commits the ribosome to initiate at the selected start codon and is paralleled by Pi release from GDP•Pi-
bound TC and the dissociation of eIF1. Subsequent 60S subunit joining and the release of eIFs is catalysed by 
the GTPase eIF5B. eIF2-GDP is recycled to eIF2-GTP by eIF2B, the guanine nucleotide exchange factor for eIF2. 
For more details, see text. A – aminoacyl-tRNA binding site, P – peptidyl-tRNA binding site, E – deacylated-tRNA 
binding site (exit), GTP – green ball, GDP – red ball, Pi – inorganic phosphate. Figure modified from (Hinnebusch 
2011).  
 
Once loaded at the 5′ cap-proximal region, 43S PIC scans the mRNA in search of an 
initiation codon, which is commonly the first AUG triplet (reviewed in Hinnebusch 2011). 
During scanning the “open” conformation of 43S PIC is stabilized by eIF1 and eIF1A, thereby 
enabling 43S PIC to thread along the mRNA (Passmore et al. 2007). Perfect base-pairing between 
the initiation codon and the anticodon of Met-tRNAi
Met  leads to a conformational change in 40S 
subunit, which likely closes the mRNA binding channel to prevents further scanning, thereby 
forming 48S PIC (Passmore et al. 2007; Maag et al. 2005; Unbehaun et al. 2004). Subsequent 
dissociation of eIF1 from the pre-initiation complex allows the release of inorganic phosphate 
(Pi) from eIF2-GDP•Pi, which drives GTP hydrolysis by eIF2 to completion and commits the 
ribosome to initiate at the selected start codon (Unbehaun et al. 2004; Maag et al. 2005; Algire, 
Maag, and Lorsch 2005). eIF2-bound GTP hydrolysis is stimulated by eIF5, however, during 
scanning the reaction seems to be reversible because the presence of eIF1 on 43S PIC precludes 
the release of Pi (Algire et al. 2002; Algire, Maag, and Lorsch 2005). eIF1 thus ensures the fidelity 
of translation initiation by allowing irreversible eIF2-bound GTP hydrolysis only upon the 
establishment of codon-anticodon base-pairing (Algire, Maag, and Lorsch 2005).  
60S subunit joining is accompanied by eIF release from the small ribosomal subunit and 
is catalyzed by the ribosome-dependent GTPase eIF5B (T V Pestova et al. 2000; Fringer et al. 
2007). Efficient subunit joining depends on the interaction between eIF5B and the C-terminus of 
eIF1A. This interaction accelerates the rate of subunit joining and, after 60S recruitment, 
enhances  the GTP hydrolysis activity of eIF5B (Acker et al. 2006; Acker et al. 2009; Fringer et al. 
2007). GTP hydrolysis is required for the rapid release of eIF5B and eIF1A, thereby producing 
and elongation-competent 80S ribosome (Acker et al. 2009; J. H. Lee et al. 2002; Shin et al. 2002). 
eIF2-GDP dissociates from a small fraction of 48S complexes upon Pi release and its release is 
further promoted by eIF5B binding to 48S PIC (Pisarev et al. 2006). However, complete 
dissociation of eIF2-GDP from the small ribosomal subunits is paralleled by 60S subunit joining 
(Pisarev et al. 2006).  
In contrast to translation initiation, which is paralleled by the recruitment of a large 
number of initiation factors, translation elongation in most eukaryotes requires the association of 
only two factors with the ribosome. The GTP-bound eukaryotic elongation factor (eEF) 1A 
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delivers the aminoacyl-tRNA (aa-tRNA) to the ribosomal acceptor (A) site (reviewed in Rodnina 
and Wintermeyer 2001). Correct codon-anticodon base-pairing triggers GTP hydrolysis by 
eEF1A followed by the dissociation of eEF1A-GDP from the ribosome, which enables the aa-
tRNA to fully accommodate in the A-site. Subsequent peptide bond formation leaves a 
deacylated tRNA in the P-site and the newly formed peptidyl-tRNA in the A-site. Before the next 
round of translation elongation can proceed the ribosome needs to move by one codon on the 
mRNA, thereby placing the deacylated tRNA and the peptidyl-tRNA in ribosomal E- and P-sites, 
respectively, and the next codon in the A-site. Translocation is catalyzed by eEF2, which 
hydrolyzes GTP to enable ribosome movement (Taylor et al. 2007; VanLoock et al. 2000). A 
third elongation factor, eEF3, exists exclusively in fungi, where it mediates the release of 
deacylated tRNA from the E-site and the binding of eEF1A-GTP-aa-tRNA ternary complex to 
the A-site (Triana-Alonso, Chakraburtty, and Nierhaus 1995; Andersen et al. 2006).  
Translation is terminated after the entry of one of the three stop codons into the 
ribosomal A-site (reviewed in Kapp and Lorsch 2004). In eukaryots, this process is governed by 
two release factors, eRF1 and eRF3. eRF1 recognizes the three stop codons and catalyzes the 
hydrolysis of peptidyl-tRNA, whereas eRF3 strongly stimulates peptide release by eRF1 through 
GTP hydrolysis. According to the current model eRF1 and eRF3 are recruited to the ribosomal 
A-site in a ternary complex with GTP (Alkalaeva et al. 2006). Importantly, the interaction 
between eRF1 and eRF3 increases the affinity of eRF3 for GTP (Hauryliuk et al. 2006; Pisareva 
et al. 2006). eRF3’s GTPase activity is triggered upon binding to the ribosome and is thought to 
result in a conformational change in eRF1 that activates peptidyl-tRNA hydrolysis by eRF1 
(Frolova et al. 1996; Alkalaeva et al. 2006). Interestingly, in S. cerevisiae mRNA export factors 
Dbp5 and Gle1 together with inositol hexakisphosphate have been implicated in translation 
termination (Bolger et al. 2008; T. Gross et al. 2007). Both Dpb5 and Gle1 physically and 
genetically interact with release factors and have been proposed to participate in mRNP 
remodelling prior to termination (Bolger et al. 2008; T. Gross et al. 2007). However, the exact 
molecular mechanism how these factors promote efficient translation termination remains to be 
determined. 
 
 
Cytoplasmic mRNA decay 
Cytoplasmic mRNA degradation machinery serves two major functions: (1) it maintains normal 
mRNA decay rates and thereby regulates the abundance of functional proteins; (2) it performs 
mRNA quality control by eliminating aberrant mRNAs that otherwise could give rise to toxic 
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proteins (reviewed in Houseley and Tollervey 2009). The five hydrolytic activities participating in 
cytoplasmic mRNA decay mediate decapping at the 5′ end, 5′→3′ exonucleolytic decay, 
deadenylation of the 3′ poly(A) tail, 3′→5′ exonucleolytic decay and endonucleolytic cleavage 
within the transcript (reviewed in Schoenberg 2011; C.-Y. A. Chen and Shyu 2011; Ling, Qamra, 
and Song 2011). The accessibility of an mRNA to these activities is determined by the structure 
of the mRNP, i.e. the complement of mRNA associated RBPs and small non-coding RNAs. 
These mRNA-associated factors can regulate mRNA decay rates directly by promoting or 
hindering the recruitment of mRNA decay machinery, and indirectly by influencing the 
translational status and/or subcellular localization of the mRNA. Depending on the substrate and 
cellular conditions, mRNA decay can be initiated by deadenylation, decapping or endonucleolytic 
cleavage followed by exonucleolytic digestion (reviewed in Garneau, Wilusz, and Wilusz 2007).  
In order to give relevant background information for the experimental part of the thesis, 
this chapter will focus on deadenylation dependent mRNA decay and on mRNA quality control 
mechanism termed nonsense-mediated mRNA decay.  
 
Deadenylation dependent mRNA decay 
Deadenylation 
The initial and often rate-limiting step in most eukaryotic cytoplasmic mRNA degradation 
pathways is deadenylation (Muhlrad, Decker, and Parker 1994; M Tucker et al. 2001). The bulk 
poly(A)-specific 3′ exoribonuclease activity is provided by the evolutionarily conserved Pan2-
Pan3 and Ccr4-Not complexes in S. cerevisiae. In Pan2-Pan3 heterodimer both subunits are 
required for enzymatic activity even though the catalytic site is harboured by Pan2 (Boeck et al. 
1996; C E Brown et al. 1996). The deadenylase activity in the multisubunit Ccr4-Not complex 
resides in Ccr4 (Morgan Tucker et al. 2002; Goldstrohm et al. 2007) and, at least in metazoans, in 
Caf1 (also known as Pop2) (Moser et al. 1997; Temme et al. 2010; Cooke, Prigge, and Wickens 
2010; Viswanathan et al. 2004; Wagner, Clement, and Lykke-Andersen 2007). Studies in yeast 
have shown that Pan2-Pan3 complex is recruited to mRNA via the interaction between Pan3 and 
the major poly(A)-binding protein Pab1 (David A Mangus, Smith, et al. 2004), which leads to the 
activation of Pan2 exonuclease activity (Alan B. Sachs and Deardorff 1992; Lowell, Rudner, and 
Sachs 1992; David A Mangus, Evans, et al. 2004). Pan2-Pan3 is suggested to trim the initially 
synthesized ~90 nt long poly(A) tails to mRNA-specific lengths of ~55-70 nt (Christine E. 
Brown and Sachs 1998). The loss of Pan2-Pan3 activity has a modest effect on mRNA 
deadenylation and decay as only a slight increase in the average poly(A) tail length of total steady-
state mRNA was observed in pan2 and pan3 deletion strains (C E Brown et al. 1996). In contrast, 
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combining pan2 deletion with ccr4 deletion led to the loss of detectable mRNA deadenylation 
activity (M Tucker et al. 2001), indicating that Ccr4-Not complex is the predominant cytoplasmic 
poly(A) nuclease (Morgan Tucker et al. 2002; M Tucker et al. 2001; J. Chen, Chiang, and Denis 
2002). Unlike Pan2-Pan3, Ccr4-Not complex does not directly bind to Pab1 (Yao et al. 2007) and 
is instead selectively recruited to mRNA through the interaction with other RBPs (reviewed in 
Doidge et al. 2012). 
 
Decapping 
Deadenylated mRNAs can undergo further decay along two different routes. The unprotected 3′ 
end can be attacked by the cytoplasmic exosome, which degrades the mRNA body in 3′→5′ 
direction (reviewed in S. Lykke-Andersen et al. 2011). Alternatively, the mRNA can be decapped 
and degraded by the 5′→3′ exoribonuclease Xrn1 (reviewed in Jones, Zabolotskaya, and Newbury 
2012). In S. cerevisiae, the bulk mRNA seems to be degraded in the latter pathway (C. J. Decker 
and Parker 1993; Hsu and Stevens 1993). This is suggested by the findings that inactivation of 
decapping or 5′→3′ exonucleolytic decay leads to the accumulation of deadenylated full-length 
transcripts (Muhlrad, Decker, and Parker 1994; Beelman et al. 1996; Muhlrad, Decker, and Parker 
1995; Dunckley and Parker 1999). Such decay intermediates can be degraded, albeit slowly, in 
3′→5′ direction, indicating that in yeast the two decay pathways are, at least to some extent, 
redundant (Muhlrad, Decker, and Parker 1994; Muhlrad, Decker, and Parker 1995).  
In wild-type (wt) yeast cells the poly(A) tail is shortened to an oligo(A) length of ~12 nt 
before the mRNA can enter the decapping pathway (C. J. Decker and Parker 1993). The packing 
density of Pab1 on poly(A) tract is approximately one molecule per 25 A residues (Baer and 
Kornberg 1980; A. B. Sachs, Davis, and Kornberg 1987). The shortening of poly(A) tail below 
this length is likely to disrupt the communication between the 5′ cap and the 3′ poly(A) tail due to 
the loss of Pab1 (Tarun and Sachs 1996b; Tarun et al. 1997; Wells et al. 1998) and consequently 
lead to a decrease in translation initiation efficiency (Munroe and Jacobson 1990; Gallie 1991). 
Inefficient translation initiation enables the decapping machinery to gain access to the mRNA 
(Beelman and Parker 1994; D C Schwartz and Parker 2000; LaGrandeur and Parker 1999) as 
indicated by the findings that a stable secondary structure in the 5′ UTR (Muhlrad, Decker, and 
Parker 1995), a poor AUG context (LaGrandeur and Parker 1999) or mutations in the translation 
initiation factors increase in vivo mRNA decapping rates (David C. Schwartz and Parker 1999). 
The catalytic core of the evolutionarily conserved decapping complex is Dcp2 (Steiger et 
al. 2003; Deshmukh et al. 2008; van Dijk et al. 2002; Z. Wang et al. 2002), which in S. cerevisiae 
forms a holoenzyme with Dcp1 (Beelman et al. 1996; Dunckley and Parker 1999; Steiger et al. 
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2003). Kinetic studies have revealed that Dcp1 enhances the catalytic step (Deshmukh et al. 2008; 
Floor et al. 2010). Unexpectedly, the overexpressed human decapping enzymes DCP1A and 
DCP2 do not form a detectable complex in vivo (Fenger-Grøn et al. 2005) and the bacterially 
produced DCP1A is not capable to stimulate the activity of DCP2 in vitro (Jens Lykke-Andersen 
2002; van Dijk et al. 2002). This discrepancy from the results obtained in yeast was explained by 
the finding that the metazoan-specific protein Hedls (also known as Ge-1 and Edc4) promotes 
complex formation between Dcp2 and Dcp1 in human and in A. thaliana and that this interaction 
enhances the catalytic activity of Dcp2 (Fenger-Grøn et al. 2005; J. Xu et al. 2006; Chang et al. 
2014).  
 
Regulation of mRNA decapping. Decapping is an irreversible process that leads to the rapid 
degradation of the mRNA body and therefore this activity needs to be tightly regulated in cells. 
The mRNA specific decapping rates seem to be determined by two properties of individual 
mRNAs. Firstly, mRNA structural features that reduce translation initiation efficiency also 
increase deadenylation and decapping rates. As mentioned above, such features include a poor 
AUG context or a stable secondary structure in the 5′ UTR (Muhlrad, Decker, and Parker 1995; 
LaGrandeur and Parker 1999). Secondly, some mRNAs contain binding sites for regulatory 
proteins that can either stimulate or inhibit decapping (Olivas and Parker 2000; Mauchi, Ohtake, 
and Irie 2010).  
Considering the inverse correlation between translation initiation and decapping 
efficiency, translation initiation factors can be viewed as general decapping inhibitors. Indeed, the 
major cytoplasmic cap-binding protein eIF4E inhibits decapping in vitro due to its ability to bind 
the cap structure (D C Schwartz and Parker 2000; Ramirez et al. 2002) and mutations in the 
subunits of eIF4F or eIF3 complexes increase the rate of decapping (David C. Schwartz and 
Parker 1999; D C Schwartz and Parker 2000). Likewise, the poly(A) tail has a negative effect on 
decapping, which is partly mediated through Pab1 (C. J. Decker and Parker 1993; Caponigro and 
Parker 1995). General decapping activators, on the other hand, enhance decapping of both stable 
and unstable mRNAs. Such proteins can act by interfering with translation, by promoting the 
catalytic activity of Dcp2, or by directly binding to the mRNA and providing a scaffold for the 
assembly of the decapping machinery. In S. cerevisiae the core set of decappin activators includes 
Pat1, Dhh1, Scd6, Edc3 and Lsm1-7, which are all conserved proteins (Sundaresan Tharun et al. 
2000; Bonnerot, Boeck, and Lapeyre 2000; Bouveret et al. 2000; J. M. Coller et al. 2001; N. 
Fischer and Weis 2002; Decourty et al. 2008). 
Several decapping activators like the DEAD-box RNA helicase Dhh1, Pat1 and Scd6 
promote decapping indirectly through mRNA translational repression. Overexpression of these 
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proteins inhibits growth of yeast cells. Further analysis of cells overexpressing either Dhh1 or 
Pat1 revealed reduced rates of translation (J. Coller and Parker 2005; Nissan et al. 2010). 
Consistent with a role in translational repression, all three proteins repress translation in vitro by 
inhibiting the formation of a stable 48S PIC (J. Coller and Parker 2005; Nissan et al. 2010). In 
case of Scd6, further in vitro analysis showed that the protein inhibits translation by directly 
binding to eIF4G, which likely blocks the recruitment of 43S PIC to the mRNA (Rajyaguru, She, 
and Parker 2012). Interestingly, in vivo experiments indicate that Dhh1 is able to repress 
translation also after the initiation step. Namely, Dhh1 was found to repress translation at a step 
subsequent to initiation by slowing ribosome movement (Sweet, Kovalak, and Coller 2012). A 
reduction in ribosome transit rate is a potent activator of mRNA turnover as suggested by the 
finding that rare codons, which restrict ribosome elongation, in the open reading frame (ORF) of 
a reporter mRNA stimulated mRNA decapping in a Dhh1-dependent manner (Sweet, Kovalak, 
and Coller 2012).  
Pat1 is an exceptional protein among decapping activators because it can stimulate 
mRNA decapping both through indirect and direct mechanisms. Besides repressing translation, 
Pat1 act as a scaffold for the assembly of the decapping machinery and enhances the catalytic 
activity of Dcp2 (S Tharun and Parker 2001; Sundaresan Tharun et al. 2000; Bonnerot, Boeck, 
and Lapeyre 2000; Pilkington and Parker 2008; Nissan et al. 2010). Recombinant Pat1 directly 
interacts with Dhh1, Scd6, Lsm1-7 complex, Xrn1, Dcp1 and Dcp2 (Nissan et al. 2010) and has 
strong two-hybrid interactions with Edc3 (Pilkington and Parker 2008). The multitude of 
interactions with the decapping machinery suggests that Pat1 is a key protein in promoting 
decapping. Indeed, except for dcp1 and dcp2 deletion strains, which lack mRNA decapping 
activity, deletion of pat1 results in the strongest defect in decapping as compared to any other 
known mutation (S Tharun and Parker 1999; Dunckley and Parker 1999; Sundaresan Tharun et 
al. 2000; Bouveret et al. 2000; J. M. Coller et al. 2001; Kshirsagar and Parker 2004; Decourty et al. 
2008).  
Similarly to Pat1, Edc1, Edc2 and Edc3 directly bind Dcp1-Dcp2 decapping complex and 
stimulate its activity (D. Schwartz, Decker, and Parker 2003; Carolyn J Decker, Teixeira, and 
Parker 2007; Tritschler et al. 2007; Harigaya et al. 2010; Nissan et al. 2010; Borja et al. 2011). 
Unlike Pat1, however, the loss of these proteins does not cause defects in mRNA decay 
(Dunckley, Tucker, and Parker 2001; Kshirsagar and Parker 2004). Instead, Edc1, Edc2 and Edc3 
become necessary for mRNA decapping when the function of Dcp1 or Dcp2 is partially 
compromised due to mutations (Dunckley, Tucker, and Parker 2001; Kshirsagar and Parker 
2004). Besides interacting with the decapping enzymes, Edc3 shows two-hybrid interactions with 
Pat1, Dhh1 and Lsm1-7 complex and has therefore been proposed to function as a scaffold for 
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the decapping mRNP assembly (Pilkington and Parker 2008; Fromont-Racine et al. 2000; Carolyn 
J Decker, Teixeira, and Parker 2007).  
Co-immunoprecipitation experiments combined with RNase treatment, which enables to 
determine the RNA-dependence of the interactions, have helped to shed light on the dynamics of 
decapping mRNP assembly. Pat1, for instance, associates in an RNase-sensitive manner with 
eIF4E, eIF4G and Pab1, suggesting that Pat1 can bind to the mRNA when it still has a 
functional poly(A) tail (S Tharun and Parker 2001). Lsm1-7 complex, on the other hand, has been 
found to preferentially interact with deadenylaed mRNAs (S Tharun and Parker 2001). 
Consistent with the loss of the poly(A) tail, eIF4E, eIF4G and Pab1 do not co-
immunoprecipitate with Lsm proteins (S Tharun and Parker 2001). Instead, Lsm1-7 complex 
associates in an RNA-dependent manner with Dcp1-Dcp2 (Sundaresan Tharun et al. 2000). 
These results imply that Pat1 and Lsm1-7 bind to mRNAs destined for decay at different times. 
However, once both Pat1 and Lsm1-7 are present on the mRNA they seem to form a stable 
complex as suggested by the finding that Pat1 co-immunopreciptiates with Lsm proteins in an 
RNase-insensitive manner (Sundaresan Tharun et al. 2000; S Tharun and Parker 2001). 
According to the current model the interaction of Pat1 with Lsm1-7 complex results in the 
formation of a binding site for Dcp2 in the C-terminal domain of Pat1 and subsequent activation 
of decapping (reviewed in Parker 2012).  
The binding efficiency of Lsm1-7 has been proposed to be the key factor in determining 
if an mRNA will be degraded in 5′→3′ or in 3′→5′ pathway (reviewed in Sundaresan Tharun 
2009). Remarkably, Lsm1-7 shows a strong binding preference for oligoadenylated mRNAs over 
polyadenylated mRNAs (S Tharun and Parker 2001; Chowdhury, Mukhopadhyay, and Tharun 
2007). Mutations in LSM1 gene that abolish the preferential binding of the Lsm1-7 complex to 
oligoadenylated mRNA impair mRNA decay (Sundaresan Tharun et al. 2005). These 
observations suggest that the Lsm1-7 complex can act as a sensor of the poly(A) tail length and 
that this ability is essential for efficient mRNA decay in vivo. Consistent with Lsm1-7 binding 
preference for oligo(A) tail, unadenylated mRNAs that are generated in vivo by ribozyme cleavage 
are not good substrates for Lsm1-7 mediated 5′→3′ decay (Chowdhury and Tharun 2008). 
Instead, such mRNAs are efficiently degraded by the exosome in the 3′→5′ decay pathway 
(Chowdhury and Tharun 2008; Meaux and Van Hoof 2006). It is therefore conceivable, that 
mRNAs that escape binding by the Lsm1-7 complex at an oligo(A) tail stage are fully 
deadenylated and subsequently degraded by the exosome (Sundaresan Tharun 2009). 
 
The relationship between mRNA decapping and P-bodies. mRNA decay intermediates 
together with proteins involved in decapping and, to a lesser extent, deadenylation can be found 
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in cytoplasmic aggregates known as processing bodies (P-bodies) (Sheth and Parker 2003; 
Teixeira and Parker 2007). Therefore, P-bodies have been proposed to be the actual sites of 
mRNA decapping (reviewed in Parker and Sheth 2007; Franks and Lykke-Andersen 2008). The 
extent of P-body assembly correlates with the cellular concentration of non-translating mRNPs 
(reviewed in Franks and Lykke-Andersen 2008). For instance, P-bodies increase in number and 
size when translation initiation is inhibited by cellular stress or mutations in translation initiation 
factors (Teixeira et al. 2005). Conversely, trapping the mRNA in polyribosomes by blocking 
translation elongation leads to the disappearance of visible P-bodies (Teixeira et al. 2005; Sheth 
and Parker 2003). The assembly of decapping mRNPs into macroscopically visible P-bodies, 
however, is not necessary for efficient mRNA decay, as the deletion of proteins or protein 
domains involved in individual mRNP aggregation into P-bodies does not substantially reduce 
mRNA turnover rates (Carolyn J Decker, Teixeira, and Parker 2007; Reijns et al. 2008). The 
functional significance of P-body formation remains therefore elusive, although the evolutionary 
conservation of the mechanism argues for an adaptive advantage. Blocking mRNA decapping or 
5′→3′ degradation results in an increase in P-bodies, suggesting that aggregation of individual 
mRNPs into P-bodies might facilitate mRNA decay under conditions where mRNA decay 
factors are limited (Sheth and Parker 2003; Andrei et al. 2005; Cougot, Babajko, and Séraphin 
2004; Teixeira and Parker 2007). Sequestration of decapping mRNPs into P-bodies might also 
help to avoid aberrant mRNA decapping by physically separating non-translating mRNPs from 
translating mRNPs (reviwed in Franks and Lykke-Andersen 2008). 
 
 
3′→5′ mRNA decay 
As mentioned above, deadenylated mRNAs can also be degraded in 3′→5′ direction by the 
cytoplasmic exosome. The catalytically inactive 9-subunite exosome core (Exo9), which is 
identical between the nuclear and cytoplasmic versions of the exosome (Hernandez et al. 2006), is 
associated with one enzymatically active protein in the cytoplasm – Dis3 (Dziembowski et al. 
2007; Allmang et al. 1999). Biochemical and structural studies suggest that RNA substrates reach 
the exoribonucleolytic site of Dis3 after having been threaded through the central channel of 
Exo9 (Bonneau et al. 2009; Malet et al. 2010). The length of the RNA binding path in Exo9 
central channel is 31-33 nt (Bonneau et al. 2009). Consequently, only RNAs with a 3′ single 
stranded region longer than 31-33 nt are efficient degraded by the cytoplasmic exosome 
(Lorentzen et al. 2008; Liu, Greimann, and Lima 2006; Bonneau et al. 2009). Dis3 also contains 
an endoribonucleolytic site, which, unlike the exoribonucleolytic site,  is accessible from solvent 
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and does not depend on substrate threading through the Exo9 central channel (Bonneau et al. 
2009).  
The cytoplasmic exosome functions together with Ski proteins as indicated by the 
findings that in yeast strains where 5′→3′ mRNA decay is blocked in cis, the loss of any of the 
four Ski proteins leads to the stabilization of mRNA 3′ end fragments (J. S. Anderson and Parker 
1998; A van Hoof et al. 2000). The evolutionarily conserved Ski2, Ski3 and Ski8 proteins (Orban 
and Izaurralde 2005) form a complex (J. T. Brown, Bai, and Johnson 2000; L. Wang, Lewis, and 
Johnson 2005) that in S. cerevisiae is recruited to the exosome via Ski7, which is a yeast-specific 
protein (Orban and Izaurralde 2005) that directly binds to the exosome (Araki et al. 2001; Ambro 
van Hoof et al. 2002). Ski2 belongs to the DExH family of RNA helicases and could therefore 
mediate ATP-dependent RNA unwinding and mRNP remodelling before the substrate is 
delivered to the exosome (Halbach, Rode, and Conti 2012). This notion is supported by recent 
biochemical data suggests that Ski complex forms a continuous RNA channel to the exosome, 
thereby coupling the RNA helicase and the exoribonuclease (Halbach et al. 2013). The RNA 
helicase activity seems to play an important role in exosome-mediated mRNA decay since also 
the TRAMP complex, which regulates the activity of the nuclear exosome (Jia et al. 2012; Jia et al. 
2011), contains a Ski2-related RNA helicase Mtr4 (Halbach, Rode, and Conti 2012). 
 
 
Cytoplasmic mRNA quality control  
Cytoplasmic mRNA quality control mechanisms target mRNAs with defects in translation. The 
three types of translational defects that trigger mRNA decay include: (1) aberrant translation 
termination due to a premature translation termination codon in the protein coding region; (2) 
translation into 3′ poly(A) tail due to the absence of a stop codon; and (3) stalled translation 
elongation due to a barrier for ribosome progression. Each of the defects activates a specific 
mRNA decay pathway that have been reviewed in (Isken and Maquat 2007; Parker 2012). A 
common theme among these decay pathways seems to be how aberrant mRNAs are 
distinguished from normal transcripts. Namely, mRNA translational defects lead to the 
recruitment of adaptor proteins that interact with the translation machinery and direct the mRNA 
into a decay pathway (reviewed in Doma and Parker 2007).  
 
Nonsense-mediated mRNA decay 
The best studied translation-dependent mRNA quality control mechanism is nonsense-mediated 
mRNA decay (NMD), which targets mRNAs with nonsense codons in the protein coding region 
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in organisms ranging from yeast to human (reviewed in Kervestin and Jacobson 2012). Such 
nonsense codons are referred to as premature termination codons (PTCs) and they can arise in 
any gene due to gene mutations and errors in mRNA transcription and splicing (Massimo Caputi, 
Kendzior, and Beemon 2002; Sayani et al. 2008; Mort et al. 2008). If translated, PTC-containing 
mRNAs can produce truncated proteins with dominant negative or gain-of-function potential, as 
illustrated by truncated β-globine, which causes a dominant negative form of β-thalassemia in 
humans (Thein et al. 1990; Hall and Thein 1994). Therefore, the purpose of NMD seems to be to 
protect cells from the potentially toxic effects of mistakes that routinely occur during gene 
expression (reviewed in Isken and Maquat 2007). It is important to note, however, that in case of 
human genetic disease efficient NMD can also lead to haploinsufficiency because truncated 
proteins, which otherwise would retain sufficient wt function, are not produced (reviewed in J T 
Mendell and Dietz 2001; Peixeiro, Silva, and Romao 2011).   
 
NMD targets and the mechanism of their recognition. Nonsense mutations are likely to arise 
only at a low frequency during gene expression (Korona, LeCompte, and Pursell 2011; M. J. 
Thomas, Platas, and Hawley 1998; Lynch 2010). Therefore, the presence of NMD pathway in all 
eukaryotes examined to date suggests that mRNAs, which contain PTCs introduced by 
mutations, are not the only targets of NMD (Baserga and Benz 1988; Brogna 1999; Isshiki et al. 
2001; Leeds et al. 1991; Cali and Anderson 1998). Indeed, genome wide studies in yeast, worm, 
fruitfly, plant and human have revealed that NMD regulates the expression of many physiological 
non-mutated transcripts (Lelivelt and Culbertson 1999; Feng He et al. 2003; Joshua T Mendell et 
al. 2004; Rehwinkel et al. 2005; Wittmann, Hol, and Jack 2006; Ramani et al. 2009; Kurihara et al. 
2009; Chan et al. 2007). The physiological NMD substrates in yeast include unspliced pre-
mRNAs that contain nonsense codons in their introns (F He et al. 1993; Sayani et al. 2008), 
transcripts with upstream open reading frames (uORFs) (Gaba, Jacobson, and Sachs 2005; Guan 
et al. 2006) or alternative AUG initiation codons beyond the initiator AUG that are out of frame 
with the main ORF (Welch and Jacobson 1999), and transcripts that induce elongating ribosomes 
to shift the reading frame by one base in 5′ or 3′ direction and consequently direct the ribosomes 
to PTCs (Belew, Advani, and Dinman 2010). In higher eukaryotes alternative splicing contributes 
to the production of NMD substrates (reviewed in L. Huang and Wilkinson 2012; McGlincy and 
Smith 2008). Most PTC-containing alternative mRNA isoforms targeted by NMD are likely the 
result of splicing errors as suggested by their relatively low abundance and by the lack of tissue-
specific expression pattern (Pan et al. 2006). However, in case of a subset of PTC-containing 
alternative mRNA isoforms the NMD pathway is exploited to exert post-transcriptional gene 
expression regulation (reviewed in L. Huang and Wilkinson 2012; McGlincy and Smith 2008). A 
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remarkable example here is the SR family of splicing regulators, where the expression of all the 
family members is regulated by alternative splicing-coupled NMD (Lareau et al. 2007; J. Z. Ni et 
al. 2007; Saltzman et al. 2008). 
How do cells distinguish between a PTC and a normal translation termination codon? 
Experiments using mRNAs with artificially extended 3′ UTRs have helped to shed light on this 
question. Namely, in organisms ranging from yeast to human a normal translation termination 
codon can be recognized as premature when positioned too far upstream of the poly(A) tail 
(Muhlrad and Parker 1999; Amrani et al. 2004; Behm-Ansmant et al. 2007; Longman et al. 2007; 
Kertesz et al. 2006; Eberle et al. 2008; Bühler et al. 2006; G. Singh, Rebbapragada, and Lykke-
Andersen 2008). Conversely, PTC-containing mRNAs can be stabilized by positioning the 
poly(A) tail closer to the PTC either by deleting the coding region downstream of the PTC or by 
folding back the 3′ UTR (Peltz, Brown, and Jacobson 1993; Hagan et al. 1995; Eberle et al. 2008). 
These observations indicate that the local mRNP structure downstream of the site of translation 
termination is a critical determinant for PTC recognition. But how does the 3′ UTR regulate PTC 
recognition? Studies in yeast, fruitfly, plant and human cells have shown that NMD reporter 
transcripts can be stabilized by localizing poly(A)-binding protein close to the PTC, thereby 
mimicking a normal 3′ UTR (Amrani et al. 2004; Behm-Ansmant et al. 2007; Kerényi et al. 2008; 
Eberle et al. 2008; G. Singh, Rebbapragada, and Lykke-Andersen 2008). The inhibitory effect of 
PABP on NMD could be mediated by PABP’s role in normal translation termination. Both Pab1 
in yeast and PABPC1 in mammals have been shown to directly interact with eRF3 (Hoshino et 
al. 1999; Cosson et al. 2002). Furthermore, Pab1 overexpression promotes translation 
termination, whereas depletion of PABPC1 increases nonsense codon readthrough (Cosson et al. 
2002; Ivanov et al. 2008). Disrupted communication between PABP and eRF3 may therefore 
signal that the translation termination event is premature and lead to NMD activation (reviewed 
in Kervestin and Jacobson 2012). This notion is also supported by the finding that human β-globin 
mRNA effectively evades NMD if the PTC is located not more than 23 codons downstream of 
the initiator AUG (Inácio et al. 2004; Silva et al. 2006). NMD resistance of such transcripts was 
shown to depend on PABPC1 and eRF3 interaction, which likely facilitates normal translation 
termination at an AUG-proximal PTC (Peixeiro, Silva, and Romao 2011). However, NMD 
activation cannot solely be a consequence of a missing interaction between eRF3 and PABP as 
indicated by the findings that, at least in yeast cells, neither Pab1, mRNA poly(A) tail nor the 
Pab1-interacting domain of eRF3 are necessary for PTC-containing mRNA recognition and 
destabilization by NMD (Meaux, van Hoof, and Baker 2008; Kervestin et al. 2012).  
Even though the exact molecular mechanism involved in PTC recognition remains 
unknown, it has been convincingly shown that translation termination at a PTC is mechanistically 
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different form translation termination at a normal termination codon (Amrani et al. 2004; 
Peixeiro et al. 2011). The latter proceeds without ribosome pausing at the termination codon as 
primer extension inhibition assay, which identifies the position of single ribosomes on mRNA, 
failed to yield toeprint signals at normal yeast and mammalian termination codons (Amrani et al. 
2004; Peixeiro et al. 2011). In contrast, PTC-containing transcripts yielded toeprint signals 
corresponding to ribosomes stalled with nonsense codons occupying the ribosomal A-sites. 
Collectively, these data indicate that translation termination at a PTC is aberrant. It has been 
suggested that the inefficient release of eRF3 from a terminating ribosome, possibly due to the 
absence of PABP, could be the aberrant step in translation termination at a PTC, which leads to 
the activation of NMD pathway (reviewd in Kervestin and Jacobson 2012).  
 
NMD factors and consequences of their activation. In all eukaryotes studied to date NMD 
substrates are identified and eliminated through the recruitment of up-frameshift (Upf) proteins, 
Upf1 (also known as Nam7), Upf2 (also known as Nmd2) and Upf3 (Hodgkin et al. 1989; Leeds 
et al. 1991; F He and Jacobson 1995; F He, Brown, and Jacobson 1997; Perlick et al. 1996; Cui et 
al. 1995; J Lykke-Andersen, Shu, and Steitz 2000; Serin et al. 2001; Gatfield et al. 2003). Single 
deletion of any of the UPF genes in yeast inhibits NMD to the same extent as Δupf1-3, indicating 
that each of the Upf proteins is essential for NMD activation (F He, Brown, and Jacobson 1997). 
Besides Upf1-3, additional proteins participate in NMD activation in metazoans (reviewed in 
Isken and Maquat 2008; Isken and Maquat 2007; Kervestin and Jacobson 2012).  
The key effector of the NMD pathway appears to be Upf1, which is thought to link 
aberrant translation termination at a PTC to NMD activation. Specifically, in the absence of Upf1 
aberrant toeprints corresponding to ribosomes stalled at PTCs fail to accumulate, suggesting that 
Upf1 regulates the extent to which a ribosome remains associated with a PTC (Amrani et al. 
2004). A role of Upf1 in translation termination is also supported by the finding that Upf1 co-
immunoprecipitates with eRF3 and eRF1 (K Czaplinski et al. 1998; Ivanov et al. 2008; Kashima 
et al. 2006; W. Wang et al. 2001). Likewise, Upf2 and Upf3 co-immunoprecipitate with eRF3 but 
not with eRF1, indicating sequential assembly of the NMD machinery (W. Wang et al. 2001).  
Upf1 has an amino terminal cysteine-histidine-rich zinc-knuckle domain (CH domain) 
connected by a flexible linker to helicase motifs common to superfamily 1 nucleic acid helicases 
(Weng, Czaplinski, and Peltz 1996; Bhattacharya et al. 2000). Biochemical and structural analysis 
indicates that in the absence of Upf2, the CH domain enhances the extent of RNA binding by 
the catalytic ATP-dependent RNA helicase domain, thereby inhibiting the ATPase activity of 
Upf1 (Chamieh et al. 2008; Chakrabarti et al. 2011). These observations support a model for 
Upf1 activation during NMD where the formation of the “surveillance complex”, i.e. a complex 
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where the interaction of Upf1 and Upf3 is bridged by Upf2 (F He, Brown, and Jacobson 1997; 
Chamieh et al. 2008; Serin et al. 2001), reduces the extent of RNA binding by the Upf1 helicase 
domain and triggers its ATPase activity (Chakrabarti et al. 2011). However, it should be noted 
that data obtained by yeast two-hybrid and genetic analysis supports a contradicting model where 
Upf1 binding to its target mRNAs is stabilized, but not destabilizes, upon interaction with Upf2 
(Feng He, Ganesan, and Jacobson 2013). Despite no clear consensus about the mechanism of 
Upf2-mediated activation of Upf1 ATP-dependent RNA helicase activity, the latter activity is 
necessary for mRNP disassembly. Namely, it has been found that in HeLa cells that harbour 
UPF1 mutants, which fail to bind or hydrolyze ATP, partially degraded NMD target mRNAs 
accumulate in P-bodies in complex with NMD factors (Franks, Singh, and Lykke-Andersen 
2010). Upf1 has also been shown to play an important role in ribosome recycling at PTCs, 
thereby enabling subsequent rounds of translation (Ghosh et al. 2010). However, it remains to be 
determined if Upf1 ATPase activity is required for this process. 
How exactly is Upf1 recruited to NMD target mRNAs and how Upf1 recruitment is 
linked to NMD activation? These questions have primarily been studied in the mammalian 
system (reviewed in Popp and Maquat 2014; Schweingruber et al. 2013). On newly synthesised 
mRNAs UPF1 has been found to transiently or weakly interacts with nuclear cap-binding 
complex component CBP80 (Hwang et al. 2010). In the presence of a PTC, UPF1-CBP80 
interaction promotes UPF1 binding to eRF1-eRF3 complex at the terminating ribosome (Hwang 
et al. 2010). UPF1 binding to an NMD target is further enhanced by the presence of an EJC 
sufficiently downstream of the PTC (Kurosaki and Maquat 2013). The role of EJC in promoting 
UPF1 recruitment is likely related to EJC serving as a binding platform for UPF2 and UPF3, 
thereby facilitating UPF1-UPF2-UPF3 interaction (reviewed in Schweingruber et al. 2013; Popp 
and Maquat 2014), which leads to the activation of UPF1 helicase activity (Chakrabarti et al. 
2011) required for the destruction of NMD targets (Franks, Singh, and Lykke-Andersen 2010). 
Importantly, PTC-free mRNAs can be bound by UPF1, albeit less efficiently than their PTC-
containing counterparts (Hwang et al. 2010; Kurosaki and Maquat 2013). The critical determinant 
of whether an mRNA is subjected to NMD therefore cannot be the binding of UPF1 to an 
mRNA but rather seems to be the association of UPF1-UPF2-UPF3 proteins as part of the 
decay-inducing complex (reviewed in Schweingruber et al. 2013; Popp and Maquat 2014), which 
contains  the ribosome, the UPF2- and UPF3-associated EJC and several proteins including 
UPF1, eRF1 and eRF3 (Yamashita et al. 2009). However, it should be noted that EJCs are 
removed by the translating ribosome likely during the pioneer round of translation (Gehring et al. 
2009; Dostie and Dreyfuss 2002; Lejeune et al. 2002) but PTC-containing transcripts can be 
subjected to NMD also during subsequent rounds of translation, as indicated by the recent 
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finding that eIF4-bound mammalian mRNAs are not immune to NMD (Rufener and 
Mühlemann 2013; Durand and Lykke-Andersen 2013). These findings raise the question how 
UPF1-UPF2-UPF3 interaction occurs in the absence of an EJC further downstream of a PTC? 
In the absence of EJCs, UPF2 and UPF3 have been proposed to bind to ribosome-bound UPF1 
(reviewed in Stalder and Mühlemann 2008), which is “found” possibly by diffusion (reviewed in 
Schweingruber et al. 2013). 
Whereas Upf1-mediated NMD activation depends on translation, Upf1 binding to 
mRNA seems to be translation-independent. Global analysis of UPF1-mRNA interactions by UV 
cross-linking and immunoprecipitation combined with high-throughput sequencing has revealed 
that UPF1 associates with mRNAs prior to translation and is displaced by translating ribosomes 
from ORF sequences (Zünd et al. 2013; J. A. Hurt, Robertson, and Burge 2013).  
NMD activation results in the rapid degradation of PTC-containing mRNAs that in S. 
cerevisiae and also in mammalian cells can be initiated from both the 5′ and 3′ end of the mRNA 
(reviewed in Isken and Maquat 2007). In D. melanogaster, the first step in the degradation of 
nonsense mRNAs is generally an endonucleolytic cleavage event in the vicinity of the PTC 
(Gatfield et al. 2003). PTC-proximal endonucleolytic cleavage has also been reported for 
mammalian cells (Eberle et al. 2009). Remarkably, in S. cerevisiae decapping of NMD substrates 
does not depend on prior deadenylation, which is a notable difference from the general 
deadenylation-dependent mRNA decay pathway (Muhlrad and Parker 1994; Cao and Parker 
2003). Besides destabilization of PTC-containing mRNAs, NMD activation has also been 
suggested to lead to Upf1-dependent proteasom-mediated destruction of truncated proteins 
(Kuroha, Tatematsu, and Inada 2009). Even though the prevalence of NMD-coupled protein 
decay has yet to be determined (reviewed in Parker 2012), it is tempting to speculate that this 
mechanism has an important role in protecting cells from potentially toxic proteins derived from 
nonsense mRNAs (Kuroha, Tatematsu, and Inada 2009). 
 
 
RNA-based RNP affinity purification 
 
Isolation of ribonucleoprotein particles (RNPs) has provided valuable knowledge about RNA-
protein interactions, which, in turn, has led to a better understanding of post-transcriptional gene 
expression regulation. Multiple methods have been developed to isolate RNPs. However, two 
general approaches exist – RNP capture via the protein or via the RNA component of the 
complex.  With a focus on the technical aspects, the following chapter will give an overview 
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about RNP affinity purification methods that relay on the capture or the RNA component of the 
RNP. 
RNA-based RNP affinity purification methods can be divided into two categories 
according to how RNPs are formed. For methods in the first category RNA-protein complex 
assembly takes place in vivo inside living cells. Methods in the second category are based on in vitro 
RNP formation that is performed after cell lysis. A common theme among all RNA-based RNP 
affinity purification methods is that the RNA of interest has to be “tagged” for purification. This 
tag can either be a chemical modification of the RNA or an RNA secondary structure element 
that binds with high affinity to a specific ligand. In both cases the introduced modification serves 
the purpose of capturing the bait RNA on the affinity matrix. The strategy used to tag the bait 
RNA depends on the nature of the bait. In vitro transcribed RNA or synthesized RNA 
oligonucleotides can be chemically modified. Naturally occurring or artificially selected RNA 
secondary structure elements can be incorporated into the RNA of interest during in vivo or in 
vitro transcription. 
 
 
RNP affinity purification using chemically modified bait RNA 
Many studies have made use of the high affinity biotin-streptavidin or biotin-avidin interaction 
(N. M. Green 1990; Sano and Cantor 1995) to capture ribonucleoprotein complexes. Biotinylated 
nucleotide analogs can be incorporated into the bait RNA during in vitro transcription. Typically, 
the labelled RNA is incubated with cell extract to allow in vitro RNP formation and the formed 
complexes are captured onto streptavidin-coated matrix. In the early studies this strategy was 
used to isolate spliceosome components from nuclear extracts of mammalian cells (Bindereif and 
Green 1987; Grabowski and Sharp 1986) and iron-responsive element-binding protein form 
human liver cytosolic extract (Rouault et al. 1989). One possible drawback of biotin labelling is 
that it can lead to structural changes of the bait RNA, which could affect RNP assembly (Walker 
et al. 2008). More recent studies have therefore utilized direct covalent coupling of the unlabelled 
bait RNA to the affinity matrix (Sela-Brown et al. 2000; Copeland et al. 2000; Allerson et al. 2003; 
M Caputi et al. 1999).  
Despite the technical improvements in chemically modified RNA use for RNP affinity 
purification, the dependence on in vitro RNP assembly is a considerable drawback of the method 
because such complexes might not contain the whole complement of interaction partners present 
in vivo. However, in some cases the method can also be adopted for the affinity purification of in 
vivo assembled RNPs. Namely, antisense 2′-O-methyl RNA oligonucleotides complementary to 
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single-stranded regions in the RNA of interest have been successfully used to purify U2 and 
U4/U6 snRNPs as well as telomerase from nuclear extracts (Wenz et al. 2001; Lingner and Cech 
1996; Blencowe et al. 1989). However, antisense RNA oligonucleotides have not found wide use 
in RNP affinity purification experiments. Single-stranded regions tend to destabilize RNP 
architecture and therefore it might not always be possible to find suitable regions in the bait RNA 
for affinity oligonucleotide annealing.  
 
 
Artificially selected RNA affinity tags 
The studies of RNP composition and function have greatly profited from the development of in 
vitro selection technology SELEX (systematic evolution of ligands by exponential enrichment), 
which has enabled to identify RNA and DNA sequences termed aptamers that bind with high 
affinity to specific ligands (reviewed in D. S. Wilson and Szostak 1999). Four different RNA 
aptamers have been commonly used to study RNA-protein interactions. All these aptamers are 
around 40 nt long stably folding RNA sequences that bind to their cognate ligand with an affinity 
in the micromolar to nanomolar range.  
The first RNA aptamer to be adopted for RNA-protein interaction studies binds to the 
aminoglycosid antibiotic streptomycin. The binding is Mg2+ dependent and has a dissociation 
constant (Kd) of around 1 µM (Wallace and Schroeder 1998). The streptomycin binding RNA 
aptamer, or the so-called StreptoTag (Bachler, Schroeder, and von Ahsen 1999) and its improved 
version STagT (Dangerfield et al. 2006), have thus far been used in in vitro studies. In a typical 
experiment the in vitro transcribed hybrid RNA containing an RNA motif of interest and the 
streptomycin aptamer, is added to the cell lysate to allow RNA-protein complex formation and 
then loaded onto streptomycin-coupled sepharose column. After washing, the bound complexes 
are specifically eluted under native conditions with high concentration of free streptomycin. This 
approach has been used to isolate 48S PICs form rabbit reticulocyte lysate, thereby significantly 
facilitating the preparation of pure 48S PIC for downstream applications (Locker, Easton, and 
Lukavsky 2006). In another study glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was 
found to be an enhancer of group II intron splicing in S. cerevisiae (Böck-Taferner and Wank 
2004). However, the identified RNA-protein interaction does not likely take place in vivo, since 
GAPDH is a cytosolic protein but the studied intron is located in yeast mitochondria. As 
eukaryotic GAPDH is more similar to the eubacterial homolog than to the archaeal homolog 
(Martin et al. 1993), the authors speculate that this result could hint to glycolytic pathway 
acquisition from the mitochondrial genome. Even though type II intron-GAPDH interaction 
INTRODUCTION 
 
44 
 
might have a biological meaning, this finding also draws the attention to the problem of possible 
falls-positive interaction identification due to in vitro RNA-protein complex assembly. In addition, 
the same study revealed that large hybrid RNAs could not be efficiently bound to the 
streptomycin matrix (Böck-Taferner and Wank 2004; Windbichler and Schroeder 2006). This is 
likely caused by folding problems of large in vitro transcribed RNA molecules and thus limits the 
size of hybrid RNAs, which can still be efficiently bound by streptomycin column, to about 600 
nt. 
Another RNA aptamer that under physiological conditions binds with a high affinity (Kd 
5 nM) to an aminoglycoside antibiotic is the tobramycin-binding J6f1 RNA (Hamasaki et al. 
1998). This aptamer fused to the 3′ end of a pre-mRNA (hybrid RNA total size 267 nt) was 
successfully used to isolate human prespliceosomes, resulting in the identification of more than 
70 prespliceosome-associated proteins by mass spectrometry (Hartmuth et al. 2002).  
SELEX using the gel filtration matrix Sephadex G-100 as a target ligand resulted in the 
identification of D8 RNA aptamer (Srisawat, Goldstein, and Engelke 2001), which has been used 
to purify in vivo assembled ribonuclease P form S. cerevisiae. The main advantage of D8 aptamer is 
that its affinity matrix Sephadex is relatively cheap and can directly be used for tagged RNA 
purification. However, the affinity of the aptamer is not very high and therefore bound RNA will 
be gradually lost form the matrix during washing steps (Walker et al. 2008). 
From the four RNA aptamers used for RNA-protein interaction studies the streptavidin-
binding S1 aptamer has received the widest use. S1 aptamer binds to streptavidin with a Kd of 
about 70 nM (Srisawat and Engelke 2001). The elution of S1 aptamer form the affinity matrix can 
be performed under native conditions in the presence of d-biotin. The unusually high-affinity 
binding of biotin to streptavidin (Kd about 10
-14 M) is essentially irreversible (N. M. Green 1990), 
thus enabling efficient elution and preventing rebinding of the eluted RNA to the matrix. The 
main disadvantage of the system is that the cellular biotin moieties have to be blocked before the 
lysate can be used for affinity purification. However, this can easily be done by pre-incubating the 
cell extract with egg white avidin, which binds biotin with a similar affinity as streptavidin. 
S1 aptamer has been used in various experimental setups to study both in vitro (Butter et 
al. 2009; Leonov et al. 2003) and in vivo (Y. Li and Altman 2002; Vasudevan and Steitz 2007; 
Srisawat and Engelke 2001) assembled RNA-protein complexes. To highlight a few studies, 
Butter et al. developed a screening method of RNA-protein interactions using in vitro transcribed 
RNA motives as bait (Butter et al. 2009). In this approach the S1-tagged RNA is first coupled to 
paramagnetic beads and then incubated with metabolically labelled mammalian cell extract. 
Metabolic labelling is performed by stable isotope labelling by amino acids in cell culture 
(SILAC), which enables to perform high-resolution, quantitative mass spectrometry (MS) to 
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analyze RNA-protein complex composition. Due to the high specificity of RNA elution by 
biotin, it was possible to perform gel-free, single-run MS analysis, thus accelerating sample 
throughput. The method proved to be highly reliable, i.e. both previously reported RNA-protein 
interactions could be identified and new interactions could be proved in follow-up experiments. 
It was recently reported that the S1 aptamer-mediated RNP pull-down efficiency could be 
increased 10-fold by adding a tRNA scaffold between the S1 aptamer sequence and the RNA 
motif of interest (Iioka et al. 2011). Interestingly, the attempt to increase the original S1 aptamer 
binding efficiency to the matrix by creating a hybrid RNA with six consecutive S1 repeats 
resulted in the opposite outcome – reduced RNA tethering efficiency as compared to hybrid 
RNA with a single S1 aptamer. The authors reasoned that this effect could be caused by one 
aptamer repeat interfering with another one, which might lead to misfolding of the RNA and 
subsequent affinity loss to streptavidin. The described tests were performed with matrix-tethered 
in vitro transcribed RNA because in vivo assembled RNA-protein complexes containing the RNA 
motif of interest fused to either one S1 aptamer, six S1 aptamers or S1 aptamer-tRNA scaffold 
could not be efficiently captured from human cell lysate. This is in contrast to some previous 
reports where, for instance, in vivo assembled RNase P could be purified via the S1 aptamer (Y. Li 
and Altman 2002).  This discrepancy underlines the need to optimize RNA-based RNP affinity 
purification conditions for each RNP of interest. 
 
 
Naturally occurring RNA secondary structure elements as RNA affinity tags  
Several powerful tools for studying RNP structure and function have been developed based on 
RNA-protein interactions found in bacteriophages. One such interaction, which, among other 
applications, has been successfully adopted for RNP affinity purification, occurs between a stem-
loop structure in the bacteriophage MS2 single stranded RNA genome and its coat protein 
(MS2CP). The 13.7 kDa MS2CP binds to the 19 nt long stem-loop as a dimer by contacting the 
nucleotides in the loop region and a bulged adenosine in the stem (C. Z. Ni et al. 1995; Valegård 
et al. 1994). The drawback of the wild type version of the coat protein for many experimental 
setups is its property to aggregate into capsid-like structures (Beckett, Wu, and Uhlenbeck 1988; 
Beckett and Uhlenbeck 1988). Structural studies of the coat protein have revealed a region 
important for the interaction of MS2CP dimers in the capsid. Several mutations in this region can 
prevent bulk capsid formation, even though multimers higher than a dimer can still form 
(Peabody and Ely 1992; LeCuyer, Behlen, and Uhlenbeck 1995). Mutational analysis of the RNA 
stem-loop in the bacteriophage R17, which is closely related to MS2, has identified a loop 
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sequence with increased affinity to the coat protein. The binding of the wt loop sequence AUUA 
to the coat protein has a Kd of 1-3 nM, whereas the mutated sequence AUCA has a Kd of 0.2-0.6 
nM (Carey et al. 1983; Lowary and Uhlenbeck 1987; Romaniuk et al. 1987; H. N. Wu, Kastelic, 
and Uhlenbeck 1988). Due to the higher affinity, the mutated loop sequence is now generally 
used to tether the MS2 or R17 coat protein (R17CP) to the stem-loop. 
The first report describing an affinity purification method based on the interaction of 
R17CP and its cognate stem-loop binding site was published by Bardwell and Wickens (Bardwell 
and Wickens 1990). The authors demonstrated that in vitro transcribed RNA containing either 
one or two R17 stem-loops could be captured with equal efficiencies by R17CP immobilized 
onto solid support. However, in the presence of additional sequences two loops were necessary 
to enable efficient capture. The applicability of the MS2CP/MS2-loop (MS2L) system for in vitro 
or in vivo assembled RNP affinity purification has since been demonstrated by many groups. For 
instance, the method has been adopted for the purification of spliceosomal complexes under 
native conditions (R. Das, Zhou, and Reed 2000; Zhou, Sim, et al. 2002; Deckert et al. 2006; 
Bessonov et al. 2008). In this approach, the MS2CP is fused to maltose-binding protein (MBP) 
and amylose beads, which bind the MBP-moiety of the fusion protein, are used for affinity 
selection. Captured complexes are eluted from the matrix under mild conditions with an excess 
of maltose. In the first attempt to affinity purify in vivo formed RNPs from prokaryotes, MS2CP-
MBP was employed to capture MS2L-tagged small non-coding RNAs (sRNAs) from Salmonella. 
sRNAs tagged with two MS2Ls were either expressed from plasmid or from the genomic locus 
and RNPs were immobilized onto MS2CP-MBP-coupled amylose column (Said et al. 2009). It 
was shown that the isolated MS2L-tagged sRNAs co-purified with the common sRNA-binding 
protein Hfq, suggesting that sRNAs were recovered in their native form.   
In the studies described in the previous paragraph only relatively short RNA sequences 
had been used for RNP affinity purification via the MS2L tag. Slobodin and Gerst have 
demonstrated that the MS2CP/MS2L system is also applicable for the purification of RNPs 
containing full-length mRNAs form S. cerevisiae (Slobodin and Gerst 2010). With the aim to 
identify new RBPs taking part in mRNA trafficking, they developed a method termed RNA-
binding protein purification and identification (RaPID). In this method, the mRNA of interest, 
which is expressed form its genomic locus, is captured via 12 tandem copies of MS2Ls inserted 
behind the coding region. In addition, the yeast strain contains a plasmid encoding for the tag-
binding protein under the control of a galactose inducible promoter. The tag-binding protein is 
comprised of three functional unites: (1) the MS2CP that binds to the MS2Ls; (2) GFP that helps 
to monitor in vivo formation of mRNPs and; (3) straptavidin binding protein that enables to 
capture the mRNPs on streptavidin-conjugated matrix. The bound mRNPs are eluted under 
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native conditions by competition with free biotin. The analysis of the affinity-eluates by reverse 
transcription PCR (RT-PCR) and immunobloting confirmed previously known RNA-protein 
interactions. In addition, Sec27, a subunit of the COPI vesicle coating complex, was identified as 
a possible interaction partner of OXA1 mRNA by MS analysis of a specifically enriched band on 
silver stained SDS-PAGE. 
An alternative approach to the MS2CP/MS2L system has been developed base on the 
interaction between bacteriophage lambda N-antiterminator protein and boxB stem-loop (Kevin 
Czaplinski et al. 2005). The N-protein forms a 1:1 complex with boxB by interacting with 
nucleotides both in the stem and the loop region (Van Gilst et al. 1997; Cilley and Williamson 
1997). The Kd of the complex determined by flouorometry is about 1 nM (Van Gilst et al. 1997). 
The first 22 N-terminal amino acids of the N-protein have been shown to bind to the boxB 
stem-loop with a similar affinity and specificity as the full-length protein (Tan and Frankel 1995). 
This short peptide can be fused to the protein of interest, which can then be recruited onto the 
target RNA containing the 19 nt boxB stem-loop (Baron-Benhamou et al. 2004).  
The versatility of possible experimental approaches to purify RNP complexes is 
emphasized by the development of RNA Affinity in Tandem (RAT) method (Hogg and Collins 
2007). This method uses an RNA tag composed of two different stem-loops. In the first 
purification step RNPs are selected based on the interaction between Pseudomonas aeruginosa phage 
7 coat protein (PP7CP) and its 25-nt binding site. The second step is provided by the binding of 
J6f1 RNA aptamer to tobramycin. PP7CP is structurally similar to MS2CP (Chao et al. 2008) and 
both coat proteins bind to their cognate stem-loop with a comparable affinity (Kd about 1 nM) 
(Francis Lim and Peabody 2002; Van Gilst et al. 1997). However, due to the tolerance to a 
broader range of salt concentration and pH than MS2CP-MS2L interaction, PP7CP and its 
binding site might represent a more robust tool for RNP affinity purification (F Lim, Downey, 
and Peabody 2001; Francis Lim and Peabody 2002; Hogg and Collins 2007). Indeed, 
optimization of the RAT tag revealed that RNP yield was higher if PP7CP/PP7-loop (PP7L) 
system was used as compared to MS2CP/MS2L system (Hogg and Collins 2007). Another 
innovative approach by Hogg and Collins besides a two-step purification strategy based on a 
double RNA tag, is the use of tobacco etch virus (TEV) protease to selectively elute RNPs after 
the first affinity purification step. Namely, the PP7CP contains a TEV protease cleavage site 
between the coat protein and protein A tag. The latter tag enables to capture RNPs onto IgG-
coupled affinity matrix during the first purification step. The method was used in mammalian cell 
culture system to purify endogenous RNPs assembled on non-coding RNAs. Combined with 
mass spectrometry, hnRNP K was identified as a component of 7SK ncRNA-containing RNPs. 
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The RNP affinity purification method established by Tsai et al. adds two novel 
approaches to the toolbox of in vivo-assembled RNP affinity purification strategies – affinity 
purification under denaturing conditions and identification of affinity purified proteins by 
SILAC-based quantitative mass spectrometry (Tsai et al. 2011). In order to capture RNPs under 
denaturing conditions, RNA-protein interactions were cross-linked by UV light prior to affinity 
purification and the high affinity biotin-straptavidin interaction was used to isolate RNPs. 
Specifically, the MS2CP was fused to HTBT tag that contains an in vivo biotinylation site, which 
allowed the capture of RNPs onto streptavidin-coated superparamagnetic beads (X. Wang et al. 
2007). This strategy enabled Tsai et al. to quantitatively identify 36 proteins binding to internal 
ribosomal entry site (IRES) of lymphoid enhancer factor-1 mRNA and to determin the RNP 
proteins common to the IRES-containing and control mRNA (Tsai et al. 2011). 
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MATERIALS and METHODS 
 
Materials 
General buffers and media were prepared as described in (Jellbauer 2009). 
 
Chemicals 
Standard chemicals were used as listed in (Fundakowski 2012). 
 
Special chemicals and reagents 
AppliChem Pepstatin A  
Triethylamine  
Bio-Rad Protein Assay Dye Reagent Concentrate 
Carl Roth Roti®-Aqua-Phenol/Chloroform/Isoamyl alcohol for RNA extraction 
EMD Millipore Pellet Paint® Co-Precipitant 
Life Technologies Ambion® Linear Acrylamide  
Applied Biosystems® TRI Reagent® Solution  
Roche Applied Science Blocking Reagent 
Complete Protease Inhibitor Cocktail Tablets 
CSPD, ready-to-use 
Sigma-Aldrich 1-Bromo-3-chloropropane  
Antifoam B Emulsion  
IgG from rabbit serum, reagent grade 
Molecular BioProducts RNase AWAY® 
Thermo Scientific Pierce ECL Western Blotting Substrate 
 
Consumables 
5 Prime Phase Lock Gel™ Heavy 2 ml  
BGB Analytik  GL Microfiber 25 mm Syringe Filter (pore size 3.1 µm and 1.2 µm) 
Biotium GelRed™ Nucleic Acid Gel Stain 
GE Healthcare Life Sciences Amersham HybondTM-P PVDF Transfer Membrane  
Whatman™ GF6 Glass Fibre Filter (Ø 10 cm, pore size 1-3 µm) 
Life Technologies Applied Biosystems® MicroAmp® Fast Optical 96-Well Reaction Pate 
Dynabeads® M-270 Epoxy 
Invitrogen™ NuPAGE® Novex 4‐12% Bis‐Tris Gel (1.0 mm) 
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SYBR® Safe DNA Gel Stain 
Roche Applied Science Nylon Membrane, positively charged 
Sarstedt Filtropur S Sterile Syringe Filter (pore size 0.2 µm) 
Thermo Scientific Fermentas GeneRuler DNA Ladder Mix 
Fermentas PageRuler Prestained Protein Ladder  
Fermentas PageRuler Unstained Protein Ladder 
 
Equipment 
Alpha Innotec FluorChem® FC2 Imaging System 
Analytik Jena AG FlexCycler 
Bachofer Vacuum Concentrator 
Bio-Rad  
 
Mini-PROTEAN® Tetra Cell 
Mini Trans-Blot® Electrophoretic Transfer Cell 
PowerPac™ Basic and HC High-Current Power Supplyis 
Trans-Blot® SD Semi-Dry Electrophoretic Transfer Cell 
EMD Millipore SNAP i.d.™ Protein Detection System 
Eppendorf  
 
Centrifuge 5415 R 
Centrifuge 5702 
Centrifuge 5810 R 
Thermomixer comfort 1.5 ml 
Fujifilm LAS-3000 Imager 
GE Healthcare Life Sciences Amersham Hybridization oven/shaker 
Amersham Typhoon™ Variable Mode Imager  
DynaMag™-15 Magnet 
Ultrospec 10 Cell Density Meter 
IKA Vibrax® VXR basic 
Infors HT  Minitron 
LI-COR Biosciences Odyssey® Infrared Imaging System 
Life Technologies Applied Biosystems® StepOnePlus™ Real-Time PCR System 
XCell SureLock® Mini-Cell 
Retsch  Mixer Mill MM400 
Schleicher & Schuell BioScience GV 100/0 Vacuum Filter Holder  
Thermo Scientific GENESYS 10 Bio UV-Vis Spectrophotometer 
NanoDrop® 1000 Spectrophotometer  
Sorvall® RC-6 PLUS 
 
Enzymes 
Agilent Technologies Herculase II Fusion DNA Polymerase 
Amsbio Zymolyase® 20T 
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Axon Taq DNA Polymerase 
Life Technologies Ambion® RNase Cocktail 
New England Biolabs conventional restriction enzymes 
RecA 
Promega GoTaq® DNA Polymerase 
RQ1 RNase-Free DNase 
Roboklon TEV Protease 
Thermo Scientific Fermentas Calf Intestine Alkaline Phosphatase (CIP) 
Fermentas conventional restriction enzymes 
Fermentas FastDigest restriction enzymes 
Fermentas Proteinase K 
Fermentas RevertAid Premium Reverse Transcriptase  
Fermentas RiboLock RNase Inhibitor 
Fermentas T4 DNA Ligase 
Fermentas T4 DNA Polymerase 
 
Commercial kits 
Agilent Technologies Prime-It II Random Primer Labelling Kit  
Qiagen QIAquick Gel Extraction Kit 
QIAquick PCR Purification Kit 
QIAprep Spin Miniprep Kit 
Life Technologies Applied Biosystems® High Capacity cDNA Reverse Transcription Kit 
Fast SYBR® Green Master Mix 
Invitrogen™ Colloidal Blue Staining Kit 
Invitrogen™ MEGAshortscript™ T7 Kit 
Invitrogen™ SilverQuestTM Silver Staining Kit 
 
Antibodies 
Primary antibodies Corresponding secondary antibodies 
Name Dilutiona Supplier Name Dilutiona  Supplier 
Peroxidase Anti-
Peroxidase (PAP) 
1:5000 Sigma-Aldrich    
Anti-She2  
(clone 1C3-11) 
1:150 AG Jansen Peroxidase-conjugated Rabbit 
Anti-Rat IgG (H+L) 
1:2000 Jackson 
ImmunoResearch  
Anti-c-myc  
(clone 9E10) 
1:1000 Roche  
Applied Science 
Peroxidase-conjugated Sheep 
Anti-Mouse IgG (H+L) 
1:3000 Jackson 
ImmunoResearch  
Anti-Pgk1 
(clone 22C5D8) 
1:3500 Invitrogen™ 
Life Technologies 
Peroxidase-conjugated Sheep 
Anti-Mouse IgG (H+L) 
1:4000 Jackson 
ImmunoResearch 
IRDye 680-conjugatedanti 
Goat Anti-Mouse IgG (H+L) 
1:3500 LI-COR 
Biosciences 
a Dilution corresponds to antibody dilution used for western blot analysis. 
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Oligonucleotides 
Oligonucleotides for epitope tagging, gene knockout and checking of transformants were 
designed according to published protocols (Janke et al. 2004; Knop et al. 1999; Haim et al. 2007). 
Oligonucleotides for fusion PCR were designed according to Shevchuk et al. (Shevchuk et al. 
2004) and for sequence- and ligation-independent cloning (SLIC) according to Li and Elledge (M. 
Z. Li and Elledge 2007). Oligonucleotides for template DNA amplification for in vitro 
transcription with T7 RNA polymerase were designed following the guidelines of manufacturer’s 
manual of MEGAshortscript T7 Kit (Life Technologies).  
 
Oligonucleotides for epitope tag integration and gene knockout 
RJO Name 5'- 3' sequence 
3560 
 
3561 
PGK1_m-TAG_F  
 
PGK1_m-TAG_R 
GGAATTGCCAGGTGTTGCTTTCTTATCCGAAAAGAAATAAcgc
tgcaggtcgacaaccc 
GGGAAAGAGAAAAGAAAAAAATTGATCTATCGATTTCAATT
CAATTCAATgcataggccactagtggatc 
3590 
 
3591 
MEX67_S1_F 
 
MEX67_S2_R 
AAGAGTAAAATAAATCGTTAAAAATTCTGCATCGCTAATAGC
AGCAAAAAAAATGcgtacgctgcaggtcgac 
CTGTATATTTTTTGTGATACTGTGCGGCTGAAACAGGGAAC
AATATCATTAatcgatgaattcgagctcg 
3848 
 
3849 
ENO2_m-TAG_F  
 
ENO2_m-TAG_R 
CTACGCCGGTGAAAACTTCCACCACGGTGACAAGTTGTAAcgc
tgcaggtcgacaaccc 
CTATGATGAAAAAATAAGCAGAAAAGACTAATAATTCTTAGT
TAAAAGCACTgcataggccactagtggatc 
3934 
 
3935 
NAM7_S3_F  
 
NAM7_S2_R 
GAGAAGAACAAAAGCATGAATTGTCAAAAGACTTCAGCAAT
TTGGGAATAcgtacgctgcaggtcgac 
GTATCACAAGCCAAGTTTAACATTTTATTTTAACAGGGTTCA
CCGAATTAatcgatgaattcgagctcg 
 
Oligonucleotides for verification of proper epitope tag integration or gene knockout 
RJO Name 5'- 3' sequence 
3562 PGK1_Det_F GGCTTTGTTAGACGAAGTTGTC 
3563 HIS3_Det_R GACTGTCAAGGAGGGTATTCTG 
3564 PGK1_Det_R CCCGAACATAGAAATATCGAATGGG 
3589 MEX67_-235_F CATGCCCACTTGCCTTTCGTAG 
3850 ENO2_Det_F CATTGCTGACTTGGTTGTCGG 
3851 ENO2_Det_R CCAGTGCATTATGCAATAGACAGC 
3936 NAM7_Det_F GTACCAGGAGGAGGCTTCTC 
3937 NAM7_Det_R TGCAAATTGCGAGTCTATCTCG 
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Oligonucleotides for RT-PCR 
RJO Name 5'- 3' sequence 
2205 
2206 
Ash1-RTPCR-E1-for  
Ash1-RTPCR-E1-rev 
CTTTATCTAAGAGACCGGAGCGC 
CTTGGACGACCTAGTCGATTCC 
3491 
303 
PGK1_mid_F  
PGK1-rev  
GGTTTTGGAAAACACTGAAATCGG 
TAAGAAAGCAACACCTGGCA 
3509 
3510 
SOD1_+240_F 
SOD1_+424_R 
ACATGTCGGTGACATGGGTAACG 
ACCACAGGCTGGTCTTGGAC 
3515 
3516 
SRL1_+413_F 
SRL1_+570_R 
AGGTCAAGTCCTTTGAACAGGCT 
CCATTGTACGTTACCTGGAGAGGT 
 
Oligonucleotides for qRT-PCR 
RJO Name 5'- 3' sequence 
2920 
2921 
Act1_qPCR_1_for  
Act1_qPCR_1_rev 
TCAGAGCCCCAGAAGCTTTG  
TTGGTCAATACCGGCAGATTC 
2916 
2917 
Eno2_qPCR_2_for  
Eno2_qPCR_2_rev 
GGTTGTCGGTTTGAGAACTGG 
TTCGATTCTCAACAATTGGTTCA 
4132 
4133 
PGK1-RT_F  
PGK1-RT_R 
GAACGGTCCACCAGGTGTT  
GACGGTGTTACCAGCAGCAG 
4135 
4136 
TPI1_F  
TPI1_R 
TGGTACCGGTTTGGCTGCT  
ATTCGCTGGCAGCCTTGTC 
4139 
4148 
18S_F 
18S_qRT_R 
TCAACACGGGGAAACTCACC  
CTAAGAACGGCCATGCACCA 
4141 
4149 
26S_F 
26S_qRT_R 
GCTTGTGGCAGTCAAGCGT  
ACAATCCAACGCTTACCGAA 
 
Oligonucleotides for cloning 
RJO Name 5'- 3' sequence 
3487 pLOX_5'MS2L_F  GTTTAAACGAGCTCTCGAGAACC 
3494 MS2CP_F GGTCGCTGAATGGATCAGCTC 
3683 pUC/M13 Forward CCCAGTCACGACGTTGTAAAACG 
3684 pUC/M13 Reverse AGCGGATAACAATTTCACACAGG 
3747 MET25_F cccctcgaggtcgacggtatcgataagcttAGCTCCGGATGCAAGGG 
3750 TEV-PrA_R ggtggcggccgctctagaactagtggatccGGCCGCAAATTAAAGCCTTCG 
3802 2_PrA5un_3un_R  CTTCATCGTGTTGCGCGGAATTCGCGTCTAC 
3803 3_PrA3un_5un_F GTAGACGCGAATTCCGCGCAACACGATGAAGCCGTG 
4059 SLIC_pRS4_PGK1gen_F ccctcgaggtcgacggtatcgataagcttTGCAAGTACCACTGAGCAGG 
4061  SLIC_PGK1prom_MS2L_R CGACCTGCAGCGgctagcTGTTTTATATTTGTTGTAAAAAGTAG
ATAATTAC 
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4062 SLIC_MS2L_PGK1prom_F CAACAAATATAAAACAgctagcCGCTGCAGGTCGACAACCC 
4063 SLIC_MS2L_CYC1_R gtgacataactaattacatgGCATGCGCATAGGCCACTAGTGGATC 
4064 SLIC_CYC1_MS2L_F GCCTATGCGCATGCcatgtaattagttatgtcacgc 
4065 SLIC_CYC1_pRS4_R ggcggccgctctagaactagtggatccaaagccttcgagcgtccc 
 
Oligonucleotides for generation of hybridization probes 
RJO Name 5'- 3' sequence 
176 
217 
sASH1nco  
ASH1 1892 REV 
CCAATAGAACCATGGAGCGC  
GAAGATGCCGCGGCGTG 
302 
303 
PGK1-forw.  
PGK1-rev. 
CTTCAAAGTTGTCTGTCCAAG  
TAAGAAAGCAACACCTGGCA 
3491 
3939 
PGK1_mid_F 
PGK1_T7p_R 
GGTTTTGGAAAACACTGAAATCGG 
taatacgactcactatagggGGCATCAGCAGAGAAAGCATC 
4109 
3938 
m-TAG_F  
MS2L_T7p_R 
CGCTGCAGGTCGACAACCC 
taatacgactcactatagggGCAGACATGGGTGATCCTCATG 
4139 
4140 
18S_F 
18S_T7_1302_R  
TCAACACGGGGAAACTCACC 
taatacgactcactatagggCGTTCGTTATCGCAATTAAGCAG 
4141 
4120 
26S_F 
26S_T7_R 
GCTTGTGGCAGTCAAGCGT 
taatacgactcactatagggCTCACGACGGTCTAAACCC 
 
 
Plasmids 
RJP Name Origin 
88 YEplac181-ASH1 pC3319 in (Long et al. 1997) 
407 pSH47 (Prein, Natter, and Kohlwein 2000) 
1116 pUN100-LEU2-mex67-5 (Segref et al. 1997) 
1117 pUN100-LEU2-MEX67 (Segref et al. 1997) 
1433 p414 Gal1 Ash1 Susanne Lange, Gene Center, Munich 
1573 p414 GALS 6MS2 PGK1  Susanne Lange, Gene Center, Munich 
1712 ploxP-HIS5-6xMS2L this study 
1751 pRS316-MET25-MS2CP-TEV-PrAx2 this study 
1783 pRS416-PGK1prom-6MS2L-CYC1 this study 
1814 YCplac22-MET25-MS2CP-PrAx2 this study 
 
RJP 1712, which is a PCR template plasmid for the amplification of 6MS2L-containig m-TAG 
cassette, was constructed from plasmid RJP 1485 (pLOXHIS5MS2L) (Haim et al. 2007) by the 
replacement of 12MS2L with 6MS2L. RJP 1485 was digested with EcoRV and the 3850 bp 
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fragment comprising the vector backbone was blunt-end ligated with 380 bp BamHI-BglII 
fragment cut out from plasmid RJP 232 (YEP lac112-LZ-MS2-ASH1) (Bertrand et al. 1998). 
RJP 1751 (CEN6, URA3), which, under the control of MET25 promoter, expresses MS2CP 
fused to four IgG-binding Z domains of protein A (PrAx2), was constructed using fusion PCR to 
create the insert (Shevchuk et al. 2004) and SLIC (M. Z. Li and Elledge 2007) to assemble the 
insert and the vector backbone. The insert comprising the sequences of MET25 promoter, 
MS2CP, TEV protease cleavage site, PrAx2 and iso-1-cytochrome c (CYC1) transcription 
terminator was created as follows. First, fragment 1 (MET25-MS2CP-TEV-PrA, 1383 bp) and 
fragment 2 (PrA-CYC1, 772 bp) were amplified form plasmid RJP 1748 (pRS316-MET25-
MS2CP-TEV-PrA) with primers RJO 3684/RJO 3802 and RJO 3803/RJO 3802, respectively. 
Due to a 31 nt homology region between the 3'-end of fragment 1 and 5'-end of fragment 2, the 
fragments could be fused in a PCR step containing polymerase and dNTPs but lacking primers 
(Shevchuk et al. 2004). The PCR fusion product was used for insert amplification (1948 bp) with 
nested primers RJO 3747/RJO 3750, which contained at 5'-ends a stretch of 30 nt homologous 
to vector backbone. Plasmid RJP 148 (pRS316) (Sikorski and Hieter 1989) opened with HindIII-
BamHI (4857 bp) was annealed with the insert following the protocol for SLIC sub-cloning using 
T4 DNA polymerase treated inserts with RecA (M. Z. Li and Elledge 2007). 
RJP 1783 (CEN6, URA3) encodes for an RNA that contains loxP-6MS2L sequence as it is 
present in the endogenously expressed mRNA tagged with 6MS2L (Haim et al. 2007). The insert 
(1676 bp) was created by a two step fusion PCR form three fragments: (1) PGK1 promoter 
containing 947 nt upstream of PGK1 start codon was amplified form yeast genomic DNA 
(gDNA) (RJY 3731) with primers RJO 4059/ RJO 4061; (2) loxP-6MS2L was amplified form 
yeast gDNA (RJY 3731) with primers RJO 4062/RJO 4063; and (3) CYC1 transcription 
terminator was amplified form plasmid RJP 111 (p413-GAL1) (Mumberg, Muller, and Funk 
1994) with primers RJO 4064/4065. The first round of fusion PCR resulted in fragment 1-2 
(amplified with RJO 4059/4063) and fragment 2-3 (amplified with RJO 4062/4065) fusion. The 
resulting PCR products were fused in a second round of PCR and amplified with primers RJO 
4059/4065. Plasmid RJP 291 (pRS416) (Sikorski and Hieter 1989) opened with HindIII-BamHI 
(4868 bp) was annealed with the insert following the protocol for SLIC sub-cloning using T4 
DNA polymerase treated inserts with RecA (M. Z. Li and Elledge 2007). 
RJP 1814 (CEN4, TRP1) expresses MS2CP-TEV-PrAx2 fusion protein under the control of 
MET25 promoter. The insert (1882 bp) comprising the sequence of MET25 promoter and the 
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fusion protein was cut out with HindIII-BamHI from plasmid RJP 1751 and inserted into 
HindIII-BamHI site of RJP 138 (YCplac22) (Gietz and Akio 1988). 
All the plasmids created in this study were verified by sequencing.  
 
 
E. coli strains 
Strain Essential genotype Origin 
TOP10
  
F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 nupG recA1 araD139 
Δ(ara-leu)7697 galE15 galK16 rpsL(StrR) endA1 λ- 
Invitrogen 
 
 
S. cerevisiae strains 
All yeast strains that were generated for this work are based on either haploid (RJY 359) or 
diploid (RJY 925) W303 wildtype cells. 
RJY Essential genotype Origin 
135 MATalpha, ade2-1, trp1-1, can1-100, leu2-3, 112, his 3-11,15, ura3, ash1::URA3 (Nasmyth et al. 1990) 
359 MATalpha, ade2-1, trp1-1, can1-100, leu2-3, 112, his3-11,15, ura3, GAL, psi+ n/a 
3166 MATa, ade2-1, can1-100, his3-11,15, leu2-3,112, trp1-1, ura3, GAL, psi+, loxP-
ProtA-TEV-CBP-SHE2 
Stephan Jellbauer, 
Gene Center, Munich 
3550 MATalpha, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, psi+, PGK1-
loxP-HIS5-loxP-6MS2L 
this study 
3558 MATa, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, psi+, 
lys1::kanMX6 
Katja Sträßer,  
Gene Center, Munich 
3639 MATa/MATalpha, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, 
psi+, LYS1/lys1::kanMX6, PGK1/PGK1-loxP-HIS5-loxP-6MS2L, pSH47(RJP 
407) 
this study 
3641 MATa/MATalpha, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, 
psi+, LYS1/lys1::kanMX6, PGK1/PGK1-loxP-HIS5-loxP-6MS2L, 
MEX67/mex67::natNT2, pUN-LEU2-mex67-5 (RJP 1116), pSH47(RJP 407) 
this study 
3644 MATalpha, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, psi+ 
lys1::kanMX6, mex67::natNT2, PGK1-loxP-6MS2L, pUN100-LEU2-mex67-5 (RJP 
1116) 
this study 
3645 MATalpha, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, psi+ 
lys1::kanMX6, mex67::natNT2, PGK1,  pUN100-LEU2-mex67-5 (RJP 1116) 
this study 
3682 MATalpha, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, psi+, 
lys1::kanMX6, mex67::natNT2, PGK1-loxP-6MS2L, pUN100-LEU2-MEX67 (RJP 
1117), pRS316-MET25-TEV-PrAx2 (RJP 1751) 
this study 
3683 MATa, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, psi+, 
lys1::kanMX6, mex67::natNT2, PGK1, pUN100-LEU2-MEX67 (RJP 1117), 
pRS316-MET25-TEV-PrAx2 (RJP 1751) 
this study 
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3715 MATa, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, psi+, 
lys1::kanMX6, mex67::natNT2, ENO2-loxP-6MS2L, pUN100-LEU2-MEX67 
(RJP 1117), pRS316-MET25-MS2CP-TEV-PrAx2 (RJP1751) 
this study 
3731 MATalpha, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, psi+ 
lys1::kanMX6, mex67::natNT2, PGK1-loxP-6MS2L, NAM7-3myc::His3MX6, 
pUN100-LEU2-mex67-5 
this study 
3739 MATalpha, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, psi+, 
lys1::kanMX6, mex67::natNT2, PGK1-6MS2L, NAM7-3myc::His3MX6, pUN100-
LEU2-mex67-5 (RJP 1116), pRS316-MET25-MS2CP-TEV-PrAx2 (RJP 1751) 
this study 
3740 MATalpha, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, psi+, 
lys1::kanMX6, mex67::natNT2, PGK1, NAM7-3myc::His3MX6, pUN100-LEU2-
mex67-5 (RJP 1116), pRS316-MET25-MS2CP-TEV-PrAx2 (RJP 1751) 
this study 
3827 MATalpha, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, psi+, 
lys1::kanMX6, mex67::natNT2, PGK1-loxP-6MS2L, NAM7-3myc::His3MX6, 
pUN100-LEU2-MEX67 (RJP 1117), pRS316-MET25-MS2CP-TEV-PrAx2 (RJP 
1751) 
this study 
3828 MATa, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, psi+, 
lys1::kanMX6, mex67::natNT2, PGK1, NAM7-3myc::His3MX6, pUN100-LEU2-
MEX67 (RJP 1117), pRS316-MET25-MS2CP-TEV-PrAx2 (RJP 1751) 
this study 
3989 MATa, ade2-1, trp1-1, can1-100, leu2-3,112, his3-11,15, ura3, GAL, psi+, 
lys1::kanMX6, mex67::natNT2, PGK1, NAM7-3myc::His3MX6, pUN100-LEU2-
MEX67 (RJP 1117), pRS416-PGK1prom-6MS2L-CYC1 (RJP 1783), YCplac22-
MET25-MS2CP-TEV-PrAx2 (RJP 1814) 
this study 
 
 
 
Methods 
 
Standard methods in molecular biology and Escherichia coli-specific techniques were performed as 
described in (Jellbauer 2009). 
 
 
Working with S. cerevisiae 
 
Optical density of yeast culture 
Yeast culture optical density (OD) was determined using Ultrospec 10 Cell Density Meter (GE 
Healthcare Life Sciences) at 600 nm. One OD unit at 600 nm (1 OD600) corresponds to 2.7 x 10
7 
cells. 
Transformation of yeast cells 
Plasmid DNA transformation was carried out, with minor modifications, according to the 
protocol published by Chen et al. (D. C. Chen, Yang, and Kuo 1992). Specifically, instead of 
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incubating the cells in DNA/One-Step Buffer mix at 45°C, the incubation was performed at 
30°C followed by incubation at 42°C for 10 or 5 min. 5 min incubation time was used for strains 
carrying the temperature sensitive mex67-5 allele. 
PCR products were introduced by high-efficiency transformation according to a protocol 
adapted from Hami-Vilmovsky and Gerst (Haim-Vilmovsky and Gerst 2009). Cells were 
harvested at OD600 0.6-0.8 by centrifugation at 1000 x g for 3 min at room temperature (RT; same 
settings were used also for subsequent centrifugation steps for cell suspension in 15 or 50 ml 
tubes), washed with 0.5 culture volume of TE and thereafter with 0.1 culture volume of 0.1 M 
lithium acetate (LiAc). Cells were resuspended in 1 ml 0.1 M LiAc, transferred into 1.5 ml tube 
and pelleted by centrifugation at 16 000 x g for 15 sec.  Subsequently, cells were resuspended in 
0.1 M LiAc to have around 3 OD600 units of cells per 50 µl cell suspension. In parallel to cell 
washing, PCR tubes containing 8 µl of PCR product (3-1 µg DNA) and 525 µl of polyethylene 
glycol (PEG)/LiAc/single stranded DNA (ssDNA) mix were prepared. A negative control was 
prepared by omitting the PCR product. 50 µl of cell suspension was added to each tube, mixed 
by brief vortexing and incubated for 30 min at 30°C. Cells were then exposed to heat shock at 
42°C for 10 or for 5 min in case of temperature sensitive strains. After heat shock 600 µl yeast 
extract-peptone (YEP) was added to the tubes and cells were pelleted by centrifugation at 1000 x 
g for 3 min. Washing was repeated once with 1 ml YEP. Finally, cells we resuspended in 1 ml 
YEP and 200 µl of cell suspension corresponding approximately to 0.6 OD600 units of cells was 
plated onto an appropriate selection plate. Colonies were allowed to form for 2-3 days at 26°C. If 
cloNAT (nourseothricin) or G418 (geneticin) was used for selection, cells were allowed to 
recover after the heat shock for 4-16 h in yeast extract-peptone-dextrose (YEPD) before plating.  
 
One-Step Buffer 
0.2 M LiAc 
40% (w/v) PEG 3350 
100 mM DTT 
Filter sterilized and stored at -20°C 
 
PEG/LiAc/ssDNA mix per one transformation 
50 µg ssDNA (stock 2 µg/µl) 
400 µl 45% (w/v) PEG 4000 
100 µl 95 mM LiOAc (in TE) 
Prepared fresh before use. ssDNA added directly before use to avoid 
reannealing of ssDNA 
 
Summary of mRNP affinity purification- and SILAC-compatible yeast strain creation 
PGK1 was tagged with 6MS2L using a PCR-based genomic tagging strategy termed m-TAG 
(Haim et al. 2007). Genomic deletion of LYS1 was achieved by mating two haploid strains of 
opposite mating types: RJY 3558 carrying Δlys1 and RJY 3550 carrying PGK1-loxP-Sphis5+-loxP-
6MS2L. In addition to LYS1 deletion, strain RJY 3558 contained plasmid RJP 407 with URA3 
selection marker. Mating of stains was performed as described in (Jellbauer 2009) and diploid 
cells were selected on synthetic complete (SC) plates lacking uracil and histidine. Yeast colony 
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PCR was performed to confirm the diploid status of selected colonies (Huxley, Green, and 
Dunham 1990). The resulting diploid strain RJY 3639 was next used for the genomic deletion of 
mex67 for experimental purposes not discussed in this thesis. After successful mex67 deletion the 
resulting strain RJY 3641 was sporulated and tetrads were dissected. One tetrad was identified 
with two haploid spores with desired genotypes: (1) Δlys1, Δmex67, PGK1 (RJY 3645); and (2) 
Δlys1, Δmex67, PGK1-loxP-6MS2L (RJY 3644). These strains were used as background strains to 
create all other strains for mRNP affinity purification experiments. 
 
 
mRNP affinity purification 
 
Coupling of Dynabeads® M-270 Epoxy with rabbit IgG 
300 mg of Dynabeads® M-270 Epoxy paramagnetic beads (Life Technologies ) were coupled 
with 50 mg of rabbit IgG (Sigma-Aldrich) as described in (Oeffinger, Wei, and Rout), except that 
rabbit IgG was reconstituted in 150 mM NaCl instead of double distilled (dd) H2O.  
 
Culturing cells for mRNP affinity purification optimization experiments 
Yeast strains were grown in SC medium containing 6.7 g/L yeast nitrogen base, 69 mg/L adenine 
sulfate, amino acids (Table 2) and 2% glucose. In the morning, 10 ml of medium was inoculated 
with a small amount of cells form freshly streaked plate and allowed to grow over day at 26°C 
with shaking at 120 rpm (growth conditions here and hereinafter). In the evening, cells were 
diluted to OD600 0.05 in 200 ml medium and grown overnight. The next morning, 1900 ml 
medium was inoculated to OD600 0.2 and the culture was allowed to reach mid-log phase (OD600 
0.8) before harvesting. 
 
Table 2. Final concentration of amino acids in SC medium lacking uracil (SC -ura). 
Amino acid mg/L 
L-arginine monohydrochloride 42 
L-histidine hydrochloride monohydrate 42 
L-isoleucine 42 
L-leucine 84 
L-lysine 50 
L-methionine 84 
L-phenylalanine 63 
L-serine 42 
L-threonine 42 
L-tryptophan 63 
L-tyrosine 69 
L-valine 189 
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Metabolic labelling by SILAC for mass spectrometry-based quantitative proteomics 
SILAC-compatible yeast strains were first tested for SILAC amino acid incorporation rate. For 
this, cells were allowed to divide ~7 times in 4 ml of appropriate SC medium containing the 
“heavy”, i.e. the stable 13C15N isotopic form of the amino acid lysine (Lys8). Yeast cells were 
disrupted in MS Cell Breakage Buffer by vigorous shaking with acid washed glass beads (Ø 0.2-
0.3 mm) for 10 min at 4°C, stopping the shaking after each 2 min to cool down the lysate on ice 
for 2 min. Protein concentration of the clarified lysate was determined using Protein Assay Dye 
Reagent (Bio-Rad) according to manufacturer’s manual and the lysate was stored at -20°C. Lys8 
incorporation test was performed by the Proteome Center Tübingen using 50 µg of lysate. The 
strains used in this study had Lys8 incorporation rates > 95%. 
For mRNP purification combined with quantitative analysis of MS2L-tagged mRNA co-
isolating proteins, two strains were grown in parallel in SC -ura medium (see previous chapter 
and table 2 for medium composition) supplemented either with “light” 12C14N isotope-containing 
lysine (Lys0) or Lys8. In order to precisely determine the number of cell divisions in Lys8-
containing medium, both strains were first grown overnight in 2 ml medium supplemented with 
Lys0. The next morning the strains were inoculated to OD600 0.2 in 4 ml of SILAC medium, 
which for one strain was supplemented with Lys0 and for the other strain with Lys8, and were 
allowed to grow for about eight hours. Then cells were diluted to OD600 0.1 in 80 ml of SILAC 
medium and were grown overnight. The following morning, the two cultures were diluted to 
OD600 0.2 in 1200 ml SILAC medium. In order to prevent both strains from reaching OD600 0.8 at 
the same time, dilutions were performed with 1 h gap in between. Cells should be allowed to 
double in SILAC medium for at least five times for full incorporation of the heavy amino acid 
(Gruhler and Kratchmarova 2008). The described growth strategy enabled cells to double at least 
8 times in SILAC medium and the determined Lys8 incorporation rates were > 95%. 
 
MS Cell Breakage Buffer 
6 M urea 
2 M thiourea 
10 mM Tris HCl, pH 8.0 
1x Protease Inhibitor Cocktail ( Roche Applied Science) 
Prepared fresh 
 
 
Harvesting of large scale yeast culture according to Öffinger et al.  
Yeast cell harvesting was modified from (Oeffinger, Wei, and Rout). Briefly, 2 L culture was 
divided into three 1 L centrifugation tubes and spun down at 4000 x g for 10 min at 4°C 
(Sorvall® RC-6 PLUS, Thermo Scientific). Supernatant was decanted and centrifugation tubes 
were placed on ice. Pellets were resuspended in 25 ml ice cold ddH2O per pellet. Cell suspension 
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was divided into two 50 ml pre-cooled conical tubes and spun down at 2600 x g for 5 min at 4°C 
(5810 R, Eppendorf). After decanting the supernatant, cells were resuspended in 25 ml ice cold 
ddH2O per pellet. Cell suspension in two 50 ml tubes was pooled into one and cells were spun 
down at 2600 x g for 5 min at 4°C. After centrifugation supernatant was decanted, cells were 
resuspended in ice cold Resuspension Buffer equal to the volume of the cell pellet and spun 
down at 2600 x g for 10 min at 4°C. Supernatant was removed by aspiration and the pellet was 
spun down once more at 2600 x g for 10 min at 4°C. The remaining of the supernatant was 
removed by aspiration and yeast cells were frozen following the protocol by Öffinger et al. 
(Oeffinger, Wei, and Rout). 
 
Resuspension Buffer 
1.2% (w/v) PVP-30  
20 mM Hepes (pH 7.4) 
Stored at 4°C 
Before use Resuspension Buffer was supplemented with:  
1x Protease Inhibitor Cocktail 
1:100 Solution P (stock: 0.4 mg/ml Pepstatin A, 18 mg/ml PMSF in absolute EtOH) 
1:1000 1M DTT 
 
 
Harvesting of large scale yeast culture according to Inada et al. 
Yeast growth medium was removed by vacuum filtration (GV 100/0, Schleicher & Schuell 
BioScience) using 2 pieces of GF6 glass fibre filters (Whatman™, GE Healthcare Life Sciences) 
pre-wetted in distilled (d) H2O. The maximal volume of mid-log phase culture that could be 
filtered before clogging of the system was 2 L. After filtration, the filter with the captured cells 
was placed into a 600 ml wide-mouth glass beaker and the cells were removed by rinsing with 25 
ml of Cell Wash Buffer pre-warmed to 30°C (Inada et al. 2002). Cell suspension was transferred 
into a 50 ml conical tube and the filter was washed with an additional 20 ml of Cell Wash Buffe 
in order to collect remaining cells. Cell suspension was pelleted at 2600 x g for 4 min at 24°C and 
supernatant was removed by decanting. In order to remove the rest of the supernatant, the 50 ml 
tube was left standing upside down on a towel paper for 10 sec before proceeding with freezing 
the cells (Oeffinger, Wei, and Rout). 
 
Cell Wash Buffer 10x Amino Acids   
20 mM Hepes (pH 7.4) 0.2 g  adenine sulfate 1 g L- isoleucine 
2 mM MgAc2 0.2 g  uracil 1 g L- phenylalanine 
100 mM KAc 0.2 g L- tyrosine 1 g  L- glutamic acid 
2% (w/v) glucose  1 g  L- tryptophan 1 g L- aspartic acid 
1x amino acids 1 g  L-histidine hydrochloride monohydrate 3 g L- valine 
1x Protease Inhib. Cocktail 1 g L- arginine monohydrochloride 4 g L- threonine 
Prepared fresh before use 1 g L- leucine 8 g L- serine 
     
 Volume brought to 1 L with ddH2O, filter sterilized, stored at 4°C 
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Disruption of yeast cells by cryolysis 
Frozen cells were disrupted under cryo conditions by grinding in mixer mill (MM400, Retch). 
The technical details of grinding are listed in table 3. Before transferring the frozen cells into 
grinding jars, the jars, as well as the steel grinding balls, were cooled down in liquid nitrogen 
(LN2). Care was taken to remove all LN2 before closing the screw cap of the grinding jar. Cells 
were ground for 6 cycles, each cycle lasting 3 min. After every cycle (including the last one) the 
grinding jars were cooled down in LN2 for about 2 min until LN2 had stops boiling. During 
cooling down, the jars were not entirely immersed in LN2 in order to prevent LN2 from seeping 
into the jars. After grinding, the grindate was transferred into 50 ml conical tubes previously 
cooled down in LN2 and stored at -80°C.  
 
Table 3. Grinding specification. Sample volume refers to the volume of frozen yeast cells. 
Initial culture vol. Sample vol. Grinding jar vol. Ball charge Grinding cycles (Hz) 
2 L ≥5 ml 50 ml 1 x Ø 25 mm 20, 2 x 14, 3 x 12 
1.2 L 2-3 ml 10 ml 1 x Ø 12 mm 20, 5 x 16 
 
 
mRNP affinity purification protocol 
The method of mRNP isolation via the mRNA component of the complex was developed based 
on a method for immunoaffinity purification of protein complexes (Oeffinger et al. 2007). The 
experiments were performed under essentially RNase-free conditions. Only RNase-free solutions 
and water (HPLC-purified or DEPC-treated H2O) were used. In order to prevent RNase 
contamination through pipettes, filter tips and serological plastic pipettes were used. In addition, 
the work area and pipettes were regularly cleaned with RNase AWAY® (Molecular BioProducts 
Sigma-Aldrich).  
Yeast cell grindate amount used for mRNP isolation depended on the downstream 
application (Table 4). Before starting with the experiment, grindate was weighed out into a 15 ml 
or 50 ml conical tube pre-cooled in LN2, and stored in LN2 or at -80°C until needed. Due to the 
loss of some material during lysate preparation 1.3 times more grindate was weighed out than 
eventually needed for the experiment (in case of grindate amounts ≤ 300 mg 1.5-2 times more 
grindate was weighed out). Once ready to proceed with the experiment, the tubes were immersed 
in ice and the grindate was allowed to thaw until it resembled thick ice cream (15 to 30 min 
depending on grindate amount). In parallel, IgG-coupled Dynabeads were washed four times 
with ice cold RNP Buffer 150 (RNPB-150). Per gram of grindate 100 µl IgG-coupled Dynabeads 
(concentration 150 mg/ml) were washed and per 100 µl beads 2 ml of RNPB-150 was used for 
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washing. Depending on the bead volume, washing was performed in 1.5 ml safe seal tube (safe 
seal tubes were used throughout the experiment) or in 15 ml conical tube. For washing, the beads 
were resuspended by pipetting or by short vortex, captured on magnet and the supernatant was 
removed by pipetting (1.5 ml tube) or by aspiration (15 ml tube). If bead washing had been 
performed in a 15 ml tube, the beads were transferred into a 1.5 ml tube after the fourth washing 
steps by rinsing the 15 ml tube twice with 1 ml RNPB-150. After washing, 100-200 µl RNPB-150 
was added to the beads and the beads were stored on ice until needed.  
 
Table 4. Grindate amount used for mRNP affinity purification.  
Grindate amount Downstream application 
300-400 mg Analysis of bead-captured RNA by northern blot and qRT-PCR
a
 
200 mg Analysis of bead-captured RNA co-isolating proteins on silver stained SDS-PAGE
b
 
100 mg Immunodetection of bead-captured RNA co-isolating proteins
b
 
1.15 g  Quantitative MS analysis of bead-captured RNA co-isolating proteins
b
 
a
 Isolated material was enough to perform several analyses. 
b
 Isolated material was enough to perform one analysis. 
 
Thawed grindate was resuspended in ice cold RNPB-150 using 9 ml of buffer per one 
gram of grindate. After adding the buffer, the tube was vortexed for ≤ 30 sec. If after 30 sec of 
vortexing the lysate still contained a frozen clump of cells, the tube was inverted until the clump 
disappeared and the lysate was immediately spun down at 940 x g for 3 min at 4°C. During the 
centrifugation step preparations were made for subsequent lysate filtration: (1) per lysate two 50 
ml wide-mouthed 100 ml glass beakers were placed on ice; (2) the piston of a fresh 10-20 ml 
syringe was removed; (3) a 25 mm glass microfiber syringe filter with a pour size of 3.1 µm (BGB 
Analytik) was attached to the syringe and placed into the glass beaker on ice. Immediately after 
centrifugation the supernatant was poured into the prepared syringe avoiding the transfer of cell 
debris and the lysate was filtered avoiding foaming. The filtration step was repeated using a 
syringe filter with pore size of 1.2 µm (BGB Analytik). The appropriate volume of clarified lysate 
(mg grindate intended to use for the experiment times 9) was transferred into a 15 ml conical 
tube (or 1.5 ml tube) and washed IgG-coupled beads were added. In case of working with several 
lysates in parallel, care was taken to use an equal volume of each lysate for the experiment and to 
divide the IgG-coupled beads equally between the samples. mRNA-protein complexes were 
captured by rotating the samples at minimal rpm (Reax 2, Heidolph) for 30 min at 4°C. A 100 µl 
aliquot of input material was stored at -20°C for western blot analysis of MS2CP-PrAx2 capture 
and cell grinding efficiency. A second aliquot of 150 µl was snap frozen in LN2 and stored at -
20°C for total RNA extraction. During lysate-bead incubation the tube containing the cell debris, 
which had been stored on ice while preparing the lysate, was spun down at 3020 x g for 5 min at 
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4°C, the supernatant was removed by aspiration and the pellet was resuspended in ice cold 
ddH2O equal to the volume of RNPB-150 used for resuspending the grindate. A 100 µl aliquot 
was removed and stored at -20°C for western blot analysis of cell grinding efficiency. 
After 30 min of binding, the tubes were placed on magnet and the supernatant was 
allowed to clear. 100 µl of cleared supernatant (flow through) was transferred into a 1.5 ml tube 
and stored at -20°C for western blot analysis of MS2CP-PrAx2 capture efficiency. A second 
aliquot of 150 µl was snap frozen in LN2 and stored at -20°C for total RNA extraction. The 
supernatant was removed from beads by pipetting (1.5 ml tube) or by aspiration (15 ml tube). 1 
ml of ice cold RNPB-150 was added to the tube for washing and the beads were resuspended by 
gentle pipetting in order to prevent disruption of captured complexes. During the first washing 
step beads were transferred from 15 ml tube into 1.5 ml tube. Washing with RNPB-150 was 
repeated once, followed by two washing steps with 1 ml of ice cold Final Wash Buffer (FWB). 
After this, either bead-captured RNA was extracted or mRNP proteins were release by RNase 
treatment. 
RNP Buffer 150  Final Wash Buffer  
20 mM Hepes (pH 7.4) 20 mM Hepes (pH 7.4) 
110 mM KAc 1 mM MgCl2 
150 mM NaCl 40 mM NaCl 
0.5% (v/v) Triton X-100 Prepared fresh before use 
0.1% (v/v) Tween-20  
0.02% (v/v) Antifoam B (Sigma-Aldrich)  
1:100 Solution P (added directly before use)  
Prepared fresh before use  
 
 
Bead-captured RNA extraction 
IgG-coupled beads with the bound mRNPs were resuspended in FWB (2 times the initial bead 
volume) supplemented with 0.1% (v/v) SDS and 200 µg/ml Proteinase K (Fermentas Thermo 
Scientific) and incubated on a water bath at 30°C for 30 min. During the incubation, beads were 
mixed every 10 min by tapping the 1.5 ml tube with a finger. After Proteinase K treatment, equal 
volume of TRI Reagent (Applied Biosystems® Life Technologies) was added to the beads and 
mixed by vortexing for 30 sec. The sample was incubated at RT for 5 min, after which 1/10 TRI 
Reagent volume of 1-bromo-3-chloropropane (Sigma-Aldrich) was added. The sample was mixed 
by vortexing and incubated at RT for additional 10-15 min. The sample wash shortly spun down 
in order to collect liquid form the lid and placed on magnet to capture the beads. The organic and 
aqueous phase was mixed by pipetting and transferred onto a pre-spun Phase Lock Gel Heavy 2 
ml (PGL, 5 Prime) tube. The PGL tube was centrifuged at 16 000 x g for 5 min at RT (5415 R, 
Eppendorf) and the aqueous RNA-containing phase was transferred into a fresh 1.5 ml tube. An 
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equal volume of chloroform (Sigma-Aldrich) was added to the tube, mixed by pipetting and 
incubated at RT for 2 min. The sample was loaded onto a pre-spun PGL tube and the 
centrifugation was repeated as above. The aqueous phase was transferred into a new 1.5 ml tube. 
The following solutions were added to the RNA sample: 1/10 RNA sample volume 3 M sodium 
acetate (pH 5.2), 0.5 µl Pellet Paint Co-Precipitant (EMD Millipore), 2.5 RNA sample volume 
absolute EtOH and 10 µg/ml Linear Acrylamide (Ambion® Life Technologies, amount 
calculated according to the final volume of RNA sample plus EtOH). The sample was mixed by 
vortexing and RNA was precipitated at -20°C overnight. The next day RNA was collected by 
centrifugation at 16 000 x g for 15 min at 4°C. After removing the supernatant by pipetting, 500 
µl of 75% EtOH was added into the tube in order to remove salt from RNA pellet and the 
sample was centrifuged at 16 000 x g for 5 min at 4°C. After removing most of the 75% EtOH, 
the sample was briefly spun down and the remaining of the liquid was removed by pipetting. The 
sample was allowed to air-dry for 2 min at RT, after which the pellet was dissolved in 12 µl 
HPLC-H2O per 400 mg initial grindate. 
 
 
mRNP protein release by RNase treatment 
For RNase treatment beads were resuspended in 1.2 times the initial bead volume of FWB. 
Subsequently, 1/24 of FWB volume of RNase Cocktail (Ambion® Life Technologies) was added 
and the sample was mixed at 24°C for 30 min on Thermomixer comfort (Eppendorf) using the 
following settings: 10 sec at 1400 rpm, 1 min break. After RNase treatment the sample was 
shortly spun down and the beads were captured on magnet. RNase eluate containing the mRNP 
proteins was transferred into a fresh 1.5 ml tube. The beads were washed with one initial bead 
volume of HPLC-H2O by pipetting, the water was pooled with the eluate and the sample was 
vacuum dried (Vacuum Concentrator, Bachofer). Vacuum drying took about 1.5 h for 250 µl 
sample. The dry eluate samples, as well as the magnetic beads, were stored at -20°C for further 
analysis. 
RNase treatment was performed with a modification for SILAC-labelled grindates. 
Specifically, before RNase treatment the washed beads from two parallel affinity purifications 
were mixed. For this, the beads in one tube were resuspended in 200 µl FWB and added to the 
beads in the other tube. The empty tube was rinsed with an additional 200 µl of FWB in order to 
collect all the beads into one tube. FWB was removed from the pooled beads and RNase 
treatment was performed as described above.  
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Total cellular RNA extraction  
An equal volume of phenol-chloroform-isoamyl alcohol (PCI, Roti-Aqua-PCI for RNA 
extraction, Carl Roth) was added to the frozen input (I) and flow through (FT) samples and 
vortexed until the samples had thawed. In order to allow mRNA-protein complexes to dissociate, 
samples were incubated at RT for 5 min and then the organic and RNA-containing aqueous 
phase were separated by centrifugation at 16 000 x g for 5 min at RT. The upper aqueous phase 
was transferred into new 1.5 ml tubes, 2.5 volumes of cold absolute EtOH was added, mixed and 
RNA was precipitated for 10 min at RT. The samples were centrifugation at 16 000 x g for 10 
min at 4°C to collect the RNA. RNA pellets were washed with 1 ml 75% cold EtOH, centrifuged 
at 16 000 x g for 5 min at 4°C and the air-dried pellets were dissolved in 50 µl HPLC-H2O. 
A small amount of grindate (~ 50 µl) was transferred into a pre-cooled 1.5 ml tube. 400 µl 
PCI and 600 µl Cross RNA Buffer I were added to the tube and vortexed for mixing. The sample 
was incubated at RT for 5 min and RNA extraction was continued as described for I and FT 
samples. 
Cross RNA Buffer I 
0.3 M NaCl  
10 mM Tris-HCl (pH 7.5) 
1 mM EDTA (pH 8.0) 
0.2% (w/v) SDS 
Stored at 4°C  
Before use the bottle was swirled to equally distribute precipitated SDS 
 
 
 
RNA analysis 
 
Northern blot analysis 
Denaturing agarose gel electrophoresis and capillary transfer of RNA onto positively charged 
nylon membrane was performed as described in (Jellbauer 2009). 
 
Hybridization probe synthesis 
Radiolabelled probe synthesis. α-[32P]-dCTP labeled DNA probes (Table 5) were synthesized 
using Prime-lt II Random Primer Labeling Kit (Agilent Technologies) according to the 
manufacturer’s manual. 25 ng PCR product was used per labelling reaction and the reaction 
products were purified from unincorporated nucleotides with probe cleanup spin columns. 
 
 
MATERIALS and METHODS 
 
67 
 
Table 5. Radiolabeled DNA probes for northern blot analysis. 
DNA probe 
Template DNA for labelling by random priming 
DNA probe length (nt) 
PCR template PCR primers 
ASH1 RJP 88 
RJO 176 
RJO 217 
1020 
PGK1 RJP 1573 
RJO 302 
RJO 303 
1226 
 
DIG-labelled probe synthesis. Antisense RNA probes were synthesized by in vitro transcription 
in the presence of digoxigenine-11-UTP (Roche Applied Science) using MEGAshortscript Kit 
(Life Technologies) according to the manufacturer’s manual (Table 6). 100 nM PCR product 
containing a T7 RNA polymerase promoter site was used as template DNA for in vitro 
transcription.  
Table 6. Antisense RNA probes for northern blot analysis. 
RNA probe 
Template DNA for in vitro transcription In vitro transcription 
PCR template PCR primers DIG-UTP:UTP Antisense RNA probe length (nt) 
PGK1-ORF RJP 1573 
RJO 3491 
RJO 3939 
1:2.5 154 
MS2L gDNA, RJY 3731 
RJO 4109 
RJO 3938 
1:2 120 
18S gDNA, RJY 3731 
RJO 4139 
RJO 4140 
1:2.5 138 
25S gDNA, RJY 3731 
RJO 4141 
RJO 4120 
1:2.5 148 
 
Northern blot hybridization 
Hybridization of DNA probes. DNA probe hybridization and signal detection were performed 
as described in (Jellbauer 2009). 
Hybridization of antisense RNA probes. Hybridization was performed with minor 
modifications as described in Engler-Blum et al. (Engler-Blum et al. 1993). Briefly, the membrane 
was prehybridized at 68°C with gentle rolling in hybridization oven/shaker (Amersham GE 
Healthcare Life Sciences) for a minimum of 2 h in 20 ml/100 cm2 Prehybridization Solution. 100 
ng denatured DIG-labelled RNA probe was added to the hybridization tube per ml of 
Prehybridization Solution and incubated overnight. After hybridization, the membrane was 
washed 3 x 20 min at 65°C with 50 ml of preheated Wash Buffer I. Subsequently, the membrane 
was transferred from the hybridization tube into a box and incubated with gentle rocking for 5 
min at RT in Wash Buffer II. Before antibody incubation the membrane was blocked in 1 
ml/cm2 Blocking Solution for 1 h, after which Anti-Digoxigenin-alkaline phosphatise, Fab 
fragments (Roche Applied Science) was added at 1:5000 dilution. After 1 h of antibody 
incubation the membrane was washed 2 x 15 min in 100 ml Wash Buffer II. The membrane was 
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equilibrated in Detection Buffer for 3 min and ready-to-use CSPD chemiluminescent substrate 
(Roche Applied Science) was applied on the membrane according to manufacturer’s instructions. 
Chemiluminescence was detected using LAS-3000 image acquisition system (Fujifilm) equipped 
with a cooled digital CCD camera.  
Prehybridization Solution 
250 mM Na-phosphate buffer (pH 7.2) 
10% (w/v) SDS 
0.5% (w/v) Blocking Reagent (Roche) 
Prepared fresh by adding Blocking Reagent (stock 5% (w/v)) 
Blocking Solution  
Wash Buffer II 
0.5% (w/v) Blocking Reagent  
Prepared fresh by adding 
Blocking Reagent (stock 5% (w/v)) 
Wash Buffer I 
20 mM Na-phosphate buffer (pH 7.2) 
1 mM EDTA 
1% (w/v) SDS 
Stored at RT 
Detection Buffer  
0.1 M Tris-HCl (pH 9.5) 
 0.1 M NaCl 
50 mM MgCl2 
Stored at RT 
Wash Buffer II 
0.1 M maleic acid (pH 8.0) 
3 M NaCl 
0.3% (v/v) Tween-20 
Stored at RT 
 
 
 
Real-time quantitative reverse transcription PCR (qRT-PCR) 
DNase treatment and cDNA synthesis 
Input and Flow Through RNA samples. In order to digest genomic DNA, total cellular RNA 
was treated with RQ1 RNase-Free DNase (Promega) prior to cDNA synthesis. 9 µl reaction 
containing 1 µg RNA, 1 U RQ1 DNase, 1 µl 10x RQ1 DNase Reaction Buffer and HPLC-H2O 
was pipette into a 200 µl thin wall PCR tube and incubated for 30 min at 37°C. All incubation 
steps during DNase treatment and cDNA synthesis were performed in a PCR cycler with a 
heated lid. Reaction was terminated by adding 1 µl RQ1 DNase Stop Solution (sample total 
volume 10 µl) and subsequently DNase was denatured by incubating the reaction for 10 min at 
65°C. RNA was reverse-transcribed using High Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems® Life Technologies). cDNA synthesis was performed in a total volume of 
12 µl containing 600 ng of DNase treated RNA, 1.2 µl 10x RT Buffer, 1.2 µl 10x RT Random 
Primers, 0.6 µl 25 mM dNTPs, 0.6 µl MultiScribe Reverse Transcriptase and HPLC-H2O. Per 
each RNA sample an 8 µl control reaction containing 400 ng of DNase treated RNA and all 
cDNA synthesis components except reverse transcriptase was prepared. cDNA synthesis was 
performed using the following settings: 10 min 25°, 120 min 37°C, 15 min 85°C. 
Bead-captured RNA samples. DNase treatment and cDNA synthesis were performed using 
the same reagents and incubation conditions as described for I and FT samples. 2 µl bead-
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captured RNA was treated with 0.2 U of DNase in a total volume of 9 µl. 6 µl of the DNase-
treated RNA was used for cDNA synthesis and 4 µl for a control reaction without reverse 
transcriptase.   
 
qRT-PCR 
qRT-PCR was performed using the StepOnePlus Real-Time PCR System (Applied Biosystems® 
Life Technologies). Each reaction contained 5 µl Fast SYBR Green PCR Master Mix (Applied 
Biosystems® Life Technologies), 4 µl appropriately diluted cDNA and 1 µl of primer mix (500 
nM each). Primers were designed using FastPCR software (PrimerDigital, http:// 
primerdigital.com/fastpcr.html). The thermocycling profile included an initial denaturation for 20 
sec at 95°C, followed by 40 cycles of amplification, which comprised denaturation at 95°C for 3 
sec and annealing/elongation at 60°C for 30 sec. A single fluorescence measurement was 
performed at the end of the elongation step of every amplification cycle. After PCR amplification 
melting curve analysis of amplification products was performed to test for the formation of 
primer-dimers and non-specific PCR products. For this, PCR amplification products were 
denatured at 95°C for 15 sec and allowed to reanneal at 60°C for 1 min. Subsequently, the 
temperature was increased in 0.3°C increments to 95°C (step-and-hold fluorescence 
measurement). Only those primer pairs (Table 7) were used for further analysis that did not 
generate any primer-dimers during the 40 PCR amplification cycles. Reactions were run in 
duplicate or in triplicate and included a no template control (cDNA replaced by ddH2O). 
 
Table 7. qRT-PCR target genes. Input refers to the RNA extracted from clarified lysate before the mRNP 
isolation step. Bead captured-RNA refers to the RNA extracted from IgG-coupled beads after mRNP isolation. 
Amplification efficiency (E) estimates for each target were calculated using a 5 fold serial dilution curve with 
five data points. 
 
Target gene Primers 
cDNA dilution 
E 
Input Bead-captured RNA 
PGK1 
RJO 4132 
RJO 4133 
20 or 100 100 1.926 
TPI1 
RJO 4135 
RJO 4136 
20 or 100 100 1.896 
ACT1 
RJO 2920 
RJO 2921 
20 or 100 100 1.944 
ENO2 
RJO 2916 
RJO 2917 
20 or 100 100 1.935 
25S 
RJO 4141 
RJO 4149 
1000 100 1.935 
18S 
RJO 4139 
RJO 4148 
1000 100 1.986 
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qRT-PCR data analysis 
qRT-PCR amplification efficiency. In order to determine qRT-PCR amplification efficiency 
(E) for each target, 5 fold serial dilutions were prepared from a cDNA sample corresponding to 
input RNA of strain RJY 3739. cDNA dilutions ranging from 10-fold to 6250-fold were run in 
triplicate and StepOne Software version 2.2 was used to generate the standard curve for each 
target. Using the slope of the linear regression line, the software calculates E of one cycle in the 
exponential phase according to the equation: E=5(-1/slope). Only those primer pairs were used for 
further analysis that showed an E value between 0.9-1 (Table 7). 
Relative quantification of qRT-PCR results. Relative quantification of qRT-PCR results was 
performed by comparative CT method (also known as the 2
 –ΔΔCT) combined with kinetic qRT-
PCR efficiency correction (Pfaffl 2001). In this model the relative expression ratio (R) of a target 
gene is calculated based on its E, and threshold cycle (CT) difference (Δ) of one unknown sample 
(e.g. drug treated sample) versus one control (e.g. untreated sample), and expressed in 
comparison to a reference gene (Pfaffl 2001) (Equation 1). 
 
Equation 1 R = (Etarget) 
ΔCT target (control – sample) ÷ (Eref) 
ΔCT ref (control – sample) 
 
In order to give an overview about how equation 1 was applied in this study, the steps of 
calculating  PGK1-6MS2L  relative enrichment after PGK1-mRNP affinity purification are listed. 
In this calculation PGK1-6MS2L and PGK1 are defined as “target” mRNAs and TPI1, ACT1 and 
ENO2 as “reference” mRNAs. For PGK1-6MS2L mRNA (and its respective reference mRNAs) 
“control” is the CT value of input sample and “sample” is the CT value of bead-captured RNA 
sample (both CT values correspond to the strain harbouring PGK1-6MS2L). Conversly, for PGK1 
mRNA (and its respective reference mRNAs) “control” is the CT value of input sample and 
“sample” is the CT value of bead-captured RNA sample (both CT values correspond to strain 
harbouring PGK1). Relative quantification of all the qRT-PCR experiments in this study was 
done analogous to the below described case.  
1) Calculation of ΔCT (normalization) 
a) CT values of strain harbouring PGK1-6MS2L 
Target ΔCT PGK1-6MS2L (CT input PGK1-6MS2L - CT bead-captured PGK1-6MS2L)  
Reference ΔCT TPI1/ACT1/ENO2 (CT input TPI1/ACT1/ENO2 - CT bead-captured TPI1/ACT1/ENO2) 
b) CT values of strain harbouring PGK1 
Target ΔCT PGK1 (CT input PGK1 - CT bead-captured PGK1) 
Reference ΔCT TPI1/ACT1/ENO2 (CT input TPI1/ACT1/ENO2 - CT bead-captured TPI1/ACT1/ENO2) 
 
2) Calculation of EΔCT from target and reference ΔCT values 
 
3) Calculation of relative expression ratio R 
a) EΔCT PGK1-6MS2L ÷ EΔCT 
TPI1/ACT1/ENO2 
b) EΔCT PGK1 ÷ EΔCT 
TPI1/ACT1/ENO2 
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4) Calculation of relative enrichment of PGK1-6MS2L as compared to PGK1 
R PGK1-6MS2L (TPI1/ACT1/ENO2) ÷ R PGK1 (TPI1/ACT1/ENO2) = x 
R PGK1 (TPI1/ACT1/ENO2) ÷ R PGK1 (TPI1/ACT1/ENO2) = 1 
 
5) Calculation of average (corresponding to TPI1, ACT1 and ENO2) relative enrichment of 
PGK1-6MS2L 
 
Reverse transcription PCR (RT-PCR) 
DNase treatment and cDNA synthesis 
Input and Flow Through RNA samples. DNase treatment of total RNA was carried out as 
described above for qRT-PCR experiment and reverse-transcribed into cDNA using reagents 
from Fermentas (Thermo Scientific). All the incubation steps during DNase treatment and 
cDNA synthesis were performed in a PCR cycler with heated lid. 15 µl reaction containing 1 µg 
DNase treated RNA, 50 pmol Oligo(dT) Primer, 50 pmol Random Hexamer Primer and 1 µl 10 
mM dNTPs was incubated for 5 minutes at 65°C in order to denature RNA secondary structures 
and rapidly cooled down on ice. 4 µl of 5x RT Buffer and 0.5 µl (20 U) of RiboLock RNase 
inhibitor were added to the reaction. Subsequently, 12 µl of the reaction was transfered into a 
new tube and 0.6 µl (120 U) RevertAid Premium Reverse Transcriptase was added. Reverse 
transcriptase was not added to the remaining 7.5 µl of reaction in order to have a control for 
genomic DNA contamination. cDNA syntheses was performed for 40 minutes at 55 °C followed 
by heat inactivation of the enzyme for 5 minutes at 85 °C.  
Bead-captured RNA samples. DNase treatment and cDNA synthesis were performed using 
the same reagents and incubation conditions as described for I and FT samples. 2 µl bead-
captured RNA was treated with 0.2 U of DNase in a total volume of 10 µl. 5 µl of the DNase-
treated RNA was used for cDNA synthesis and 5 µl for a control reaction without reverse 
transcriptase.  
 
Protein analysis 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)  
Sample preparation. 5x Laemmli Sample Buffer (Laemmli 1970) was added to lysate samples 
taken from I, FT and pellet material to obtain a 1x solution and proteins were denatured by 
heating for 10 min at 70°C. Vacuum dried RNase eluate containing the mRNP proteins was 
dissolved in 10 µl Solution A and heated for 5 min at 70°C, after which 10 µl Solution B was 
added and heated for an additional 10 min at 70°C. After removing the RNase eluate form the 
IgG-coupled beads, the beads were resuspended in 40 µl Solution A and B mix (1:1, v/v) and 
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heated for 10 min at 70°C. The beads were captured on a magnet and the protein-containing 
supernatant was transferred into a new 1.5 ml tube. Beads were resuspended in an additional 40 
µl Solution A and B mix, heated for 2 min at 70°C and the supernatant was pooled with the 
previous supernatant to obtain a 4x diluted sample as compared to the RNase eluate. Prior to 
loading on SDS-PAGE, the samples were spun down at 16 000 x g for 2 min at RT. 
Protein gel electrophoresis. SDS-PAGE was performed as described in (Sambrook and Russell 
2001). Standard gels were run using Mini-PROTEAN Tetra Cell electrophoresis system (BioRad) 
at 100 V for 20 min, followed by 150 V until the dye front had reached the lower edge of the gel. 
NuPAGE Novex 4‐12% Bis‐Tris gels (Invitrogen™ Life Technologies) were run according to 
manufacturer’s manual. 
 
Western blot 
Protein transfer onto membrane. Towbin Transfer Buffer without methanol was used for 
electrophoretic protein transfer onto PVDF membrane. Semi-dry transfer was carried using 
Trans-Blot SD (Bio-Rad) semi-dry transfer device at 12 V (1 gel) or 18 V (2 gels) for 35 min. If 
efficient transfer of large proteins (>100 kDa) was desired, transfer was performed in Mini 
Trans-Blot (Bio-Rad) tank transfer system for 1 h at 350 mA. Two types of PVDF membranes 
were used depending on the nature of the signal to be detected. Proteins were transferred onto 
Hybond-P (Amersham GE Healthcare Life Sciences) for chemiluminescent signal detection and 
onto Immobilon-FL (EMD Millipore) for fluorescent signal detection following the 
manufacturer’s guidelines for membrane handling. 
Solution A  
0.5 M Tris-HCl (pH 8.0) 
5% SDS (w/v) 
Stored at RT 
Laemmli Sample Buffer (1x) 
60 mM Tris-HCl (pH 6.8) 
2% SDS (w/v) 
10% glycerol (v/v)  
5% β-mercaptoethanol, 710 mM 
0.01% bromphenol blue 
Stored at -20°C 
Towbin Transfer Buffer 
25 mM Tris 
192 mM glycine 
Solution B  
75% glycerol (v/v) 
124.5 mM DTT 
0.05% bromphenol blue (w/v) 
Stored at -20°C 
 
 
Protein detection. Membrane blocking and antibody incubation was performed using SNAP i.d. 
Protein Detection System (EMD Millipore) according to the manufacturer’s manual. Membrane 
was blocked with phosphate-buffered saline (PBS) solution containing 0.2% (w/v) non-fat dry 
milk and 0.1% (v/v) Tween-20. Routinely, membrane was incubated with antibody solution for 
20 min. After the final washing step in SNAP i.d., the membrane was removed from the blot 
holder and was washed with gentle rocking for an additional 10 min in PBS-0.1% (v/v) Tween-
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20. Horseradish peroxidise enzymatic activity was detected with ECL Western Blotting Substrate 
(Pierce Thermo Scientific) and chemiluminescent image was captured with LAS-3000 or 
MultiImage II (Alpha Innotech) imaging system and quantified using FluorChem FC2 image 
analysis software (Alpha Innotech). Fluorescent signal was detected with Odyssey Infrared 
imaging system (LI-COR) and quantified using Image Studio (Li-COR).  
 
 
Protein visualization by staining 
In order to visualize mRNA co-purifying proteins, an RNase eluate volume corresponding to 
~200 mg initial grindate used for mRNP affinity purification was separated on  10% SDS-PAGE 
and the proteins were stained using SilverQuest Silver Staining Kit (Invitrogen™ Life 
Technologies) according to the Basic Staining Protocol. For protein identification by mass 
spectrometry, an RNase eluate volume corresponding to ~1 g of initial grindate was separated on 
NuPAGE Novex 4‐12% Bis‐Tris Gel (Invitrogen™ Life Technologies) and stained using 
Colloidal Blue Staining Kit (Invitrogen™ Life Technologies). 
 
 
Mass spectrometry-based quantitative proteomics  
MS analysis of MS2L-tagged mRNA co-purifying proteins was conducted at Proteome Center 
Tübingen (http://www.pct.uni-tuebingen.de/index.php?id=2) by Dr. Mirita Frantz. Briefly, 
SILAC-labelled RNase eluate was separated by 1D SDS-PAGE and the gel was cut into several 
slices, which were subjected to in-gel enzymatic digestion of proteins with LysC endoproteinase. 
Liquid chromatography (LC) coupled to electrospray and tandem MS (MS/MS) analysis of 
peptide mixture was performed on Easy-nLC (Proxeon Biosystems) nanoscale chromatography 
system coupled to Linear Trap Quadrupole (LTQ)-Orbitrap XL mass spectrometer (Thermo 
Scientific). The raw MS spectra containing peptide mass and intensity information were 
processed and prepared for database search using MaxQuant software (Cox and Mann 2008). 
MS/MS spectra were searched using the Mascot search engine against a yeast database containing 
common contaminants and a reversed version of all sequences.  
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AIMS 
 
In order to elucidate the mechanisms of mRNA regulation it is important to know which 
proteins interact with the mRNA during its lifetime. Methodological advances in high-throughput 
methods such as quantitative mass spectrometry have allowed to compile a comprehensive list of 
mammalian and yeast RNA-binding proteins (Baltz et al. 2012; Castello et al. 2012; S. F. Mitchell 
et al. 2013). However, the analysis of mRNA-bound proteome of specific cellular mRNPs has 
been hampered due to the lack of a suitable method that would combine fast and easy affinity 
purification of specific mRNPs with efficient identification of the captured proteins. Therefore, 
the aims of the current study were: (1) to develop an mRNP affinity purification method that can 
be used to capture in vivo-assembled mRNPs form S. cerevisiae; and (2) to test the applicability of 
the method for mRNA-bound proteome analysis using SILAC-based quantitative proteomics for 
the identification of mRNP proteins. Our goal was to study mRNP composition under normal 
yeast growth conditions with glucose as the carbon and energy source. We wished to get an idea 
of the full spectrum of mRNA-protein and protein-protein interactions mRNPs are involved in 
during their lifetimes. Therefore, the mRNP affinity purification method was optimized to 
prevent mRNA degradation and to preserve ribosome-association with the mRNA. In order to 
test whether the established mRNP affinity purification method is suitable for the analysis of 
mRNA-bound proteome, proteins co-purifying with the two abundant cellular mRNAs, PGK1 
and ENO2, were identified. Another goal of the study was to determine which proteins have the 
potential to interact with the RNA-tag that was chromosomally integrated after the translation 
termination codon to “mark” endogenous PGK1 and ENO2 mRNAs for affinity purification. 
Therefore, the proteins co-purifying with a plasmid-encoded mRNA-like transcript containing 
the RNA tag sequence were analysed. 
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RESULTS 
 
Single-step mRNP affinity purification strategy 
 
We isolate endogenously assembled mRNA-protein complexes from Saccharomyces cerevisiae via the 
mRNA component of the mRNP. In order to capture the mRNA of interest the mRNA is 
tagged before the 3′ UTR with  binding sites for bacteriophage MS2 coat protein (MS2CP), which 
is a 421 nt long sequence containing 6 stably folding stem-loop structures (MS2L) (Haim et al. 
2007). mRNPs assembled on tagged messages are captured from cell lysate by using the wt 
version of MS2CP (Jou et al. 1972) fused with 4 IgG-binding Z domains of Staphylococcus aureus 
protein A (MS2CP-PrAx2) (B. Nilsson et al. 1987). 
Conventional yeast cell lysis methods, such as glass bead milling and French press, result 
in rapid RNA degradation upon cell wall disruption (López de Heredia and Jansen 2004). Our 
strategy for preserving mRNP integrity includes cryolysis and fast mRNP capture by magnetic 
separation (Fig. 5). Previously, a similar strategy was used to isolate complexes containing protein 
A-tagged RNA binding proteins (Oeffinger et al. 2007). We adopted this method for mRNA-
based mRNP affinity purification by replacing protein elution under denaturing conditions with 
selective RNA-associated protein release via ribonuclease (RNase) treatment. Finally, proteins co-
isolating with MS2L-tagged mRNAs are identified by mass spectrometry.  
 
 
Optimization of mRNP affinity purification 
 
mRNA integrity during mRNP affinity purification 
For efficient mRNP capture only minor degradation of MS2L-taggd mRNA during mRNP 
affinity purification is tolerable. Therefore, we first wanted to know if RNase inhibitors are 
needed to keep RNA intact while performing the experiment. We tested the effect of 3 different 
RNase inhibitors on mRNA integrity: (1) E. coli tRNA (500 µg/ml) as a competitor substrate for 
RNases; (2) heparin (500 µg/ml) as a non-specific RNase inhibitor; and (3) recombinant RNasin 
(50 U/ml) as a protein that inactivates RNases via non-covalent binding. In the negative control  
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Figure 5. Experimental workflow of mRNP affinity purification. After harvesting, S. cerevisiae cells are frozen 
in liquid nitrogen and disrupted under cryo conditions using Retch mixer mill MM400. Cell grindates can be 
stored at -80°C until proceeding with mRNP isolation. Upon grindate resuspension in buffer, cell debris is spun 
down and the lysate is filtered. IgG-coupled superparamagnetic particles (Dynabeads) are incubated with the 
lysate for 30 min at 4°C, then captured by magnetic force, washed and used either for bead-captured RNA or 
protein extraction. RNA is isolated by Proteinase K digestion followed by PCI extraction and proteins are eluted 
by RNase A/T1 treatment. Isolated RNA and proteins are analysed. 
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RNase inhibitors were not added to the lysate. As a positive control for non-degraded RNA total 
RNA was extracted directly from yeast cell grindate by phenol-chlorophorm-isoamyl alcohol 
(PCI) extraction. The experiment was performed similarly to mRNP affinity purification except 
that the IgG-coupled beads were not added to the lysate. Samples for total RNA extraction were 
taken at different steps of the protocol, i.e. from crude lysate, from clarified lysate and from 
clarified lysate incubated at 4°C for 30 min and for 1 h.  
We examined the stability of plasmid encoded ASH1 (Fig. 6A) expressed under GAL1 
promoter control and genomically encoded PGK1 (Fig. 6B). ASH1 was chosen as a 
representative of an unstable transcript. The mRNA exhibits a half-life of around 3 min when 
expressed from the wild-type allele introduced at ASH1 locus by gene replacement (Zheng et al. 
2008). In contrast, PGK1 is a very stable yeast transcript with a half-life of more than 60 min 
(Grigull et al. 2004; Y. Wang et al. 2002). 
RNA samples were analysed by northern blot. Smear underneath the signal 
corresponding to the full-length transcript indicates mRNA degradation. ASH1 degradation was 
observed already in the clarified lysate for samples not containing any RNase inhibitors (Fig. 6A, 
lane 7) or only tRNA (Fig. 6A, lane 8). Furthermore, rRNA was not entirely intact in these 
samples as shown by smearing of rRNA signal on methylene blue stained membrane. After 30 
min of incubation, the full-length transcript seemed to be entirely degraded in the absence of 
RNase inhibitors (Fig. 6A, lane 11) and after 1 h also in the presence of tRNA (Fig. 6A, lane 16). 
Additionally, extensive rRNA degradation was observed for these samples. Remarkably, tRNA in 
combination with heparin or heparin and RNasin prevented ASH1 degradation even after 1 h of 
lysate incubation (Fig. 6A, lane 17 and 18). Sharp 25S and 18S rRNA bands on methylene blue 
stained membrane also indicated intact rRNA.  
Surprisingly, endogenous PGK1 transcript seemed to be relatively stable throughout the 
whole experiment even in the absence of RNase inhibitors (Fig. 6B, lanes 2, 6, 10, 14) as no 
prominent smearing was observed. The lower signal intensity of the full-length mRNA in the 
clarified lysate that was incubated for 30 min in the absence of RNase inhibitors (Fig. 6B, lane 10) 
could be explained by less total RNA loaded as the signals for 25S and 18S rRNAs were also 
slightly weaker on methylene blue stained membrane. 
We concluded that RNase inhibitors are crucial to preserve mRNA integrity if mRNP 
purification of overexpressed mRNAs with a short half-life, like ASH1, is performed. In this case 
a combination of tRNA and heparin should be used as tRNA alone did not allow efficient 
mRNA protection. Addition of RNasin is not essential; in the presence of tRNA and heparin 
RNasin did not seem to provide any additional mRNA stabilizing effect. However, in case of the 
stable endogenous PGK1 transcript RNase inhibitors are not needed. Astonishingly, PGK1 did 
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not show obvious degradation in any of the samples even after 1 h of lysate incubation (Fig. 6B 
lanes 14-17).  
 
 
 
Figure 6. RNase inhibitors are needed to prevent degradation of overexpressed ASH1 but not endogenously 
expressed PGK1 during mRNP affinity purification. The effect of yeast tRNA (500 µg/ml), heparin (500 µg/ml) 
and recombinant RNasin ribonuclease inhibitor (50 U/ml) on mRNA stability was tested in two experiments 
imitating mRNP affinity purification. Yeast cell lysate was handled similarly to mRNP purification except that 
IgG-coupled beads were not added. Aliquots for total RNA extraction by PCI were taken after: (1) grindate 
resuspension in mRNP-isolation buffer (crude); (2) removal of cell debris by centrifugation at 4000 x g 
(clarified); (3) incubation of clarified lysate at 4°C for 30 min; (4) and for 1 h. RNA extracted by PCI directly from 
grindates was used as a control for intact RNA (grindate). 5 µg of total RNA was separated on 1.2% agarose-
formaldehyde gels and transferred onto positively charged nylon membranes. After methylene blue staining, 
the membranes were hybridized with radiolabelled DNA probes against ASH1 (A) or PGK1 (B). The hybridization 
signal corresponding to the full-length transcripts and the position of 25S and 18S rRNAs on methylene blue 
stained membranes are indicated. (A) ASH1 was expressed for 1 h from centromeric plasmid (RJP 1433) in 
response to 4% galactose in logarithmically growing Δash1 strain (RJY 135) before cell harvesting. RNA 
extracted from strain RJY 135 not containing ASH1-encoding plasmid shows a non-specific crosshybridization 
band with ASH1 probe (lane 1, Δash1). RNA extracted from grindate after 1h of galactose induction of ASH1 
(pASH1) (B) Δash1 strain (RJY 135) expressing PGK1 from the genomic locus. 
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TAP-She2p as a tool for mRNP affinity purification optimization 
Starting point of mRNP affinity purification optimization – high non-specific mRNA and 
protein binding to IgG-coupled beads  
Specificity is an important aspect of any affinity purification method. In case of mRNP pull-
down the result should essentially be free of non-specific mRNAs to avoid contamination by 
RNA-binding proteins not belonging to the mRNP of interest. She2 is a yeast RNA-binding 
protein (Böhl et al. 2000) that targets several transcripts to the distal tip of the daughter cell 
(Long et al. 1997; Shepard et al. 2003). mRNA localization is achieved by She2 directly binding to 
the mRNA and linking it via the adaptor protein, She3, to the myosin Myo4 motor. Myo4 then 
delivers the cargo along actin cables to the bud tip (Müller et al. 2009; Müller et al. 2011). 
Öffinger et al. showed that affinity purification of PrA-tagged She2 resulted in co-purification of 
a very distinct set of proteins – She3, Myo4, Myo2 and Act1 (Oeffinger et al. 2007) – making 
She2 a perfect bite for accessing the specificity of an affinity tag-based RNA-protein complex 
purification method. Moreover, She2 affinity purification would also allow to characterize the 
method’s specificity at the RNA level as more than 30 transcripts are known to specifically co-
isolate with She2 (Shepard et al. 2003; Oeffinger et al. 2007).  
In order to optimize our mRNP affinity purification protocol we first determined the 
level of non-specific adhesion of cellular mRNAs and proteins to the IgG-coupled beads. As an 
equivalent to She2-PrA used by Öffinger et al. (Oeffinger et al. 2007) we used TAP-She2. TAP is 
a double epitope tag (Rigaut et al. 1999) that, in our case, consists of an N-terminal PrA tag 
followed by the tobacco etch virus (TEV) protease cleavage site and a calmodulin binding 
peptide. TAP-She2 purification was performed under low stringency conditions (here and 
hereafter low stringency conditions refer to the use of 110 mM KAc as the only salt in RNP 
Buffer) in the presence of E. coli tRNA, heparin and RNasin. In a parallel control purification a 
lysate containing the untagged wt version of She2 was used. After washing, half of the beads were 
used to isolate bead-captured RNA by proteinase K digestion and PCI extraction, while the other 
half was used to elute proteins under denaturing conditions.  
Western blot comparison of TAP-She2 signal in input and flow through samples using 
anti-She2 antibody showed that about 50% of TAP-She2 was isolated from the lysate after 
incubation with IgG-coupled beads (Fig. 7A, upper panel, compare lanes 2 and 4). TAP-She2 
capture from lysate was confirmed by the analysis of the eluate sample with peroxidase anti-
peroxidase soluble complex (PAP) antibody (Fig. 6A lower panel, lane 6). In the untagged strain 
She2 signal intensity in samples taken before and after lysate incubation with IgG-coupled beads 
remained constant (Fig. 7A, upper panel, compare lanes 1 and 3). This finding argues that She2 is 
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not non-specifically captured by the beads. Unfortunately, the eluate sample of mock purification 
could not be used to analyse the possible non-specific binding of She2 to IgG-coupled beads 
because the about 25 kDa rabbit IgG light chain present in the eluate cross-reacts with the 
primary and/or secondary antibody used for She2 detection, thereby resulting in a signal in 30-25 
kDa region and masking the possible non-specifically bound She2 signal (Fig. 7A, upper panel, 
compare lanes 5 and 6). 
 
 
 
Figure 7. High non-specific RNA and protein binding to IgG-coupled beads as the starting point for mRNP 
affinity purification protocol optimization. Grindates of strains RJY 359 and RJY 3166 expressing the wt (mock) 
or TAP-tagged version of She2 (TAP), respectively, were subjected to TAP-She2 affinity purification using IgG-
coupled superparamagnetic beads. mRNP capture and washing was performed in the presence of 110 mM KAc. 
(A) Upper panel: She2 and TAP-She2 immunodetection with α-She2 antibody 1C3-11. Quantification of 
western blot signal is indicated below the lanes. On lanes 2 and 4 a signal at about 34 kDa is visible. This signal 
may correspond to TAP-She2 proteolytic degradation product that has lost the protein A part of the tag 
because the signal is not detectable on the lower panel. Lower panel: TAP-She2 immunodetection with 
peroxidase anti peroxidase (PAP) soluble complex. Inp – input, lysate after removal of cell debris; FT – flow 
through, immunodepleted lysate; E – eluate, proteins eluted under denaturing conditions from IgG-coupled 
beads. Proteins were separated on 12% SDS-PAGE. (B) Silver staining of Inp and E samples separated on a 4-
12% NuPAGE Novex BisTris gel. (C) RT-PCR analysis of RNA isolated from IgG-coupled beads by Proteinase K 
digestion and PCI extraction. TAP-She2 co-isolating mRNAs ASH1 and SRL1 were amplified from serially diluted 
cDNA. -RT, control for genomic DNA contamination (reverse transcriptase omitted); +RT, cDNA; H2O, negative 
control lacking cDNA template.  
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The comparison of She2 signal in input and flow through samples suggested that She2 is 
not non-specifically captured by IgG-coupled beads (Fig. 7A, upper panel, compare lanes 1 and 
3). However, silver staining of the affinity eluates revealed an identical protein pattern for both 
the TAP-She2 and the untagged strain (Fig. 7B, compare lanes 4 and 5), indicating high non-
specific protein binding to the beads. Furthermore, RT-PCR uncovered that She2 target mRNAs 
ASH1 and SRL1 (Shepard et al. 2003; Oeffinger et al. 2007) were present at similar levels in 
bead-captured RNA samples of both the TAP-She2 and the untagged control strain (Fig. 7C). 
This was surprising as western blot analysis had suggested no non-specific She2 binding to the 
beads. The RT-PCR result could be explained by high levels of non-specific mRNA attachment 
to the beads, possibly via non-specifically bound polyribosomes. In this case the contribution of 
the low levels of specifically captured ASH1 and SRL1 to the signal intensity of semi-quantitative 
RT-PCR could be masked by high levels of non-specifically captured ASH1 and SRL1. 
 
Small changes can make a big difference – revised IgG coupling to Dynabeads 
We assumed that the high non-specific mRNA binding to our IgG-coupled beads might arise 
from a small modification of the coupling protocol published by Öffinger et al. (Oeffinger et al. 
2007). Namely, after coupling beads are washed extensively to remove non-covalently bound 
IgG. One of the steps includes washing 5 times for 5 min with PBS. During this step we added 
insulin (0.05% w/v) and E. coli tRNA (200 µg/ml) to the washing buffer to block the sites on the 
beads that have the potential to non-specifically interact with proteins and RNA. Analogous 
blocking agents are regularly used to block sepharose beads, which are incubated with low-
immunogenic proteins such as BSA (C. Gilbert and Svejstrup 2012) or with tRNA (Slobodin and 
Gerst 2010) prior to using in immunoprecipitation experiments.  
We prepared a new batch of IgG-coupled beads completely following the protocol by 
Öffinger et al. (Oeffinger et al. 2007). Neither insulin nor E. coli tRNA were used as blocking 
agents. In addition, a new magnetic separation rack for 15 ml tubes was used. This enabled to 
reduce the bead capture time after washing from about 2 min to 20 sec. Fast removal of two 
washing solutions, one containing 100 mM glycine and the other 100 mM triethylamine, is 
important according to Öffinger et al. (Oeffinger et al. 2007).  
Using the new batch of IgG-coupled beads, TAP-She2 affinity purification was repeated 
under low stringency conditions. In parallel, we further wanted to test if the addition of tRNA, 
heparin and RNasin during mRNP capture was necessary for preserving mRNA integrity as had 
been observed earlier for overexpressed ASH1 (Fig. 6A). Therefore, TAP-She2 affinity 
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purifications were performed either in the presence or in the absence of the above mentioned 
RNase inhibitors. 
RT-PCR analysis of bead-captured RNA samples (Fig. 8A) indicated that ASH1 was 
enriched to a comparable extent both in the presence and in the absence of tRNA, heparin and 
RNasin. The same was observed also for SRL1. In order to study the level of non-specific 
mRNA binding, PCR was performed with primers specific for PGK1 and SOD1. These two 
mRNAs should not specifically co-isolate with TAP-She2. PGK1 signal could be detected for 
undiluted cDNA sample if TAP-She2 purification had been performed in the absence of tRNA, 
heparin and RNasin. In contrast, SOD1 signal was detected for undiluted and for 10-fold diluted 
cDNA if tRNA, heparin and RNasin had been present. Importantly, the signal of She2-target 
mRNAs was stronger than the signal of control mRNAs in all the tested cDNA dilution, 
indicating that non-specific RNA binding to the beads had not been as extensive as in the 
previous experiment (compare Fig. 7C and 8A). Therefore, IgG coupling to the beads was 
hereafter carried out using the new magnetic separation rack and excluding the blocking agents 
insulin and E. coli tRNA. 
 
 
 
Figure 8. Optimization of mRNP affinity purification protocol to reduce non-specific RNA binding to IgG-
coupled beads. (A) TAP-She2 co-isolating mRNAs are enriched to a similar extent after TAP-She2 affinity 
purification both in the absence (-) and presence (+) of RNase inhibitors. Using IgG-coupled beads, two parallel 
purifications from lysate containing TAP-She2 (strain RJY 3166) were carried out either in the absence of RNase 
inhibitors or in the presence of E. coli tRNA (500 µg/ml), heparin (500 µg/ml) and recombinant RNasin 
ribonuclease inhibitor (20 U/ml). mRNP capture and washing was performed in the presence of 110 mM KAc. 
Bead-captured RNA was isolated by Proteinase K digestion and PCI extraction and reverse transcribed. The 
levels of TAP-She2p target mRNAs ASH1 and SRL1 as well as negative control mRNAs PGK1 and SOD1 were 
determined by PCR from serially diluted cDNA. +RT, cDNA; -RT, control for genomic DNA contamination 
(reverse transcriptase omitted); H2O, negative control lacking cDNA template. (B) TAP-She2 purification in the 
presence of 150 mM NaCl results in reduced non-specific RNA binding to IgG-coupled beads. Lysates containing 
untagged wt She2 (strain RJY 359, mock) or TAP-She2 (RJY 3166, TAP) were used for TAP-She2 affinity 
purification with IgG-coupled beads. mRNP capture and washing was performed in the presence of 150 mM 
NaCl and 110 mM KAc. Bead-captured RNA was isolated and subjected to RT-PCR as described in (A).  
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It is likely that TAP-She2-bound mRNAs are protected from RNases as ASH1 and SRL1 
enrichment by TAP-She2 resulted in similar efficiencies independent of the presence of RNase 
inhibitors. Addition of tRNA, heparin and RNasin did not also seem to influence the extent of 
non-specific RNA capture as PGK1 could be detected in the absence and SOD1 in the presence 
of RNase inhibitors. Therefore, in the subsequent experiments tRNA, heparin and RNasin were 
omitted from the mRNP affinity purification.   
 
Increased buffer stringency reduces non-specific RNA binding to IgG-coupled beads to 
minimum 
In order to further reduce the non-specific RNA binding by IgG-coupled beads, we increased the 
stringency of mRNP capture conditions and performed the next TAP-She2 affinity purification 
in the presence of 150 mM NaCl (RNP Buffer 150, see Methods for buffer composition). Mock 
purification of wt untagged She2 served as the negative control.   
Addition of 150 mM NaCl to TAP-She2 capture and washing steps resulted in a dramatic 
increase in affinity purification specificity (Fig. 8B). ASH1 and SRL1 could only be detected in 
bead-captured RNA samples of the TAP-She2 strain. Control mRNA PGK1 could neither be 
detected in the eluate of the untagged nor of the TAP-She2 strain. A similar result was obtained 
also for SOD1 except that a very weak signal was detected for the undiluted cDNA sample of the 
TAP-She2 strain. 
 
 
PGK1 mRNA isolation via MS2L::MS2CP-PrA::IgG interaction 
Having optimized mRNP affinity purification conditions, we wanted to test if MS2L-tagged 
PGK1 could be specifically captured using our method. Lysates containing MS2CP-PrAx2 and 
either the wt untagged PGK1 or the 6MS2L-tagged PGK1 were subjected to mRNP affinity 
purification. Bead-captured RNA analysis by RT-PCR showed that PGK1 was enriched only if 
the mRNA contained the MS2L tag (Fig. 9A, upper panel, lanes 4-6). No PGK1 PCR product 
could be detected for mock purification of untagged PGK1 (Fig. 9A, upper panel, lanes 1-2). In 
order to further analyse the levels of non-specific mRNA capture, RT-PCR was performed with 
primers for SOD1 and ADH1. These mRNAs were chosen as controls because their transcript 
copy number is in the same range compared to PGK1, which on average has 177 copies per cell 
grown on YEPD (Miura et al. 2008). ADH1 and SOD1 have 306 and 93 copies per cell, 
respectively. PCR products could be detected for neither of the control mRNAs even after 30 
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PCR cycles (Fig. 9A lower panel, lanes 1-4), thus confirming low non-specific mRNA capture by 
IgG-coupled beads using the optimized mRNP affinity purification protocol (see Methods, 
“mRNP affinity purification protocol”). 
 
 
 
Figure 9. PGK1-6MS2L affinity purification – analysis of co-purifying RNAs and proteins. (A) PGK1-6MS2L is 
specifically enriched after mRNP affinity purification. Lysates containing MS2CP-PrAx2 and PGK1-6MS2L (MS2L, 
strain RJY 3683) or, as a control, MS2CP-PrAx2 and the untagged wt PGK1 (no tag, strain RJY 3682) were 
subjected to mRNP affinity purification using IgG-coupled beads. Bead-captured RNA isolated by Proteinase K 
digestion and PCI extraction was used in RT-PCR analysis. PGK1 (upper panel) and negative control mRNAs 
SOD1 and ADH1 (lower panel) were amplified from serially diluted cDNA. -RT, control for genomic DNA 
contamination (reverse transcriptase omitted); +RT, cDNA; H2O, negative control lacking cDNA template. (B) 
mRNP protein elution via RNase treatment enables detection of specifically enriched proteins. Lysate 
containing PGK1-6MS2L and MS2CP-PrAx2 (strain RJY 3682) was subjected to mRNP affinity purification 
(MS2L). As a negative control, lysate expressing untagged wt version of PGK1 and MS2CP-PrAx2 (strain RJY 
3683) was used (no tag). RNA-associated proteins were eluted using RNase A/T1, eluates were resolved on 4-
12% NuPAGE Novex BisTris gel and stained with Colloidal Blue.  Two bands were specifically enriched for PGK1-
6MS2L affinity purification. These bands, as well as the corresponding parts of the negative control lane, were 
analysed by mass spectrometry and the identified proteins are indicated by red (Upf1-), green (Pab1, 
Ssb1/Ssb2, Ded1) and black (Ded1) arrowheads.  
 
 
RNase treatment of affinity-captured mRNPs enables identification of 
PGK1-6MS2L co-isolating proteins 
After optimization of mRNP capture conditions our mRNP affinity purification method fulfilled 
two requirements for a reliable mRNP affinity purification method – specific enrichment of 
MS2L-tagged message and negligible background binding of non-specific mRNAs (Fig. 9A). 
Next, we wanted to test if PGK1-6MS2L purification would result in co-isolation of specifically 
enriched proteins. In order to release only RNA-associated proteins, we decided to use RNase 
A/T1 treatment for protein elution (Michlewski and Cáceres 2010). 
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PGK1-6MS2L affinity purification resulted in the detection of two specific bands 
compared to the negative control, the untagged wt PGK1 (Fig. 9B). These bands were analysed 
by mass spectrometry and altogether four proteins were identified: Upf1, Pab1, Ssb1/Ssb2 and 
Ded1. The analysis of the corresponding parts of the negative control lane identified Ded1. 
Interestingly, all of the four proteins have a role in mRNA life cycle. Furthermore, three of them 
(Upf1, Pab1, Ded1) can directly bind RNA (Chakrabarti et al. 2011; Iost, Dreyfus, and Linder 
1999; A. B. Sachs, Davis, and Kornberg 1987). This result implies that intact endogenous mRNPs 
can be isolated via MS2L-tagged mRNA.  
 
 
Formaldehyde crosslinking and cycloheximide treatment  
as means of mRNP composition stabilization 
Silver stained eluates from several PGK1-6MS2L affinity purification experiments revealed a 
similar protein pattern showing two specifically enriched bands in the upper molecular weight 
region and faint bands in the lower molecular weight region (Fig. 10A, lanes 1-2 and data not 
shown). Due to a weak signal it was not possible to spot clear differences in the protein patter 
between the MS2L-tagged PGK1 and the untagged control below the 60 kDa marker band. 
Consequently, we addressed the question whether stabilization of the mRNP composition would 
allow us to detect more specifically enriched proteins in PGK1-6MS2L affinity purification. In 
addition, we wanted to confirm Upf1 co-isolation with PGK1-6MS2L by western blot analysis. 
For that, thee copies of c-myc epitope tag were inserted at the C-terminus of Upf1. 
First, we tried out cross-linking with 0.05% formaldehyde (v/v) as described by (Slobodin 
and Gerst 2010) to stabilize mRNA-protein and protein-protein interactions (Fig. 10A). This 
resulted in the detection of more bands in the lower molecular weight region when compared to 
the untreated control. However, no additional specifically enriched bands for PGK1-6MS2L 
purification were observed after cross-linking. Therefore, it was decided not to use formaldehyde 
cross-linking in the subsequent experiments. 
Western blot analysis clearly demonstrated that Upf1-3myc specifically co-purified with 
MS2L-tagged PGK1 but not with the untagged control (Fig. 10C). Interestingly, a fraction of 
Upf1-3myc remained on the beads even after RNase treatment (Fig. 10C, lanes 4 and 8). This 
could be caused by incomplete RNA degradation during RNase treatment or, alternatively, by 
non-specific attachment of the released protein to IgG-coupled beads. The signal intensity of 
Upf1-3myc was comparable between the input and immunedepleted samples (Fig. 10B, 
uppermost panel, compare lanes 3-4 and 7-8). This is not surprising as probably only a minor 
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fraction of total cellular Upf1-3myc is bound to PGK1-6MS2L. The analysis of MS2CP-PrAx2 
capture efficiency indicated that roughly 50% of the protein present in the lysate was bound to 
IgG-coupled beads during the 30 min of incubation time (Fig. 10B, middle panel). MS2CP-PrAx2 
capture efficiency of around 50% was routinely observed if 15 mg of IgG-coupled beads per 1 g 
cell grindate was used (data not shown). 
 
 
 
Figure 10. Formaldehyde crosslinking does not result in the detection of additional specifically enriched 
proteins. Lysates containing MS2CP-PrAx2 together with untagged wt PGK1 (strain RJY 3740, no tag) or 6MS2L-
tagged PGK1 (strain RJY 3739, MS2L) were used for mRNP affinity purification. (A) Comparison of RNase eluate 
patterns of untreated and 0.05% formaldehyde cross-linked cells. During harvesting cells were cross-linked with 
0.05% formaldehyde (v/v) for 10 min (+) or this step was omitted (-). After mRNP affinity purification RNA-
associated proteins were released by RNase A/T1 treatment. Eluate volume corresponding to 185 mg initial 
grindate used for the experiment was loaded on each lane, separated on 10% SDS-PAGE and silver stained. Red 
arrowheads indicate the bands previously identified as Upf1, and green arrowheads as Pab1, Ssb1/Ssb2, Ded1. 
(B) Western blot analysis of Upf1-3myc levels with anti-myc antibody 9E10 (upper panel) and MS2CP-PrAx2 
with PAP (lower panel). Quantification of MS2CP-PrAx2 signal is indicated below the lanes (100 = control band). 
I – input, lysate after removal of cell debris; FT – flow through, immunodepleted lysate. 5 µl of sample was 
loaded on each lane and separated on 10% gel. Equal loading was verified by Ponceau S staining of the 
membrane. (C) Western blot analysis of Upf1-3myc co-isolation with PGK1-6MS2L using anti-myc antibody 
9E10. E – eluate, RNA-associated proteins eluted by RNase A/T1 treatment; BB – boiled beads, in order to 
remove proteins bound to beads after RNase treatment, beads were boiled in SDS-sample buffer.  
 
Next, we used the protein synthesis inhibitor cycloheximide (CHX) to stabilize mRNPs 
that are associated with or part of translating ribosomes. CHX blocks the translocation step of 
elongation (Tatyana V. Pestova and Hellen 2003; Obrig et al. 1971; Schneider-Poetsch et al. 2010) 
and thereby stalls ribosomes on the transcript (Fig. 11). We reasoned that performing cell 
harvesting and mRNP capture in the presence of CHX (0.1 mg/ml) should result in more 
ribosomes co-isolating with PGK1-6MS2L. Most yeast ribosomal proteins have a size of 10-30 
kDa (Michel, Traut, and Lee 1983). Upon CHX treatment it was therefore expected to find more 
proteins in that molecular weight range for PGK1-6MS2L affinity purification.  In addition, if 
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translation is stalled during the pioneer round, CHX treatment can also prevent ribosomes from 
removing other mRNA-binding proteins from the transcript, possibly leading to the detection of 
additional specifically enriched bands (Dostie and Dreyfuss 2002; Lejeune et al. 2002; Sato and 
Maquat 2009). 
 
 
 
Figure 11. Cycloheximide (CHX) treatment does not result in the detection of additional specifically enriched 
proteins. Lysates containing MS2CP-PrAx2 together with untagged wt PGK1 (strain RJY 3740, no tag) or 6MS2L-
tagged PGK1 (strain RJY 3739, MS2L) were used for mRNP affinity purification. (A) Comparison of RNase eluate 
patterns of untreated and 0.1 mg/ml CHX treated cells. In case of CHX treatment (+) cell harvesting and mRNP 
purification was carried out in the presence of 0.1 mg/ml CHX. For control cells CHX was omitted (-). Eluate 
volume corresponding to 360 mg initial grindate used for the experiment was loaded on each lane, separated 
on 10% SDS-PAGE and silver stained. Red arrowhead indicates the band previously identified as Upf1, and 
green arrowheads as Pab1, Ssb1/Ssb2, Ded1. (B) Western blot analysis of Upf1-3myc levels with α-myc 
antibody 9E10. I – input, lysate after removal of cell debris; FT – flow through, immunodepleted lysate. 5 µl of 
sample was loaded on each lane and separated on 10% gel. Equal loading was verified by Ponceau S staining of 
the membrane. (C) Western blot analysis of Upf1-3myc co-isolation with PGK1-6MS2L using α-myc antibody 
9E10. E – eluate, RNA-associated proteins eluted by RNase A/T1 treatment; BB – boiled beads, in order to 
remove proteins still bound to beads after RNase treatment, beads were boiled in SDS-sample buffer.  
 
Surprisingly, in this experiment we could detect distinct protein bands in the lower 
molecular weight region also for the control lysates, which were not treated with CHX (Fig. 11A, 
lanes 1-2). However, the protein pattern below 60 kDa did not significantly differ between the 
untagged control strain and PGK1-6MS2L strain. In fact, the pattern in that region was very 
similar among all four samples. The only clearly detectable difference between CHX-treated and -
untreated lysates was that the band corresponding to Upf1 had disappeared upon CHX treatment 
(Fig. 11A, compare lanes 2 and 4). This could be confirmed also by western blot analysis (Fig. 
11C, compare lanes 3-4 and 7-8). The total Upf1 level in the lysates remained constant upon 
CHX treatment (Fig. 11B). Altogether, CHX treatment did not lead to improved results and was 
therefore not used in the subsequent experiments. 
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mRNP affinity purification recapitulated 
Before applying our affinity purification method to analyse the protein composition of PGK1-
6MS2L containing mRNPs we further wanted to characterize the performance of the method. 
The individual aspects of the method’s performance not yet studied included: (1) integrity of 
bead-captured PGK1-6MS2L mRNA; (2) precise enrichment levels of PGK1-6MS2L compared to 
control purification; (3) efficiency of PGK1-6MS2L affinity purification; (4) the levels of non-
specific ribosome binding to IgG-coupled beads compared to specific ribosome enrichment via 
co-isolation with PGK1-6MS2L; and (5) the influence of cell harvesting method on PGK1-6MS2L 
affinity purification. 
We addressed all these questions in one experiment. Starting from question no. 5, we 
prepared grindates for mRNP affinity purification following two different cell harvesting 
protocols. Previously we had been performing harvesting according to the protocol by Öffinger 
et al. (Oeffinger et al. 2007), where cells are collected and washed at 4°C in the absence on amino 
acids and glucose. Due to many washing and centrifugations steps it takes about 1.5 h before 
yeast cells are frozen in liquid N2. This lengthy procedure is likely to alter the translational profile 
of the cells. Ashe et al. have shown that in yeast after 2.5 min of glucose deprivation actively 
translating polyribosomes almost entirely redistributed into 80S monosomes (Ashe, De Long, 
and Sachs 2000). However, polyribosomes could be preserved if harvesting was carried out in the 
presence of glucose and amino acids (Inada et al. 2002; Ashe, De Long, and Sachs 2000). Our 
goal was to study mRNP composition under physiological conditions. Therefore, we tested a new 
protocol that allowed the completion of the whole harvesting process in only 20 min. Cells were 
collected by vacuum filtration and washed once. This washing step was performed in the 
presence of glucose and amino acids at room temperature as described by Inada et al. (Inada et al. 
2002). Grindates prepared from cells harvested according to the above-mentioned protocols we 
subjected to 4 parallel mRNP affinity purifications. In order to answer the questions about 
PGK1-6MS2L integrity, enrichment and capture-efficiency, as well as ribosomal RNA levels, 
lysate samples for total RNA extraction before and after mRNP isolation were collected and 
bead-captured RNA was extracted.  
 
Affinity purified PGK1-6MS2L integrity and enrichment level 
Northern blot analysis using a probe complementary to a 154 nt long sequence in the second half 
of PGK1 ORF (Fig. 12A) indicated specific capture of the ~2 kb long PGK1-6MS2L full-length 
mRNA (Fig. 12B, uppermost panel). Mock purifications with lysates containing untagged wt 
PGK1 mRNA (~1.6 kb) did not result in any detectable hybridization signal (Fig. 12B, uppermost 
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panel, lanes 9-11 and 15-17). In contrast, PGK1-6MS2L could be detected in up to 100-fold 
diluted bead-captured RNA samples (Fig. 12B, upper panel, lane 14 and 20). No extensive smear 
beneath the signal corresponding to the full-length transcript was observed suggesting affinity 
purification of mostly intact PGK1-6MS2L. However, hybridization with a probe complementary 
to 120 nt in the MS2 stem-loop region (Fig. 12A) revealed the presence of a large fraction of 
5′→3′ shortened PGK1-6MS2L RNA species (Fig. 12B, lower panel). Interestingly, the intensity 
of the smear appeared higher if cells had been harvested according to Öffinger et al. (Oeffinger et 
al. 2007) (Fig 12B, lower panel, compare lanes 13 and 19). Full-length PGK1-6MS2L 
quantification indicated that about 1.3-times more of the tagged transcript was captured if cells 
had been harvested according to Inada et al. (Inada et al. 2002).  
Interestingly, the level of total PGK1-6MS2L was considerably lower than that of PGK1 
(Fig. 12B, upper panel, compare lanes 1 and 3, 5 and 7). This does not seem to influence cell 
fitness, as the tagged and untagged strains have similar growth rates (data not shown). Minor 
mRNA degradation was observed for both PGK1 and PGK1-6MS2L in the input samples. The 
degradation levels did not seem to increase during the 30 min of mRNP capture as the intensity 
of the smear underneath the full-length transcript remained about equal between input and flow 
through samples. This observation is in good agreement with the previous result showing that 
endogenous PGK1 is stable even in the absence of RNase inhibitors (Fig. 12B, lower panel).  
By the time of performing the described experiment quantitative real-time reverse 
transcription PCR (qRT-PCR) analysis had become available in our laboratory. This enabled us to 
determine the precise PGK1-6MS2L level after affinity purification (Fig. 13A). Relative 
enrichment analysis (see Methods, “Relative quantification of qRT-PCR results”) indicated more 
than 1000-fold enrichment of PGK1-6MS2L compared to PGK1. Slightly more PGK1-6MS2L 
was affinity-captured if cells had been harvested according to Inada et al. (Inada et al. 2002). The 
1.52-fold difference between the two harvesting methods correlates well with northern blot 
quantification results (Fig. 12B, compare lanes 13 and 19). 
 
 
 
Figure 12. (A) In scale diagram of PGK1 ORF and 6MS2L region. Annealing sites for hybridization probes (PGK1-
ORF and MS2L) are indicated as well as start codon (ATG), stop codon (STOP), loxP site (orange bar) and six 
MS2-loops (green bars). Figure 12B, see next page.  
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Figure 12. (B) Northern blot analysis of affinity captured PGK1-6MS2L integrity (see next page). Yeast cells 
containing MS2CP-PrAx2 together with PGK1-6MS2L (MS2L, strain RJY 3827) or PGK1 (no tag, strain RJY 3828) 
were harvested following two different protocols. The first protocol (Öffinger) involves harvesting at 4°C in the 
absence of glucose and amino acids, whereas in the second protocol (Inada) cells are collected at growth 
temperature in the presence of the above mentioned nutrients. Samples for total RNA analysis were taken 
before (I – input) and after (FT – flow through) PGK1 mRNP isolation. Bead-captured RNA was isolated form 
IgG-coupled beads by Proteinase K and PCI treatment. 1.5 µg total RNA as well as 1/6
th
 (1), 1/60
th
 (10) and 
1/600
th
 (100) of bead-capture RNA were separated on 1.3% agarose-formaldehyde gels and blotted onto 
positively charged nylon membranes. After methylene blue staining, the membranes were hybridized with DIG-
UTP-labelled antisense RNA probes complementary to PGK1 ORF (upper panel) or beginning of 6MS2L-tag 
(MS2L, lower panel). The hybridization signal corresponding to the full-length transcript, as well as non-specific 
cross-reaction with 25S rRNA, is indicated. On a methylene blue stained membrane, 25S and 18S rRNAs are 
marked. Quantification of the selected hybridization signals is indicated below the lanes (1 = control band). 
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Figure 13. Relative enrichment and capture efficiency of PGK1-6MS2L after PGK1-mRNP affinity purification. 
Yeast cells expressing MS2CP-PrAx2 together with wt untagged PGK1 (no tag, strain RJY 3828) or 6MS2L-tagged 
PGK1 (MS2L, strain RJY 3827) were collected for mRNP affinity purification following 2 different harvesting 
protocols (Öffinger, Inada). (A) mRNP affinity purification results in more than 1000-fold enrichment of PGK1-
6MS2L compared to PGK1. Affinity-purified RNA was isolated form IgG-coupled beads by Proteinase K digestion 
and PCI extraction and subjected to qRT-PCR analysis. The level of affinity-captured PGK1-6MS2L or PGK1 was 
normalized to the level of the corresponding transcript in input RNA sample. The same normalization was 
applied to control mRNAs TPI1, ACT1 and ENO2. Data is presented as the arithmetic mean (indicated above the 
bars) of three relative enrichment values (corresponding to 3 control mRNAs) ± standard deviation, n=1. (B) 
Only negligible amount of total PGK1-6MS2L is affinity captured. qRT-PCR analysis of PGK1 and PGK1-6MS2L 
levels before (Inp – input, lysate after removal of cell debris) and after ( FT – flow through, immunodepleted 
lysate) mRNP isolation. PGK1 and PGK1-6MS2L levels in Inp and FT were normalized to TPI1, ACT1 and ENO2. 
The normalized PGK1 and PGK1-6MS2L levels in Inp (value 1) were compared to the levels in FT. Data is 
presented as the arithmetic mean of three relative PGK1 or PGK1-6MS2L levels in FT (corresponding to 3 
control mRNAs) ± standard deviation, n=1. 
 
In order to get an idea about the capture-efficiency of the tagged PGK1, its level in the 
lysate before and after incubation with IgG-coupled beads was determined by qRT-PCR (Fig. 
13B). The same analysis was performed for untagged PGK1 where a reduction in the level of 
PGK1 after mRNP capture step should reflect the fraction of non-specifically bound and/or 
degraded PGK1. Compared to the input, the untagged PGK1 level did not significantly change 
after mRNP capture. Unexpectedly, the same was observed also for PGK1-6MS2L. Northern 
blot analysis had suggested that a considerable fraction of cellular PGK1-6MS2L had been 
captured on IgG-coupled beads as a reduction in the hybridization signal intensity could be 
observed by visual comparison of input and flow through samples (Fig. 12B, upper panel, 
compare lanes 3 and 4, 7 and 8; lower panel, compare lanes 7 and 8). However, after repeating 
the northern blot several times a similar signal reduction in flow through sample was observed 
only for some of the experiments, whereas in other experiments the signal intensity of PGK1-
6MS2L appeared equal for input and flow through samples (Fig. 12B, lower panel, lanes 3-4 and 
data not shown). The inconsistencies in northern blot results, as well as the large variability of 
qRT-PCR data, make it impossible to precisely assess the mRNP capture efficiency. However, 
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these data suggest that only a minor fraction of total cellular PGK1-6MS2L is captured onto IgG-
coupled beads. 
 
The level of total cellular PGK1 or PGK1-MS2L mRNA and the corresponding protein  
Northern blot quantification indicated a 3.85- and 1.79-fold reduction in total PGK1-6MS2L level 
compared to PGK1 for cells harvested according to Öffinger et al. (Oeffinger et al. 2007) and 
Inada et al. (Inada et al. 2002), respectively (Fig. 12B, upper panel). qRT-PCR confirmed reduced 
total PGK1-6MS2L levels. However, compared to PGK1, the reduction was about 2-fold for both 
of the cell harvesting protocols (Fig. 14A). Interestingly, the analysis of Pgk1 protein level 
showed no difference between the untagged control and PGK1-6MS2L strain (Fig. 14B). Given 
that PGK1 is an essential gene, this finding can explain the similar growth rates of PGK1 and 
PGK1-6MS2L strains (data not shown). As expected, the harvesting method did not have any 
significant effect neither on the total level of PGK1 nor PGK1-6MS2L (Fig. 14C). 
 
 
 
Figure 14. Steady-state level of PGK1 or PGK1-6MS2L mRNA and the corresponding protein. Yeast cells were 
collected for mRNP affinity purification following 2 different harvesting protocols (Öffinger, Inada). Total RNA 
or protein was extracted from cell lysate of strain RJY 3828, containing untagged PGK1 (no tag), or RJY 3827 
containing PGK1-6MS2L (MS2L). (A) Total PGK1-6MS2L level is significantly reduced compared to PGK1. qRT-
PCR analysis of relative steady-state PGK1-6MS2L level compared to PGK1. Untagged or tagged PGK1 level in 
bead-captured RNA sample was normalized to input level of these transcripts. The same normalization was 
applied to control mRNAs TPI1, ACT1, and ENO2. Data are presented as the arithmetic mean (indicated above 
the bars) of three relative enrichment values (corresponding to 3 control mRNAs) ± standard deviation, n=1. 
***, P < 0.001. (B) Pgk1 protein level is not reduced in strain expressing 6MS2L-tagged PGK1 compared to 
untagged PGK1. Western blot analysis of total cell lysates with anti-Pgk1 and anti-She2 antibodies. Pgk1 signal 
was normalized to She2. Quantification of normalized signal is indicated below the lanes (control band in bold). 
(C) PGK1 or PGK1-6MS2L level is not significantly influenced by the cell harvesting method. qRT-PCR analysis  of 
relative PGK1 expression level in cells harvested according to Öffinger et al. compared to Inada et al. Untagged 
or 6MS2L-tagged PGK1 level in bead-captured RNA sample was normalized to input level of these transcripts. 
The same normalization was applied to control mRNAs TPI1, ACT1, and ENO2. Data are presented as the 
arithmetic mean of three relative enrichment values (corresponding to 3 control mRNAs) ± standard deviation, 
n=1.  
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Ribosomal RNA detection in bead-captured RNA samples 
Since mRNA translation is part of the mRNA life cycle, mRNA-based mRNP affinity 
purification should result in co-isolation of ribosomal RNA and proteins. However, ribosomal 
proteins also belong to common contaminants of affinity purifications (Trinkle-Mulcahy et al. 
2008), suggesting non-specific ribosome binding to various types of affinity matrices. Therefore, 
we were interested to compare the level of ribosomes specifically co-isolating with PGK1-6MS2L 
to the level of ribosomes captured due to non-specific attachment to IgG-coupled beads. As 
polyribosomes can easily be lost while cells are collected (Ashe, De Long, and Sachs 2000) we 
also wanted to compare harvesting methods from Öffinger et al. (Oeffinger et al. 2007) and 
Inada et al. (Inada et al. 2002) for the levels of rRNA co-isolation with PGK1-6MS2L.  
Assuming that a higher enrichment level of rRNA after PGK1-6MS2L affinity 
purification compared to mock purification of PGK1 is an indicative of active translation, we first 
performed northern blot analysis with hybridization probes complementary to 25S and 18S 
rRNA (Fig. 15A). rRNA could easily be detected in bead-captured RNA samples both for PGK1-
6MS2L affinity purification and for mock purification of untagged PGK1. However, independent 
of the used harvesting protocol, hybridization signal quantification indicated that rRNA levels 
were lower for mock purification (Fig 15A, compare lanes 10 and 13, 16 and 19), suggesting 
specific ribosome co-isolation with PGK1-6MS2L. Comparison of the cell harvesting protocols 
by Öffinger et al. (Oeffinger et al. 2007) and Inada et al. (Inada et al. 2002) showed that the 
enrichment level of both 25S and 18S rRNA was higher after PGK1-6MS2L affinity purification 
if the latter harvesting protocol was used (Fig. 15A, compare lanes 13 and 19). Remarkably, in the 
mock purification the level of captured rRNA was comparable between the two cell harvesting 
methods (Fig. 15A, compare lanes 10 and 16). This result indicate that the non-specific binding 
of ribosomes to the beads is, in contrast to specific co-isolation with PGK1-6MS2L, not 
influenced by the cell harvesting method. Not surprisingly, a higher level of ribosome co-isolation 
with PGK1-6MS2L was observed for cells harvested in the presence of glucose and amino acids. 
Next, in order to more precisely determine the levels of rRNA, we performed qRT-PCR 
on the same bead-captured RNA samples as used for northern blot analysis (Fig. 15B). Even 
though the absolute enrichment values determined by northern blot quantification and qRT-PCR 
analysis differed, the same trend was observed for both methods. Compared to mock 
purification, rRNA was significantly enriched for PGK1-6MS2L affinity purification for cells 
harvested according to Inada et al. (Inada et al. 2002). A 2.36- and 3.73-fold increase for 25S and 
18S rRNA, respectively, was determined. Surprisingly, the same comparison for cells harvested 
according to Öffinger et al. (Oeffinger et al. 2007) showed almost identical 25S rRNA levels for 
PGK1-6MS2L and mock purification and a nonsignificant increase of 1.79-fold for 18S rRNA.  
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Figure 15. The level of ribosome co-isolation with PGK1 and PGK1-6MS2L. Yeast strain expressing MS2CP-
PrAx2 and wt untagged PGK1 (no tag, strain RJY 3828) or 6MS2L-tagged PGK1 (MS2L, strain RJY 3827) were 
collected for mRNP affinity purification following 2 different harvesting protocols (Öffinger, Inada). Total RNA 
from lysate samples taken before (Inp – input, lysate after removal of cell debris) and after (FT – flow through, 
immunodepleted lysate) mRNP affinity purification was extracted by PCI. Affinity-purified RNA was isolated 
from IgG-coupled beads by Proteinase K digestion and PCI extraction. (A) PGK1-6MS2L affinity purification as 
well as mock purification of PGK1 results in ribosome capture. Northern blot analysis of 25S and 18S rRNA in 
total RNA and bead-captured RNA samples. 1 ng total RNA as well as 1/6
th
 (1), 1/60
th
 (10) and 1/600
th
 (100) of 
bead-capture RNA was separated on 1.3% agarose-formaldehyde gel and blotted onto positively charged nylon 
membrane. 25S and 18S rRNA was detected using DIG-UTP-labelled antisense RNA probes. Hybridization signal 
quantification of 10x diluted samples is shown below the lanes (1 = control band). (B) Cell harvesting according 
to Inada et al. results in significant rRNA enrichment upon PGK1-6MS2L affinity purification. qRT-PCR 
comparison of strains containing PGK1-6MS2L or PGK1 for rRNA enrichment in bead-captured RNA samples. 
rRNA levels in bead-captured RNA samples were normalized to input levels of rRNA. The same normalization 
was applied to control mRNAs TPI1, ACT1, and ENO2. Data is presented as the arithmetic mean (indicated 
above the bars) of three relative enrichment values (corresponding to 3 control mRNAs) ± standard deviation, 
n=1. **, P < 0.01. (C) Cell harvesting method does not influence non-specific ribosome attachment to IgG-
coupled beads. However, it significantly influences the level of ribosome co-isolation with PGK1-6MS2L. qRT-
PCR comparison of two cell harvesting methods for rRNA levels in bead-captured RNA samples. Data are 
presented as the arithmetic mean (indicated above the bars) of three relative enrichment values 
(corresponding to control mRNAs TPI1, ACT1, and ENO2) ± standard deviation, n=1. *, P < 0.05. 
RESULTS 
 
95 
 
Similarly to northern blot analysis, qRT-PCR results suggest specific ribosome co-isolation with 
PGK1-6MS2L for cells harvested according to Inada et al. (Inada et al. 2002). However, in 
contrast to northern blot, qRT-PCR indicated no significant rRNA enrichment for cells harvested 
according to Öffinger et al. (Oeffinger et al. 2007). It should be noted that the northern blot 
signal of 25S and 18S rRNA could not be normalized against a reference gene, whereas qRT-PCR 
results were normalized against three reference genes and should therefore represent a more 
reliable quantification. 
The same qRT-PCR dataset was used for a second comparison to determine if the cell 
harvesting method influenced bead-captured rRNA levels (Fig. 15C). As already observed by 
northern blot analysis (Fig. 15A, compare lanes 9-11 and 15-17), the cell harvesting method did 
not significantly influence the background binding of rRNA to IgG-coupled beads. Specifically, 
PGK1 mock purification from the cells harvested according to Inada et al. (Inada et al. 2002) 
resulted in a non-significant increase of 1.19- and 1.49-fold for 25S and 18S rRNA, respectively, 
as compared to cells harvested according to Öffinger et al. (Oeffinger et al. 2007). In contrast, 
when MS2L-tagged PGK1 was affinity purified, the harvesting protocol by Inada et al. (Inada et 
al. 2002) enabled to capture 2.73- and 3.11-times more 25S and 18S rRNA, respectively, as 
compared to the harvesting protocol by Öffinger et al. (Oeffinger et al. 2007). qRT-PCR thus 
clearly demonstrated that ribosomes co-isolation with PGK1-6MS2L was more efficient if cells 
were harvested in the presence of nutrients. Consequently, in the following experiments the 
harvesting method by Inada et al. (Inada et al. 2002) was used. 
 
 
TEV protease cleavage as a possible alternative to RNase treatment  
for mRNP protein release 
Protein elution via RNase treatment does not only release mRNA-associated proteins, but also 
ribosomal and ribosome-associated proteins via the disintegration of rRNA. A high level of non-
specifically bound ribosomes can therefore pose a problem for mRNP protein composition 
analysis by mass spectrometry because it would reduce the signal to noise ratio, i.e. low 
abundance proteins specifically co-isolating with PGK1-6MS2L could be detected as false-
negative due to the signal overlap with background proteins. We reasoned that proteolytic 
cleavage could confer specific mRNP protein release yet prevent the elution of proteins 
associated with non-specifically attached ribosomes because the rRNA would remain intact 
during proteolytic cleavage. Therefore, a tobacco etch virus (TEV) protease cleavage site was 
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inserted between MS2CP and PrAx2. Upon treatment with TEV protease MS2CP should be 
released from affinity matrix together with the bound mRNP (Fig. 16). 
 
 
 
Figure 16. TEV protease cleavage as an alternative to RNase treatment for releasing affinity purified mRNA-
associated proteins. Yeast lysates containing MS2CP-PrAx2 and an MS2L-tagged transcript were subjected to 
mRNP affinity purification using IgG-coupled magnetic beads. (A) mRNP release from IgG-coupled beads by TEV 
cleavage is inefficient in the presence of bead-captured RNA. After mRNP capture IgG-coupled beads were 
incubated in the presence of 0.2 U/μl TEV protease (Roboklon). An aliquot of beads was taken 0, 30 and 60 min 
after incubation. Bead-bound proteins were released by boiling in SDS-sample buffer and separated on 12% 
SDS-PAGE. MS2CP-PrAx2 was immunodetected with PAP. Signal quantification is indicated below the lanes 
(100 = control band). (B) MS2CP-PrAx2 cleavage by TEV protease is efficient after RNase treatment. Following 
mRNP capture IgG-coupled beads were incubated in the presence of RNase for 30 min and then TEV protease 
was added to a final concentration of 0.2 U/μl. Bead aliquots were taken after 0, 10, 30 and 60 min of TEV 
protease cleavage. Samples were used for MS2CP-PrAx2 immunodetection as described under (A).  
 
In the first TEV protease cleavage time course experiment the protease was added to the 
IgG-coupled beads after mRNP capture to a final concentration of 0.2 U/µl. Western blot 
analysis of cleavage efficiency indicated that at least 90% of bead-bound MS2CP-PrAx2 remained 
uncleaved even after 60 min of incubation (Fig. 16A). Repeating the experiment using a higher 
final TEV protease concentration (0.5 U/µl) did not result in more efficient cleavage (data not 
shown). We assumed that the low proteolytic cleavage efficiency could be possibly due to the 
masking the TEV protease cleavage site. To further investigate this possibility, the time course 
experiment was repeated by first degrading bead-captured RNA by RNase treatment followed by 
TEV protease cleavage (0.2 U/µl, Fig. 16B). In contrast to the previous experiments, a clear time-
dependent reduction in bead-captured MS2CP-PrAx2 signal intensity was observed.  Western 
blot quantification indicated that already after 10 min 63% of MS2CP-PrAx2 had been cleaved. 
After 1 h, the cleavage efficiency had risen to 90%. This result clearly demonstrates that in our 
experimental setup the prerequisite for efficient proteolytic cleavage is the removal of intact 
mRNPs by RNase treatment. Consequently, TEV protease cleavage cannot be used as an 
alternative to RNase treatment for mRNP protein release.  
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Quantitative proteomic analysis of in vivo-assembled  
mRNA-protein complexes 
 
In order to obtain quantitative information about mRNP protein composition we employed 
stable isotope labelling by amino acids in cell culture (SILAC) (Ong et al. 2002). SILAC enables 
the labelling of newly synthesized proteins through normal metabolic process with either the 
natural “light” isotope-containing (i.e. 12C, 14N, H) amino acids or with “heavy” SILAC amino 
acids containing stable isotopes (i.e. 13C, 15N, 2H). Compared to peptides generated from proteins 
containing light amino acids, incorporation of heavy amino acids into proteins results in a mass 
shift of the corresponding peptides. This mass shift can be detected by mass spectrometry and 
upon mixing heavy and light samples in 1:1 ratio, used for the detection of differences in the 
relative protein abundance in these samples. The general workflow of SILAC-based relative 
quantification of mRNP proteins is depicted on figure 17. In the “forward” experiment the 
proteome of the MS2L-tagged yeast strain is labelled with heavy lysine (Lys8) and of the untagged 
control strain with light non-labelled lysine (Lys0, see Methods, “Metabolic labelling by SILAC 
for mass spectrometry-based quantitative proteomics”). Consequently, proteins specifically co-
purifying with MS2L-tagged mRNAs are enriched from the heavy lysate resulting in a heavy (H) 
to light (L) SILAC ratio >1, whereas the non-specific background binders display a H/L ratio 
around 1. In order to be able to detect dynamic protein-protein interactions, mRNP affinity 
purification is performed separately from the two SILAC states (see Methods, “mRNP affinity 
purification protocol”). Mixing heavy and light lysates prior to affinity purification has been 
shown to result in the exchange of dynamically interacting proteins between the heavy and light 
labelled protein complexes, leading to the erroneous identification of dynamically interacting 
proteins as background binders (X. Wang and Huang 2008). To avoid this, two parallel 
purifications are carried out and IgG-coupled beads are combined immediately prior to RNase 
elution. In order to increase the specificity of relative quantification, each SILAC mRNP affinity 
purification is also carried out in “reverse”, i.e. the amino acid labelling conditions are switched 
so that the proteome of the untagged control strain is labelled with Lys8 and of the MS2L-tagged 
strain with Lys0. The H/L ratios of the two biological replicate experiments determined for each 
identified protein are manually analysed to single out proteins specifically co-isolating with the 
tagged mRNAs. Specific binders are characterized by a high H/L ratio (H/L ratio >1) in the 
forward experiment, whereas in the reverse experiment the H/L ratio should have a reciprocal 
value to the forward experiment H/L ratio. 
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Figure 17. Experimental workflow of SILAC-based quantitative proteomic analysis of in vivo-assembled 
mRNA-protein complexes. In the forward experiment the proteome of S. cerevisiae strain expressing MS2L-
tagged mRNA is metabolically labelled with “heavy” isotope-containing lysine (Lys8), whereas the untagged 
control strain is labelled with “light” isotope-containing lysine (Lys0). mRNP affinity purification is carried out in 
parallel from Lys8- and Lys0-labelled cells. IgG-coupled beads with the captured complexes are combined 
immediately before RNase digestion. The protein composition of RNase eluate is analysed by LC-MS/MS. In the 
reverse experiment the amino acid labelling condition are swapped. Proteins specifically co-purifying with 
MS2L-tagged mRNA are characterized by high heavy-to-light ratio in the forward experiment and a low heavy-
to-light ratio in the reverse experiment. Non-specific background binders show 1:1 heavy-to-light ratio under 
both labelling conditions. m/z – mass-to-charge ratio. 
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Using our mRNP affinity purification strategy combined with SILAC-based quantitative 
proteomics, we have analysed the protein composition of mRNPs containing endogenously 
expressed MS2L-tagged PGK1 and ENO2. Besides PGK1, ENO2 was chosen to test the 
applicability of the established mRNP affinity purification method for quantitative analysis of 
mRNP protein composition because, similarly to PGK1, it is a stable and abundant yeast 
transcript (Y. Wang et al. 2002; Grigull et al. 2004; Miura et al. 2008). Affinity purification of 
ENO2-6MS2L-containing mRNPs could therefore be carried out without further optimization of 
the mRNP affinity purification protocol. In addition, we reasoned that PGK1- and ENO2-
containing mRNPs would share similarities in their mRNP protein composition because both 
mRNAs encode enzymes that participate in the same metabolic pathways, glycolysis and 
glyconeogenesis (Lam and Marmur 1977; McAlister and Holland 1982; Hitzeman, Clarke, and 
Carbon 1980). By studying the composition of PGK1- and ENO2-containing mRNPs we wished 
to determine the general mRNP composition of glycolytic enzymes and thereby shed light on the 
proteome of mRNPs translated on cytosolic ribosomes under normal yeast growth conditions 
(Reid and Nicchitta 2012).  
In order to study what proteins might directly bind to the MS2L tag, we have also 
analysed what proteins co-purify with an exogenously expressed RNA containing the 6 MS2 
stem-loops (6MS2L-RNA). The in silico predicted structural and experimentally determined 
functional properties of 6MS2L-RNA will be discussed in the following chapter.   
 
 
Control RNA to determine the effect of MS2L tag on  
mRNP protein composition 
In order to identify the proteins co-purify with the MS2L tag, the 421 bp long loxP-6MS2L 
sequence identical to the MS2L tag present at the genomic loci of PGK1- and ENO2-6MS2L 
genes (Haim et al. 2007) was cloned into a yeast centromeric plasmid under the control of PGK1 
promoter and iso-1-cytochrome c (CYC1) transcriptional terminator (see Materials, Plasmids, 
RJP 1783). The PGK1 promoter was chosen to control 6MS2L-RNA expression in order to 
ensure comparable transcriptional gene expression regulation to PGK1 mRNA. Important 
aspects of 6MS2L-RNA expression that we reasoned would be similar to PGK1 due to PGK1-
promoter controlled transcription were 6MS2L-RNA expression level and transcriptional start 
site (TSS) selection. The cloned PGK1 promoter fragment extended from position –947 to 
position –1 upstream of PGK1 initiator AUG (here and hereafter A is assigned as +1) and 
contained all identified transcription factor binding sites (Chambers et al. 1989; Packham, 
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Graham, and Chambers 1996). The well characterized CYC1 transcriptional terminator sequence  
was used to ensure efficient termination of 6MS2L-RNA transcript (Osborne and Guarente 1989; 
Zaret and Sherman 1982; Russo et al. 1993; Guo and Sherman 1996). 
As both the promoter and transcriptional terminator of 6MS2L-RNA are derived from 
genes transcribed by RNA PolII, the transcript is predicted to carry a 5' cap and 3' poly(A) tail 
(reviewed in Houseley and Tollervey 2009). The predicted size of 6MS2L-RNA is around 680 nt 
(Fig. 18A). PGK1 transcriptional start sites in S. cerevisiae have been mapped to a region spanning 
positions –48 to –27 (van den Heuvel et al. 1989; Hitzeman et al. 1982; Mellor et al. 1985; Z. 
Zhang and Dietrich 2005) with the major TSS mapped to position –40 (Z. Zhang and Dietrich 
2005). We assumed that 6MS2L-RNA transcription is initiated from the same promoter region as 
for PGK1 mRNA, likely at position –40. Several polyadenylation sites in CYC1 gene have been 
mapped to a 58 bp region downstream of position +468 (Russo et al. 1993). Assuming that 
polyadenylation of 6MS2L-RNA would take place at the major poly(A) site spanning positions 
+503 to +505 (Russo et al. 1993; Russo and Sherman 1989), the length of CYC1 3' UTR present 
in 6MS2L-RNA would be around 150 nt. The average poly(A) tail length of CYC1 mRNA is 60 
nt (Christine E. Brown and Sachs 1998; Dheur et al. 2005), which we reasoned would be similar 
for 6MS2L-RNA. 
In order to determine if 6MS2L-RNA carries coding potential, the predicted transcript 
sequence was analysed for the presence of open reading frames with ORF Finder (Sequence 
Manipulation Suit, Version 2). A thorough analysis of 6MS2L-RNA’s coding potential was 
necessary in order to be able to better interpret the SILAC-based quantitative proteomics results. 
The 6MS2L-RNA contains 3 full-length ORFs (containing a start and a stop codon) of at least 30 
codons and 2 full-length ORFs of at least 10 codons, all of which are located in the MS2L-tag 
region. The preferred nucleotide sequence around the initiation codon  in S. cerevisiae is reported 
to be AAAAAAAAAAUGUC (AUG represents the translation initiation codon) (Cavener and 
Ray 1991). Nucleotide bias around the initiation codon in yeast is especially strong at positions –
3, +4 and +5 with the most frequent appearance of A, U and C, respectively (Nakagawa et al. 
2008). PGK1 with the sequence UAUAAAACAAUGUC matches the preferred initiation codon 
context at 11 positions out of 14, including positions –3, +4 and +5. The first AUG triplet of the 
predicted 6MS2L-RNA transcript is located within the loxP site. Importantly, the sequence 
xxxxxxAxAAUGUx (x denotes a mismatch compared to the preferred yeast initiation codon 
context) contains the preferred nucleotides A and U at positions –3 and +4, respectively. The 
nucleotides at positions –3 and +4 are known to have a strong effect on translation initiation 
efficiency (Kozak 1986a) and therefore the presence of the preferred nucleotides at these 
positions is likely to promote translation initiation from the first AUG triplet in 6MS2L-RNA. 
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The predicted ORF is 8 codons long. There are two additional AUG triplets 5' to the 6 MS2 
stem-loops, which, if used as translation initiation sites would encode for 7 and 8 aa long 
peptides. However, as the surrounding sequence of these AUG triplets does not match the 
preferred translation initiation site context in any of the 3 important positions, these AUG 
triplets are not likely to be used as translation initiation codons.   
Each 19 nt long MS2 stem-loop contains 2 AUG triplets. The analysis of the surrounding 
nucleotides revealed several matches with the preferred S. cerevisiae initiation codon context. 
Importantly, in the sequence xxAxAAAxAUGxx an A is present at position –3 and in the 
sequence xxAxxAxxxAUGUC a U and a C are present at positions +4 and +5, respectively. It 
should be noted that in the RNA genome of bacteriophage MS2 the initiation codon of the 
replicase gene is located in the MS2 stem-loop and corresponds to the AUG triplet in the 
sequence xxAxxAxxxAUGUC (Borisova et al. 1979).  
Considering the context of the two AUG triplets present in MS2L sequence, it seems 
possible that both of them could serve as translation initiation codons. However, this would 
mean that the 43S pre-initiation complex would have to scan past at least 3 upstream AUG 
codons. Furthermore, the interaction between MS2 stem-loop and MS2 coat protein is likely too 
strong to be dissociated by the scanning 43S PIC. The physiological role of MS2L-MS2CP 
interaction in the bacteriophage MS2 RNA genome is to repress translation of the viral replicase 
gene (Fouts, True, and Celander 1997; Bernardi and Spahr 1972). To our knowledge, the effect of 
a 5' UTR-located MS2 stem-loop on the translational efficiency of yeast genes in the presence of 
MS2CP has not been studied. However, in E. coli the expression of MS2CP resulted in a 30-50-
fold repression of protein synthesis from MS2 replicase-β-galactosidase reporter gene (Peabody 
1990). In our experimental setup 6MS2L-RNA is expressed in the presence of MS2CP-PrAx2. 
Therefore, the AUG triplets present in MS2L sequence are not likely accessible for translation 
initiation. 
Besides the translation initiation codon context, RNA secondary structures upstream of 
the translation initiation site can have a dramatic effect on translation initiation efficiency (Kozak 
1986b; Babendure et al. 2006). Translation efficiency can be reduced to minimum by a stem-loop 
with thermal stability above –35 kcal/mol, whereas a stem-loop with thermal stability up to –25 
kcal/mol, if not placed directly downstream of the 5' cap, does not significantly influence 
translation efficiency (Babendure et al. 2006). The predicted 6MS2L-RNA transcript was analysed 
for RNA folding with RNAfold from ViennaRNA Web Service (Gruber et al. 2008). As could be 
expected, the first 40 nt of 6MS2L-RNA that are transcribed from the PGK1 promoter did not 
contain any stable RNA stem-loops. The following loxP sequence, where the first AUG triplet of 
6MS2L-RNA is located, forms a stem-loop with minimum free energy of –13.7 kcal/mol and 
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should therefore be efficiently removed by 43S PIC-associated RNA helicase activity (Tatyana V 
Pestova and Kolupaeva 2002; S. F. Mitchell et al. 2010; Rogers et al. 2001; Marintchev et al. 
2009). The MS2 stem-loop has a minimum free energy of –5.3 kcal/mol, which the 43S PIC is 
likely able to unwind only in the absence of MS2CP. 
 
 
 
Figure 18. 6MS2L-RNA is expressed and enriched on IgG-coupled beads after mRNP affinity purification. (A) 
Schematic representation of predicted 6MS2L-RNA transcript. (B) A yeast strain containing plasmids encoding 
for 6MS2L-RNA and MS2CP-PrAx2 (RJY 3989) was used for mRNP affinity purification. Strain RJY 3827, which 
contains plasmid encoded MS2CP-PrAx2 and genomically encoded PGK1-6MS2L, served as positive control. 
RNA extracted from input material (total RNA) and from IgG-coupled beads (bead-captured RNA) was used in 
RT-PCR analysis. 6MS2L tag was amplified from serially diluted cDNA. Quantification of RT-PCR signal is 
indicated below the lanes. To determine the total level of 6MS2L-RNA as compared to PGK1-6MS2L (1 = control 
band), the signals corresponding to total RNA (10x cDNA dilution) were directly compared. To determine the 
level of beads-captured 6MS2L-RNA as compared to PGK1-6MS2L, the signal corresponding to beads-captured 
RNA (500x cDNA dilution) was first normalized to signal corresponding to total RNA (10x cDNA dilution). -RT, 
control for genomic DNA contamination (reverse transcriptase omitted); +RT, cDNA; H2O, negative control 
lacking cDNA template. 
 
Experimental characterization of 6MS2L-RNA involved testing if the predicted transcript 
would be expressed and if it could be captured from yeast cell lysate via MS2L::MS2CP-PrA::IgG 
interaction. For this, a yeast strain transformed with plasmids encoding for 6MS2L-RNA and 
MS2CP-PrAx2 was subjected to mRNP affinity purification. As a positive control, a parallel 
PGK1-6MS2L affinity purification was performed. Indeed, RT-PCR analysis of total RNA 
extracted from input material showed that 6MS2L-RNA is expressed (Fig. 18B, lanes 9-11). 
Quantification of RT-PCR signal indicated that 6MS2L-RNA level in total RNA is 2.3-fold 
higher than that of PGK1-6MS2L mRNA. Analysis of bead-captured RNA demonstrated that 
6MS2L-RNA can also be captured from yeast cell lysate by IgG-coupled beads (Fig. 18B, lanes 
13-15), albeit 2.1-times less efficiently than PGK1-6MS2L.  
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The analysis of quantitative MS data:  
enrichment criteria and distribution of H/L ratios 
Using our mRNP affinity purification strategy combined with SILAC-based quantitative 
proteomics, the proteome of mRNPs containing endogenously expressed 6MS2L-tagged PGK1 
or ENO2 were analysed. In addition, proteins with the potential to co-purify with the 6MS2L-tag 
were identified by affinity capture of plasmid-encoded 6MS2L-RNA. Our first quantitative 
proteomic analysis was performed on PGK1-6MS2L-containing mRNPs. Besides identifying 
proteins that co-purify with PGK1-6MS2L mRNA, we analysed the efficiency of mRNP protein 
release from IgG-coupled beads during RNase treatment. mRNP proteins were first eluted by 
RNase treatment; the remaining proteins were subsequently release by heating the IgG-coupled 
beads in SDS sample buffer at 70°C and both protein samples were analysed by LC-MS/MS. In 
case of ENO2-6MS2L and 6MS2L-RNA affinity purification, only the RNase eluate was analysed 
by LC-MS/MS. The following chapter gives an overview about MS data analysis to identify the 
enriched proteins among MaxQuant-quantified proteins as well as discusses the quality of the 
data. The next chapter will focus on the comparison of proteins enriched in PGK1-6MS2L 
RNase eluate or BB sample to analyse the efficiency of RNase elution. 
The number of proteins identified at a false discovery rate (FDR) of 1% (Käll et al. 2008) 
in the 8 analysed samples is listed in table 8. The enriched proteins were identified by integrating 
the MS data from the forward and reverse labelling experiments. In order to be classified as an 
enriched interaction partner the quantified proteins, i.e. proteins with MaxQuant-assigned H/L 
ratios, had to meet two criteria: (1) proteins identified by a single peptide were considered 
enriched only if in one of the biological replicate experiments the protein was identified by more 
than 1 peptide; (2) the H/L ratio had to meet the set threshold criteria in both forward and 
reverse labelling experiment. In order to facilitate the comparison of H/L ratios of the two 
biological replicate experiments, all normalized H/L ratios were first converted into log2 space. 
We applied two arbitrarily defined thresholds to classify the quantified proteins as enriched: (1) a 
less stringent threshold of log2 (H/L) >0.5 or <–0.5; and (2) a more stringent threshold of log2 
(H/L) >1 or <–1. The thresholds log2 (H/L) >0.5 and >1, which correspond to H/L ratio of 
1.41 and 2, respectively, were applied to identify the enriched proteins in forward labelling 
experiment. The thresholds log2 <–0.5 and <–1, which correspond to H/L ratio of 0.71 and 0.5, 
respectively, were applied to identify the enriched proteins in reverse labelling experiment. 
Using two thresholds of different stringencies enabled us to define two sets of enriched 
proteins: firstly, a set containing specific interaction partners with likely few if any contaminating 
proteins; and, secondly, a set containing also low abundance and/or low affinity interaction 
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partners including possible contaminating proteins. Depending on the MS data set, the low 
abundance proteins comprised 20-40% of all enriched proteins. Figure 19 shows the distribution 
of quantified proteins in each LC-MS/MS run as well as the two subsets of enriched proteins 
identified by comparing log2 (H/L) ratios determined for the forward and reverse experiment. 
Importantly, ~70-90% of quantified proteins in each MS data set did not classify as enriched, 
emphasising the importance of robust quantitative analysis based on SILAC metabolic labelling 
to distinguish between specific interactors and contaminating proteins. The number of proteins 
>1.41-fold enriched (threshold log2 (H/L) >0.5 or <–0.5) in PGK1-6MS2L RNase eluate and BB 
sample, respectively, was 78 and 64. By applying the more stringent threshold of log2 (H/L) >1 
or <–1, which corresponds to >2-fold enrichment, the number of enriched proteins in both data 
sets was reduced roughly by 40% to 45 in RNase eluate and to 39 in BB sample. The number of 
proteins >1.41-fold enriched after ENO2-6MS2L and 6MS2L-RNA affinity purifications was 103 
and 90, respectively. The number of proteins >2-fold enriched was reduced by ~20% to 83 and 
to 71 for ENO2-6MS2L and 6MS2L-RNA, respectively.  
 
Table 8. Number of identified proteins in each LC-MS/MS run. The data were processed with a setting of 1% 
for the FDR, i.e. with an estimation that 1% of all identifications are false-positive.  
 
PGK1 – Boiled Beads PGK1 – RNase eluate ENO2 6MS2L 
for rev for rev for rev for rev 
614 384 688 380 404 312 454 363 
 
Table 9. Number of significantly enriched (significance B <0.01) proteins in each LC-MS/MS run.  
 
PGK1 – Boiled Beads PGK1 – RNase eluate ENO2 6MS2L 
for rev for rev for rev for rev 
28 19 26 18 1 7 14 13 
 
Table 10. SILAC mixing error – median of unnormalized heavy-to-light ratios of each LC-MS/MS run. 
 
PGK1 – Boiled Beads PGK1 – RNase eluate ENO2 6MS2L 
for rev for rev for rev for rev 
0.99 0.67 1.39 0.64 5.21 0.53 0.74 0.92 
 
The largest number of proteins was classified as enriched for ENO2-6MS2L affinity 
purification. However, the number of statistically significant H/L ratio changes, as expressed 
through a quantity termed significance B (Cox and Mann 2008), was the lowest in the 
corresponding forward and reverse experiment MS data sets (Table 9). Notably, in the two MS 
data sets the distribution of log2 (H/L) ratios of proteins that did not classify as enriched appears 
more scattered as compared to other MS data sets (Figure 19). Indeed, box plot statistics 
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Figure 19. SILAC-based quantitative mass spectrometry of mRNP proteome. Plots display log2 values of 
normalized heavy-to-light ratios (H/L, x axis) and log10 values of summed peptide intensities (y axis) for all 
identified proteins (FDR 1%). Blue dots represent proteins that did not classify as enriched by comparing the 
H/L ratios determined in two biological replicate experiments. Red dots represent proteins that, at least in one 
of the biological replicate experiments, were >1.41-fold but <2-fold enriched. Green dots represent protein 
that were >2-fold enriched in both biological replicate experiments. for – forward labelling, rev – reverse 
labelling. 
RESULTS 
 
106 
 
confirms that the log2 (H/L) values are more dispersed in ENO2-6MS2L forward and reverse 
MS data sets as compared to other MS data sets (Figure 20). The reason for higher variability in 
the spread of H/L ratios in the above mentioned data sets could lie in unequal mixing of heavy 
and light protein populations. Namely, from the 8 analysed samples the largest SILAC mixing 
errors, 5.21 and 0.53, were determined for ENO2-6MS2L forward and reverse experiment, 
respectively. Table 10 shows the values of SILAC mixing errors, i.e. the median of all 
unnormalized H/L ratios determined for each LC-MS/MS run. Assuming that heavy and light 
protein populations are mixed in 1:1 ratio and that most of the proteins captured during affinity 
purification are non-specific background binders, the sample’s peptide median H/L ratio should 
be around 1. Inequality in the heavy and light protein populations introduced by unequal protein 
mixing or other imperfections during mRNP affinity purification can result in a median H/L 
ratio that considerably deviates from 1. In order to remove mixing errors, the H/L ratios 
determined in each LC-MS/MS run are normalized so that the mean of all log2-transformed H/L 
ratios is zero (Cox and Mann 2008). Despite the possibility to correct for mixing errors of total 
protein amounts by normalization, inaccurate mixing of heavy and light protein populations may 
affect the dynamic range over which accurate peptide masses can be determined and thus reduce 
the overall accuracy of the LC-MS/MS analysis (reviewed in Bantscheff et al. 2012; Bantscheff et 
al. 2007). 
A step in our mRNP affinity purification protocol that could possibly introduce inequality 
between the pools of heavy and light proteins is lysate preparation. The preparation of lysates of 
the same protein concentrations relies on weighing in the same amount of yeast cell grindate per 
each analysed strain (see Materials and Methods, “mRNP affinity purification protocol”). The 
grindate has to be filled into tubes cooled down in LN2 to avoid grindate thawing. Determining 
the exact weight of the grindate filled into a cooled tube might be imprecise because of the water 
vapour condensing on the walls of the cooled tube. Even though the tube is cooled several times 
during weighing in the grindate to keep a constant temperature, it is possible that this step in the 
mRNP affinity purification protocol can lead to differences in the amount of grindate used for 
lysate preparation between the MS2L-tagged strain and the wt control strain. In order to test if 
the protein concentration of heavy and light lysates had been the same in the experiment with the 
largest SILAC mixing error, the same volume of heavy and light lysate from ENO2-6MS2L 
forward experiment was separated on SDS-PAGE and stained with Coomassie dye (Ulrike Thieβ, 
unpublished data). Densitometric analysis of the stained gel confirmed that the two lysates in this 
case had had exactly the same protein concentrations. Therefore, in ENO2-6MS2L forward 
experiment the imbalance between the heavy and light protein populations must have been 
introduced at some other step than weighing in the grindate. 
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Figure 20. Box plots showing the distribution of SILAC ratios determined for mRNP affinity purification 
experiments shown in figure 19. Box plots demarcate the median (stripe), the mean (open rectangle), the 25th 
to 75th percentile (interquartile range, box), 1.5× the interquartile range (whiskers) and outliers (open circles).  
 
Two of the three sets of mRNP affinity purification experiments were performed without 
technical problems as indicated by the spread of the determined H/L ratios (Fig. 19 and 20) as 
well as by SILAC mixing errors (Table 10), which were within an acceptable error range for 
PGK1-6MS2L and 6MS2L-RNA affinity purifications. However, the high SILAC mixing errors 
determined for ENO2-6MS2L forward and reverse experiment suggest that during the course of 
the experiment an imbalance in the heavy and light protein pools can be introduced, underlying 
the importance of careful and precise performance of the experiment.  
 
 
RNase elution efficiency  
Western blot analysis had shown that Upf1, which specifically co-purified with PGK1-6MS2L 
mRNA (Fig. 9B), was present both in the RNase eluate and in the BB sample (Fig. 10C). This 
result hinted at the possibility that the 30 min of RNase treatment might not be sufficient to 
release all mRNP proteins because of insufficient RNA degradation. However, northern blot 
analysis of PGK1-6MS2L mRNA integrity after RNase treatment suggested the opposite – 
efficient degradation of bead-captured PGK1-6MS2L (Fig. 21B and data not shown). In this 
experiment, the sample was split after PGK1-6MS2L affinity purification. Half of the IgG-
coupled beads were treated with proteinase K followed by PCI RNA extraction to isolate the 
bead-captured RNA (Fig. 21A). The other half of the beads was first treated with RNase and the 
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RNase eluate, as well as the RNase-treated IgG-coupled beads, was subjected to RNA isolation as 
described above. Northern blot hybridization with PGK1-ORF (Fig. 21B) and MS2L (data not 
shown) antisense RNA probes resulted in a detectable hybridization signal only if RNase 
treatment had been omitted (Fig. 21B, compare lanes 7-9, 12-14 and 17-19 and data not shown). 
The 30 min of RNase treatment seems not only sufficient to degrade bead-captured PGK1-
6MS2L but also rRNA (Fig 21B, methylene blue staining and data not shown). PGK1-6MS2L but 
not untagged PGK1 affinity purification resulted in the detection of two bands on methylene blue 
stained membrane that migrated at the same height as 25S and 18S rRNA. However, these bands 
could only be detected if bead-captured PGK1-6MS2L had not been treated with RNase (Fig. 
21B, methylene blue staining, compare lanes 7, 12 and 17).  
Unable to detect any PGK1-6MS2L degradation products after RNase treatment, we 
reasoned that Upf1 is efficiently released from RNA during RNase treatment but non-specifically 
reattaches to the IgG-coupled beads. During RNase treatment other proteins might behave 
similarly to Upf1 and therefore in our first quantitative proteomic analysis we wished to identify 
the proteins that were enriched both in the RNase eluate and in the BB sample. In addition, we 
were interested to determine if some proteins were exclusively enriched in BB sample. Therefore, 
the proteins >1.41-fold enriched in PGK1-6MS2L RNase eluate and BB sample were grouped 
into three categories: (1) “Unique; (2) “Possible common; and (3) “Common”. Categories 
“Unique” and “Common” contain proteins that were unambiguously identified as enriched only 
in one or in both of the data sets, respectively. Proteins that were classified as enriched in one of 
the data sets but failed partly to fulfil the set threshold criteria to be classified as enriched in the 
other data set, for example due to a missing H/L ratio in one of the biological replicate 
experiments, were classified as “Possible common” (Appendix, Table 2). From the 78 proteins 
enriched in RNase eluate, 27 (35%) classified as “Unique”, 21 (26%) as “Possible common” and 
30 (39%) as “Common”. 18 (28%) of the 64 enriched proteins in BB sample classified as 
“Unique” and 16 (25%) as “Possible common”. The 30 proteins classified as “Common” 
comprised 47% of the enriched proteins in BB sample. 
The comparison of the enriched proteins in RNase eluate and BB sample revealed that 
besides Upf1, 29 proteins were enriched in both data sets. Assuming that PGK1-6MS2L mRNA 
was efficiently degraded as suggested by northern blot analysis (Fig. 21B), this finding 
demonstrates that many eluted proteins could only be partly removed from the IgG-coupled 
beads. 60% of the proteins classified as “Common” were present among the top 50% of enriched 
proteins in both RNase eluate and BB sample if the data was sorted according to log2 (H/L) 
values determined for forward experiment (if the data was sorted according to log2 (H/L) values 
determined for reverse experiment 70% and 63% of “Common” proteins mapped to top 50% of 
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enriched proteins in RNase eluate and in BB sample, respectively). The distribution of the 
proteins enriched both in RNase eluate and BB sample thus revealed that the more highly 
enriched proteins are more likely to be only partly removed from the IgG-coupled beads. 
 
 
 
Figure 21. Northern blot analysis of PGK1-6MS2L mRNA integrity after RNase digestion. (A) Schematic 
representation of sample preparation for northern blot analysis. After mRNP affinity purification the sample 
was divided into two. One part of the sample was subjected to RNA extraction, whereas the other part was first 
treated with RNase. After RNase treatment RNA was extracted from RNase eluate and RNase-treated IgG-
coupled beads. + RNase – RNase digestion; prot K – proteinase K treatment; PCI – phenol-chlorophorm-isoamyl 
alcohol RNA extraction. (B) Northern blot hybridization with DIG-UTP-labelled antisense RNA probes 
complementary to PGK1 ORF. mRNP affinity purification was performed from yeast cells containing MS2CP-
PrAx2 together with PGK1-6MS2L (MS2L, strain RJY 3827) or PGK1 (no tag, strain RJY 3828). Samples for total 
RNA analysis were taken before (I – input) and after (FT – flow through) PGK1 mRNP isolation. 1.5 µg total RNA 
and 10-fold serial dilutions of RNA extracted after mRNP affinity purification (1/6
th
 to 1/600
th
 of total sample) 
were separated on 1.3% agarose-formaldehyde gels and blotted onto positively charged nylon membranes. The 
hybridization signal corresponding to the full-length PGK1 and PGK1-6MS2L, as well as non-specific cross-
reaction with 25S rRNA, is indicated. On methylene blue stained membrane 25S and 18S rRNAs are marked. 
Red arrowheads indicate two bands corresponding in size to 25S and 18S rRNA that became visible after 
adjusting image contrast. 
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Slightly more than a quarter of the enriched proteins in BB sample classified as “Unique”, 
suggesting that not all PGK1-6MS2L co-purifying proteins could be efficiently eluted from IgG-
coupled beads by RNase treatment. Remarkably, 7 of the 18 proteins in this category are involved 
in rRNA processing. According to Saccharomyces Genome Database (Cherry et al. 2012) 
proteins encoded by RRP7, UTP22, KRI1, KRR1, NOP4, RPP1 and NUG1 are all predominantly 
nucleolar proteins participating in various aspects of ribosome biogenesis. Besides the 7 
aforementioned rRNA processing factors unique for BB sample, the two data sets include only 3 
additional proteins with the function in rRNA processing – the gene products of CBF5 and 
DIM1 in BB sample and of NOP58 in RNase eluate – all classified as “Possible common”.  
The second largest group of functionally related proteins among the proteins exclusively 
enriched in BB sample is comprised of 4 large ribosomal subunit proteins. Further analysis of the 
distribution of 60S ribosomal subunit proteins in the two data sets of enriched proteins raised the 
possibility that 60S rRNA might not have been completely degraded during the 30 min of RNase 
treatment. Specifically, 11 60S ribosomal proteins were enriched in BB sample, whereas only 5 
were enriched in RNase eluate. In contrast, the small ribosomal subunit proteins were relatively 
more abundant among the enriched proteins in RNase eluate. RNase eluate contained 19 and BB 
sample 13 enriched 40S ribosomal proteins. Notably, in addition to the 19 40S ribosomal subunit 
proteins detected as enriched after RNase treatment, only 6 additional 40S ribosomal subunit 
proteins were detected as enriched after heating the RNase-treated IgG-coupled beads in SDS 
sample buffer. This is in contrast to the results obtained for 60S ribosomal proteins – only 5 60S 
proteins were detected as enriched after RNase treatment, whereas heating the RNase-treated 
beads resulted in the detection of 9 additional enriched 60S ribosomal proteins. These results 
suggest that the less complex 40S rRNA might be more efficiently degraded during RNase 
treatment than the more complex 60S rRNA, thereby leading to the detection of relatively more 
40S ribosomal subunit proteins in RNase eluate. 60S ribosomal subunit proteins, on the other 
hand, seem to have more efficiently dissociated from rRNA during protein denaturation by 
heating in SDS sample buffer. 
Due to financial limitations we did not wish in the subsequent SILAC mRNP affinity 
purification experiments to determine the composition of BB sample. Due to time limitations it 
was unfortunately also impossible to further optimize RNase treatment conditions to ensure full 
rRNA degradation. Therefore, it can be expected that not all ENO2-6MS2L and 6MS2L-RNA 
co-purifying proteins have been detected.  The MS2L-tagged mRNA co-purifying proteins that 
might not be efficiently released by RNase treatment from IgG-coupled beads under current 
experimental conditions include nucleolar rRNA processing factors and large ribosomal subunit 
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proteins; the latter escaping detection possibly due to incomplete rRNA degradation during 
RNase treatment.  
 
 
The proteome of in vivo-assembled mRNPs is enriched for proteins 
 involved in mRNA biology 
In order to facilitate the comparison of proteins enriched after PGK1-6MS2L, ENO2-6MS2L and 
6MS2L-RNA affinity purification, PGK1-6MS2L co-purifying proteins identified in RNase eluate 
or BB sample were integrated into one data set. The classification of the enriched proteins 
according to Protein Class using PANTHER classification system (P. D. Thomas et al. 2003; Mi, 
Muruganujan, and Thomas 2012) revealed a close functional similarity among proteins 
specifically co-purifying with PGK1-6MS2L, ENO2-6MS2L and 6MS2L-RNA (Fig. 22). Within 
each of the three quantitative MS data sets PANTHER classification results were very similar 
between proteins >1.4-fold and >2-fold enriched (Table 11). Independent of the set threshold, 
more than 50% of the enriched proteins in the three data sets classified as nucleic acid binding 
proteins (Fig. 22A). Within this category 76-83% of proteins were classified as RNA binding 
proteins (Fig. 22B). The most prominent class of proteins among RBPs were ribosomal proteins 
with 42-49% of RBPs classifying under this category in the three MS data sets (Fig. 22C). The 
enrichment of ribosomal proteins in all three MS data sets indicates that not only PGK1-6MS2L 
and ENO2-6MS2L but also 6MS2L-RNA can be engaged in translation. In addition to 
translation, the three MS2L-tagged RNAs seem to undergo largely the same processes. With only 
one exception – a single protein classified as DNA-directed RNA polymerase in ENO2-6MS2L 
data set – the enriched RBPs in the three data sets classified to the same 8 subcategories (Fig. 
22C). Furthermore, the fraction of enriched proteins mapped to a specific RBP subcategory was 
very similar for PGK1-6MS2L, ENO2-6MS2L and 6MS2L-RNA. 
 
Table 11. PANTHER Protein Class ontology classification (version 8.1) of enriched proteins. Table depicts 
percent of gene hit against total number of Protein Class hits. 
 
MS2L-tagged RNA log2
a
 Nucleic acid binding RNA binding protein Ribosomal protein 
PGK1 0.5 
1 
54 
51 
80 
76 
46 
42 
ENO2 0.5 
1 
58 
55 
79 
77 
48 
44 
6MS2L 0.5 
1 
60 
69 
79 
83 
48 
49 
a
 log2 0.5 corresponds to threshold log2 (H/L) >0.5 or <-0.5; log2 1 corresponds to threshold log2 (H/L) >1 or <-1. 
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Figure 22. PANTHER Protein Class ontology classification of proteins that classified as enriched by applying 
the threshold log2 (H/L) >0.5 or <-0.5. Figures depict percent of gene hit against total number of Protein Class 
hits. (A) Initial classification of all enriched proteins in the three MS data sets: PGK1-6MS2L (proteins enriched 
in RNase eluate and BB sample were combined into one data set), ENO2-6MS2L and 6MS2L-RNA co-purifying 
proteins (B) Further classification of proteins in the category “nucleic acid binding”. (C) Further classification of 
proteins in the category “RNA-binding protein”. 
 
PANTHER Protein Class category “RNA-binding protein“ contained not only known 
mRNA-binding proteins but also proteins interacting with other cellular RNAs such as rRNA 
and tRNA. Consequently, several proteins classified as RBPs have previously not been implicated 
in mRNA biology. In order to estimate how many of the enriched proteins are annotated 
mRNA-binding proteins or proteins known to play a role in mRNA biology,  a manual literature-
based analysis of the three MS data sets was performed (Appendix, Table 3). Depending on the 
data set, 60-67% of the >1.41-fold enriched proteins belonged to one of the following categories: 
mRNA nuclear maturation, export, localization, decay and translation. The latter category 
contained translation initiation factors, ribosomal proteins and proteins involved in mRNA 
translational control or co-translational nascent peptide maturation. Among the proteins >2-fold 
enriched, 67-72% of the proteins could be classified under one of the above-mentioned 
categories. The prevalence of proteins with a role in mRNA biology among the MS2L-tagged 
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RNA co-purifying proteins clearly demonstrates that 6MS2L::MS2CP-PrAx2::IgG interaction can 
be employed to capture in vivo-assembled mRNPs for quantitative MS analysis. The identification 
of proteins involved in various stages of mRNA life cycle both in the nucleus and in the 
cytoplasm indicates that a variety of mRNPs from diverse cellular compartments could be affinity 
purified (see table 12 for examples). However, the repertoire of the MS2L-tagged RNA co-
purifying proteins also suggests that the efficiency of detecting certain mRNP proteins is 
influenced by mRNP abundance in different cellular compartements (see Discussion, Part 2 “The 
analysis of mRNA-bound proteome is likely influenced by mRNP abundance in different cellular 
compartments“).  
In order to better visualize how proteins that specifically co-purified with an MS2L-
tagged RNA are related to each other, the lists of enriched proteins were analysed using STRING 
database, which integrates the information about known and predicted physical and functional 
protein-protein interactions to create a protein interaction network (L. J. Jensen et al. 2009). 
Figures 23-25 depict the STRING networks obtained for PGK1-6MS2L, ENO2-6MS2L and 
6MS2L-RNA. Proteins >1.41-fold enriched are shown.  
A common feature of the three STRING networks is the high degree of connectivity 
between the proteins in each network even when using the highest confidence score (0.900) for 
generating the networks. In each data set only 10-14% of all proteins >1.41-fold enriched are not 
linked to any other protein in the core network (Fig. 23-25). Among the proteins >2-fold 
enriched the fraction of such unconnected proteins is remarkably similar – 9-12% (data not 
shown). This result suggests that the threshold log2 (H/L) >0.5 or <–0.5 can efficiently filter out 
non-specific background binding proteins. Non-specific background binders are expected to be 
less enriched compared to proteins specifically interacting with MS2L-tagged RNAs. In addition, 
they would be more likely to carry out functions unrelated to mRNA metabolism and therefore 
would be less likely linked to proteins forming the core of the STRING network. The finding 
that for each MS2L-tagged RNA the number of unconnected proteins in the STRING network is 
very similar among proteins >1.41-fold and >2-fold enriched thus suggests that the proteins that 
do not classify as enriched if the more stringent threshold is applied are mostly specific 
interaction partners of MS2L-tagged RNAs.  
An overall functional similarity among proteins specifically co-purifying with PGK1-
6MS2L, ENO2-6MS2L and 6MS2L-RNA suggested by PANTHER classification (Fig. 22) 
becomes evident through the STRING interaction networks. Distinct clusters within the 
networks common to all three MS2L-tagged RNAs are formed by ribosomal proteins and by 
proteins involved in cytoplasmic mRNA decay. Translation and mRNA turnover thus appear to 
be the two central processes in the life cycles of the studied MS2L-tagged RNAs. Each STRING 
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network, however, also shows unique features, revealing some interesting differences in the 
physiology of the studied RNAs. The following chapter will give an overview of the enriched 
proteins in the context of the determined protein interaction networks. 
 
 
 
Figure 23. Protein-protein interaction network of proteins enriched after PGK1-6MS2L affinity purification. 
The enriched proteins in two MS data sets – RNase eluate and BB sample – are combined. Image modified from 
the image created by STRING database (v.9.1) using the highest confidence score (0.9). Each circle represents 
RESULTS 
 
115 
 
an individual protein with the standard name depicted. The colour coding corresponds to the H/L ratios 
determined in the forward labelling experiment. If a protein was enriched both in RNase eluate and BB sample, 
the colour was chosen according to the H/L ratio determined for RNase eluate. Connecting lines represent 
association. 
 
 
 
Figure 24. Protein-protein interaction network of proteins enriched after ENO2-6MS2L affinity purification. 
Image modified from the image created by STRING database (v.9.1) using the highest confidence score (0.9). 
Each circle represents an individual protein with the standard name depicted. The colour coding corresponds to 
the H/L ratios determined in the forward labelling experiment. Connecting lines represent association. 
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Figure 25. Protein-protein interaction network of proteins enriched after 6MS2L-RNA affinity purification. 
Image modified from the image created by STRING database (v.9.1) using the highest confidence score (0.9). 
Each circle represents an individual protein with the standard name depicted. The colour coding corresponds to 
the H/L ratios determined in the forward labelling experiment. Connecting lines represent association. 
 
 
Overview of MS2L-tagged RNA co-purifying proteins 
Literature-based analysis of the enriched proteins indicated that 26-35% of proteins in each MS 
data set (Appendix, Table 4) are mRNA-binding proteins or components of multiprotein 
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complexes with known mRNA-binding subunits (examples shown in Table 12). Most of the 
detected mRNA-binding or mRNA-associated proteins are part of cytoplasmic mRNPs engaged 
in translation or in mRNA decay. The enriched proteins involved in translation include 
translation initiation factors (Table 13), the major yeast poly(A) binding protein Pab1, 
components of polyribosome-associated mRNPs (Scp160, Bfr1) and proteins involved in 
translation repression (e.g. Sbp1, Dhh1, see also Table 15). Several enriched proteins of the latter 
class are functionally linked to mRNA degradation as decapping activators (e.g. Dhh1, Pat1, see 
also Table 16). Besides decapping activators, the enriched mRNA decay factors include Dcp1-
Dcp2 decapping complex and 5′→3′ exonuclease Xrn1. Remarkably, most mRNA decay factors 
were among the highly enriched proteins (>5-fold enrichment), suggesting that a large 
subpopulation of cellular MS2L-tagged RNA-containing mRNPs are involved in mRNA 
degradation. The co-purification of one protein – the nonsense-mediated mRNA decay factor 
Upf1 – with all three MS2L-tagged RNAs suggests that the studied mRNAs may be targeted by 
NMD and thus subjected to accelerated mRNA decay leading to high enrichment levels of 
mRNA decay factors (see Discussion, Part 1, “MS2L-tagged RNAs may be targeted by nonsense-
mediated decay”). MS2L-tagged RNAs also co-purified with several proteins implicated in stress 
granule formation (e.g. Pbp1, Pub1, see also Table 19), hinting at the possibility that a 
subpopulation of mRNPs might be stalled in the process of translation initiation in these 
cytoplasmic mRNP granules. The nuclear stage of the mRNA life cycle is reflected by co-
purification of MS2L-tagged RNAs with several RBPs know to be loaded on mRNPs in the 
nucleus (e.g. Nab2, Sro9, Cbc2-Cbc1, see also Table 20). 
The largest group of MS2L-tagged RNA co-purifying proteins is comprised of rRNA-
binding proteins; 38-43% of the enriched proteins in each MS data set classified under this 
category. The majority of the rRNA-binding proteins are ribosomal proteins of the 40S or 60S 
subunit. The enrichment of ribosomal proteins of both the small and large subunit strongly 
suggests that the MS2L-tagged RNAs have been captured while bound to 80S ribosomes and 
thus engaged in translation.  The minor group among the enriched rRNA-binding proteins is 
composed of 17 ribosome biogenesis factors (e.g. Mrd1, Arx1, see also Table 21). Most of the 
ribosome biogenesis factors were enriched only in single MS data sets. Furthermore, the 
enrichment level of these proteins was mostly moderate (<3-fold enrichment), raising the 
question whether ribosome biogenesis factors might have co-purified with contaminating 
ribosomes. Even though we cannot rule out that the enriched ribosome biogenesis factors 
represent false-postitive interactors in our experiments, recent findings from other groups 
suggest that mRNA binding by ribosome biogenesis factors might be a common phenomenon 
both in yeast and in mammalian cells (S. F. Mitchell et al. 2013; Castello et al. 2012; Baltz et al. 
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2012) (see Discussion, Part 1, “Ribosome biogenesis factors co-purifying with MS2L-tagged 
RNAs“).  
Ribosome biogenesis factors were not the only group of proteins that are known to bind 
RNA but not known to associate with mRNA among the MS2L-tagged RNA co-purifying 
proteins. We also identified 3 tRNA methyltransferases (Trm44, Trm2, Ncl1) and 3 tRNA 
pseudouridine synthases (Pus1, Pus4, Pus7). Most of these proteins were highly enriched (>5-
fold enrichment) and co-purified with at least two MS2L-tagged RNAs (Table 23). Remarkably, 
the human homologs of 4 enriched tRNA-modifying enzymes out of 5 conserved proteins (Pus4 
is not conserved between yeast and human) have been found to co-purify with poly(A)+ RNA 
from mammalian  cells (Castello et al. 2012; Baltz et al. 2012), suggesting that Trm2, Ncl1, Pus1 
and Pus7 play a jet undefined but conserved role in mRNA biology. 
The studied MS2L-tagged RNAs co-purified with several proteins which have been 
implicated in RNA-binding but whose RNA-interaction partners remain unknown or whose 
function in general or in the context of mRNA biology is not well understood. Such proteins 
include, for instance, the putative RBP Ygr250c and the GTPase Rbg1 together with its 
interaction partner Tma46, all three proteins have a possible role in translation initiation, or the 
deubiquitinase Ubp3 and its positive regulator, a putative RBP Bre5, or the putative homolog of 
DEAH-box family of RNA-dependent ATPases Ylr419w. All the mentioned proteins and their 
human homologs have been identified in several studies to co-purify with poly(A)+ RNA or with 
Pab1 (S. F. Mitchell et al. 2013; Castello et al. 2012; Baltz et al. 2012; Klass et al. 2013; R. 
Richardson et al. 2012). Hence, our results confirm previous observations and identify Ygr250c, 
Rbg1, Tma46, Ubp3, Bre5 and Ylr419w as mRNP proteins. Three proteins, the general vacuolar 
RNAse Rny1 involved in rRNA and tRNA decay, the mitochondrial RNA polymerase Rpo41 
and the intronic branchpoint binding complex component Msl5 were highly enriched after 
ENO2-6MS2L affinity purification. Even though all the mentioned proteins are RBPs, their role 
in the context of ENO2 mRNA, which is transcribed from an intronless gene and encodes a 
cytoplasmic protein, remains unknown. 
14-22% of MS2L-tagged RNA co-purifying proteins have previously not been identified 
as RBPs. This group include proteins that have likely co-purified with mRNA in association with 
mRNA-bound ribosomes; however, in case of many of the enriched proteins with no known 
RNA-binding activity the mechanism underlying co-purification with MS2L-tagged RNAs remain 
elusive. Ribosome-association of proteins involved in nascent peptide maturation can easily 
explain why the MS2L-tagged RNAs have co-purified, for instance, with the components of the 
ribosome-associated chaperone triad (Leidig et al. 2013) or the NatA N-terminal acetyltransferase 
(Matthias Gautschi et al. 2003; Polevoda et al. 2008) (Table 14). Ribosome-association is also a 
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plausible reason for the co-purification of three proteins involved in tRNA aminoacylation (Arc1, 
Gus1, Ths1, Table 32) with 6MS2L-RNA. Interestingly, several aminoacyl-tRNA synthetases 
have been found to associate with ribosomes in organisms as diverse as humans and archaea 
(Kaminska et al. 2009; Raina et al. 2012; David et al. 2011; Godinic-Mikulcic et al. 2014). The 
enrichment of Pgk1 protein after PGK1-6MS2L affinity purification and enolase 2 after ENO2-
6MS2L affinity purification but not vice versa suggests that the nascent peptide has co-purified 
with the mRNA it is encoded by as an mRNA-ribosome-nascent peptide complex (see 
Discussion, Part 1 “Ribosomal proteins, translation factors, nascent peptide modifying enzymes 
and proteins involved in translation regulation – mRNP proteome reveals translation and a 
network of translation-associated molecular events as part of MS2L-tagged RNA life cycle”). This 
chain of interactions might also contribute to the co-purification of several glycolytic enzymes 
with PGK1-6MS2L (Table 31). Namely, several lines of evidence indicate that glycolytic enzymes 
associate into multi-enzyme complexes presumably for optimal pathway activity (Campanella, 
Chu, and Low 2005; Puchulu-Campanella et al. 2013; Araiza-Olivera et al. 2013; Araiza-Olivera et 
al. 2010). The co-purification of PGK1-6MS2L with Pgk1 protein and additional glycolytic 
enzymes thus hints at the possibility of co-translational glycolytic enzyme complex formation (see 
Discussion, Part 1 “PGK1-6MS2L co-purifies with several glycolytic enzymes – co-translational 
formation of a supramolecular glycolytic enzyme complex?”). 
Besides the glycolytic enzymes that were enriched after PGK1-6MS2L affinity 
purification, 13 additional metabolic enzymes co-purified with the MS2L-tagged RNAs (Table 
25). None of these proteins is known to have RNA-binding activity, however, the high 
enrichment level and co-purification with more than one of the tested RNAs suggests that the 
association of at least 6 of the identified metabolic enzymes with the MS2L-tagged RNAs is 
specific. Remarkably, 5 of these 6 proteins have previously been found to co-purify with poly(A)+ 
RNA or Pab1, including the inosine monophosphate dehydrogenase isozymes Imd2, Imd3 and 
Imd4, the mitochondrial trifunctional C1-tetrahydrofolate synthase Mis1 and the mitochondrial 
serine hydroxymethyltransferase Shm1 (S. F. Mitchell et al. 2013; Castello et al. 2012; Klass et al. 
2013; R. Richardson et al. 2012). Our results are thus in agreement with previous observations 
and suggest that the above mentioned proteins play a jet undefined role in mRNA biology (see 
Discussion, Part1, “Metabolic enzymes co-purifying with MS2L-tagged RNAs”). The sixth 
protein in this group, the mitochondrial aldehyde dehydrogenase Ald5, might specifically interact 
with the 6MS2L-tag. Even though the protein has not been found to co-purify with poly(A)+ 
RNA (S. F. Mitchell et al. 2013; Castello et al. 2012; Baltz et al. 2012) or with Pab1 (Klass et al. 
2013; R. Richardson et al. 2012), Ald5 was highly enriched after the affinity purification of all 
three MS2L-tagged RNAs. The remaining 7 metabolic enzymes co-purified only with single 
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MS2L-tagged RNAs and were mostly <2-fold enriched, suggesting that at least some of these 
enriched proteins might represent false-positive interactors. Additional moderately enriched 
proteins in single MS data sets included Vph1, a subunit of the vacuolar ATPase V0 domain; 
Sec16, COPII coat assembly protein; Tra1, a subunit of SAGA and NuA4 histone 
acetyltransferase complexes; Hsp60, a mitochondrial  chaperonin; Bmh2, a 14-3-3 protein; 
Ymr046c, the Gag nucleocapsid protein of retrotransposon Ty1, etc. While non-specific 
interaction with MS2L-tagged RNA-containing mRNPs might contribute to the isolation of some 
of these proteins, other proteins such as Bmh2 and Ymr046c possibly represent bona fide 
interaction partners (see Discussion). 
 
Table 12. Examples of MS2L-tagged RNA co-purifying proteins identified by quantitative MS. An MS2L-tagged 
RNA co-purifying protein was considered enriched if it fulfilled the threshold criteria log2 (H/L) > 0.5 or <0.5 (+).   
 
Category Gene Protein 
ID 
Function BB
a
 RNase ENO2 6MS2L 
mRNA-binding protein TIF4631 P39935 Translation initiation + + + + 
SCP160 P06105 Translation regulation + +  + 
DHH1 P39517 Translation repression, 
Decay 
  +  
DCP2 P53550 Decay + + +  
XRN1 P22147 Decay + + + + 
NAB2 P32505 Export  +  + 
KHD1 P38199 Localization  +  + 
WHI3 P34761 Unknown  +   
rRNA-binding protein/ 
ribosome-associated 
protein 
RPL4A P10664 Ribosomal 60S subunit 
protein 
+ + + + 
MRD1 Q06106 Ribosome biogenesis   + + 
ARX1 Q03862 pre-60S subunit export + + +  
ZUO1 P32527 Ribosome-associated 
chaperone 
+ + + + 
GUS1 P46655 Cytosolic glutamyl-tRNA 
synthetase 
   + 
PGK1 P00560 Glycolytic enzyme + +   
tRNA-binding protein TRM2 P33753 tRNA methyltransferase  + + + 
PUS7 Q08647 tRNA, snRNA, rRNA 
pseudouridine synthase 
  + + 
Undefined  
RNA-binding protein 
YGR250C YGR250C Putative RBP  +  + 
UBP3 Q01477 Ubiquitin-specific 
protease 
+ + +  
RPO41 P13433 Mitochondrial RNA 
polymerase 
  +  
Not annotated as RBP IMD4 P50094 Inosine monophosphate 
dehydrogenase 
 + + + 
ALD5 P40047 Mitochondrial aldehyde 
dehydrogenase 
 + + + 
VHP1 P32563 Subunit of vacuolar 
ATPase 
+    
a
 Abbreviations here and hereafter: BB – Boiled Beads sample of PGK1-6MS2L affinity purification, RNase – 
RNase eluate of PGK1-6MS2L affinity purification. 
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mRNP affinity purification: 
our strategy and the obtained results at a glance 
 
In order to analyse the proteome of in vivo-assembled mRNA-protein complexes in S. cerevisiae, 
we have established an affinity purification method that enables to capture specific mRNAs 
together with the mRNA-associated proteins. Our approach makes use of two naturally occurring 
high affinity interactions: (1) the interaction between the bacteriophage MS2 coat protein and its 
RNA binding site (Lago et al. 1998); and (2) the interaction between IgG and the IgG-binding Z 
domains of Staphylococcus aureus protein A (Cedergren et al. 1993). The mRNA of interest is 
genomically tagged with MS2 stem-loops (Haim et al. 2007) and co-expressed with MS2 coat 
protein fused to IgG-binding domains. mRNPs assembled on the tagged mRNAs are isolated 
using IgG-coupled beads (Oeffinger et al. 2007). Quantitative analysis of the mRNP proteome is 
achieved by using SILAC metabolic labelling technique in combination with sample analysis by 
liquid chromatography-tandem mass spectrometry. Using this system, we have analysed the 
proteins co-purifying with 6MS2L-tagged PGK1 and ENO2. In addition, we have identified the 
proteins that associate with an mRNA-like transcript containing the 6MS2L tag. 
Our approach should provide an overall picture of the various interactions an mRNP is 
involved in during its life cycle. In order to preserve the native structure of the mRNP, we used 
optimized yeast cell harvesting and lysis conditions. Harvesting was done in the presence of 
glucose and amino acids, which enabled to preserve ribosome binding to the tagged mRNA (Fig. 
15A and 15B). mRNA degradation during cell lysis could be prevented by breaking the cells 
under cryo conditions (Fig. 6B). Removal of cell debris by a short centrifugation step followed by 
lysate filtration, the use of superparamagnetic IgG-coupled beads as the affinity matrix and a 
short capture time of the tagged mRNPs (30 min) enabled to finish the whole affinity purification 
procedure in about 70 min. The relatively fast completion of the affinity purification should 
further help to maintain the native structure of the mRNPs. 
We did not include a cross-linking step to stabilize mRNP composition. On the one 
hand, excluding a cross-linking step helps to avoid possible changes in mRNP protein 
composition that might occur in response to cross-linking. The two commonly used cross-linking 
approaches to stabilize RNA-protein interactions – cross-linking by 254 nm UV light or by 
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formaldehyde – often involve removal of the cells from their natural growth environment 
(Slobodin and Gerst 2010; S. F. Mitchell et al. 2013). This likely alters the mRNP composition of 
mRNAs engaged in translation; removal of the carbon source has been shown to result in rapid 
inhibition of translation in S. cerevisiae which is paralleled by the loss of polyribosomes (Ashe, De 
Long, and Sachs 2000). Cross-linking may also induce a stress response and thereby influence the 
abundance of mRNPs in different subcellular compartments. For instance, exposure to UV light 
has been shown to increase the accumulation of P-body marker proteins in P-bodies (Teixeira et 
al. 2005), indicating an increase in the translationally repressed pool of mRNPs. On the other 
hand, omitting a cross-linking step may result in the loss of weak or transient interaction partners 
during mRNP affinity purification. Indeed, in several cases we observed that only certain 
subunits of well defined heteromeric protein complexes were enriched after MS2L-tagged RNA 
affinity purification. In a test experiment the treatment of yeast cells with formaldehyde (0.05% 
v/v) (Slobodin and Gerst 2010) did not enable us to detect additional specifically enriched 
proteins compared to the purification of untagged control mRNA. In this experiment the protein 
pattern of RNase eluates was compared on silver stained SDS-PAGE (Fig. 10A). We cannot rule 
out that by using a more sensitive method such as mass spectrometry to analyse the protein 
composition of the RNase eluate samples we would have been able to detect a beneficial effect of 
formaldehyde cross-linking on mRNP stability. 
Despite not using cross-linking to stabilize mRNP composition, a relatively large number 
of proteins were enriched after MS2L-tagged RNA affinity purification. The number of proteins 
that were >2-fold enriched in both biological replicate experiments was 58, 83 and 71 for PGK1-
6MS2L (combined proteins enriched in RNase eluate and boiled beads samples), ENO2-6MS2L 
and 6MS2L-RNA, respectively. PANTHER Protein Class analysis indicated that >50% of the 
enriched proteins in each MS data set were nucleic acid binding proteins (Table 11). A manual 
literature-based analysis identified 26-35% of the enriched proteins as previously known mRNA-
binding proteins or as components of protein complexes containing annotated mRNA-binding 
subunits (Appendix, Table 3 and 4). Importantly, 60-72% of the MS2L-tagged RNA co-purifying 
proteins perform a function related to mRNA biology (Appendix, Table 3). The repertoire of the 
proteins co-purifying with the three MS2L-tagged RNAs reflects both nuclear and cytoplasmic 
steps of mRNP life cycle. Many of the enriched proteins in each MS data set have a role in 
mRNA translation or decay, suggesting that a large subpopulation of the MS2L-tagged RNAs is 
engaged in these two processes. The large number of enriched proteins involved in mRNA 
biology as revealed by PANTHER analysis and the literature-based analysis thus indicates that 
the established mRNP affinity purification method is successful at capturing in vivo-assembled 
mRNPs. This notion is also supported by STRING analysis, which demonstrated that the 
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proteins co-purifying with a specific MS2L-tagged RNA are largely physically or functionally 
linked to each other (Fig. 23-25). 
In addition to the enriched proteins with a well defined role in mRNP life cycle, many of 
the MS2L-tagged RNA co-purifying proteins participate in cellular processes not connected to 
mRNA function. Interestingly, in several such cases we found that the protein has previously 
been implicated in association with mRNA or the major yeast poly(A) binding protein Pab1 (S. F. 
Mitchell et al. 2013; Castello et al. 2012; Baltz et al. 2012; Tsvetanova et al. 2010; Scherrer et al. 
2010; Klass et al. 2013; R. Richardson et al. 2012). Collectively, our mRNA-associated proteome 
analysis suggests a role for several ribosome biogenesis factors, tRNA modifying enzymes and 
metabolic enzymes in mRNA biology. Our results also point to the possibility of co-translational 
glycolytic enzyme complex formation. However, each MS data set also contains a few proteins 
which possibly represent false-positive interactors. Non-specific association of cellular proteins 
with MS2L-tagged RNA-containing mRNPs likely takes place during the 30 min of mRNP 
capture when proteins released from different cellular compartments can form interactions that 
normally would not occur. Candidate false-positive interactors include some cytoplasmic 
metabolic enzymes and mitochondrial proteins that have previously not been found to associate 
with mRNA and also some RBPs that might non-specifically interact with the MS2L-tagged 
RNAs due to deregulated RNA-binding activity upon cell lysis. During mRNP capture the bona 
fide mRNP proteins, especially those with fast association and dissociation rates, might also 
rearrange between mRNPs assembled on different mRNAs (X. Wang and Huang 2008). 
However, these rearrangements should not lead to changes in protein SILAC ratios since mRNP 
affinity purification from heavy and light labelled lysate is carried out separately. The IgG-
coupled beads with the captured mRNPs from two parallel purifications are only mixed prior to 
mRNP protein release by RNase treatment (Fig. 17), thus preventing the exchange of heavy and 
light labelled forms of dynamically interacting mRNP proteins between MS2L-tagged RNA-
containing mRNPs and the untagged control RNA-containing mRNPs. 
The focus of the first part of the discussion is on the analysis of the mRNA-bound 
proteome and the possible molecular mechanisms responsible for the co-purification of a certain 
set of proteins with each tested MS2L-tagged RNA. The second part of the discussion tries to 
find answers to the questions that stem from the results of mRNP proteome analysis. For 
instance, what features of mRNA-protein and protein-protein interactions determine their 
efficient capture using our mRNP affinity purification method? What are the limitations of the 
MS2L system for mRNP affinity purification and how these limitations could be overcome? In 
the final part of the discussion unanticipated findings regarding mRNP protein composition will 
be recapitulated.  
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Part 1 
 
Ribosomal proteins, translation factors, nascent peptide modifying enzymes and proteins 
involved in translation regulation – mRNP proteome reveals translation and a network of 
translation-associated molecular events as part of MS2L-tagged RNA life cycle 
The analysis of mRNP proteome of PGK1-6MS2L, ENO2-6MS2L and 6MS2L-RNA revealed 
that ribosomal proteins comprise the most abundant group of enriched proteins in the three MS 
data sets. Depending on the data set, 49-70% of the 33 S. cerevisiae small ribosomal subunit 
proteins and 30-37% of the 46 large ribosomal subunit proteins classified as enriched (reviewed 
in D. N. Wilson and Cate 2012). The relative abundance of enriched 40S ribosomal proteins 
compared to 60S ribosomal proteins is thus not specific for PGK1-6MS2L affinity purification 
(see Results, “RNase elution efficiency”), supporting the notion that 60S rRNA might have been 
less efficiently degraded than 40S rRNA during RNase treatment.  
The presence of both 40S and 60S ribosomal proteins among the enriched proteins 
suggest that all three MS2L-tagged RNAs can be captured while bound to 80S ribosomes. This 
finding is in agreement with northern blot and qRT-PCR results showing that 18S and 25S 
rRNAs are enriched after PGK1-6MS2L affinity purification compared to the mock purification 
of untagged PGK1 (Fig. 15). The enrichment of 80S ribosomal components after affinity 
purification of the three MS2L-tagge RNAs thus suggests that a subset of PGK1-6MS2L, ENO2-
6MS2L and 6MS2L-RNA transcripts has been engaged in translation at the moment of flash 
freezing the yeast cells in LN2. Enrichment of several canonical translation factors and ribosome-
associated proteins involved in translational control or nascent peptide maturation further 
supports the notion that we have been able to capture mRNPs that in living cells were engaged in 
protein synthesis. In addition, the protein product of PGK1-6MS2L or ENO2-6MS2L is among 
the enriched proteins in the respective MS data set. The simplest explanation to this finding is 
that the nascent peptide has co-purified with the mRNA it is encoded by as a nascent peptide-
ribosome-mRNA complex. Alternatively, Pgk1 and enolase 2 could directly bind to the mRNA 
the respective protein is encoded by. While there is no experimental evidence suggesting that 
enolase 2 would possess RNA-binding activity (Castello et al. 2012; Baltz et al. 2012; Tsvetanova 
et al. 2010; Scherrer et al. 2010), Pgk1 has been identified as a candidate RBP in mammalian cells 
by poly(A)+ RNA affinity purification combined with co-purifying protein identification by label-
free quantitative MS (Castello et al. 2012). However, in a similar study in mammalian cells the 
protein was not detected after poly(A)+ RNA affinity purification (Baltz et al. 2012). 
Furthermore, Pgk1 also failed to be identified as an RBP in S. cerevisiae in two separate studies 
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where RBPs were identified by probing high-density protein microarrays with mRNA 
(Tsvetanova et al. 2010) or with different types of cellular RNA (Scherrer et al. 2010). These latter 
findings suggest that Pgk1 is not an RBP and thus the likely reason for Pgk1 protein co-
purification with PGK1-6MS2L is the association between the Pgk1 nascent peptide, the 
ribosome and the mRNA. Identification of Pgk1 as a candidate RBP by Castello et al. could in 
fact also be due to the above-mentioned chain of interactions. In this study, many ribosomal 
proteins were identified as RBPs, suggesting poly(A)+ RNA co-purification with translating 
ribosomes (Castello et al. 2012). Since UV crosslinking was used to covalently crosslink direct 
RNA-protein interactions (Castello et al. 2012), Pgk1 nascent peptide could have been 
crosslinked to ribosomal exit tunnel (Bhushan et al. 2010), ultimately leading to Pgk1 
identification as a candidate RBP. 
The only translation factors enriched in all three MS data sets are the two eIF4G isoforms 
in S. cerevisiae, eIF4G1/TIF4631 and eIFG2/TIF4632 (Goyer et al. 1993) (Table 13). During 
translation initiation eIF4G acts as a scaffold protein, which coordinates the interaction between 
the mRNA 5′ cap and the 3′ poly(A) tail, as well as promotes the recruitment of 43S PIC to the 
mRNA (reviewed in Hinnebusch 2011). Among its direct interaction partners are the cap-binding 
protein eIF4E  (Goyer et al. 1989; J. D. Gross et al. 2003) and the RNA helicase eIF4A 
(Dominguez et al. 1999; Neff and Sachs 1999; P. Schütz et al. 2008). Both proteins were found 
among the enriched proteins: eIF4E/CDC33 was enriched in 6MS2L-RNA affinity purification 
and eIF4A/TIF1 was enriched in PGK1-6MS2L affinity purification.  
eIF5B/FUN12, the ribosome-dependent GTPase that mediates ribosomal subunit 
joining, was found enriched in two MS data sets (ENO2-6MS2L and 6MS2L-RNA). Other 
identified translation initiation factors were enriched in single MS data sets. 6MS2L-RNA co-
purified with eIF3a/RPG1 (also known as TIF32), which is one of five eIF3 core subunits in S. 
cerevisiae (Phan et al. 1998). Besides eIF3a, a possible eIF3 subunit encoded by CLU1/TIF31 
(Vornlocher et al. 1999) was also found enriched. ENO2-6MS2L co-purified with eIF2 subunits 
eIF2α/SUI2 and eIF2γ/GCD11. The third eIF2 subunit eIF3β/SUI3 was enriched in the 
forward experiment but was not quantified in the reverse experiment, suggesting that the subunit 
might have dissociated from eIF2 heterotrimer during affinity purification. Besides eIF2, which 
delivers the initiator methionyl tRNA to the 40S ribosome during canonical translation initiation, 
ENO2-6MS2L co-purified with a second protein with the potential to direct the binding of Met-
tRNAi
Met to small ribosomal subunit – eIF2A/YGR054W (Merrick and Anderson 1975). 
Importantly, the requirements of the two proteins for Met-tRNAi
Met binding to 40S ribosome are 
different – eIF2 requires GTP (Safer et al. 1975) whereas eIF2A the presence of an AUG codon 
(Merrick and Anderson 1975). Consistent with a role in translation initiation, eIF2A genetically 
DISCUSSION 
 
126 
 
interacts with several yeast translation initiation factors (Wilmes et al. 2008; Komar et al. 2005) 
and binds to 40S ribosomal subunit and 80S ribosome (Komar et al. 2005); however, the exact 
molecular function of the protein remains elusive (Komar et al. 2005; Reineke et al. 2011).  
Among the proteins enriched in single MS data sets was also the only identified translation 
elongate factor – eEF3 (encoded by paralogous genes YEF3 and HEF3), which was enriched 
after PGK1-6MS2L affinity purification. 
 
Table 13. MS2L-tagged RNA co-purifying translation factors. Log2 (H/L) ratios of enriched proteins are in bold.  
 
Protein 
ID 
Protein 
name 
Gene 
BB RNase ENO2 6MS2L 
for rev for rev for rev for rev 
P39935 
P39936 
P07260 
P38912 
P39730 
P38249 
Q03690 
P20459 
P32481 
P09064 
P53235 
P16521; 
P53978 
eIF4G1 
eIF4G2 
eIF4E 
eIF4A 
eIF5B 
eIF3a 
eIF3 p135 
eIF2α 
eIF2γ 
eIF2β 
eIF2A 
eEF3 
 
TIF4631 
TIF4632 
CDC33 
TIF1 
FUN12 
RPG1 
CLU1 
SUI2 
GCD11 
SUI3 
YGR054W 
YEF3; 
HEF3 
1.42 
1.78 
 1.29 
0.46 
0.20 
0.31 
-0.19 
0.17 
-0.64 
0.27 
0.73 
 
-2.08 
-2.34 
 
 
 -0.01 
-0.04 
0.19 
 0.73 
 -0.82 
 
1.23 
1.76 
-0.68 
1.40 
0.36 
1.26 
0.12 
-0.18 
-0.07 
-0.32 
0.10 
1.52 
 
-1.76 
-2.37 
0.21 
-0.54 
0.16 
 0.08 
0.29 
0.15 
0.68 
0.06 
-1.38 
 
0.92 
2.04 
-1.73 
2.38 
2.09 
 -0.07 
1.25 
1.02 
1.13 
1.94 
0.63 
 
-2.39 
-3.70 
1.37 
 -3.41 
 -2.08 
-1.25 
-1.34 
 -2.82 
-0.21 
 
4.51 
5.31 
3.72 
-0.32 
1.60 
1.22 
1.67 
0.26 
0.30 
 
 0.10 
 
-4.78 
-5.76 
-3.03 
-1.29 
-1.37 
-0.99 
-1.20 
0.09 
-0.05 
 -0.72 
-0.66 
 
 
Co-translational nascent peptide maturation steps reflected in mRNP proteome 
The nascent polypeptide emerging from the ribosomal exit tunnel undergoes several co-
translational maturation steps, which may include N-terminal enzymatic processing, chaperone-
assisted protein folding and targeting to endoplasmatic reticulum (ER). The ribosome plays an 
important role in the spatial and temporal coordination of these maturation steps by acting as a 
binding platform for the processing enzymes (reviewed in Kramer et al. 2009; Jha and Komar 
2011). The proteome of the studied mRNPs contains several enzymes participating in co-
translational maturation of the nascent peptide (Table 14). Among the proteins enriched in all 
three MS data sets are Ssb2, Ssz1 and Zuo1, which form a functional ribosome-associated 
chaperone triad (Matthias Gautschi et al. 2002; Leidig et al. 2013; Albanèse et al. 2006). Ssb2 and 
its functionally interchangeable isoform Ssb1 belong to the Hsp70 family of proteins (Boorstein, 
Ziegelhoffer, and Craig 1994) whose members participate in various protein folding processes in 
the cell (reviewed in Mayer and Bukau 2005). The chaperone function of Hsp70 proteins 
depends on ATP binding and hydrolysis. The J-domain co-chaperones promote stable Hsp70 
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interaction with the substrate by stimulating Hsp70 ATPase activity, whereas nucleotide exchange 
factors control the duration of Hsp70 interaction with the substrate by stimulating ADP-ATP 
exchange on Hsp70 (reviewed in Kampinga and Craig 2010). The co-chaperone function in the 
Ssb/Ssz1/Zuo1 ribosome-associated chaperone triad is performed by Ssz1 and Zuo1, which 
form the so-called ribosome-associated complex (RAC) (M Gautschi et al. 2001; P. Huang et al. 
2005; Conz et al. 2007). RAC dynamically associates with the ribosome in the vicinity of the 
peptide tunnel exit through Zuo1-mediated interactions with ribosomal proteins and rRNA 
(Raue, Oellerer, and Rospert 2007; Peisker et al. 2008; Leidig et al. 2013). Ssb associates with the 
ribosome independently of RAC (Rakwalska and Rospert 2004); however, the direct binding site 
of Ssb remains unknown (reviewed in Peisker, Chiabudini, and Rospert 2010). Unlike RAC, the 
co-immunoprecipitation of nascent polypeptides with Ssb is not abolished by ribosome release, 
suggesting a stable interaction between Ssb and the newly synthesised proteins (Albanèse et al. 
2006). Collectively, these findings indicate that Ssz1 and Zuo1 interaction with the MS2L-tagged 
RNAs is ribosome-mediated. Ssb2 interaction with the MS2L-tagged RNAs is also likely 
ribosome-mediated but interactions with the nascent peptide may contribute to Ssb2 co-
purification with PGK1-6MS2L and ENO2-6MS2L mRNAs. 
6MS2L-RNA co-purified with the α-subunit of the heterodimeric nascent polypeptide-
associated complex (NAC). The prevalent cellular version of yeast NAC is composed of an α-
subunit encoded by EGD2 and a β-subunit encoded by EGD1 (Reimann et al. 1999). The exact 
molecular function of NAC remains unknown; however, the complex interacts both with the 
nascent peptide and the ribosome (Reimann et al. 1999; Wiedmann et al. 1994; Beatrix, Sakai, and 
Wiedmann 2000; Wegrzyn et al. 2006) and has therefore been proposed to act as a molecular 
chaperone (reviewed in Kramer et al. 2009; Jha and Komar 2011). Ribosome-association of NAC 
is mediated by the β-subunit, which has been shown to bind to the large ribosomal subunit 
protein L25 located adjacent to peptide tunnel exit (Wegrzyn et al. 2006). The complex can be 
dissociated from ribosomes by high salt wash and purified as an intact heterodimer from both 
yeast and mammalian cells, thus suggesting a stable interaction between the α- and β-subunit 
(Wiedmann et al. 1994; Reimann et al. 1999). Considering the high salt concentration needed to 
release NAC from ribosomes (500 mM KAc) as well as the salt-resistance of the α- and β-subunit 
interaction, it is surprising that only one of the NAC subunits was enriched after 6MS2L-RNA 
affinity purification. Similarly, in ENO2-6MS2L MS data set the α- and β-subunit of NAC were 
enriched for only one of the biological replicate experiments. These results hint at the possibility 
that in our experimental setup the ribosome- and possibly also nascent peptide-mediated 
interaction between the MS2L-tagged RNA and the NAC complex might have been prone to 
dissociation.  
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Nascent polypeptide emergence from the peptide tunnel exit is for the majority of 
proteins accompanied by the removal of the N-terminal methionine (reviewed in Giglione, 
Boularot, and Meinnel 2004; Kramer et al. 2009; Jha and Komar 2011). The enrichment of 
methionine amonopeptidase-2/MAP2 (MetAP-2) after ENO2-6MS2L affinity purification 
suggests that the enolase 2 protein is subjected to N-terminal methionine excision (NME). 
Whether a protein undergoes NME or not is determined by the second residue; an N-terminal 
methionine followed by a small and uncharged residue is removed (Boissel et al. 1985; 
Tsunasawa, Stewart, and Sherman 1985; Flinta et al. 1986; Ben-Bassat et al. 1987; S. Huang et al. 
1987; Hirel et al. 1989; Moerschell et al. 1990). Importantly, the second residue in enolase 2, 
alanine, belongs to the group of amino acids known to elicit NME (Boissel et al. 1985; 
Tsunasawa, Stewart, and Sherman 1985; Flinta et al. 1986), thus suggesting that ENO2-6MS2L 
has been captured in complex with the nascent peptide undergoing NME. Pgk1 with serine as the 
second residue should also be subjected to NME; however, neither of the two N-terminal 
aminopeptidases expressed in yeast was enriched after PGK1-6MS2L affinity purification. 
Assuming that Pgk1 is an NME substrate, this result suggests that the interaction between Pgk1 
nascent peptide and the N-terminal aminopeptidase might have been lost during mRNP affinity 
purification.  
Co-purification of ENO2-6MS2L with the two subunits of the N-terminal 
acetyltransferase NatA reveals another nascent peptide enzymatic modification step. N-terminal 
acetylation is a very common protein modification in eukaryotic cells; more than 50% of yeast 
and 80% of mammalian proteins are N-terminally acetylated (Arnesen et al. 2009). Since in most 
of the yeast proteins the N-terminal methionine is removed, the majority of the proteins are 
acetylated by NatA – the N-terminal acetyltransferase family member whose activity depends on 
prior NME (Soppa 2010; Starheim, Gevaert, and Arnesen 2012; Kramer et al. 2009). The transfer 
of the acetyl moiety form acetyl coenzyme A to the N-terminal α-amino group is catalyzed by 
NatA subunit Ard1 (also known as Naa10); the auxiliary subunit Nat1 (also known as Naa15) 
mediates NatA ribosomal association (Matthias Gautschi et al. 2003; Polevoda et al. 2008) likely 
in the vicinity of the peptide tunnel exit (reviewed in Kramer et al. 2009). Surprisingly, enolase 2 
has been shown not to be N-terminally acetylated (Polevoda and Sherman 2003; Arnesen et al. 
2009), raising the question why an enzyme mediating N-terminal acetylation would co-purify with 
ENO2-6MS2L. The answer to this question may lie in the finding that Nat1 does not only cross-
link to nascent peptides that are NatA substrates but also efficiently cross-links to nascent 
peptides that are not subjected to N-terminal acetylation (Matthias Gautschi et al. 2003). Cross-
link formation between Nat1 and the nascent peptide is abolished after puromycin treatment, 
which leads to premature nascent chain release from the ribosome, indicating that Nat1 
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interaction with the nascent peptide can be ribosome-mediated (Matthias Gautschi et al. 2003). A 
likely explanation for Nat1 and Ard1 co-purification with ENO2-6MS2L would therefore be that 
ENO2-6MS2L mRNA is translated on ribosomes that are associated with NatA. Unlike enolase 
2, Pgk1 is N-terminally acetylated (Polevoda and Sherman 2003; Arnesen et al. 2009). Even 
though NatA subunits were not classified as enriched after PGK1-6MS2L affinity purification, 
Nat1 with log2 (H/L) ratio 0.41 in the forward experiment and -0.6 in the reverse experiment 
almost fulfilled the set threshold criteria for enriched proteins. Therefore, it seems likely that at 
least the ribosome-binding subunit of NatA complex has co-purified also with PGK1-6MS2L.  
 
Table 14. MS2L-tagged RNA co-purifying proteins involved in co-translational nascent peptide maturation. 
Log2 (H/L) ratios of enriched proteins are in bold. 
 
Protein ID Gene 
BB RNase ENO2 6MS2L 
for rev for rev for rev for rev 
Ribosome-associated chaperone triad 
P40150 
P38788 
P32527 
 
SSB2 
SSZ1 
ZUO1 
 
1.08 
0.90 
0.75 
 
-1.55 
-0.89 
-1.45 
 
1.89 
1.08 
1.10 
 
-1.74 
-1.42 
-1.37 
 
2.13 
2.83 
2.75 
 
-3.70 
-3.75 
-3.65 
 
1.68 
1.08 
1.01 
 
-1.49 
-0.63 
-0.62 
 
Nascent polypeptide-associated complex 
P38879 
 
EGD2 
 
  0.02 
 
-0.28 
 
0.39 
 
-1.36 
 
0.79 
 
-0.52 
 
N-terminal methionine excision 
P38174  MAP2   -0.31 0.54 2.25 -2.99  -0.48 
N-terminal acetylation by NatA 
P07347 
P12945 
 
ARD1 
NAT1 
 
-0.91 
0.49 
 
 
 0.41 
 
 -0.60 
 
1.67 
2.08 
 
-2.41 
-2.52 
 
 
-0.56 
 
 
 
mRNP proteome reveals complex translation regulation of MS2L-tagged RNAs  
Several proteins enriched in the three MS data sets are ribosome-associated proteins implicated in 
translation regulation (Table 15). The repertoire of these proteins suggests that the translation of 
the studied MS2L-tagge RNA is dynamically regulated to enable both active translation on 
polyribosomes as well as translational repression to promote mRNA decapping and decay.  
A highly enriched protein (>5-fold enrichment) in all three MS data sets involved in both 
translation-promoting and -repressing molecular events is Asc1 (Ceci et al. 2003; Shor et al. 2003; 
Chantrel et al. 1998; Sezen, Seedorf, and Schiebel 2009; Rachfall et al. 2013). Asc1 is a core 
protein of the 40S ribosomal subunit believed to mediate signals from the cellular signalling 
pathways to the ribosome (reviewed in J. Nilsson et al. 2004). Consistent with a role in signal 
transduction, the loss of ASC1 leads to defects in multiple cellular processes (Valerius et al. 2007; 
Rachfall et al. 2013; Zeller, Parnell, and Dohlman 2007; Melamed et al. 2010). This evolutionarily 
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highly conserved protein is located on the 40S subunit in close proximity to the mRNA exit site 
and is proposed to form a binding platform for the simultaneous recruitment of multiple factors 
(Sengupta et al. 2004; Taylor et al. 2009; Ullah et al. 2008). One such protein whose ribosome-
association seems to be partly mediated by Asc1 is Scp160 (Baum et al. 2004) – a protein also 
enriched after PGK1-6MS2L and 6MS2L-RNA affinity purification. Scp160 is a KH domain 
RNA-binding protein (Weber et al. 1997) proposed to bind most if not all cellular mRNAs 
(Hogan et al. 2008a). Scp160 has been shown to associate with cytosolic as well as membrane-
bound polyribosomes (Frey, Pool, and Seedorf 2001). The protein likely associates with 
polyribosomes as a component of mRNP complexes as suggested by the findings that Scp160 
polysome-association is mRNA-dependent (Frey, Pool, and Seedorf 2001) and that upon EDTA 
treatment, which dissociates polysomes and 80S monosomes into single subunits (Nolan and 
Arnstein 1969; Blobel 1971), Scp160 is released from ribosomes in a complex also containing the 
major yeast poly(A)-binding protein Pab1(Lang and Fridovich-Keil 2000). A third protein 
identified in complex with Scp160 and Pab1 after yeast cell cytosolic extract treatment with 
EDTA was Bfr1 (Lang and Fridovich-Keil 2000). This protein was also among the enriched 
proteins in our mRNP affinity purification experiments. Several lines of evidence suggest that 
Scp160 and Bfr1 are functionally related. Firstly, both proteins bind a large and overlapping set of 
cellular mRNAs (Hogan et al. 2008a). Secondly, gene deletion of either SCP160 or BFR1 results 
in similar phenotypes characterized by increased cell ploidy and abnormal cell morphology 
(Wintersberger, Kühne, and Karwan 1995; C. L. Jackson and Képès 1994). As mentioned above, 
the two proteins also seem to be physically associated as components of mRNP complexes (Lang 
and Fridovich-Keil 2000). Similarly to Scp160, Bfr1 associates with polyribosomes in an RNase-
sensitive manner (Lang et al. 2001). However, the exact molecular function of Scp160 and Bfr1 
interactions with the mRNA and polyribosomes has remained elusive. The deletion of BFR1 has 
been shown to largely disrupt Scp160 recruitment to polyribsomes; interestingly, the opposite 
was not observed (Lang et al. 2001). This finding suggests a role for Bfr1 in recruiting Scp160-
containing mRNPs to ribosomes for translation (Lang et al. 2001). The role of Scp160 in 
translation was recently addressed in our laboratory (Hirschmann et al. 2014). Unexpectedly, the 
results point to the possibility that Scp160 may exert its positive effect on translation by 
increasing the pool of tRNAs available for the translation machinery via promoting tRNA 
recycling and/or preventing tRNA diffusion. 
PGK1-6MS2L and ENO2-6MS2L have co-purified with two related proteins – the 
GTPase Rbg1 and its binding partner Tma46. Both proteins cosediment with 80S ribosomes and 
polyribosomes in sucrose density gradients, suggesting a function in translation (Francis et al. 
2012; Daugeron et al. 2011). Ribosome recruitment of the Rbg1-Tma46 complex is mediated by 
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the latter protein, which also modulates Rbg1’s GTP binding and hydrolytic activity (Francis et al. 
2012). Rbg1 and Tma46 seem to perform overlapping roles with several other proteins – a severe 
growth defect is only observed in a triple knock-out strain where RBG1 and its paralog RBG2 is 
deleted in combination with SLH1 (Daugeron et al. 2011), a gene encoding for a putative RNA 
helicase (Martegani et al. 1997; V. Pena et al. 2009). The reduced amount of polyribosomes and 
accumulation of 80S monosomes in Δrbg1Δrbg2Δslh1 strain hints at a possible role for Rbg1 and 
Tma46 in translation initiation because a similar change in polysome profile is observed also for 
strains defective in translation initiation (Daugeron et al. 2011). 
 
Table 15. MS2L-tagged RNA co-purifying proteins involved in translation regulating. Log2 (H/L) ratios of 
enriched proteins are in bold. 
 
Protein ID Gene 
BB RNase ENO2 6MS2L 
for rev for rev for rev for rev 
Possible role in general translation regulation 
P38011 
P06105 
P38934 
 
ASC1 
SCP160 
BFR1 
 
0.90 
0.79 
2.01 
 
-2.61 
-1.18 
-2.61 
 
2.68 
0.87 
1.79 
 
-3.02 
-0.76 
-2.60 
 
2.39 
-0.23 
3.05 
 
-3.68 
-0.93 
-4.43 
 
2.52 
1.49 
2.51 
 
-1.88 
-1.25 
-1.67 
 
Possible role in translation initiation 
P39729 
Q12000 
P53316 
P40561 
 
RBG1 
TMA46 
YGR250C 
SGN1 
 
3.95 
4.05 
0.67 
 
 
-2.76 
-2.96 
 -1.07 
 
2.49 
2.70 
1.23 
0.95 
 
-3.07 
-3.25 
-1.37 
-1.28 
 
2.87 
1.07 
 
 
 
-3.21 
-3.19 
-3.51 
-3.59 
 
 
 4.02 
3.92 
 
 
 -3.53 
-3.27 
 
Role in translation repression 
P10080 
P39015 
P39517 
P25644 
 
SBP1 
STM1 
DHH1 
PAT1 
 
1.97 
2.50 
 
 
 
-0.39 
-2.76 
 -3.82 
 
0.66 
2.51 
0.48 
3.76 
 
-0.91 
-2.97 
-0.54 
-4.70 
 
0.02 
2.54 
1.05 
3.88 
 
-2.07 
-4.39 
-2.34 
-6.48 
 
3.51 
1.82 
0.61 
3.19 
 
-2.03 
-1.42 
-0.01 
-3.13 
 
mRNA- and ribosome-associated protein 
Q04600 
 
TMA64 
 
  1.21 
 
-1.67 
 
3.33 
 
   
 
A putative RBP encoded by YGR250C (Feroli et al. 1997; Sartori et al. 2000) was 
enriched after PGK1-6MS2L and 6MS2L-RNA and possibly also after ENO2-6MS2L affinity 
purification. In case of the latter mRNA, Ygr250c was not quantified in the forward labelling 
experiment; however, the H/L ratio obtained in the reverse labelling experiment suggested >11-
fold enrichment. An interaction between Rbg1 and Ygr250c has been identified by yeast 2-hybrid 
system (Wout et al. 2009; Ito et al. 2000). However, this interaction was not observed in a 
genome-wide analysis of yeast protein complex composition (Gavin et al. 2006). Instead, the 
most highly scored Ygr250c’s interaction partner in this study was Sgn1 (Gavin et al. 2006) – an 
mRNA-binding protein proposed to modulate mRNA expression in the cytoplasm possibly by 
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enhancing translation initiation (Winstall et al. 2000). A role for Sgn1 in translation initiation is 
also supported by the findings of a genome-wide analysis of yeast protein complex composition. 
Namely, the two highest scoring interaction partners of Sgn1 in this study were eIF4G1/TIF4631 
and eIF4G2/TIF4632 (Gavin et al. 2006). Furthermore, 8 out of 10 identified interaction 
partners of Ygr250c (including eIF4G1/TIF4631 and eIF4G2/TIF4632) were also among the 
interaction partners of Sgn1 (Gavin et al. 2006), suggesting that the two proteins act in concert 
possibly as components of one protein complex.  
In our experiments Sgn1 was enriched, similarly to Ygr250c, after PGK1-6MS2L and 
6MS2L-RNA affinity purification. In case of ENO2-6MS2L, Sgn1 was not quantified in the 
forward labelling experiment but was >12-fold enriched in the reverse labelling experiment, 
suggesting that the protein might also associate with ENO2-6MS2L-containig mRNPs. The 
missing H/L ratio in ENO2-6MS2L MS data set for both Sng1 and Ygr250c in the forward 
labelling experiment and a similar enrichment level in the reverse labelling experiment supports 
the notion that the two proteins might function as part of one protein complex.  
Several enriched proteins in each MS data set have been implicated in translation 
repression. These proteins include Sbp1, Stm1 and the mRNA decapping activators Dhh1 and 
Pat1. The latter protein was enriched in all three MS data sets and with >8.5-fold enrichment was 
also the most highly enriched of the four above-mentioned proteins. In vitro experiments have 
shown that Pat1 interferes with an early step in translation by limiting the formation of 48S PIC 
(Nissan et al. 2010). 
The second protein among the translational repressors enriched in all three MS data sets 
was Stm1. This ribosome-associated protein (M. W. Van Dyke et al. 2004; N. Van Dyke, Baby, 
and Van Dyke 2006) has been shown by genetic analysis to promote Dhh1-meidated translational 
repression and mRNA decay (Balagopal and Parker 2009). In vitro studies have revealed that Stm1 
can block translation after ribosomal subunit joining (Balagopal and Parker 2011).  
The determined H/L ratios hint at the possibility that Sbp1 and Dhh1 are similarly to 
Pat1 and Stm1 enriched after the affinity purification of all three MS2L-tagged RNAs. However, 
the set threshold criteria for enriched proteins were fulfilled by Sbp1 only after PGK1-6MS2L and 
6MS2L-RNA affinity purification and by Dhh1 only after ENO2-6MS2L affinity purification. 
Translational repression upon glucose deprivation is attenuated in Δsbp1 as well as in Δdhh1 yeast 
cells, revealing a role for both proteins in global translation repression of mRNAs (J. Coller and 
Parker 2005; Segal, Dunckley, and Parker 2006). Genetic analysis has shown that Sbp1 and Dhh1 
function together to promotes translation repression (Segal, Dunckley, and Parker 2006); 
however, Dhh1 alone is required for mRNA decapping, revealing an important difference in the 
function of the two proteins (Segal, Dunckley, and Parker 2006; J. M. Coller et al. 2001). Sbp1 
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has been proposed to block the recruitment of 43S PIC to the mRNA because recombinant Sbp1 
can directly bind eIF4G and repress the translation of a reporter mRNA (Rajyaguru, She, and 
Parker 2012). In vitro, Dhh1 has been shown to interfere with stable 48S PIC formation (J. Coller 
and Parker 2005), whereas in vivo the protein seems to interfere with the elongation step by 
reducing ribosome transit rate (Sweet, Kovalak, and Coller 2012). 
The protein encoded by TMA64 was enriched after PGK1-6MS2L and possibly also after 
ENO2-6MS2L affinity purification. In case of the latter mRNA, Tma64 was 10-fold enriched in 
the forward labelling experiment but was not quantified in the reverse labelling experiment, 
suggesting that the protein might have dissociated form the mRNP during affinity purification. 
The function of Tma64 is unknown. The protein contains a putative pseudouridine synthase and 
archaeosine transglycosylase (PUA) RNA-binding domain (Fleischer et al. 2006), which, among 
other proteins, is found in pseudouridine synthase enzymes and in RNA methyl transferases 
(reviewed in Pérez-Arellano, Gallego, and Cervera 2007). Tma64 has been found to co-purify 
with ribosomes (Fleischer et al. 2006) and with epitope-tagged Pab1 in an RNA-independent 
manner (R. Richardson et al. 2012). These findings hint at the possibility that Tma64 is a 
component of mRNPs engaged in translation. 
 
MS2L-tagged RNAs seem to be largely degraded in the  
5′→3′ exonucleolytic decay pathway  
All studied MS2L-tagged RNAs have co-purified with several mRNA decay factors (Table 16). 
The repertoire of these proteins suggests that the decay of PGK1-6MS2L and ENO2-6MS2L and 
possibly also 6MS2L-RNA is mechanistically similar and involves the same cellular mRNA decay 
pathways. Most of the identified mRNA decay factors were highly enriched after MS2L-tagged 
RNA affinity purification with log2 (H/L) ratios >2 or <-2. The high enrichment of mRNA 
decay factors suggests that mRNA degradation comprises a prominent step in the life cycle of the 
studied RNAs. 
The proteome of PGK1-6MS2L and ENO2-6MS2L-containing mRNPs indicates that the 
mRNAs are degraded in 5′→3′ exonucleolytic decay pathway. The prerequisite for mRNA 
degradation in 5′→3′ direction is 5′ cap removal. Indeed, both MS2L-tagged mRNAs have co-
purified with almost the entire set of proteins known to assemble into a decapping mRNP, 
including the two subunits of the decapping complex and several decapping activators (see 
Introduction, “Decapping” and references therein). Dcp2, the catalytic core of the decapping 
complex, was >9-fold enriched after PGK1-6MS2L and ENO2-6MS2L affinity purification and 
Dcp1, which stimulates the catalytic step, was >2.5-fold enriched. Structural analysis of the yeast 
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decapping complex has shown that Dcp2 and Dcp1 form a 1:1 complex (She et al. 2008) with 
Dcp2 being the subunit that interacts with the 5′ cap and the mRNA body (Deshmukh et al. 
2008). Therefore, the lower enrichment level of Dcp1 likely reflects the loss of this subunit from 
the decapping complex during affinity purification. 
 
Table 16. MS2L-tagged RNA co-purifying proteins involved in mRNA decay. Log2 (H/L) ratios of enriched 
proteins are in bold. 
 
Protein ID Gene 
BB RNase ENO2 6MS2L 
for rev for rev for rev for rev 
Decapping complex 
P53550 
Q12517 
 
DCP2 
DCP1 
 
4.38 
 
 
-5.01 
 
 
4.28 
1.91 
 
-4.10 
-2.29 
 
3.24 
1.52 
 
-3.90 
-2.71 
 
 
 -0.07 
 
Decapping activators
a
 
P39998 
P40070 
P47017 
P38203 
 
EDC3 
LSM4 
LSM1 
LSM2 
 
 -4.04 
 
 -0.49 
 
3.54 
1.59 
1.82 
3.26 
 
-4.00 
-1.55 
 
 
 
3.11 
0.58 
2.46 
2.87 
 
-4.60 
-0.82 
-2.94 
-3.17 
 
 3.42 
 
 
 
 -2.23 
-2.81 
 
 
mRNA exoribonucleases 
P22147 
P53010 
P36102 
 
XRN1 
PAN2 
PAN3 
 
2.99 
 
 
 
-3.42 
 
 
 
2.89 
3.09 
3.13 
 
-2.98 
-3.88 
-4.30 
 
3.16 
3.10 
3.10 
 
-4.08 
-4.45 
-4.22 
 
3.39 
4.63 
5.87 
 
-2.60 
-4.99 
-4.74 
 
Nonsense-mediated decay 
P30771 
Q03466 
Q12129 
 
UPF1 
EBS1 
NMD4 
 
6.78 
4.99 
 
 
-7.41 
-5.20 
 
 
5.92 
4.47 
4.65 
 
-6.08 
-5.49 
 
 
3.18 
4.86 
1.65 
 
-4.78 
-4.72 
-4.17 
 
4.45 
 4.56 
 
-4.08 
 -3.06 
 
a 
The Log2 (H/L) of decapping activators Pat1 and Dhh1 are listed in table 15.
 
 
From the well characterized decapping activators Pat1, Dhh1, Scd6, Edc3 and Lsm1-7 
only Scd6 was not found among the enriched proteins after PGK1-6MS2L or ENO2-6MS2L 
affinity purification. Pat1 and Edc3 with >8.5-fold enrichment were the most highly enriched 
decapping activators in both MS data sets. Dhh1 was >2-fold enriched after ENO2-6MS2L 
affinity purification. The protein did not classified as enriched after PGK1-6MS2L affinity 
purification; however, the determined log2 (H/L) ratios 0.48 and -0.54 suggest that Dhh1 also co-
purified with PGK1-6MS2L. Neither PGK1-6MS2L nor ENO2-6MS2L co-purified with all seven 
subunits of the Lsm1-7 complex. The enriched subunits included Lsm4, Lsm1 and Lsm2 in 
ENO2-6MS2L MS data set and Lsm4 in PGK1-6MS2L MS data set. In case of the latter mRNA, 
Lsm1 and Lsm2 were enriched in the forward labelling experiment but were not quantified in the 
reverse labelling experiment, suggesting that the same set of Lsm1-7 subunits may have co-
purified with PGK1-6MS2L as with ENO2-6MS2L. The absence of Lsm3 and Lsm5-7 among the 
enriched proteins, as well as Lsm1 and Lsm2 missing detection in PGK1-6MS2L reverse 
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experiment indicates that Lsm1-7 complex is prone to dissociation during mRNP affinity 
purification. Interestingly, the Lsm subunits enriched in our MS data sets have been shown to 
interact with mRNA or with Pat1 (Chowdhury, Mukhopadhyay, and Tharun 2007; Sharif and 
Conti 2013; D. Wu et al. 2013). These interactions likely help to maintain Lsm4, Lsm1 and Lsm2 
attached to the mRNP during MS2L-tagged mRNA affinity purification. 
Decapped mRNAs are rapidly degraded by the 5′→3′ exoribonuclease Xrn1. Xrn1was 
>7-fold enriched after PGK1-6MS2L and ENO2-6MS2L affinity purification, indicating that the 
exorbonuclease is, at least partly, responsible for the degradation of MS2L-tagged PGK1 and 
ENO2. 
The set of mRNA decay factors co-purifying with 6MS2L-RNA had one major difference 
compared to PGK1-6MS2L and ENO2-6MS2L co-purifying proteins – the two subunits of the 
decapping complex did not co-purify with 6MS2L-RNA. However, other important components 
of the 5′→3′ exonucleolytic decay pathway, including Pat1 and the Lsm4 subunit of the Lsm1-7 
complex plus the 5′→3′ exoribonuclease Xrn1, were among the enriched proteins. These results 
suggest that 6MS2L-RNA is similarly to PGK1-6MS2L and ENO2-6MS2L degraded in 5′→3′ 
decay pathway. The decapping complex might have been lost from 6MS2L-RNA during affinity 
purification.  
In the deadenylation dependent mRNA decay pathway mRNA decapping and 5′→3′ 
exonucleolytic decay is preceded by poly(A) tail shortening to oligo(A) length. Surprisingly, none 
of the MS2L-tagged RNAs co-purified with components of the Ccr4-Not complex, which is 
believed to be the major poly(A)-specific 3′ exoribonuclease in yeast (see Introduction, 
“Deadenylation” and references therein). Instead, the components of the heterodimeric Pan2-
Pan3 complex were >8-fold enriched in all three MS data set. Pan2-Pan3 complex has been 
shown to mediate the shortening of the newly synthesised poly(A) tails to mRNA-specific 
lengths. Therefore, the enrichment of Pan2-Pan3 in all three MS data sets may reflect the 
trimming step of poly(A) tails of the MS2L-tagged RNAs. However, resent findings by Sun et al. 
(M. Sun et al. 2013) suggest that Pan2-Pan3 complex could also perform the deadenylation of the 
MS2L-tagged RNAs leading to mRNA decapping and decay. Namely, comparative dynamic 
transcriptome analysis suggested that Ccr4-Not and Pan2-Pan3 deadenylase complexes prefer 
different mRNA substrates (M. Sun et al. 2013). Unfortunately, PGK1 and ENO2 were not 
among the analysed mRNAs in this study and therefore it is not known if these mRNAs would 
be preferentially deadenylated by Pan2-Pan3 complex. It remains possible that Pan2-Pan3 
complex is, in addition to trimming the initially synthesised poly(A) tails, responsible for PGK1-
6MS2L, ENO2-6MS2L and 6MS2L-RNA deadenylation, ultimately leading to the 5′→3′ 
exonucleolytic decay of these RNAs.  
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MS2L-tagged RNAs may be targeted by nonsense-mediated decay 
The most highly enriched protein after PGK1-6MS2L affinity purification in the two biological 
replicate experiments was Upf1 – the key effector of nonsense-mediated mRNA decay pathway 
(see Introduction, “NMD factors and consequences of their activation” and references therein). 
The protein was also highly enriched after ENO2-6MS2L and 6MS2L-RNA affinity purification, 
raising the possibility that the studied MS2L-tagged RNAs may be targeted by NMD (Table 16).  
The only difference between PGK1-6MS2L and ENO2-6MS2L and the respective wt 
mRNAs is the 6MS2L tag inserted immediately downstream of the translation termination 
codon, which increases the distance to poly(A) tail by 421 nt compared to wt mRNA. Positioning 
the normal stop codon too far upstream of the poly(A) tail has been shown to redefine the stop 
codon as premature and activate NMD (see Introduction, “NMD targets and the mechanism of 
their recognition” and references therein). The MS2L-tagging technique (Haim et al. 2007) may 
thus have the potential to turn wt mRNAs into NMD targets.  
6MS2L-RNA may also contain NMD-activating features, which may include a large 
distance between the stop codon and the poly(A) tail. Proteins of the translation machinery co-
purifying with 6MS2L-RNA indicate that the transcript is translated. Therefore, 6MS2L-RNA 
seems to be sensed as an mRNA by the yeast cells. If the first AUG codon of the predicted 
6MS2L-RNA transcript (see Results, “Control RNA to determine the effect of MS2L tag on 
mRNP protein composition”) is used to initiate translation, 500 nt would separate the translation 
stop codon from the poly(A) tail, possibly leading to NMD activation due to a large distance 
between the stop codon and the poly(A) tail. 
Other enriched proteins in the three MS data sets implicated in NMD include Ebs1 and 
Nmd4. Ebs1 was >22-fold enriched after PGK1-6MS2L and ENO2-6MS2L affinity purification 
but was missing among the enriched proteins after 6MS2L-RNA purification. Nmd4 was 
enriched after ENO2-6MS2L and 6MS2L-RNA affinity purification. In case of PGK1-6MS2L 
purification, the protein was 25-fold enriched in the forward experiment but was not quantified 
in the reverse experiment, suggesting that Nmd4 might have dissociated from the mRNP during 
affinity purification. Very little is known about the role of Nmd4 in nonsense-mediated decay. 
The protein was originally identified in a yeast 2-hybrind screen searching for Upf1 interaction 
partner (F He and Jacobson 1995). Later genetic studies have shown that NMD4 deletion 
suppresses growth defects in Δxrn1 cells, whereas the deletion of NMD4 in Δlsm7 or Δski2 cells 
leads to a stronger growth defect than in single mutants (Wilmes et al. 2008). The role of Ebs1 in 
NMD is also not well defined. The protein seems to perform a non-essential function in 
canonical NMD as suggested by the finding that the level of NMD substrates is less elevated in 
Δebs1 cells than in Δupf1, Δupf2 or Δupf3 cells (Luke et al. 2007). Upf1 co-immunoprecipitates 
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with Ebs1 in an RNase-insensitive manner, suggesting a physical interaction between the proteins 
(Luke et al. 2007). 
 
MS2L-tagged RNA co-purifying proteins implicated in poly(A) tail-mediated interactions 
Poly(A) tail provides a platform for a multitude of RNA-protein and protein-protein interactions. 
An important role in the poly(A) tail-mediated interactions is played by the major yeast poly(A)-
binding protein Pab1. In one study the protein was shown to be involved in about 200 RNA-
dependent but ribosome-independent protein-protein interactions (Klass et al. 2013). Another 
study identified 55 proteins that co-immunoprecipitated with Pab1 in an RNA-independent 
manner (R. Richardson et al. 2012). Collectively, these two studies identify a set of proteins that 
associate with Pab1-containing mRNPs. Table 17 shows the identified proteins in the above-
mentioned studies that were also enriched in our affinity purification experiments. Altogether, 61 
proteins enriched in our MS data sets have previously been found to co-purify with Pab1, 
indicating that the MS2L-tagged RNAs are involved in multiple protein-protein interactions 
through their Pab1-bound poly(A) tails. The current chapter will focus on four proteins in the 
SILAC protein-protein interaction networks whose association with the mRNP is mediated by 
the poly(A) tail (Table 18). 
As expected, Pab1 was enriched after PGK1-6MS2L and ENO2-6MS2L affinity 
purification, indicating that these mRNAs carry a poly(A) tail that is bound by Pab1. Pab1 was 
enriched also after 6MS2L-RNA affinity purification, confirming our hypothesis that the CYC1 
transcriptional terminator would provide the necessary signals for poly(A) addition to the 
6MS2L-RNA transcript. Surprisingly, the enrichment level of Pab1 was roughly 6-fold higher 
after 6MS2L-RNA affinity purification compared to the affinity purifications of the two MS2L-
tagged mRNAs. This finding hints at the possibility that compared to the MS2L-tagged mRNAs, 
6MS2L-RNA has on average a longer poly(A) tail that can accommodate more Pab1 molecules, 
thus leading to a higher enrichment level of Pab1 after 6MS2L-RNA affinity purification 
(Beilharz and Preiss 2007). A difference in the average poly(A) tail length can reflect differences 
in deadenylation and mRNA decay kinetics (reviewed in Eckmann, Rammelt, and Wahle 2011); 
however, it remains to be experimentally determined whether the deadenylation rate differs 
between 6MS2L-RNA and the MS2L-tagged mRNAs. 
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Table 17. MS2L-tagged RNA co-purifying proteins previously found to co-purify with epitope-tagged Pab1 
(see next page). Protein co-purification with Pab1 was shown to be RNA-independent (reference 1) or RNA-
dependent but ribosome-independent (reference 2). An MS2L-tagged RNA co-purifying protein was considered 
enriched if it fulfilled the threshold criteria log2 (H/L) > 0.5 or <0.5 (+). 
 
Description Reference
a
 Gene BB
b
 RNase ENO2 6MS2L 
Translation initiation, elongation
c
 1, 2 eIF4G1/TIF4631 + + + + 
 1,2 eIF4G2/TIF4632 + + + + 
 2 eIF5B/FUN12   + + 
 2 eIF2α/SUI2   +  
 2 eIF2γ/GCD11   +  
 1, 2 eIF2A/YGR054w   +  
 2 eIF4E/CDC33    + 
 1, 2 eIF3 p135/CLU1    + 
 1, 2 eEF3/YEF3 + +   
Translation repression 2 STM1 + + + + 
 2 PAT1  + + + 
 2 SBP1  +  + 
mRNA decay 1, 2 XRN1 + + + + 
 2 LSM4  + + + 
 2 LSM2   +  
Nonsense-mediated decay 1 UPF1 + + + + 
 2 EBS1 + + +  
Nuclear cap-binding complex 2 CBC2    + 
 1, 2 CBC1    + 
Poly(A)
+
 RNA-binding protein 1 HRB1  + +  
 2 NAB2  +  + 
 1, 2 PUB1  +  + 
RNA-binding protein 2 BFR1 + + + + 
 2 KHD1  + + + 
 2 SRO9  + +  
 1, 2 YGR250C  +  + 
 1, 2 SGN1  +  + 
 1 LHP1  +   
 2 DED1    + 
Splicing 2 MSL5   +  
 2 PSP2   +  
Ribosome biogenesis 2 ARX1 + + +  
 1, 2 CBF5 +  +  
 1, 2 RRP5    + 
 2 DIM1 +    
 2 RRP7 +    
 2 UTP22 +    
 2 NOP4 +    
 1 KRR1 +    
 1 KRI1 +    
 1 NUG1 +    
Mitochondrial 1, 2 MIS1 +  + + 
 1, 2 YLR419W +  +  
 2 SHM1   + + 
 2 MGM101   +  
 2 MSS116 +    
Translation machinery-associated 2 RBG1 + + +  
 1, 2 TMA46 + + +  
Ubiquitin-specific protease 1, 2 UBP3 + + + + 
Ubiquitin protease cofactor 2 BRE5 +    
Inosine monophosphate dehydrogenase 2 IMD4  + + + 
Nascent peptide maturation 2 ARD1   +  
Histone acetyltransferase complex 2 TRA1 +    
 
a
 Reference 1 (R. Richardson et al. 2012), reference 2 (Klass et al. 2013). 
b
 Abbreviations: BB – Boiled Beads sample of PGK1-6MS2L affinity purification, RNase – RNase eluate of PGK1-6MS2L 
affinity purification. 
c
 Ribosomal proteins are omitted from the comparison.  
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Pab1 has been found to interact with Pbp1 in yeast 2-hybrid assay (D A Mangus, Amrani, 
and Jacobson 1998). Using the same method, an interaction was identified between Pbp1 and 
Pbp4 (David A Mangus, Smith, et al. 2004), as well as between Pbp1 and Mkt1 (Tadauchi et al. 
2004). ENO2-6MS2L and 6MS2L-RNA co-purified with all four above-mentioned proteins. 
PGK1-6MS2L co-purified with Pab1 and Mkt1 and possibly also with Pbp1, which was among 
the enriched proteins in the forward labelling experiment but was not quantified in the reverse 
labelling experiment (Table 18). The exact molecular function of Pbp1, Mkt1 and Pbp4 is not 
well defined; all three proteins are encoded by non-essential genes and seem to regulate the 
expression of their target mRNAs at the post-transcriptional level. Pbp1 is a negative regulator of 
Pan2-Pan3 deadenylase activity (David A Mangus, Smith, et al. 2004); the protein cosediments 
with polyribosomes in sucrose density gradients (D A Mangus, Amrani, and Jacobson 1998; 
Tadauchi et al. 2004) and localizes to stress granules upon glucose deprivation (Buchan, Muhlrad, 
and Parker 2008). Stress granules are thought to store mRNPs stalled in translation initiation 
because the typical components of these cytoplasmic aggregates are translation initiation factors 
and the 40S ribosomal subunit (reviewed in Carolyn J. Decker and Parker 2012). Pbp1 also plays 
a role in stress granule formation as indicated by  a strong reduction in stress granule formation 
in Δpbp1 cells upon glucose deprivation (Buchan, Muhlrad, and Parker 2008). Glucose 
deprivation also leads to the accumulation of Pbp4 in stress granules; however, unlike Δpbp1 cells, 
Δpbp4 cells do not show a strong defect in stress granule formation (Swisher and Parker 2010). 
 
Table 18. MS2L-tagged RNA co-purifying proteins that either directly or indirectly bind the poly(A) tail. Log2 
(H/L) ratios of enriched proteins are in bold. 
 
Protein ID Gene 
BB RNase ENO2 6MS2L 
for rev for rev for rev for rev 
P04147 
P53297 
Q07362 
P40850 
 
PAB1 
PBP1 
PBP4 
MKT1 
 
2.46 
1.55 
 1.49 
 
-3.26 
-2.00 
 -1.67 
 
2.58 
1.30 
-0.51 
1.34 
 
-3.36 
 0.43 
-1.60 
 
2.12 
2.75 
3.30 
2.00 
 
-3.66 
-4.12 
-3.43 
-2.95 
 
5.33 
3.23 
3.49 
3.43 
 
-5.58 
-2.99 
-2.67 
-2.88 
 
 
Pbp1 has been implicated together with Mkt1 in positive regulation of HO endonuclease 
mRNA translation (Tadauchi et al. 2004). Similarly to Pbp1, Mkt1 cosediments with 
polyribosomes (Tadauchi et al. 2004). Mkt1 polysome-association depends on Pbp1, but not vice 
versa (Tadauchi et al. 2004). A role for Mkt1 in post-transcriptional gene expression regulation is 
further supported by the large number of different cellular processes that are influenced by allelic 
variation of MKT1. Namely, the gene encoding for MKT1 has been identified in several 
quantitative trait locus mapping studies to provide resistance to stressful growth conditions 
including exposure to high temperature (L. M. Steinmetz et al. 2002; Sinha et al. 2006), high 
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ethanol (Swinnen et al. 2012) or low glucose (Parreiras, Kohn, and Anderson 2011). MKT1 allelic 
variation also contributes to sporulation efficiency (Deutschbauer and Davis 2005), 
mitochondrial genome maintenance (Dimitrov et al. 2009) and drug sensitivity (Demogines et al. 
2008).  
 
A subpopulation of MS2L-tagged RNA-containing mRNPs might be sequestered to 
stress granules for translation repression 
The more than 6-fold enrichment of two stress granule components, Pbp1 and Pub4, after 
ENO2-6MS2L and 6MS2L-RNA affinity purification (Table 18) hinted at the possibility that a 
subpopulation of mRNPs containing these two transcripts might be stalled in the process of 
translation initiation and are possibly localized to stress granules. Stress granules generally contain 
40S ribosomal subunits and translation initiation factors eIF4E, eIF4G, eIF4A, eIF4B, eIF3 and 
eIF2. Besides these components, four additional proteins are considered to be typical stress 
granule constituents: Pab1 and Pbp1 discussed in the previous chapter plus Pub1 and Ded1 
(reviewed in Carolyn J. Decker and Parker 2012).  
Pub1 was enriched after PGK1-6MS2L and 6MS2L-RNA affinity purification and likely 
co-purified also with ENO2-6MS2L (Table 19). Besides Pab1, Pub1 is the major proteins that is 
crosslinked to poly(A)+ RNA by UV light (J. T. Anderson, Paddy, and Swanson 1993; Matunis, 
Matunis, and Dreyfuss 1993). The protein contains three RNA recognition motifs, which have a 
high binding preference for U- or UA-rich sequences (Santiveri et al. 2011). Pub1 has been 
shown to directly bind to eIF4G1/TIF4631 (Santiveri et al. 2011) and to the poly(A)+ RNA-
binding protein Nab2 (Apponi et al. 2007), both of which were among the enriched proteins in 
several MS data sets (Table 13 and 20). Pub1 does not co-sediment with polyribosomes on 
sucrose density gradients (J. T. Anderson, Paddy, and Swanson 1993; Ripmaster and Woolford 
1993), which is in agreement with a role as a component of translationally inactive mRNPs 
(Buchan, Muhlrad, and Parker 2008). Interestingly, Pub1 was considerably more enriched after 
6MS2L-RNA affinity purification (>4.5-fold enrichment) compared to PGK1-6MS2L affinity 
purification (>1.5 fold enrichment), suggesting that the subpopulation of translationally repressed 
mRNPs might be higher for 6MS2L-RNA. 
The DEAD-box RNA helicase Ded1 (reviewed in Tarn and Chang 2009) was enriched 
only after 6MS2L-RNA affinity purification. The later protein seems to play an important 
regulatory role in stress granule formation (Hilliker et al. 2011). On the one hand, Ded1 may act 
as a translational repressor because the binding of Ded1 to eIF4F leads to mRNP accumulation 
in stress granules. On the other hand, Ded1 may activate translation in an ATP-dependent 
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manner. ATP hydrolysis by Ded1 leads to mRNP exit from stress granules and completion of 
translation initiation (Hilliker et al. 2011). The relatively low enrichment level (>1.5-fold 
enrichment) of Ded1 after 6MS2L-RNA affinity purification suggests that only a minor fraction 
6MS2L-RNA-containing mRNPs are associated with this protein. 
 
Table 19. MS2L-tagged RNA co-purifying proteins implicated in stress granule formation. Log2 (H/L) ratios of 
enriched proteins are in bold. 
 
Protein ID
a
 Gene 
BB RNase ENO2 6MS2L 
for rev for rev for rev for rev 
P32588 
P06634 
 
PUB1 
DED1 
 
 0.23 
 
 0.07 
 
0.65 
0.22 
 
-0.73 
0.02 
 
0.35 
0.55 
 
-1.80 
0.45 
 
2.89 
1.09 
 
-2.22 
-0.64 
 
a
 The Log2 (H/L) of stress granule components Pab1 and Pbp1 are listed in table 18. 
 
 
The nuclear history of MS2L-tagged RNAs is reflected by the enriched RBPs 
All three tested MS2L-tagged RNAs have co-purified primarily with proteins whose steady state 
localization is cytoplasmic. The nuclear phase of mRNA life cycle of the studied transcripts is 
reflected by a few enriched shuttling RNA-binding proteins and nuclear RNA decay factors 
(Table 20). 
The enriched shuttling RBPs co-purifying with MS2L-tagged RNAs include Nab2, Hrb1, 
Sro9 and Khd1 (also known as Hek2), all of which were enriched after PGK1-6MS2L affinity 
purification. ENO2-6MS2L co-purified with Hrb1 and Sro9 and possibly also with Nab2 and 
Khd1, which were enriched in one of the biological replicate experiments. 6MS2L-RNA co-
purified with Nab2 and Khd1 but not with Sro9 or Hrb1. The latter protein is a shuttling SR-like 
RBP (Häcker and Krebber 2004) that is recruited to the transcribed genes via the THO complex 
(Häcker and Krebber 2004; E. Hurt et al. 2004). Recent findings indicated that Hrb1 is a quality 
control factor that ensures the export of only correctly spliced mRNAs (Hackmann et al. 2014). 
Hrb1 may recruit the TRAMP complex to initiate mRNA decay of incorrectly spliced transcripts 
(Hackmann et al. 2014). On properly spliced mRNAs, however, Hrb1 can recruit the mRNA 
export receptor Mex67 to enable quality controlled mRNA export (Hackmann et al. 2014).  
Interestingly, the binding of Hrb1 is not limited to intron-containing transcripts (E. Hurt et al. 
2004; Hackmann et al. 2014), explaining why the protein co-purified with PGK1-6MS2L and 
ENO2-6MS2L derived from intronless genes. 
Sro9, which similarly to Hrb1 co-purified with PGK1-6MS2L and ENO2-6MS2L, is 
associated with both transcribed genes (Röther et al. 2010) and translating ribosomes (Sobel and 
Wolin 1999). The protein has therefore been proposed to be loaded onto mRNA during 
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transcription and shuttle with the mature mRNP to cytoplasm (Röther et al. 2010). The exact 
molecular function of Sro9 remains unknown; however, since the protein has been shown not to 
be essential for the expression and stability of specific transcripts, the association of Sro9 with 
translating ribosomes hints at a role for Sro9 in translation regulation of bound mRNAs (Röther 
et al. 2010). 
 
Table 20. Nuclear or shuttling RNA-binding proteins that co-purify with MS2L-tagged RNAs. Log2 (H/L) ratios 
of enriched proteins are in bold. 
 
Protein ID Gene 
BB RNase ENO2 6MS2L 
for rev for rev for rev for rev 
Shuttling RNA-binding proteins 
P32505 
P38922 
P25567 
P38199 
 
NAB2 
HRB1 
SRO9 
KHD1 
 
  1.16 
1.77 
1.30 
0.54 
 
-1.25 
-1.87 
-1.69 
-0.76 
 
1.78 
3.10 
1.65 
 
 -5.22 
-3.69 
-2.63 
 
3.80 
 
 3.05 
 
-3.75 
 
 -2.38 
 
Nuclear cap-binding complex 
Q08920 
P34160 
 
CBC2 
CBC1 
 
  
 0.79 
 
-0.12   4.68 
4.89 
 
-4.74 
-5.38 
 
Nuclear mRNA decay factors 
P47047 
Q02792 
 
MTR4 
RAT1 
 
0.36  0.12 
0.05 
 
0.33 
0.12 
 
0.95 
1.21 
 
 -1.52 
 
0.99 
 
 
-0.60 
-1.52 
 
 
The multifunctional poly(A)+ RNA binding protein Nab2 (see Introduction, “mRNP 
export factors are recruited during transcription”) co-immunoprecipitates with a large fraction of 
the yeast transcriptome, including PGK1 (Batisse et al. 2009). This protein-mRNA interaction 
could be confirmed – Nab2 was moderately enriched (>2-fold enrichment) after PGK1-6MS2L 
affinity purification.  Co-purification of Nab2 with ENO2-6MS2L was detected only in the 
forward labelling experiment (3.4-fold enrichment), suggesting that ENO2-6MS2L interaction 
with Nab2 might have been lost during affinity purification in the reverse labelling experiment. 
Remarkably, Nab2 was >13-fold enriched after 6MS2L-RNA affinity purification. This finding 
points to the possibility that the mRNA-like 6MS2L-RNA transcript may be differently regulated 
than the MS2L-tagged mRNAs. Nab2 is released from the mRNP at the cytoplasmic face of the 
nuclear pore complex (reviewed in Oeffinger and Zenklusen 2012). The higher level of Nab2 co-
purification with 6MS2L-RNA therefore suggests that 6MS2L-RNA-containg ribonucleoprotein 
complex export form the nucleus to the cytoplasm and/or remodelling at the NPC cytoplasmic 
face may happen at a slower rate compared to MS2L-tagged mRNA-containing mRNPs.  
The KH-domain protein 1, Khd1, was moderately enriched (>1.41-fold enrichment) after 
PGK1-6MS2L and relatively highly enriched (>5.2-fold enrichment) after 6MS2L-RNA affinity 
purification. The 6.2-fold enrichment of Khd1 in ENO2-6MS2L forward labelling experiment 
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suggests that Khd1 might also interacts with this mRNA. Even though Khd1 is associated with a 
large number of yeast transcripts (Hasegawa, Irie, and Gerber 2008; Hogan et al. 2008a), the 
interaction with PGK1 and ENO2 has previously not been reported (Hasegawa, Irie, and Gerber 
2008), suggesting that Khd1 may have even more cellular targets than currently known. Hogan et 
al. have shown that immunoaffinity enrichment of mRNAs associated with Khd1 is negatively 
correlated with ribosome occupancy (Hogan et al. 2008a). Since Khd1 is required for the 
translational repression of ASH1 mRNA expression during mRNA localization to the distal tip 
of the daughter cell (Paquin et al. 2007), the protein has been proposed to participate also in the 
translational control of its other target mRNAs (Hogan et al. 2008a). 
6MS2L-RNA has co-purified with the two subunits of the nuclear cap-binding complex. 
Remarkably, more than 25-fold enriched, Cbc2 and Cbc1 (also known as Sto1) were among the 
most highly enriched proteins in 6MS2L-RNA MS data set. In contrast, the nuclear CBC 
subunits were not among the enriched proteins after affinity purification of the two MS2L-tagged 
mRNAs. Despite this, PGK1 and ENO2 are expected to be bound by the nuclear CBC (see 
Introduction, “Transcription elongation and the concomitant pre-mRNA processing events” and 
references therein). A 1.7-fold enrichment of Cbc1 in PGK1-6MS2L forward labelling experiment 
therefore suggests that only a minor fraction of the total cellular PGK1-6MS2L or ENO2-6MS2L 
pool is bound by the nuclear CBC. The steady state translation depends on the cap-binding 
translation initiation factor eIF4E (reviewed in Topisirovic et al. 2011). The exchange of the 
nuclear CBC to eIF4E is thought to take place before or during the pioneer round of translation 
(see Introduction, “Translation is accompanied by mRNP remodelling” and references therein). 
The absence of Cbc2 and Cbc1 among the enriched proteins after MS2L-tagged mRNA affinity 
purification indicates that the majority of cellular PGK1-6MS2L and ENO2-6MS2L transcripts 
have lost the nuclear CBC. Therefore, it is plausible to think that the MS2L-tagged mRNAs 
become rapidly engaged in translation upon export from the nucleus. The efficiency of 
nucleocytoplasmic export, RNP remodelling after export and/or pioneer translation initiation 
complex formation might be less efficient for 6MS2L-RNA-containing RNPs, leading to a 
prolonged association with the nuclear CBC. Collectively, the high enrichment of the nuclear 
CBC and Nab2 after 6MS2L-RNA affinity purification indicate that some aspects of 6MS2L-
RNA regulation are different compared to MS2L-tagged mRNAs. 
Besides cytoplasmic 5′→3′ exonucleolytic mRNA decay, ENO2-6MS2L and 6MS2L-
RNA transcripts seem also to be degraded in the nucleus (Table 20). The RNA helicase encoded 
by MTR4 was enriched after 6MS2L-RNA and possibly also after ENO2-6MS2L affinity 
purification. Mtr4 is a component of the TRAPM complex, which acts as a co-factor for the 
nuclear RNA exosome (see Introduction, “Nuclear mRNP quality control” and references 
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therein). The gene product of RAT1, the nuclear 5′→3′ exonuclease, was enriched after ENO2-
6MS2L and possibly also after 6MS2L-RNA affinity purification. The relatively low enrichment 
level of Mtr4 and Rat1, which does not exceed 3-fold enrichment, suggests that nuclear mRNA 
decay of ENO2-6MS2L and 6MS2L-RNA is by far less prominent than cytoplasmic 5′→3′ 
exonucleolytic decay of these RNAs (Table 16). 
 
 
Ribosome biogenesis factors, tRNA-modifying enzymes, metabolic enzymes, 
mitochondrial proteins etc. – the studied MS2L-tagged RNA-containing mRNPs are 
involved in many unanticipated interactions with other cellular proteins 
The functional diversity of proteins co-purifying with the MS2L-tagged RNAs is surprisingly 
high. The determined mRNP proteomes do not only contain proteins that participate in the 
various steps of the mRNA life cycle like mRNP biogenesis, translation and mRNA decay but 
also contain many proteins with well established roles in cellular processes that are unrelated to 
mRNA biology. The following chapter will introduce the MS2L-tagged RNA co-purifying 
proteins whose “standard” cellular function is not in mRNA regulation.  
 
Ribosome biogenesis factors co-purifying with MS2L-tagged RNAs 
Several ribosome biogenesis factors were enriched after affinity purification of the MS2L-tagged 
RNAs (Table 21). Most of these proteins were not highly enriched; only two proteins, Arb1 and 
Arx1, were >5-fold enriched. None of the ribosome biogenesis factors classified as enriched in all 
three MS data sets, although in one data set out of three Mrd1 and Arx1 failed only slightly to 
fulfil the threshold criteria, suggesting that the two proteins might have co-purified with all tested 
MS2L-tagged RNAs. Interestingly, the largest number of ribosome biogenesis factors classified as 
enriched in the BB sample MS data set, followed by ENO2-6MS2L MS data set. 
 
Table 21. MS2L-tagged RNA co-purifying proteins involved in ribosome biogenesis. Log2 (H/L) ratios of 
enriched proteins are in bold. 
 
Protein ID Gene 
BB RNase ENO2 6MS2L 
for rev for rev for rev for rev 
P33322 
Q06106 
P41819 
P25368 
P53254 
Q05022 
CBF5 
MRD1 
DIM1 
RRP7 
UTP22 
RRP5 
1.24 
 0.51 
1.26 
1.07 
0.76 
-1.12 
 -1.18 
-0.52 
-1.01 
-0.36 
0.89 
0.64 
1.39 
 
 0.62 
 -0.30 
 
 
 -0.38 
1.25 
1.34 
 
 
 
 
-2.03 
-2.60 
 
 
 
 
 1.27 
 
 
 1.96 
 -0.76 
 
 
 -1.72 
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Protein ID Gene 
BB RNase ENO2 6MS2L 
for rev for rev for rev for rev 
P25586 
P42846 
Q12499 
P40024 
Q03862 
P38779 
Q08208 
P53883 
P40010 
P37838 
P38786 
 
KRR1 
KRI1 
NOP58 
ARB1 
ARX1 
CIC1 
NOP12 
NOP13 
NUG1 
NOP4 
RPP1 
 
0.82 
0.96 
0.60 
0.43 
1.28 
 0.95 
 0.56 
0.73 
0.70 
 
-0.88 
-1.10 
-0.26 
-0.40 
-1.44 
 
 
 -0.75 
-0.63 
-2.40 
 
 
 0.74 
1.57 
1.27 
-0.05 
0.40 
-0.10 
 
 
 
 
 
 -0.66 
-1.40 
-1.50 
 
 0.11 
 
 
 
 
 
 
 3.26 
2.33 
0.53 
1.07 
0.69 
 
 
 
 
 -3.34 
 -3.44 
-3.97 
-1.20 
-1.69 
-1.40 
 
 
 
 
 
 
 
 1.16 
 
 1.64 
 
 
 
 
 
 
 
 -0.43 
 -1.38 
-0.36 
 
 
 
 
 
Table 22. Description of the enriched proteins involved in ribosome biogenesis. 
 
Gene
a
 
Pre-
ribosome 
Location
b
 Description Reference 
CBF5 pre-90S noc Catalytic subunit of box H/ACA snoRNPs, which 
pseudouridylates both large and small rRNA 
(D. L. Lafontaine et al. 1998; Duan 
et al. 2009) 
MRD1 pre-90S noc 40S biogenesis; required for initial A0-A2 cleavage of 35S 
pre-rRNA to produce 18S rRNA 
(Jin et al. 2002; Segerstolpe et al. 
2013) 
DIM1 pre-90S noc 40S biogenesis; rRNA dimethyladenosine tranferase; 
depletion leads to diminished accumulation of mature 
18S rRNA 
(Grandi et al. 2002; D. Lafontaine, 
Vandenhaute, and Tollervey 
1995) 
RRP7 pre-90S noc, nuc 40S biogenesis; component of CURI complex (Baudin-Baillieu et al. 1997; Rudra 
et al. 2007; Lin et al. 2013) 
UTP22 pre-90S noc, nuc 40S biogenesis; component of CURI complex (Rudra et al. 2007; Bernstein et al. 
2004; Lin et al. 2013) 
RRP5 pre-90S noc 40S and 60S biogenesis; required for cleavage of 35S pre-
rRNA at sites A0-A3 to produce 18S rRNA and 5.8S rRNA 
(Venema and Tollervey 1996; de 
Boer et al. 2006) 
KRR1 pre-90S noc 40S biogenesis; physically and functionally interacts with 
Kri1 
(Gromadka and Rytka 2000; 
Sasaki, Toh-E, and Kikuchi 2000) 
KRI1 pre-90S noc 40S biogenesis; associates with snR30, which is a box 
H/ACA snoRNA 
(Sasaki, Toh-E, and Kikuchi 2000; 
Hoareau-Aveilla et al. 2012) 
NOP58 pre-90S noc box C/D snoRNP component, required for cleavage of 35S 
pre-rRNA at sites A0 and A2 to produce 18S rRNA 
(D. L. Lafontaine and Tollervey 
1999; P. Wu et al. 1998; Grandi et 
al. 2002) 
ARB1 pre-90S, 
40S, 60S 
nuc, cyt 40S and 60S biogenesis; depletion leads to delayed 
processing of rRNA in 40S and 60S biogenesis pathways; 
shuttles  
(Dong et al. 2005; Altvater et al. 
2012) 
ARX1 pre-60S noc, nuc, 
cyt 
pre-60S subunit export (Bradatsch et al. 2007) 
CIC1 pre-60S noc Cic1 co-purifies with 60S pre-ribosomes; interacts with 
26S proteasome 
(Oeffinger et al. 2007; Jäger et al. 
2001; Harnpicharnchai et al. 
2001) 
NOP12 pre-60S noc 60S biogenesis; involved in pre-25S processing; similar to 
Nop13 and Nsr1 
(K. Wu, Wu, and Aris 2001; 
Granneman, Petfalski, and 
Tollervey 2011) 
NOP13 pre-60S noc, nuc Nop13 contains RNA recognition motif; similar to Nop12 
and Nsr1 
(K. Wu, Wu, and Aris 2001) 
NUG1 pre-60S noc, nuc 60S export; putative GTPase (Bassler et al. 2001; Oeffinger et 
al. 2007) 
NOP4 pre-60S noc, nuc 60S biogenesis; depletion leads to diminished 
accumulation of mature 25S rRNA  
(C. Sun and Woolford 1997; C. 
Sun and Woolford 1994) 
RPP1 - noc, nuc, 
cyt 
Component of RNase MRP and RNase P; RNase MRP 
required for production of 5.8S rRNA 
(Houser-Scott et al. 2002; Marvin 
et al. 2011) 
 
a
 Localization and function data was retrieved from Saccharomyces Genome Database (http://www.yeastgenome.org/; see also reference 
(Cherry et al. 2012)). 
b
 Abbreviations: noc – nucleolus, nuc – nucleus, cyt – cytoplasm. 
 
DISCUSSION 
 
146 
 
The repertoire of the enriched ribosome biogenesis factors covers various ribosome 
biogenesis steps from pre-rRNA processing to mature 18S and 25S rRNAs and pre-60S 
ribosomal particle export. Ribosome biogenesis starts within the nucleolus with the transcription 
of 35S pre-rRNA (reviewed in Kressler, Hurt, and Baβler 2010). Pre-rRNA transcription is 
accompanied by rRNA folding, modification and cleavage, as well as association with ribosomal 
proteins and trans-acting factors. Small nucleolar ribonucleoprotein particles (snoRNPs) perform 
pre-rRNA 2′-O-ribose methylation of nucleoside ribose moieties and uridine conversion into 
pseudouridines. 35S pre-rRNA is cleaved in 90S pre-ribosomal particle that, besides the pre-
rRNA, contains around 50 non-ribosomal proteins, U3 snoRNA and several small subunit 
ribosomal proteins. Pre-rRNA sequential cleavage at sites A0, A1 and A2 separates pre-40S and 
pre-60S ribosomal particles, which continue maturation along two independent assembly 
pathways. The maturation of pre-40S and pre-60S ribosomal particles, which includes final 
cleavage of rRNA, association of a few ribosomal proteins and release of trans-acting factors, is 
completed in the cytoplasm (reviewed in Panse 2011). Importantly, pre-40S and pre-60S 
ribosomal subunits acquire translation competence only after all the maturation steps have been 
successfully completed (reviewed in S. Schütz and Panse 2012). Therefore, it seems highly 
unlikely that ribosome biogenesis factors could have co-purified with MS2L-tagged RNAs owing 
to interactions with ribosomes engaged in translation of the MS2L-tagged RNAs. A more likely 
explanation to ribosome biogenesis factor co-purification with MS2L-tagged RNAs is that these 
proteins directly bind to mRNA and/or Pab1. This notion is supported by the findings from 
other groups, which have identified several ribosome biogenesis factors among the enriched 
proteins after epitope-tagged Pab1 affinity purification (Table 17) from yeast cell extracts treated 
with RNase A (R. Richardson et al. 2012) or supplemented with EDTA (Klass et al. 2013), which 
disrupts the association of ribosomal subunits. A large set of ribosome biogenesis factors was 
also enriched after poly(A)+ RNA affinity purification form glucose deprived yeast cells; the 
authors present evidence that the enrichment of ribosome biogenesis factors was not due to co-
purification of ribosomes (S. F. Mitchell et al. 2013). The human homologues of most of the 
enriched ribosome biogenesis factors (Appendix, Table 3) have been found to co-purify with 
poly(A)+ RNA also in mammalian cells (Castello et al. 2012; Baltz et al. 2012). Collectively, our 
results support the notion that there may be extensive cross-talk between mRNA regulation and 
ribosome biogenesis (S. F. Mitchell et al. 2013).  
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tRNA-modifying enzymes co-purifying with MS2L-tagged RNAs 
tRNA-modifying enzymes that perform uridine to pseudouridine isomerisation or methylation of 
ribonucleotide nucleobase or ribose comprise a small but interesting group of enriched proteins 
in each MS data set because several of these enzymes are highly enriched (Table 23 and 24). One 
of the six identified tRNA-modifying enzymes, Pus1, has previously been found to co-purify with 
poly(A)+ RNA from glucose deprived yeast cells (S. F. Mitchell et al. 2013). Our results point to 
the possibility that association of tRNA-modifying enzymes with mRNA may be more common 
than previously known. The finding that several tRNA-modifying enzymes were enriched not 
only after MS2L-tagged PGK1 and ENO2 affinity purification but also after mRNA-like 6MS2L-
RNA affinity purification suggests that tRNA-modifying enzymes might play an important role in 
the regulation of a wide variety of mRNAs. Remarkably, the human homologues of Pus1, Trm2, 
Ncl1 and Pus7 have also been found to co-purify with poly(A)+ RNA (Castello et al. 2012; Baltz 
et al. 2012), suggesting that the role of tRNA-modifying enzymes in mRNA biology is 
evolutionarily conserved.  The low abundance of mRNAs has hampered the analysis of mRNA 
modifications (reviewed in Ge and Yu 2013; Motorin and Helm 2011; Motorin, Lyko, and Helm 
2010). Therefore, it remains to be determined if tRNA-modifying enzymes also catalyze the 
modification of mRNA and, if yes, what the exact effect of these modifications on mRNA 
regulation would be. 
An additional protein involved in tRNA maturation, Lhp1, was enriched after PGK1-
6MS2L affinity purification and the protein possibly also co-purified with ENO2-6MS2L and 
6MS2L-RNA (Table 23). In case of the latter MS2L-tagged RNAs, Lhp1 was quantified only in 
one of the biological replicate experiments, suggesting that Lhp1 may associate with all three 
MS2L-tagged RNAs. Lhp1 is not a tRNA-modifying enzyme. Instead, the protein stabilizes 
tRNA structure to enable proper tRNA 3′ end formation (Yoo and Wolin 1997). The protein has 
been proposed to act as a molecular chaperone for all RNA Pol III transcripts since Lhp1 also 
stabilizes the newly synthesised U6 RNA to facilitate the assembly of U6 snRNP (Pannone, Xue, 
and Wolin 1998). Lhp1 has also been found to co-purify with epitope-tagged Pab1 (R. 
Richardson et al. 2012). Surprisingly, the interaction with Pab1 was RNA-independent, suggesting 
that protein-protein interactions contribute to Lhp1 association with Pab1-containing mRNPs. 
The possible role of Lhp1 in the context of an mRNP remains to be determined; however, it 
seems plausible that Lhp1 could act as a molecular chaperone also for RNA Pol II transcription 
products. 
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Table 23. MS2L-tagged RNA co-purifying enzymes involved in tRNA modification. Log2 (H/L) ratios of enriched 
proteins are in bold. 
 
Protein ID Gene 
BB RNase ENO2 6MS2L 
for rev for rev for rev for rev 
Q02648 
P33753 
P38205 
Q12211 
P48567 
Q08647 
P33399 
 
TRM44 
TRM2 
NCL1 
PUS1 
PUS4 
PUS7 
LHP1 
 
3.26 
 
 
 
 
 
 
 3.71 
3.46 
0.89 
1.02 
1.82 
0.51 
0.91 
 
-4.93 
-3.49 
 
 
 -0.25 
-1.05 
 
3.76 
4.22 
1.06 
1.49 
2.44 
0.91 
1.3 
 
-6.77 
-6.11 
 -2.40 
-4.71 
-1.95 
 
 4.64 
4.78 
 3.33 
2.49 
 
 -6.24 
-4.24 
-1.91 
-3.24 
-1.83 
-2.44 
 
 
Table 24. Description of the enriched tRNA-modifying enzymes. 
 
Gene
a
 Location
b
 Description 
TRM44 cyt tRNASer Um44 2'-O-methyltransferase 
TRM2 UNK tRNA(m5U54) methyltransferase  
NCL1 nuc tRNA(m5C34, m
5C40, m
5C48, m
5C49) methyltransferase 
PUS1 nuc pseudouridine synthase; catalyzes pseudouridylation at positions 26-28, 34-36, 65, and 67 in tRNA, as well as 
at position 44 in U2 snRNA 
PUS4 nuc, mito tRNA pseudouridine synthase; catalyzes pseudouridylation at position 55 in cytoplasmic as well as 
mitochondrial tRNAs 
PUS7 nuc pseudouridine synthase; catalyzes pseudouridylation at positions 35 and 56 in U2 snRNA, position 50 in 5S 
rRNA, position 13 in cytoplasmic tRNAs, and position 35 in pre-tRNATyr 
a
 Localization and function data was retrieved from Saccharomyces Genome Database (http://www.yeastgenome.org/; see also reference 
(Cherry et al. 2012)). 
b
 Abbreviations: cyt – cytoplasm, nuc – nucleus, mito – mitochondrion, UNK – unknown. 
 
Metabolic enzymes co-purifying with MS2L-tagged RNAs 
All tested MS2L-tagged RNAs have co-purified with several metabolic enzymes (Table 25). The 
gene products of IMD2, IMD3, IMD4, ALD5 and MIS1 were enriched in all three MS data sets, 
whereas the proteins encoded by ADH3, MET6, LEU2, ZWF1, ARO1, HIS4 and URA3 were 
enriched only in single MS data sets. The latter proteins were almost exclusively <2-fold enriched. 
In contrast, Imd2, Imd3, Imd4, Ald5 and Mis1 were >2-fold enriched in most affinity 
purification experiments. Except for Ald5, these enzymes have previously been found to co-
purify with mRNPs in yeast (S. F. Mitchell et al. 2013; Klass et al. 2013), suggesting that their co-
purification with MS2L-tagged RNAs is specific. IMD2, IMD3 and IMD4 are closely related 
genes in S. cerevisiae, which encode for proteins with potential inosine monophosphate 
dehydrogenase (IMDH) activity (Hyle, Shaw, and Reines 2003). IMDH is a key enzyme in de novo 
GTP biosynthesis, which catalyses the first committed step in the pathway. The three Imd 
proteins have been found to form heteromeric complexes in vivo (McPhillips, Hyle, and Reines 
2004), suggesting that they may have co-purified with the MS2L-tagged RNAs as one complex. 
In mammalian cells, IMDH has been shown to be recruited to actively transcribed genes through 
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phosphorylated serine 2 in RNA Pol II C-terminal domain (J.-H. Park and Ahn 2010) and to 
bind to RNA in vivo (McLean et al. 2004; Mortimer and Hedstrom 2005). In S. cerevisiae, Imd2-4 
were among the enriched proteins after poly(A)+ RNA affinity purification from glucose deprived 
cells (S. F. Mitchell et al. 2013) and Imd4 was enriched after TAP-tagged Pab1 affinity 
purification from logarithmically growing cells (Klass et al. 2013). The experimental conditions 
used in the latter study enabled the detection of RNA-dependent but ribosome-independent 
RNA-protein and protein-protein interactions, suggesting that Imd4 is a component of Pab1-
containing mRNPs that are devoid of ribosomes. Our results thus further confirm the existing 
evidence that Imd2, Imd3 and Imd4 are mRNP proteins (S. F. Mitchell et al. 2013; Klass et al. 
2013). The role of Imd2-4 in mRNA metabolism remains undefined. However, this role is 
probably not essential since yeast cells can survive without the four genes encoding for IMDH 
isozymes if their growth medium is supplemented with guanine, indicating that the only essential 
function of Imd2-4 (IMD1 is likely a pseudogene) is in GTP biosynthesis (Hyle, Shaw, and 
Reines 2003). 
All tested MS2L-tagged RNAs co-purified with the gene product of MIS1, which encodes 
for the mitochondrial trifunctional C1-tetrahydrofolate synthase (Shannon and Rabinowitz 1988). 
The enzyme catalyses the synthesis of mitochondrial 10-formyltetrahydrofolate (Shannon and 
Rabinowitz 1988) that provides an active one-carbon unit for the formylation of mitochondrial 
initiator tRNA, Met-tRNAf
Met (Dickerman et al. 1967). Interestingly, two different studies have 
identified Mis1 among the enriched proteins after epitope-tagged Pab1 affinity purification (Klass 
et al. 2013; R. Richardson et al. 2012). Mis1 co-purified with Pab1 also when the lysate used for 
Pab1 immunoprecipitation was previously treated with RNase to eliminate Pab1 binding to 
poly(A) tail (R. Richardson et al. 2012), indicating that the two proteins are associated via protein-
protein interactions. Our results and the previous results from others (Klass et al. 2013; R. 
Richardson et al. 2012) thus suggest that Mis1 is an mRNP protein. The role of Mis1 in mRNA 
metabolism remains to be identified; however, since the deletion of MIS1 has no detectable 
impact on cell growth (Shannon and Rabinowitz 1988), Mis1 function in mRNA metabolism 
cannot be essential.  
The last of the metabolic enzymes enriched in all three MS data sets – the minor isoform 
of mithocondrial aldehyde dehydrogenase encoded by ALD5 – has previously not been reported 
to associate with mRNA nor Pab1 (Klass et al. 2013; R. Richardson et al. 2012; Tsvetanova et al. 
2010; Scherrer et al. 2010; S. F. Mitchell et al. 2013).  These results argue against a possibility that 
Ald5 could be an mRNP protein. However, the relatively high enrichment level of Ald5 after 
affinity purification of all three MS2L-tagged RNAs suggests that Ald5 co-purification has been 
specific. A common element in all three RNAs subjected to mRNP affinity purification is the 
DISCUSSION 
 
150 
 
6MS2L-tag. This RNA sequence, which naturally does not occur in yeast transcripts, might have 
the potential to bind Ald5. 
 
Table 25. Metabolic enzymes co-purifying with MS2L-tagged RNAs. Log2 (H/L) ratios of enriched proteins are 
in bold. 
 
Protein ID Gene 
BB RNase ENO2 6MS2L 
for rev for rev for rev for rev 
P38697 
P50095 
P50094 
P40047 
P09440 
P37292 
P07246 
P05694 
P04173 
P11412 
P08566 
P00815 
P03962 
 
IMD2 
IMD3 
IMD4 
ALD5 
MIS1 
SHM1 
ADH3 
MET6 
LEU2 
ZWF1 
ARO1 
HIS4 
URA3 
 
 
 
 
 2.52 
 
 -0.02 
2.09 
 0.05 
0.40 
 
 
 
 
 
 -2.96 
 
 
 -0.30 
 -0.23 
-0.20 
 
 
-0.03 
0.62 
0.81 
1.38 
2.10 
0.56 
1.08 
1.17 
0.83 
1.42 
0.41 
1.05 
2.70 
 
-0.54 
-1.10 
-1.36 
-1.26 
 
-0.09 
-0.71 
-0.65 
-0.54 
 0.06 
0.07 
 
 
1.55 
1.81 
2.16 
2.79 
1.82 
3.61 
0.04 
1.59 
-0.89 
0.87 
0.63 
0.85 
0.41 
 
-3.37 
-3.00 
-3.72 
-4.16 
-3.95 
-4.65 
 1.49 
1.63 
-0.75 
-0.61 
 
 
 
2.16 
2.78 
2.95 
2.62 
1.97 
1.2 
0.09 
-0.42 
-0.20 
0.22 
0.25 
0.50 
0.60 
 
-1.84 
-1.95 
-2.41 
-2.29 
-1.46 
-1.05 
0.63 
-1.42 
0.76 
0.39 
0.35 
-0.67 
-1.07 
 
 
Table 26. The function of the enriched metabolic enzymes not discussed in the text.  
 
Gene
a
 Location
b
 Description 
ADH3 mito Mitochondrial alcohol dehydrogenase isozyme III; involved in the shuttling of mitochondrial NADH to the 
cytosol under anaerobic conditions and ethanol production 
MET6 cyt, pl memb Cobalamin-independent methionine synthase; involved in methionine biosynthesis and regeneration; requires 
a minimum of two glutamates on the methyltetrahydrofolate substrate, similar to bacterial metE homologs 
LEU2 cytosol Beta-isopropylmalate dehydrogenase (IMDH); catalyzes the third step in the leucine biosynthesis pathway; 
can additionally catalyze the conversion of β-ethylmalate into α-ketovalerate 
ZWF1 cyt Glucose-6-phosphate dehydrogenase (G6PD); catalyzes the first step of the pentose phosphate pathway; 
involved in adapting to oxidative stress; homolog of the human G6PD which is deficient in patients with 
hemolytic anemia; protein abundance increases in response to DNA replication stress 
ARO1 cyt Pentafunctional arom protein; catalyzes steps 2 through 6 in the biosynthesis of chorismate, which is a 
precursor to aromatic amino acids 
HIS4 cyt Multifunctional enzyme containing phosphoribosyl-ATP pyrophosphatase; phosphoribosyl-AMP 
cyclohydrolase, and histidinol dehydrogenase activities; catalyzes the second, third, ninth and tenth steps in 
histidine biosynthesis 
URA3 cytosol Orotidine-5'-phosphate (OMP) decarboxylase; catalyzes the sixth enzymatic step in the de novo biosynthesis 
of pyrimidines, converting OMP into uridine monophosphate (UMP); converts 5-FOA into 5-fluorouracil, a 
toxic compound 
a
 Localization and function data was retrieved from Saccharomyces Genome Database (http://www.yeastgenome.org/; see also reference 
(Cherry et al. 2012)). 
b
 Abbreviations: cyt – cytoplasm, ch – chromatin, pl memb – plasma membrane, mito – mitochondrion 
 
The gene product of SHM1 was highly enriched after ENO2-6MS2L affinity purification 
(>12-fold enrichment) and classified as an enriched protein also after 6MS2L-RNA affinity 
purification (>2-fold enrichment). The gene encodes for the mitochondrial isozyme of serine 
hydroxymethyltransferase (McNeil et al. 1994), which, depending on the yeast growth conditions, 
may synthesise serine form glycine and one-carbon units or provide one-carbon units for purine 
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synthesis (Kastanos, Woldman, and Appling 1997). Shm1 has not been identified as an RBP in 
yeast (Tsvetanova et al. 2010; Scherrer et al. 2010); however, the protein was found to co-purify 
with epitope-tagged Pab1 in an RNA-dependent manner (Klass et al. 2013). The high enrichment 
level of Shm1 after ENO2-6MS2L affinity purification further suggests that Shm1 is an mRNP 
protein. Interestingly, Shm1 participates in interconversion of the one-carbon units carried by 
tetrahydrofolate together with the above-mentioned protein Mis1, hinting at the possibility that 
the two proteins might have co-purified with ENO2-6MS2L as components of one protein 
complex. 
Based on previously published findings, only one of the seven metabolic enzymes 
enriched in single MS data sets (Table 26) can be functionally related to the MS2L-tagged RNA it 
has co-purified with. The gene product of MET6, a cobalamin-independent methionine synthase, 
co-purified with PGK1-6MS2L. Interestingly, Met6 and Pgk1 can both be detected in isolated 
yeast plasma membrane fraction (Delom et al. 2006). Same subcellular localization of the two 
proteins may provide the basis for Met6 co-purification with PGK1-6MS2L, possibly via the 
ribosome-bound Pgk1 nascent peptide. The association of Pgk1 and Met6 was also observed in a 
large-scale screen of yeast protein complexes (Gavin et al. 2006), further suggesting that Met6 co-
purification with PGK1-6MS2L is specific. 
 
MS2L-tagged RNA co-purifying proteins involved in ubiquitin-mediated regulation  
Two MS2L-tagged RNA co-purifying proteins suggest that mRNPs may be associated with 
deubiquitination activity provided by the Ubp3-Bre5 deubiquitination complex (Table 27). The 
ubiquitin-specific protease 3, Ubp3 (Baker, Tobias, and Varshavsky 1992), classified as enriched 
after MS2L-tagged PGK1 and ENO2 affinity purification. A relatively high (4.4-fold) enrichment 
in 6MS2L-RNA reverse labelling experiment suggests that the protein might also co-purify with 
this mRNA-like transcript. Bre5, an essential positive regulator of Ubp3-mediated 
deubiquitination (Cohen et al. 2003), classified as enriched only in the BB sample MS data set. 
However, it seems likely that Bre5 has co-purified also with ENO2-6MS2L since the protein was 
12.8-fold enriched in ENO2-6MS2L forward labelling experiment. Ubp3-Bre5 complex is 
involved in diverse cellular processes such as transcription activation and elongation (Chew et al. 
2010; Kvint et al. 2008), DNA repair by non-homologous end joining (Bilsland et al. 2007), 
maintenance of an efficient ER to Golgi secretory pathway (Cohen et al. 2003) and autophagy of 
mature ribosomes in response to starvation (Kraft et al. 2008; Ossareh-Nazari et al. 2010). So far, 
Ubp3-Bre5 complex has not been implicated in mRNA regulation. However, the protein 
complex has been found to co-purify with poly(A)+ RNA (S. F. Mitchell et al. 2013; Tsvetanova 
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et al. 2010), as well as with epitope-tagged Pab1 (Klass et al. 2013). The evolutionarily conserved 
Ubp3 protein has been found to co-purify with poly(A)+ RNA also in mammalian cells (Castello 
et al. 2012; Baltz et al. 2012). Collectively, these findings are in line with our results showing that 
Ubp3-Bre5 can co-purify with in vivo-assembled mRNPs. Since Bre5 contains an RNA-
recognition motif (K. Li et al. 2005), Ubp3-Bre5 complex could be directly recruited to mRNA 
by Bre5. However, additional Pab1-mediated protein-protein interactions might contribute to the 
association with mRNA. Namely, Ubp3 was found to co-purify with Pab1 in an RNA-
independent manner (R. Richardson et al. 2012). Considering that several proteins participating in 
mRNA maturation, export and decay are regulated by ubiquitination (reviewed in Finley et al. 
2012), it seems plausible that an mRNP-associated deubiquitination activity may provide a means 
to proofread ubiquitination-regulated steps in mRNP life cycle.   
Surprisingly, all three tested MS2L-tagged RNAs have co-purified with an RNA Pol II 
degradation factor encoded by DEF1 (Woudstra et al. 2002) (Table 27).  Def1 is a cytoplasmic 
protein that upon transcription-impeding DNA damage is processed in a ubiquitin- and 
proteasome-dependent manner, leading to nuclear accumulation of the activated Def1 protein 
(M. D. Wilson et al. 2013). In the nucleus, Def1 binds to the stalled RNA Pol II and recruits the 
Elongin-Cullin E3 ligase complex, which polyubiquitinates the Rpb1 subunit and thus triggers the 
proteasome-mediated degradation of the stalled RNA Pol II (M. D. Wilson et al. 2013). RNA Pol 
II seems not to be the only cellular target of Def1-mediated proteolytic decay. In the context of a 
stalled DNA replication fork, Def1 promotes the degradation of the catalytic subunit of DNA 
polymerase δ (Daraba et al. 2014). Whether Def1 participates also in mRNA regulation has not 
been experimentally addressed. However, since the protein has been found to co-purify with 
Pab1 under conditions, which preserve ribosome-association with the mRNA (Klass et al. 2013), 
it is possible that Def1 could participate in the regulation of translationally active mRNAs. Since 
Def1 has been shown to act as an adaptor for E3 ubiquitin ligase recruitment to stalled RNA Pol 
II (M. D. Wilson et al. 2013) it seems plausible that the protein might have a similar activity in the 
context of an mRNP. 
 
Table 27. MS2L-tagged RNA co-purifying proteins involved in ubiquitin-mediated regulation. Log2 (H/L) ratios 
of enriched proteins are in bold. 
 
Protein ID Gene 
BB RNase ENO2 6MS2L 
for rev for rev for rev for rev 
Q01477 
P53741 
P35732 
 
UBP3 
BRE5 
DEF1 
 
2.30 
2.21 
1.14 
 
-2.57 
-2.55 
-1.02 
 
1.97 
2.25 
0.89 
 
-2.22 
 -0.83 
 
2.27 
3.67 
0.66 
 
-3.96 
 -2.45 
 
 
 1.25 
 
-2.12 
 -0.62 
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Mitochondrial proteins co-purifying with MS2L-tagged RNAs 
In addition to the mithocondrial enzymes discussed above (Table 25 and 26), ENO2-6MS2L and 
possibly also PGK1-6MS2L have co-purified with a few additional mitochondrial proteins (Table 
28). The gene products of YLR419W, MGM101, and RPO41, which co-purified with ENO2-
6MS2L, were all highly enriched (>8.5-fold enrichment). YLR419W encoded protein was also 
relatively highly enriched (>5.3-fold enrichment) in BB sample MS data set, suggesting co-
purification with PGK1-6MS2L. YLR419W encodes for a putative homolog of DEAH-box 
family of RNA-dependent ATPases (reviewed in de la Cruz, Kressler, and Linder 1999), whose 
protein product has been found to be present in isolated highly pure mitochondria (Sickmann et 
al. 2003). Remarkably, several studies have identified Ylr419w among the enriched proteins after 
mRNA or eppitope-tagged Pab1 affinity purification (S. F. Mitchell et al. 2013; Klass et al. 2013; 
R. Richardson et al. 2012). The protein seems to be mRNA-associated under normal yeast 
growth conditions (Klass et al. 2013; R. Richardson et al. 2012) as well as upon glucose 
deprivation (S. F. Mitchell et al. 2013). mRNA-association of Ylr419w has also been detected in 
human (Castello et al. 2012; S. F. Mitchell et al. 2013). Our results thus confirm the previous 
observations that Ylr419w is an mRNP protein. The predicted role of Ylr419w in mRNA 
biogenesis remains to be elucidated; however this role cannot be essential since Δylr419w yeast 
cells are viable (Colley et al. 2000; Shiratori et al. 1999). 
RPO41 encodes for the mitochondrial RNA polymerase (Greenleaf, Kelly, and Lehman 
1986) and MGM101 a component of the mitochondrial nucleoid (Meeusen et al. 1999) that 
participates in recombinatorial mitochondrial DNA repair (Mbantenkhu et al. 2011). The two 
proteins are found in the same protein complex since TAP-tagged Rpo41 co-purifies with 
Mgm101 (Markov et al. 2009). Mgm101 is a ssDNA-binding protein (Mbantenkhu et al. 2011), 
which also seems to bind RNA – the protein was identified in a screen for RNA-binding proteins 
by probing a high density yeast protein microarray with different sorts of RNA (Scherrer et al. 
2010). Furthermore, the protein has been found to co-purify with Pab1 in an RNA-dependent 
but ribosome-independent manner (Klass et al. 2013), suggesting that Mgm101 is an mRNP 
protein. Mgm101 co-purification with ENO2-6MS2L might therefore be physiologically relevant 
and also contribute to Rpo41 co-purification with this MS2L-tagged mRNA. 
Besides Ylr419w, BB sample MS data set contained one additional enriched 
mitochondrial protein – the DEAD-box splicing factor Mss116 (reviewed in de la Cruz, Kressler, 
and Linder 1999). The protein has been found to be required for group I and II intron splicing in 
mitochondria and proposed to facilitate splicing by destabilizing stable but inactive RNA 
structures (H.-R. Huang et al. 2005). Considering the role of Mss116 in mitochondrial splicing, it 
is not surprising that the protein has been found to co-purify with epitope-tagged Pab1 (Klass et 
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al. 2013; R. Richardson et al. 2012). However, since PGK1 is an intronless cytoplasmic mRNA, 
PGK1-6MS2L co-purification with Mss116 could represent a false-positive interaction that might 
have occurred due to the release of mitochondrial proteins from this compartment during cell 
lysis. Assuming that the interaction between PGK1-6MS2L and Mss116 is specific, the relatively 
low enrichment level of Mss116 (about 1.8-fold enrichment) suggests that only a minor fraction 
of cellular PGK1-6MS2L is associated with Mss116. The same conclusion can be drawn for 
Hsp60. This mitochondrial chaperonin was about 1.5-fold enriched in RNase eluate after PGK1-
6MS2L affinity purification. The protein has not been implicated in mRNA metabolism and 
therefore the physiological relevance of PGK1-6MS2L and Hsp60 interaction remains elusive. 
 
Table 28. Mitochondrial proteins co-purifying with PGK1-6MS2L and ENO2-6MS2L. Log2 (H/L) ratios of 
enriched proteins are in bold. 
 
Protein ID Gene 
BB RNase ENO2 6MS2L 
for rev for rev for rev for rev 
Q06698 
P32787 
P13433 
P15424 
P19882 
 
YLR419W 
MGM101 
RPO41 
MSS116 
HSP60 
 
2.41 
0.41 
 0.74 
0.29 
 
-2.67 
 
 -0.97 
-0.28 
 
-3.30 
0.93 
1.72 
 0.54 
 
 
 
 
 -0.59 
 
3.09 
3.57 
3.19 
 0.92 
 
-4.70 
-6.27 
-4.42 
 -0.12 
 
 
 
 
 
 0.27 
 
 
Vacuolar and vesicular transport-involved proteins co-purifying with MS2L-tagged RNAs  
The enriched proteins involved in vesicular transport or vacuolar function are listed in table 29. 
With one exception, these proteins showed relatively low enrichment levels. The exception, the 
RNaseT2 family member encoded by RNY1 (reviewed in Luhtala and Parker 2010), was >19-
fold enriched after ENO2-6MS2L affinity purification. The protein was not quantified in other 
MS2L-tagged RNA affinity purification experiments, suggesting that Rny1 might play a specific 
role in ENO2-6MS2L mRNA regulation. RNaseT2 family members are general RNases that 
cleave ssRNA producing mono- or oligonucleotides with a terminal 3′ phosphate group (Scheer 
et al. 2011). In logarithmically growing yeast cells Rny1 is found in vacuoles from where it is 
released into the cytoplasm upon oxidative stress (Thompson and Parker 2009). Released from 
the vacuoles, Rny1 may cleave tRNA and rRNA, as well as promote cell death independent of its 
nuclease activity (Thompson and Parker 2009). Rny1-dependent tRNA cleavage has also been 
observed in vacuole or in vacuole-like compartment, suggesting that tRNA cleavage by Rny1 may 
also occur at, or inside, the vacuole (Luhtala and Parker 2012). Whether Rny1 also participates in 
mRNA cleavage remains unknown. However, it seems unlikely that Rny1 could have interacted 
with ENO2-6MS2L in the cytoplasm because the yeast cells used for mRNP affinity purification 
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were harvested in mid-log phase when Rny1 protein localization is restricted to the vacuoles 
(Thompson and Parker 2009). It seems more likely that ENO2-6MS2L has associated with Rny1 
at or within the vacuole. mRNAs have been proposed to be targeted to the vacuole during 
autophagy of aggregated mRNPs (reviewed in Luhtala and Parker 2010). Since several P-body 
and stress granule components (reviewed in Carolyn J. Decker and Parker 2012) co-purified with 
ENO2-6MS2L, it is possible that ENO2-6MS2L-containing mRNPs aggregate and may thus be 
targeted by autophagy for degradation in the vacuole.  
The gene products of VPH1, IMH1 and SEC16, whose protein functions are listed in 
table 30, have not been implicated in mRNA metabolism. Assuming that the interaction between 
these proteins and the corresponding MS2L-tagged RNAs is specific, the relatively low 
enrichment level of Vph1, Imh1 and Sec16 suggests that they are not associated with the majority 
of MS2L-tagged RNA-containing RNPs. 
 
Table 29. MS2L-tagged RNA co-purifying vacuolar proteins and proteins involved in vesicular transport. Log2 
(H/L) ratios of enriched proteins are in bold. 
 
Protein ID Gene 
BB RNase ENO2 6MS2L 
for rev for rev for rev for rev 
Vacuolar proteins 
Q02933 
P32563 
 
RNY1 
VPH1 
 
 1.32 
 
 -1.55 
 
  4.28 
 
 
-4.88 
 
 
  
Vesicular transport 
Q06704 
P48415 
 
IMH1 
SEC16 
 
 0.76 
 
 -1.13 
 
0.32 
 
 
-0.06 
 
 
0.88 
 
 
-1.76 
 
 
1.06 
 
 
-0.54 
 
 
 
Table 30. The function of the vacuolar and vesicular transport-involved proteins not discussed in the text. 
 
Gene
a
 Location
b
 Description 
VPH1 vac memb Subunit a of vacuolar-ATPase V0 domain; vacuolar acidification 
IMH1 cytosol, Golgi Protein involved in vesicular transport; mediates transport between an endosomal 
compartment and the Golgi 
SEC16 ER to Golgi transport 
vesicle membrane 
COPII vesicle coat protein required for ER transport vesicle budding; essential factor in 
endoplasmic reticulum exit site (ERES) formation, as well as in COPII-mediated ER-to-Golgi 
traffic 
a
 Localization and function data was retrieved from Saccharomyces Genome Database (http://www.yeastgenome.org/; see also reference 
(Cherry et al. 2012)). 
b
 Abbreviations: vac memb – vacuole membrane 
 
 
PGK1-6MS2L co-purifies with several glycolytic enzymes – co-translational formation of a 
supramolecular glycolytic enzyme complex? 
Several steps of the 10 enzymatic reactions that are needed to convert one molecule of glucose 
into 2 molecules of pyruvate, concomitantly generating 2 ATP, are reflected in the proteome of 
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PGK1-6MS2L. Besides Pgk1, three proteins in the glycolytic pathway – the gene products of 
HXK2, PGI1 and TDH3 – classified as enriched after PGK1-6MS2L affinity purification (Table 
31). Three additional proteins encoded by TPI1, TDH2 and ENO2 failed to meet the set 
threshold criteria only slightly in one of the biological replicate experiments. None of the 
enriched or the possibly enriched glycolytic enzymes co-purifying with PGK1-6MS2L has 
previously been identified as an RNA-binding protein in yeast (Tsvetanova et al. 2010; Scherrer et 
al. 2010) nor has been found to be associated with mRNPs (D. N. Richardson et al. 2011; Klass 
et al. 2013; S. F. Mitchell et al. 2013). Therefore, it seems unlikely that a direct binding of the 
glycolytic enzymes to PGK1-6MS2L or to PGK1-6MS2L-associated RBPs provides the basis for 
glycolytic enzyme co-purification with 6MS2L-tagged PGK1. An emerging view is that proteins 
that participate in a common metabolic or signalling pathway are organized into supramolecular 
complexes for optimal pathway performance (reviewed in Vonck and Schäfer 2009; Dai, Hall, 
and Hell 2009). Glycolysis seems to be one of such metabolic pathways whose activity can be 
regulated by supramolecular complex formation. Glycolytic enzyme association with membranes 
and cytoskeletal elements, as well as interaction between enzymes participating in sequential 
reactions was observed already about three decades ago (reviewed in Srere 1987). Since then a 
multi-enzyme glycolytic complex has been demonstrated to exist on the human erythrocyte 
membranes (Campanella, Chu, and Low 2005; Puchulu-Campanella et al. 2013). In S. cerevisiae the 
association of glycolytic enzymes has been shown to confer resistance against enzymatic activity 
inhibition by a compatible solute trehalose (Araiza-Olivera et al. 2010). Glycolytic enzymes seem 
to assemble in association with filamentous F-actin, which co-immunoprecipitates with several 
glycolytic enzymes and, in the filamentous form, increases fermentation rate and protects against 
trehalose inhibition in permeabilized yeast cells or yeast cell cytoplasmic extracts (Araiza-Olivera 
et al. 2013). Glycolytic enzyme assembly into a supramolecular complex may thus provide the 
answer why several proteins of this metabolic pathway were enriched after PGK1-6MS2L mRNA 
affinity purification. As discussed earlier, PGK1-6MS2L co-purifies with the nascent peptide likely 
as an mRNA-ribosome-nascent peptide complex. The emerging Pgk1 protein may co-
translationally be recruited to a glycolytic enzyme complex. Pgk1 nascent peptide-mediated 
protein-protein interactions could therefore provide a link between PGK1-6MS2L and the 
glycolytic enzymes. 
Interestingly, the gene product of ACT1 was among the enriched proteins in BB sample 
MS data set (Appendix, Table 1). Even though the protein is often found as a contaminant in 
affinity purification experiments (Mellacheruvu et al. 2013), the role of F-actin in glycolytic 
enzyme complex assembly would also provide a physiologically meaningful explanation for actin 
co-purification with PGK1-6MS2L mRNA. 
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Large-scale analysis of yeast protein complexes has identified an almost identical set of 
glycolytic enzymes associated with Pgk1 and enolase 2 (Gavin et al. 2006), suggesting that 
similarly to Pgk1, enolase 2 is among the glycolytic enzymes that may associate into a 
supramolecular complex. Furthermore, both proteins also co-immunoprecipitate with actin 
(Araiza-Olivera et al. 2013). Therefore, it is surprising that besides enolase 2 no other glycolytic 
enzyme co-purified with ENO2-6MS2L. Since cell’s metabolic state could have a profound effect 
on the formation of a glycolytic enzyme complex, it is important to note that yeast cells were 
collected in mid-log phase in all mRNP affinity purification experiments, thereby excluding the 
possibility that PGK1-6MS2L- or ENO2-6MS2L-containing cells would have been in different 
metabolic states. The lack of glycolytic enzyme co-purification with ENO2-6MS2L could be 
explained by weak protein-protein interactions between the glycolytic enzymes, which could be 
lost during affinity purification; this observation has also been made by others (Brandina et al. 
2006). 
 
Table 31. Several glycolytic enzymes are enriched after PGK1-6MS2L affinity purification. Log2 (H/L) ratios of 
enriched proteins are in bold. Log2 (H/L) ratios of proteins that did not fulfil the set threshold criteria log2 (H/L) 
>0.5 or <0.5 in one of the biological replicate experiments are in gray. 
 
Gene Name 
BB RNase ENO2 6MS2L 
for rev for rev for rev for rev 
HXK1 
HXK2 
GLK1 
PGI1 
PFK1 
PFK2 
FBA1 
TPI1 
TDH1 
TDH2 
TDH3 
PGK1 
GPM1 
ENO1 
ENO2 
CDC19 
 
Hexokinase-1 
Hexokinase-2 
Glucokinase-1 
Glucose-6-phosphate isomerase 
6-phosphofructokinase subunit alpha 
6-phosphofructokinase subunit beta 
Fructose-bisphosphate aldolase 
Triosephosphate isomerase 
Glyceraldehyde-3-phosphate dehydrogenase 1 
Glyceraldehyde-3-phosphate dehydrogenase 2 
Glyceraldehyde-3-phosphate dehydrogenase 3 
Phosphoglycerate kinase 
Phosphoglycerate mutase 1 
Enolase 1 
Enolase 2 
Pyruvate kinase 1 
 
 
 
 
0.06 
0.01 
-0.04 
0.66 
 
 
-0.67 
-2.44 
1.68 
 
 
-0.17 
-0.02 
 
 
 
 
 
-0.20 
-0.04 
-0.10 
 
-0.22 
-0.13 
1.47 
-5.09 
 
 
-0.13 
-0.14 
 
-0.37 
0.94 
-0.23 
1.05 
0.05 
0.12 
0.81 
0.27 
-0.18 
2.98 
1.13 
0.75 
0.77 
0.18 
1.21 
0.26 
 
 
-1.51 
 
-1.84 
0.56 
0.84 
-0.17 
-1.55 
-0.13 
-0.45 
-0.70 
-3.58 
0.29 
-0.82 
-0.23 
-0.38 
 
 
-0.64 
 
2.35 
-1.82 
-0.31 
1.95 
2.67 
0.17 
2.17 
1.87 
0.54 
-1.29 
2.70 
0.80 
1.38 
 
 
1.31 
 
2.00 
1.75 
0.93 
0.94 
2.63 
-0.31 
 
2.49 
1.42 
4.83 
 
-2.72 
0.90 
 
 
-0.88 
 
-1.14 
0.02 
0.01 
-0.66 
-1.54 
-0.25 
0.17 
0.15 
-0.35 
0.14 
-0.91 
-1.16 
-0.52 
 
 
-0.91 
 
-1.16 
0.00 
0.09 
0.14 
-0.83 
-0.59 
 
-0.45 
-0.01 
0.80 
-1.05 
-0.77 
-0.14 
 
 
 
MS2L-tagged RNA co-purifying proteins that were enriched in single MS data sets 
Each MS data set contains proteins that appear to have co-purified with only one of the MS2L-
tagged RNAs. Such proteins include the glycolytic enzymes that co-purified with PGK1-6MS2L 
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(Table 31) and some metabolic enzymes listed in table 25. Maybe the most remarkable example 
of a protein that has exclusively co-purified only with one MS2L-tagged RNA is the vacuolar 
RNaseT2 family member Rny1, which was >19-fold enriched after ENO2-6MS2L affinity 
purification but was not quantified in other MS data sets (table 29). The following chapter will 
introduce additional proteins that were enriched in single MS data sets (Table 32). 
The protein encoded by WHI3 was >4-fold enriched after PGK1-6MS2L affinity 
purification. Whi3 is an RRM-containing RBP (Nash, Volpe, and Futcher 2001) that localizes to 
stress granules and/or P-bodies upon glucose deprivation or heat shock (Holmes et al. 2013; Cai 
and Futcher 2013). The protein seems to have many mRNA targets (Colomina et al. 2008; Vergés 
et al. 2007; Holmes et al. 2013; Cai and Futcher 2013); up to a thousand mRNAs have been 
identified as Whi3 targets (Holmes et al. 2013). Interestingly, PGK1 has not been reported to be a 
Whi3 target mRNA, raising the possibility that the 6MS2L-tag might contribute to Whi3 co-
purification with PGK1-6MS2L mRNA. The role of Whi3 in the regulation of its target mRNAs 
is not very well understood; however, the protein appears to have a mild destabilizing effect on 
its targets (Holmes et al. 2013; Cai and Futcher 2013). 
The gene products of TRA1 and YNL050C were enriched in the BB sample MS data set, 
suggesting that the proteins co-purify with PGK1-6MS2L. The later gene encodes for a putative 
protein with unknown function (Cherry et al. 2012). Interestingly, Ynl050c was identified as an 
RBP by probing a high-density yeast protein microarray with different cellular RNAs (Scherrer et 
al. 2010), suggesting that Ynl050c could directly bind to PGK1-6MS2L mRNA. Tra1 is a 
common subunit of SAGA and NuA4 histone acetyltransferase complexes (Grant et al. 1998; 
Saleh et al. 1998; C E Brown et al. 2001). Surprisingly, this nuclear protein involved in 
transcription activation has also been found to co-purify with epitope-tagged Pab1 in an RNA-
dependent manner (Klass et al. 2013), suggesting that Tra1 might have a secondary role, possibly 
in the nuclear compartment, as an mRNP component.  
ENO2-6MS2L mRNA co-purified with two proteins implicated in pre-mRNA splicing. 
The gene product of MSL5 is a component of the commitment complex, which defines the first 
step in splicing. PSP2 encodes for a suppressor of group II intron-splicing defects with a possible 
role in mitochondrial mRNA splicing. ENO2-6MS2L does not contain introns and should not be 
subjected to mRNA splicing. Therefore the biological role of ENO2-6MS2L association with 
Msl5 and Psp2 remains unclear. The low enrichment level (<2.2-fold enrichment) of the two 
proteins suggests that only a minor fraction of total cellular ENO2-6MS2L is associated with 
Msl5 and Psp2. 
6MS2L-RNA co-purifying proteins encoded by ARC1, GUS1 and THS1 participate in 
tRNA aminoacylation. GUS1 encodes for cytosolic glutamyl-tRNA synthetase (cERS) and THS1 
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encodes for cytosolic threonyl-tRNA synthetase (cTRS). The gene product of ARC1 is a non-
enzymatic protein that together with cERS and cytosolic methionyl-tRNA synthetase forms the 
so called multiaminoacyl-tRNA synthetase (MARS) complex in yeast (reviewed in Frechin et al. 
2010). The MARS subunits Arc1 and Gus1 might have co-purified with 6MS2L-RNA as 
components of one protein complex; however, the third subunit of MARS complex might have 
been lost during affinity purification. The <2-fold enrichment of Arc1, Gus1 and Ths1 indicates 
that the interaction between the three proteins and the 6MS2L-RNA-containing RNPs is either 
transient or weak, which, in both cases, could lead to low enrichment levels after mRNP affinity 
purification.  
Recent findings in human cells and archaea point to the possibility that Arc1, Gus1 and 
Ths1 might have co-purified with 6MS2L-RNA in complex with the translating ribosome 
(Kaminska et al. 2009; David et al. 2011; Raina et al. 2012; Godinic-Mikulcic et al. 2014). In both 
organisms several aminoacyl-tRNA synthetases (aaRSs) have been found to co-purify with 
ribosomal proteins (Kaminska et al. 2009; Raina et al. 2012) or to co-fractionate with 
polyribosomes on sucrose density gradients (David et al. 2011; Kaminska et al. 2009). Further 
biochemical studies in archaeon Methanothermobacter thermautotrophicus have identified an interaction 
surface for two archaeal aaRSs on the large ribosomal subunit in the vicinity of the flexible 
L7/L12 stalk (Godinic-Mikulcic et al. 2014). Since aaRS-ribosome association is observed in 
distantly related species, such as humans and archaea, it seems plausible that aaRSs can also 
associate with ribosomes in S. cerevisiae. This notion is supported by the finding that in yeast, as 
well as in most other organisms examined, tRNA diffusion away from the ribosome is slower 
than translation rate, suggesting that out-going tRNAs remain bound to the ribosome 
(Cannarozzi et al. 2010). Ribosome-associated aaRSs are the likely candidates to prevent tRNA 
diffusion from the translating ribosome (Raina et al. 2012). These proteins might capture and 
aminoacylate the out-going tRNAs, thereby keeping a constant supply of aminoacylated tRNAs 
at the translating ribosome. The co-purification of Arc1, Gus1 and Ths1 with 6MS2L-RNA 
might therefore reflect the process of tRNA channelling to the ribosome during translation.  
The 6MS2L-RNA co-purifying proteins encoded by SPC110, SKN7 and BMH2 have 
previously not been implicated in mRNA biology (Tsvetanova et al. 2010; Scherrer et al. 2010; S. 
F. Mitchell et al. 2013; R. Richardson et al. 2012). With about 1.5-fold enrichment, Bmh2 was the 
least enriched of the four proteins. Bmh2 belongs to the family of 14-3-3 proteins, whose 
members participate in multiple cellular processes through binding to other proteins. 14-3-3 
proteins may regulate the activity or subcellular location of their interaction partners or connect 
two binding partners with each other (reviewed in van Heusden 2009). Considering the large 
number of protein-protein interactions the two yeast 14-3-3 proteins are involved in (Kakiuchi et 
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al. 2007), it is likely that Bmh2 has co-purified with 6MS2L-RNA in complex with some other 
6MS2L-RNA-bound protein(s). Indeed, a large-scale analysis in yeast found two 6MS2L-RNA 
co-purifying proteins – Upf1 and Spc110 – to be associated with Bmh1 and Bmh2 (Kakiuchi et 
al. 2007). Spc110 is a core component of the spindle pole body, which is the yeast microtubule 
organizing centre (reviewed in Jaspersen and Winey 2004). The >2-fold enrichment of Spc110 in 
both biological replicate experiments suggests that the interaction between 6MS2L-RNA and 
Spc110 is specific. Since 6MS2L-RNA is not a normal cellular mRNA, it may be involved in 
interactions that normally do not exist between mRNA and proteins. Alternatively, Spc110 may 
co-purify with 6MS2L-RNA due to protein-protein interactions between common interaction 
partners; the latter possibility may involve 6MS2L-RNA and Spc110 co-localization to the same 
cellular compartment. 
6MS2L-RNA co-purified with the gene product of SKN7, a protein that regulates the 
nuclear response to oxidative and osmotic stress (Morgan et al. 1997; Brombacher et al. 2006; 
Ketela et al. 1998). Skn7 has not been implicated in mRNA regulation and the role of the protein 
in 6MS2L-RNA biogenesis remains unknown. However, since Skn7 acts as a transcription factor 
(Morgan et al. 1997; Raitt et al. 2000) the interaction between Skn7 and 6MS2L-RNA may 
involve the nuclear compartment.  
 
Table 32. MS2L-tagged RNA co-purifying proteins that were enriched in single MS data sets. Log2 (H/L) ratios 
of enriched proteins are in bold. 
 
Protein ID Gene 
BB RNase ENO2 6MS2L 
for rev for rev for rev for rev 
P34761 
P38811 
P53952 
Q12186 
P50109 
P46672 
P46655 
P04801 
P32380 
P38889 
P34730 
P0CX63 
Q04215 
 
WHI3 
TRA1 
YNL050C 
MSL5 
PSP2 
ARC1 
GUS1 
THS1 
SPC110 
SKN7 
BMH2 
YGR161W-B 
YMR046C 
 
 1.41 
2.07 
-0.02 
0.23 
 0.06 
-0.22 
-0.06 
0.05 
 0.42 
0.03 
 
 -1.07 
-0.91 
0.07 
0.21 
 -0.48 
-0.26 
1.00 
-1.00 
0.61 
-0.12 
 
 
2.01 
 
 0.00 
0.48 
-0.27 
-0.10 
-0.29 
-0.28 
0.41 
-0.17 
0.42 
0.01 
 
-2.37 
 
 -0.08 
0.22 
0.51 
0.45 
0.73 
1.27 
-0.64 
-0.15 
0.10 
0.18 
 
 
 
 1.12 
0.66 
-0.26 
0.17 
-0.76 
 
 1.14 
0.21 
0.01 
 
 
 
 -0.58 
-0.61 
-0.27 
-0.31 
0.06 
 -1.84 
 -0.44 
0.12 
 
 
 
 
 
 0.54 
0.75 
0.59 
3.84 
1.91 
0.56 
1.62 
1.16 
 
 
 
 
 -0.28 
-0.96 
-0.80 
-0.89 
-1.56 
-1.36 
-0.67 
-1.26 
-0.71 
 
 
Two 6MS2L-RNA co-purifying proteins reveal an interesting difference in the 
metabolism of this mRNA-like transcript and the MS2L-tagged PGK1 and ENO2.  The Gag-Pol 
polypeptide (Ygr161w-B) and Gag polypeptide (Ymr046c) of yeast retrotransposons Ty2 and 
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Ty1, respectively, were enriched after 6MS2L-RNA affinity purification but not after MS2L-
tagged mRNA affinity purification. Retrotransposons are mobile DNA elements, which replicate 
over an RNA intermediate that is transported to the cytoplasm and translated (reviewed in 
Perlman and Boeke 2004). Besides serving as mRNA, the RNA intermediate also serve as 
genomic RNA and is packaged into virus-like particle (VLP) in the cytoplasm. In VLP the RNA 
is reverse transcription and a double-stranded cDNA copy is synthesized that integrates into a 
new site in the nuclear DNA. Interestingly, different cellular mRNAs have been found to 
associate with VPLs (H. Xu and Boeke 1990). This finding suggests that non-Ty RNA may be 
packaged into VLPs, revealing that the packaging process is not highly specific (reviewed in Roth 
2000). VLP formation is a multistep process that involves the association of Ty genomic RNA 
plus Gag and Gag-Pol polypeptides into an immature particle that does not completely 
encapsulate the RNA (Burns et al. 1992). Collectively, these findings point to the possibility that 
the abundant 6MS2L-RNA transcript (see Results, “Control RNA to determine the effect of 
MS2L tag on mRNP protein composition”) might be packaged into VLPs, which, in their 
immature form, presumably provide access to the 6MS2L-tag sequence for MS2CP-PrAx2::IgG 
interaction. 
 
 
 
Part 2 
 
Don’t mess with 3′ UTR – integration of MS2 stem-loops affects  
normal regulation of at least some cellular mRNAs 
The steady state level of PGK1-6MS2L was about 50% of the wt untagged PGK1 level (Fig. 14A). 
This finding indicates that the integration of the 6MS2L tag has altered PGK1 mRNA regulation 
and thus raises several questions. What is the mechanism behind the reduction of PGK1 steady 
state levels upon integration of MS2 stem-loops? Is Pgk1 protein function affected by the 
integration of the MS2L tag? Would other cellular mRNAs be affected in as similar way as PGK1? 
Is the altered mRNA regulation upon MS2-tag integration perhaps a yeast-specific effect or 
would the MS2L tag have a similar effect also in other model organisms? Would it be possible to 
modify the MS2 system so that the integration of the MS2L tag would not affect mRNA 
regulation? The following chapter will try to find answers to these questions. 
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Integration of MS2 stem-loops likely activates nonsense-mediated mRNA decay of PGK1 
and ENO2 
The steady state mRNA expression level is proportional to the rate of mRNA transcription and 
degradation. A decrease in PGK1 mRNA steady state level upon 6MS2L tag integration (Fig. 
14A) can thus be a consequence of decreased mRNA transcription or increased mRNA decay (or 
both). The 6 MS2 stem-loops are integrated between PGK1’s translation termination codon and 
the 3′ UTR. This insertion should not affect signals in the 3′ UTR important for proper 3′ end 
formation, which, if compromised, might lead to defects in pre-mRNA cleavage and poly(A) tail 
addition, ultimately reducing the efficiency of export-competent mRNP assembly (see 
Introduction, “3′ end formation and mRNA export are coupled”). Interestingly, the nuclear 
basket-associated proteins Mlp1 and Mlp2 have been shown to reduce reporter mRNA 
transcription in response to inefficient mRNP assembly in yeast cells containing a defective RNA 
export adapter Yra1 (Vinciguerra et al. 2005). This finding reveals a feedback mechanism 
between mRNP assembly and transcription (reviewed in Schmid and Jensen 2008)  and points to 
the possibility that suboptimal mRNP assembly caused by other defects, such as inefficient 3′ end 
processing, could result in transcriptional downregulation. However, since the integration of the 
6MS2L-tag should not interfere with proper 3′ end formation, it seems unlikely that the reason 
behind the decrease in PGK1-6MS2L steady state level is a reduction in mRNA transcription. 
A large body of evidence indicate that an increase in the physical distance between the 
normal stop codon and the 3′ UTR can lead to rapid mRNA decay due to the activation of post-
transcriptional mRNA surveillance mechanism termed nonsense-mediate mRNA decay (see 
Introduction, “Nonsense-mediated mRNA decay” and references therein). The integration of the 
6MS2L tag adds an extra 421 nt between the stop codon and the 3′ UTR in PGK1-6MS2L and 
may thereby introduce an NMD-activating feature. Indeed, Upf1, the central regulator of NMD 
pathway, was the most abundant protein co-purifying with PGK1-6MS2L (>60-fold enrichment). 
Furthermore, an additional NMD factor, Ebs1, and several proteins involved in 5′→3′ decay 
(Table 16) were also highly enriched after PGK1-6MS2L affinity purification. These results 
strongly suggest that the major mechanism behind the decrease in the steady state level of PGK1-
6MS2L is an increase in the rate of mRNA decay due to the activation of NMD. Since ENO2-
6MS2L has co-purified with a similar set of NMD and 5′→3′ decay factors (Table 16), it seems 
highly likely that the integration of the 6MS2L tag has also compromised the normal regulation of 
this mRNA.  
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PGK1-6MS2L encodes for a functional protein whose expression might be promoted by 
the presence of MS2CP-PrAx2 
The growth rate of yeast cells carrying the untagged or the 6MS2L-tagged PGK1 allele was 
comparable; the doubling time of both strains at 26°C in SC -ura supplemented with 2% glucose 
was around 3 h (data not shown, see Materials and Methods, “Culturing cells for mRNP affinity 
purification optimization experiments” for yeast cell growth conditions). Since the function of 
Pgk1 protein is essential, this result indicates that the Pgk1 protein expressed from PGK1-6MS2L 
allele is functional.  
Western blot analysis showed that Pgk1 protein levels were almost identical in yeast 
strains carrying the untagged or the 6MS2L-tagged PGK1 allele (Fig. 14B). This result suggests 
that despite reduced steady state levels of PGK1-6MS2L mRNA, the yeast cells can produce a 
similar amount of Pgk1 protein compared to the strain carrying the wt PGK1 allele. Importantly, 
the tested strains also expressed MS2CP-PrAx2. Further analysis revealed that in the absence of 
MS2CP-PrAx2 the Pgk1 protein level was reduced proportionally to the reduction in PGK1-
6MS2L mRNA level (the tested yeast strains were isogenic to the strains used in mRNP affinity 
purification experiments except that they contained C-terminal 3myc epitope-tagged Upf1 or 
Stm1 and, as mentioned, did not express MS2CP-PrAx2; Ulrike Thieβ, unpublished data). This 
finding raises the possibility that binding of MS2CP-PrAx2 to the MS2 stem-loops may promote 
better translation of PGK1-6MS2L transcripts. Interestingly, a similar observation was made by 
Tsai et al., who have established an MS2L-MS2CP interaction-based in vivo-assembled mRNP 
affinity purification method from human cells (Tsai et al. 2011). They found that in the presence 
of the tag-binding protein the luciferase activity of a reporter mRNA containing 4 MS2L stem-
loops downstream of the firefly luciferase stop codon was slightly elevated (Tsai et al. 2011). 
Since the effect of the integration of the MS2 stem-loops on mRNA stability was not addressed 
in this study, it remains unknown whether in mammalian system the integration of the 4MS2L 
tag had an mRNA destabilizing effect as observed by us for 6MS2L tag integration in S. cerevisiae.  
 
Would the stability of all cellular mRNAs be affected by the integration of the MS2L tag? 
For creating yeast strains carrying 6MS2L-tagged PGK1 and ENO2 we used a PCR-based 
chromosomal gene tagging method (Haim et al. 2007). This method was initially developed for in 
vivo visualization of specific endogenously expressed mRNAs in S. cerevisiae and has since been 
used in several studies to analyse mRNA localization (as a rule, 12 MS2 stem-loops are integrated 
for mRNA visualization purposes) (Zipor et al. 2009; Kilchert and Spang 2011; Casolari et al. 
2012; Fundakowski, Hermesh, and Jansen 2012). The effect of the integration of MS2 stem-loops 
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on mRNA stability has been addressed in case of one localized mRNA, ASH1, which is targeted 
to the distal tip of yeast daughter cells during anaphase (Long et al. 1997; Takizawa et al. 1997). 
Remarkably, the cell-cycle dependent relative level of the MS2L-tagged ASH1 was found to be 
unaltered compared to wt ASH1 mRNA (Haim et al. 2007), demonstrating that the effect of the 
MS2L tag on mRNA stability is mRNA-specific. This raises the question why ASH1-12MS2L is 
immune to the mRNA destabilizing effect of the MS2L tag and PGK1-6MS2L is not? The answer 
to this question likely lies in the different mode of translational control of the two mRNAs. 
PGK1 is expected to be efficiently recruited to the translating mRNA pool upon export from the 
nucleus (Arava et al. 2003). In contrast, ASH1 mRNA is transported in a translationally repressed 
state to the but tip (Irie et al. 2002; Gu et al. 2004) where it is translated only during a short 
period in late anaphase (Bobola et al. 1996). Since mRNA translation is a prerequisite for NMD 
(reviewed in Maquat 2004), PGK1-6MS2L likely becomes susceptible to NMD immediately after 
export to the cytoplasm. ASH1-12MS2L, if targeted by NMD at all, should be immune to NMD 
during mRNA localization and become sensitive to NMD only during mRNA translation. This 
notion is supported by the finding that in a translationally repressed state a PTC-containing 
ASH1 allele is insensitive to NMD but becomes sensitive once protein synthesis is initiated 
(Zheng et al. 2008).  
It remains to be experimentally determined whether ASH1-12MS2L is subjected to 
NMD during mRNA translation. The finding that the cell-cycle dependent relative level of 
ASH1-12MS2L is unchanged compared to ASH1 (Haim et al. 2007) suggests that unlike PGK1, 
ASH1 mRNA is not destabilized by an increased distance between the normal stop codon and 
the poly(A) tail. Collectively, the analysis of PGK1-6MS2L (Fig. 14A) and ASH1-12MS2L (Haim 
et al. 2007, see Fig. 2C) steady state levels indicate that the MS2L tag affects the stability of 
different cellular mRNAs to a different extent. Assuming that the integration of the MS2 stem-
loops introduces an NMD-activating feature, the mRNAs that are efficiently engaged in 
translation upon mRNA export should be destabilized to a greater extent than mRNAs whose 
translation is repressed or inefficient. 
 
The MS2 system provides an attractive approach to capture in vivo assembled mRNPs 
also from mammalian cells – what about MS2L-tagged mRNA stability?  
As mentioned above, Tsai et al. have developed a method based on the MS2 system for affinity 
purification of specific in vivo-assembled mRNPs from mammalian cells (Tsai et al. 2011). 
Similarly to us, Tsai et al. analysed the proteome of the captured mRNPs by SILAC-based 
quantitative proteomics. To our knowledge this is the only study published to date that combines 
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affinity purification of specific in vivo-assembled mRNPs with mRNP proteome analysis by 
SILAC-based quantitative proteomics. The analysis indicated that mRNPs undergoing processing 
in the nucleus or translation in the cytoplasm could be efficiently captured (Tsai et al. 2011). In 
contrast to our results, however, Tsai et al. did not identify mRNA decay factors among the 
proteins co-purifying with the tested MS2L-tagged mRNAs. From the NMD factors only UPF1 
was identified, which, according to the recent observations in mammalian cells, seems to 
associate with mRNAs before NMD targets are selected (Zünd et al. 2013; J. A. Hurt, Robertson, 
and Burge 2013). Therefore, UPF1 co-purification alone, without other NMD factors, cannot be 
considered as an indicative of mRNA targeting by NMD. The findings by Tsai et al. thus raise the 
question whether in mammalian cells MS2 stem-loops integrated downstream of the normal 
translation termination codon have the potential to destabilize mRNA. Considering that an 
increased distance between the stop codon and the poly(A) tail is an efficient trigger of NMD not 
only in yeast (Zaborske, Zeitler, and Culbertson 2013) but also in mammalian cells (Eberle et al. 
2008), it seems unlikely that in mammalian cells MS2L-tagged transcripts per se would be 
insensitive to NMD. A possible explanation therefore for the absence of mRNA decay and 
NMD factors among the identified mRNP proteins in the study by Tsai et al. is that the 
integration of 4 MS2 stem-loops did not increase the distance between the stop codon and the 
poly(A) tail sufficiently to trigger NMD of the tested mRNAs. However, even if NMD was not 
triggered, the cells should contain mRNPs engaged in constitutive cytoplasmic deadenylation-
dependent mRNA decay (reviewed in C.-Y. A. Chen and Shyu 2011). A possible reason for not 
detecting this pool of mRNPs in the study by Tsai et al. could be that the subpopulation of 
4MS2L-tagged mRNA-containing mRNPs undergoing deadenylation-dependent mRNA decay is 
very small, which might lead to mRNA decay factors escaping quantification. Alternatively, some 
technical reasons could be responsible in this study for not detecting mRNA decay factors. It 
therefore remains an open question whether integration of 4 MS2 stem-loops would have an 
mRNA-destabilizing effect also in mammalian cells.  
In order to visualize single mRNAs in living mammalian cells, the integration of 24 MS2 
stem-loops has routinely been used (Fusco et al. 2003; Shav-Tal et al. 2004; Mili, Moissoglu, and 
Macara 2008; Grünwald and Singer 2010; Darzacq et al. 2007; Mor et al. 2010). The experiments 
have largely relied on ectopic expression of artificial reporter mRNAs to analyse RNA Pol II 
transcription kinetics (Darzacq et al. 2007) and  mRNP movement (Fusco et al. 2003; Shav-Tal et 
al. 2004), export (Grünwald and Singer 2010; Mor et al. 2010) or localization (Mili, Moissoglu, 
and Macara 2008). A more natural context for mRNA visualization in mammalian cells has only 
recently become available through the generation of a transgenic mouse line carrying 24 MS2 
stem-loops in the 3′ UTR of both β-actin alleles (Lionnet et al. 2011). For the first time the effect 
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of the 24MS2L-tag on mRNA stability could be directly compared; northern blot analysis 
indicated that in mouse embryonic fibroblasts (MEFs) derived from a heterozygous knock-in 
mouse line the steady state level of MS2L-tagged β-actin mRNA was about 50% compared to the 
untagged mRNA level (Lionnet et al. 2011, see supplementary Fig. 3). This result suggests that 
the stability of the endogenous β-actin mRNA is affected by the integration of the 24 MS2 stem-
loops, thus hinting at the possibility that 24MS2L-tagged endogenous mRNAs in mammalian 
cells might not behave completely in the same way as their wt counterpart. Considering the 
emerging paradigm that mRNA levels are buffered by coupling between transcription and 
mRNA decay (Trcek et al. 2011; Bregman et al. 2011; Shalem et al. 2011; M. Sun et al. 2013; 
Haimovich et al. 2013; Goler-Baron et al. 2008), the presumed faster decay kinetics of 24MS2L-
tagged β-actin should result in enhanced mRNA transcription, which might lead to inaccurate 
estimations when such an mRNA is used for the analysis of mRNA transcription regulation on a 
single-cell level (Lionnet et al. 2011). Another proposed application for the 24MS2L-tagged β-
actin is mRNP isolation via the MS2L-tag (Lionnet et al. 2011). Our quantitative mRNA-bound 
proteome analysis results suggest that a 50% reduction in the steady state level of an MS2L-
tagged mRNA is caused by enhanced mRNA decay. The possible destabilizing effect of the 
MS2L tag on mammalian mRNAs should therefore be considered when establishing an mRNP 
affinity purification method based on MS2L-MS2CP interaction. 
 
Possible strategies to prevent NMD activation upon integration of the MS2L tag 
Even though our results indicate that the integration of the 6MS2L tag can hamper the normal 
regulation of at least some cellular mRNAs, an mRNP affinity purification method based on the 
capture of the mRNA component of the mRNP remains an attractive approach for determining 
the composition of specific in vivo-assembled mRNPs. To date, a simple and reliable method for 
the protein composition analysis of specific mRNPs, which would have met wide use, is missing 
(see Introduction, “RNA-based RNP affinity purification”). Consequently, on the level of a 
specific mRNA, our understanding of the spectrum, functional importance and spatio-temporal 
dynamics of mRNA-protein interactions is very limited (reviewed in Müller-McNicoll and 
Neugebauer 2013). Currently, only two alternatives exist for “marking” specific endogenous 
RNAs for affinity capture: (1) antisense 2′-O-methyl RNA oligonucleotides complementary to 
single-stranded regions; and (2) chromosomal integration of an RNA affinity tag (see 
Introduction, “RNA-based RNP affinity purification” and references therein). Due to the ease of 
use and reliability the second approach is by far the more popular one. An RNA affinity tag that 
could be integrated without affecting the regulation of the mRNA therefore seems to be the 
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optimal solution for marking specific endogenous mRNAs for affinity purification. Since our 
mRNP affinity purification method is based on the MS2L-MS2CP interaction, in the following 
section we consider different possibilities for reducing the destabilizing effect of the 6MS2L tag 
on mRNA stability.  
Several studies have found that NMD activation by a premature termination codon can 
be reduced by decreasing the distance between the PTC and the poly(A) tail (Peltz, Brown, and 
Jacobson 1993; Hagan et al. 1995; Eberle et al. 2008). Therefore, reducing the number of MS2 
stem-loops should decrease the potential of the MS2L tag to elicit NMD. However, reducing the 
number of MS2 stem-loops might also affect the capture efficiency of the MS2L-tagged RNA. 
Even though the capture efficiency of 6MS2L-tagged PGK1 could not be precisely determined, it 
seems likely that not more than a few per cent of the total cellular PGK1-6MS2L could be 
captured onto IgG-coupled beads (Fig. 13B). One possible explanation for the low capture 
efficiency of PGK1-6MS2L is that the amount of used IgG-coupled beads per affinity purification 
was too low to enable the capture of more PGK1-6MS2L-coniaining mRNPs. Alternatively, not 
all 6MS2L-tagged PGK1 transcripts might be bound by MS2 coat protein and consequently 
would not be captured onto IgG-coupled beads. The local mRNP structure might “hide” the 
MS2 stem-loops so that they would not be accessible for the interaction with MS2 coat protein. 
Indeed, the mRNP structure of PGK1-6MS2L-containing mRNPs seems to be relatively compact 
as suggested by the finding that in affinity purified mRNPs the TEV protease cleavage site 
between MS2CP and PrAx2 became accessible for cleavage only after RNase treatment, which 
disassembles the mRNPs by digesting the MS2L-tagged mRNA (Fig. 16 and data not shown). It 
remains to be experimentally determined whether the number of integrated MS2 stem-loops 
influences the capture efficiency of the tagged mRNA. However, if this is the case then the trade-
off of increased mRNA stability due to the integration of less MS2 stem-loops would likely be a 
reduction in mRNP capture efficiency. 
Besides reducing the distance between the PTC and the poly(A) tail, NMD targets can be 
stabilized by tethering poly(A)-binding protein close to the PTC (Amrani et al. 2004; Behm-
Ansmant et al. 2007; Kerényi et al. 2008; Eberle et al. 2008; G. Singh, Rebbapragada, and Lykke-
Andersen 2008). These findings suggest that MS2L-tagged mRNAs could be stabilized by 
localizing Pab1 to the MS2 stem-loops. Instead of using MS2CP-PrAx2 to capture the mRNPs of 
interest onto IgG-coupled beads, a fusion protein of MS2CP-Pab1-PrAx2 could be used. 
Alternatively, Pab1 could be tethered downstream of the MS2L tag by using the PP7 system (see 
Introduction, “Naturally occurring RNA secondary structure elements as RNA affinity tags” and 
references therein). Since the stabilizing effect of Pab1 likely depends on the number of Pab1 
molecules tethered, this approach would enable to control the magnitude of mRNA stabilization.  
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The integration of the RNA stability element (RSE) from Rous sarcoma virus (RSV) 
downstream of the MS2 stem-loops might provide an additional possibility to stabilize MS2L-
tagged mRNAs. RSV is an avian retrovirus whose unspliced mRNA is subjected to NMD if it 
contains a PTC in the gag gene (Weil and Beemon 2006). However, the PTC-free full-length RSV 
mRNA is protected from NMD despite the fact that the normal gag translation termination 
codon is located 7 kb from the 3′ poly(A) tail (Weil and Beemon 2006). The stability of the full-
length RSV mRNA depends on a 401-nt long sequence element immediately downstream of gag 
stop codon (Weil and Beemon 2006). Currently, it is not known if this RNA element prevents 
NMD by preventing Upf1 recruitment or by increasing translation termination efficiency 
(reviewed in Quek and Beemon 2014). Since NMD is an evolutionarily conserved cellular 
mechanism (see Introduction, “NMD factors and consequences of their activation” and 
references therein), it seems plausible that RSV RNA stability element could provide protection 
against NMD also in yeast cells. 
 
 
The mRNA-bound proteome – how much of it could we actually capture? 
The three main classes of proteins co-purifying with the MS2L-tagged PGK1 and ENO2 mRNAs 
as well as with the mRNA-like 6MS2L-RNA transcript were: (1) proteins involved in mRNA 
translation; (2) mRNA 5′→3′ decay factors; and (3) proteins associated with the poly(A) tail. The 
latter class includes proteins involved in mRNA poly(A) tail trimming in the cytoplasm and stress 
granule-associated proteins. Importantly, the three classes of enriched proteins participate in 
cytoplasmic processes, raising the question why nuclear events of the mRNA life cycle, such as 
transcription, 3′ end processing and mRNP export, should be underrepresented in the mRNA-
bound proteome. This is one of the issues that will be discussed in the following chapter, which 
focuses on the question why some mRNA-protein and protein-protein interactions might miss 
detection using our mRNP affinity purification strategy. 
 
The analysis of mRNA-bound proteome is likely influenced by mRNP abundance in 
different cellular compartments 
In comparison to cytoplasmic mRNP proteins, the number of enriched nuclear proteins in each 
MS data set was much lower (Table 20). The enriched proteins that are known to associate with 
mRNPs in the nucleus include, for instance, the two subunits of the nuclear cap-binding complex 
that co-purified with 6MS2L-RNA and the shuttling RNA-binding proteins Hrb1 and Sro9 that 
co-purified with 6MS2L-tagged PGK1 and ENO2. We could not detect proteins involved in 
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mRNA export such as the mRNA export receptor Mex67/Mtr2 or the mRNA export adapters 
Sub2 and Yra1 even though these proteins are expected to interact with the MS2L-tagged RNAs 
(see Introduction, “mRNP export factors are recruited during transcription”). Likewise, we could 
not detect proteins involved in mRNA transcription and 3′ end processing. These results suggest 
that nuclear mRNPs might be poorly accessible for affinity purification possibly due to their low 
abundance compared to cytoplasmic mRNPs. Besides physiological reasons such as the relatively 
short time it takes to assemble export-competent mRNPs upon transcription induction, which 
occurs within 5-40 min in mammalian cells (Mor et al. 2010), or the fast decay of pre-mRNAs if 
the mRNP assembly is delayed (Rougemaille et al. 2007; Saguez et al. 2008), inefficient breakage 
of nuclei during cryogenic grinding might contribute to low abundance of nuclear mRNPs in the 
cell lysate. However, another experiment done in our laboratory speaks against this latter 
possibility. Namely, SILAC-based quantitative proteomic analysis of mRNPs containing brome 
mosaic virus RNA3 (reviewed in Noueiry and Ahlquist 2003) identified many nuclear proteins 
(Hanna Tumin and Ulrike Thieβ, unpublished data). This result shows that nuclear mRNPs are 
not, per se, less accessible for mRNP affinity purification than the cytoplasmic mRNPs. The 
efficiency of mRNP capture from certain subcellular compartments therefore rather seems to 
depend on mRNP abundance in these compartments. Transcription in the yeast nucleus is not a 
natural part of brome mosaic virus’s life cycle; this positive-strand RNA virus replicates on the 
perinuclear ER membranes in plant cells (reviewed in den Boon, Diaz, and Ahlquist 2010). It 
seems plausible to think that the nucleocytoplasmic export of RNA3-conaining mRNPs is less 
efficient compared to normal cellular mRNAs, which likely contributes to the co-purification of 
MS2L-tagged RNA3 with multiple nuclear proteins. In case of MS2L-tagged PGK1 and ENO2 
and the mRNA-like 6MS2L-RNA transcript, however, the number of mRNPs on the nuclear 
assembly line at any given moment is presumably much lower than the number of cytoplasmic 
mRNPs engaged in processes such as mRNA translation or decay (Arava et al. 2003). Detection 
of low abundance proteins by LC-MS/MS is challenging due to dynamic range limitations 
(reviewed in Bantscheff et al. 2007). At very low peptide signals, bona fide interaction partners are 
difficult to distinguish from background noise and therefore such proteins may escape detection. 
Even though we did not observe non-specific binding of untagged mRNAs to IgG-coupled 
beads (Fig. 9A, 12B, 21B and data not shown), our mRNP affinity purification experiments may 
suffer from relatively high background of non-specifically captured proteins. Namely, northern 
blot (Fig. 15A) and qRT-PCR (Fig. 15B) analysis revealed non-specific ribosome binding to the 
IgG-coupled beads; roughly every third ribosome seems to have co-purified non-specifically (Fig. 
15B, Inada harvesting protocol). Since RNase treatment releases ribosomal proteins not only 
from ribosomes specifically co-purifying with MS2L-tagged RNAs but also from non-specifically 
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captured ribosomes, ribosomal proteins likely comprise abundant contaminants in our mRNP 
affinity purification experiments. The level of contaminating ribosomal proteins may be similar to 
or even exceed the level of some specific mRNA interactors and therefore detection of low 
abundance proteins poses a key challenge for the established mRNP affinity purification method. 
 
The position of the MS2L tag may influence the affinity purification efficiency of some 
mRNP proteins – is this the case in our experiments?  
All tested MS2L-tagged RNAs co-purified with factors involved in mRNA 5′→3′ 
exoribonucleolytic decay (Table 16), indicating that the 5′→3′ decay pathway plays an important 
role in the turnover of the three MS2L-tagged RNAs (see Discussion, Part 1, “MS2L-tagged 
RNAs seem to be largely degraded in the 5′→3′ exonucleolytic decay pathway” for further 
discussion). In contrast, the number of proteins involved in mRNA decay from the 3′ end was 
limited to the two subunits of the Pan poly(A)-specific 3′ exoribonuclease that trims the newly 
synthesised poly(A) tails to mRNA specific lengths (see Introduction, “Deadenylation” and 
references therein). Subunits of other protein complexes involved in the 3′→5′ decay pathway – 
the Ccr4-Not complex, the exosome and the Ski complex – could not be detected (see 
Introduction, “Deadenylation” and “3′→5′ mRNA decay” and references therein). This is 
surprising since normal, deadenylation-dependent mRNA decay, as well as fast mRNA decay 
promoted by NMD involve mRNA exonucleolytic degradation from both the 5′- and 3′ end (see 
Introduction, “NMD factors and consequences of their activation” and references therein).  
The reason for the absence of mRNA 3′→5′ decay factors among the enriched proteins 
might be related to the position of the 6MS2L tag close to 3′ end of the mRNA (Haim et al. 
2007). Once the MS2 stem-loops are degraded by the concerted action of the cytoplasmic 
exosome-Ski assembly (Halbach et al. 2013), the mRNA cannot be bound by MS2CP-PrAx2 and 
thus such mRNPs would be excluded from the proteomics analysis. For similar reasons, the 
capture of mRNPs involved in nuclear 3′→5′ decay by the exosome-TRAMP complex assembly 
might be problematic. Since, Ccr4-Not complex mediates mRNA deadenylation but not the 
3′→5′ decay of the mRNA body (see Introduction, “Deadenylation” and references therein), it 
should in principle be possible to capture Ccr4-Not-containing mRNPs. The failure to detect 
components of the Ccr4-Not complex among the enriched proteins might therefore be caused by 
dissociation of these proteins from mRNA during mRNP affinity purification. Alternatively, 
instead of the Ccr4-Not complex, poly(A) tail removal from the studied MS2L-tagged RNAs 
might be carried out by the Pan2-Pan3 heterodimer (see Discussion, Part1, “MS2L-tagged RNAs 
seem to be largely degraded in the 5′→3′ exonucleolytic decay pathway” for further discussion). 
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Even though it remains an open question what proteins are responsible for the deadenylation of 
the MS2L-tagged RNAs, co-purification of some subunits of the Lsm1-7 complex with all three 
MS2L-tagged RNAs suggests that a subpopulation of these transcripts is deadenylated. Namely, 
Lsm1-7 complex has been found to preferentially associate with deadenylated mRNAs (S Tharun 
and Parker 2001). 
Interestingly, northern blot analysis of the bead-captured PGK1-6MS2L mRNA 
demonstrated the accumulation of shortened PGK1-6MS2L RNA species (Figure 12B, compare 
upper and lower panel, lanes 12-13 and 18-19) that could be detected only with MS2L 
hybridization probe but not with PGK1-ORF probe (Figure 12A). This result suggests that the 
detected mRNA decay intermediates have lost the 5′ part of the mRNA with the annealing site of 
PGK1-ORF probe; however, the 3′ part of the mRNA, which contains MS2L probe annealing 
site, has not been degraded. Further analysis would be necessary to determine if the 5′→3′ 
shortened PGK1-6MS2L RNA species also contain the 3′ UTR. The presence of the 3′ UTR 
would support the notion that the 3′→5′ mRNA decay by the exosome-Ski assembly plays a 
minor role in the degradation of the analysed MS2L-tagged mRNAs. Since the smear below the 
signal corresponding to full-length PGK1-6MS2L forms a long “tail” (Figure 12B, lower panel, 
lane 13 and 19), it seems plausible that these mRNA decay intermediates indeed contain 
sequences downstream of the MS2L tag. Therefore, the main reason for not detecting subunits of 
the exosome or the Ski complex among the enriched proteins might not be related to the 
position of the 6MS2L tag or the instability of 3′→5′ mRNA decay factor interaction with the 
mRNA. Instead, northern blot results hint at the possibility that the subpopulation of MS2L-
tagged RNAs degraded in 3′→5′ direction is very small and therefore could escape detection. 
 
Many proteins are likely lost during mRNP affinity purification due to a weak association 
with the mRNP 
Our mRNP affinity purification strategy does not include a covalent cross-linking step to stabilize 
mRNA-protein and protein-protein interactions. Consequently, the mRNPs are prone to lose 
weak or transient interaction partners during mRNP affinity purification. This problem is 
illustrated, for example, by the enrichment of most translation initiation factors in single MS data 
sets or by the enrichment of only certain subunits of the heptameric Lsm1-7 complex. In 
addition, many proteins were quantified in only one of the biological replicate experiments and 
therefore the number of enriched proteins in each MS data set is likely underestimated 
(Appendix, Table 1). 
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The only translation initiation factor enriched in all MS data sets was eIF4G (Table 13). 
The protein makes multiple contacts with the mRNA body (Berset et al. 2003; E.-H. Park et al. 
2011; Yanagiya et al. 2009) and also interacts with the poly(A) tail-bound Pab1 (E.-H. Park et al. 
2011; Svitkin et al. 2009; Tarun et al. 1997). Unlike most other translation factors, which 
dissociate from the mRNA by the end of the translation initiation step, eIF4G remains associated 
with the mRNA throughout the whole translation cycle (reviewed in Hinnebusch 2011). 
Therefore, proteins whose association with the mRNA is stable in terms of interaction strength 
and duration can likely be efficiently captured using our mRNP affinity purification strategy. The 
enrichment of most other translation initiation factors only in single MS data sets suggest that the 
interaction of these initiation factors with the mRNA, rRNA or ribosomal proteins and other 
initiation factors (Herrmannová et al. 2012; W.-L. Chiu et al. 2010; Lebaron et al. 2012; Shin et al. 
2011; Hashem et al. 2013) is not strong enough to be efficiently retained throughout the affinity 
purification procedure. 
The only subunit of the Lsm1-7 complex enriched in all three MS data sets was Lsm4 
(Table 16). Two additional subunits, Lsm1 and Lsm2, were enriched after ENO2-6MS2L affinity 
purification. In one of the biological replicate experiments these two subunits co-purified also 
with PGK1-6MS2L. Likewise, Lsm1 co-purified with 6MS2L-RNA in one of the biological 
replicate experiment. These results indicate that the interaction between the subunits of the 
heptameric Lsm1-7 complex is not very stable and raise the question why the Lsm1, Lsm2 and 
Lsm4 subunits but not the Lsm3 and Lsm5-7 were detected? UV cross-linking experiments 
indicate that Lsm1 and possibly also Lsm4 directly contact the mRNA (Chowdhury, 
Mukhopadhyay, and Tharun 2007). Since Lsm4 was the only subunit co-purifying with all tested 
MS2L-tagged RNAs, our results hint at the possibility that the major RNA-binding subunit of 
Lsm1-7 complex may be Lsm4. Structural studies indicate that the order of the subunits in the 
heptameric ring is Lsm1-2-3-6-5-7-4 (Sharif and Conti 2013). The interaction between the 
subunits 1 and 2 may help to stabilize Lsm2 interaction with the mRNP. The decapping activator 
Pat1, which was enriched in all MS data sets (Table 15), has been found to bind a composite 
surface of Lsm2 and Lsm3 (Sharif and Conti 2013). This interaction might also contribute to the 
stability of Lsm2 interaction with the mRNP during affinity purification.  
Collectively, the mRNA-bound proteome analysis indicates that the efficiency of 
detection of certain mRNP-associated mRNA-protein and protein-protein interactions is 
influenced by the stability and cellular abundance of these interactions. Considering these 
limitations, it is remarkable that many proteins with no previously identified role in mRNA 
regulation have co-purified with the MS2L-tagged RNAs, suggesting that such proteins indeed 
represent true mRNP-associated proteins (see Discussion, Part 3, “mRNA-bound proteome 
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analysis revealed many unexpected proteins – a hint to novel RNA-binding proteins and 
previously uncharacterized cellular mechanisms?”). However, the inefficient detection of low-
abundance, weak or transient interactions also implies that the determined mRNA-associated 
proteomes do not reflect all the cellular events the MS2L-tagged RNAs are engaged in. For 
instance, we consistently could not detect Upf2 and Upf3 among the enriched proteins. Besides 
Upf1, these two proteins are essential for NMD, which is triggered upon interaction of the three 
Upf proteins on NMD target mRNAs (see Introduction, “NMD factors and consequences of 
their activation” and references therein). The absence of Upf2 and Upf3 among the enriched 
proteins raises the possibility that the MS2L-tagged mRNAs might not be targeted by NMD. 
This problem points to the need to use several parallel methods to study mRNA-protein 
interactions and the biological mechanisms underlying these interactions. The involvement of 
NMD in the turnover of MS2L-tagged RNAs, for instance, can be determined by monitoring 
MS2L-tagged mRNA decay upon transcription shutoff in wt, Δupf1 and Δupf2 strain background; 
NMD targets should be stabilized to a comparable extent in Δupf1 and Δupf2 cells (F He, Brown, 
and Jacobson 1997). 
 
 
 
Part 3 
 
mRNA-bound proteome analysis opens up a host of new questions  
What are the biological mechanisms behind the co-purification of a certain set of proteins with 
MS2L-tagged PGK1, ENO2 or the mRNA-like 6MS2L-RNA transcript? This is not an easy 
question to answer especially since the three analysed mRNA-bound proteomes did not only 
contain proteins with well established roles in the different steps of mRNA life cycle but also 
contained many proteins that have previously not been implicated in mRNA regulation. The final 
chapter of the thesis will highlight the proteins that possibly represent novel mRNP proteins. We 
will also compare the mRNA-bound proteomes of 6MS2L-RNA transcript to MS2L-tagged 
PGK1 and ENO2 to analyse how the MS2L tag might influence mRNP protein composition. 
Finally, the intriguing possibility of co-translational assembly of a supramolecular glycolytic 
enzyme complex will be discussed. 
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6MS2L-RNA – not quite an mRNA 
We set out to study what proteins co-purify with a heterologously expressed RNA containing the 
6 MS2 stem-loops (see Results, “Control RNA to determine the effect of MS2L tag on mRNP 
protein composition”) to identify cellular proteins that have the potential to bind to the MS2L 
tag. Interestingly, the majority of proteins co-purifying with 6MS2L-RNA were also enriched 
after PGK1-6MS2L or ENO2-6MS2L affinity purification, indicating that during its life cycle the 
6MS2L-RNA transcript is engaged in a similar network of cellular interactions as the MS2L-
tagged PGK1 and ENO2. It seems plausible that 6MS2L-RNA is sensed as an mRNA by the 
yeast cells. We assume that the PGK1-derived 5′ UTR and the CYC1-derived 3′ UTR that are 
necessary regions for in vivo expression of 6MS2L-RNA are responsible for this. As a 
consequence, the 6MS2L-RNA-bound proteome is comprised not only of proteins that bind to 
the MS2 stem-loops but also contains proteins that associate with the 5′ and 3′ UTRs. The high 
degree of overlap between the proteomes of 6MS2L-RNA and the MS2L-tagged mRNAs 
suggests that many cellular proteins have the potential to bind to the MS2 stem-loops; however, 
this binding likely depends on the mRNA context provided by 5′ and 3′ UTRs of the 6MS2L-
RNA. It seems plausible that not many cellular proteins bind to the MS2 stem-loops per se. 
The small differences in the repertoire or enrichment level of 6MS2L-RNA co-purifying 
proteins hint at interesting differences in the regulation of this mRNA-like transcript compared 
to the two MS2L-tagged mRNAs. The analysis of these differences helped to understand better 
the mechanisms responsible for co-purification of a certain set of proteins with the studied 
MS2L-tagged RNAs. For instance, the two subunits of the nuclear cap-binding complex, Cbc2 
and Cbc1, were among the most highly enriched proteins in 6MS2L-RNA MS data set (Table 20). 
In contrast, these proteins did not classify as enriched after PGK1-6MS2L or ENO2-6MS2L 
affinity purification. Since the nuclear cap-binding complex is replaced by eIF4E before or during 
the pioneer round of translation, these results indicate that the association of eIF4E with 6MS2L-
RNA is perturbed (see Discussion, Part1, “The nuclear history of MS2L-tagged RNAs is reflected 
by the enriched RNA-binding proteins” for further discussion). A possible reason for that could 
be slower remodelling kinetics of 6MS2L-RNA-containing mRNPs at the cytoplasmic side of the 
nuclear pores. This notion is supported by the finding that the shuttling poly(A)+ RNA-binding 
protein Nab2, which is removed after mRNP export to the cytoplasm, was >13-fold enriched 
after 6MS2L-RNA affinity purification compared to the about 2.3-fold enrichment after PGK1-
6MS2L affinity purification (Table 20).  
Ribosomal proteins of both the large and small subunit were among the enriched proteins 
after 6MS2L-RNA affinity purification (Figure 25), demonstrating that 80S ribosomes can form 
on this mRNA-like transcript. Since 80S ribosome formation is paralleled by initiation of 
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translation elongation (see Introduction, “mRNP interactions in cap-dependent translation” and 
references therein), this finding strongly suggests that 6MS2L-RNA can be translated. mRNA 
translation, however, is a prerequisite for nonsense-mediated mRNA decay (see Introduction, 
“Nonsense-mediated mRNA decay” and references therein). The predicted NMD-activating 
feature in 6MS2L-RNA as in MS2L-tagged PGK1 and ENO2 is a long distance between the 
translation termination codon and the poly(A) tail (see Discussion, Part 1, “MS2L-tagged RNAs 
may be targeted by nonsense-mediated decay” for further discussion). The comparable 
enrichment level of Upf1 with all three studied MS2L-tagged RNAs as well as co-purification of 
Nmd4 with 6MS2L-RNA suggests that this mRNA-like transcript is subjected to NMD (Table 
16). However, RT-PCR analysis of the steady state level of 6MS2L-RNA compared to PGK1-
6MS2L (Fig. 18B) hints at the possibility that the decay kinetics and thus the decay mechanism of 
the two RNAs might be different. The transcription of 6MS2L-RNA is under the control of 
PGK1 promoter. We reasoned that PGK1 promoter-controlled expression of 6MS2L-RNA would 
result in a similar expression level of 6MS2L-RNA compared to untagged PGK1.  However, this 
hypothesis could not be experimentally tested because the two transcripts to be compared cannot 
be amplified with the same set of primers. Therefore, we have compared the steady state levels of 
6MS2L-RNA and PGK1-6MS2L. The level of the latter mRNA is about 50% of the level of 
untagged PGK1 (Fig. 14A). The 2.3-fold higher level of 6MS2L-RNA compared to PGK1-6MS2L 
suggests that 6MS2L-RNA transcript levels are comparable to PGK1 as hypothesised. This 
finding thus suggests that 6MS2L-RNA is not subjected to accelerated mRNA decay due to 
NMD. However, we cannot rule out the possibility that despite the PGK1 promoter-controlled 
expression, the expression level of 6MS2L-RNA is actually higher than that of PGK1. Therefore, 
in order to unambiguously determine whether 6MS2L-RNA is subjected to NMD the decay of 
this transcript should be examined in wt and Δupf1 strain backgrounds.   
 
mRNA-bound proteome analysis revealed many unexpected proteins – a hint to novel 
mRNP proteins and previously uncharacterized cellular mechanisms?  
The mRNA-bound proteome analysis revealed several proteins that might, in addition to other 
cellular functions, participate in mRNA regulation. This class of proteins contains metabolic 
enzymes Imd2, Imd3, Imd4, Mis1 and Shm1 (Table 25), tRNA modification enzymes Trm44, 
Trm2, Pus4 and Pus7 (Table 23), ribosome biogenesis factors Cbf5, Mrd1, Arb1 and Arx1 (Table 
21) and proteins involved in ubiquitin-mediated regulation (Ubp3 and Def1, Table 27). All the 
above-mentioned proteins co-purified with at least two of the tested MS2L-tagged RNAs. 
Importantly, most of these proteins have previously been found to co-purify with poly(A)+ RNA 
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(Imd2, Imd3, Imd4, Cbf5, Mrd1 and Ubp3) or with Pab1 (Imd4, Mis1, Shm1, Cbf5, Arx1 and 
Ubp3) in yeast (S. F. Mitchell et al. 2013; Klass et al. 2013; R. Richardson et al. 2012). Further 
evidence for mRNA-association has been obtained for the ubiquitin-specific protease Ubp3 
(Baker, Tobias, and Varshavsky 1992), which has been found to associate with >1000 mRNAs in 
S. cerevisiae (Tsvetanova et al. 2010). However, for all of these proteins the possible function in 
context of an mRNP remains unknown. 
The only proteins whose mRNA-related function has been studied to some extent are the 
inosine monophosphate dehydrogenase isozymes encoded by IMD2, IMD3 and IMD4. Genetic 
studies in yeast have demonstrated that the only essential function of the three proteins is de novo 
synthesis of GTP (Hyle, Shaw, and Reines 2003). However, observations in human cells suggest 
that IMPDH has a “moonlighting” function in translation regulation (reviewed in Hedstrom 
2009). Several mutations in human inosine monophosphate dehydrogenase isozyme type 1 
(IMPDH1) are associated with autosomal dominant form of retinitis pigmentosa (adRP) (Bowne 
et al. 2002; Kennan et al. 2002; Bowne et al. 2006). Surprisingly, the analysed adRP-associated 
mutations in IMPDH1 gene do not affect the activity of the enzyme (Mortimer and Hedstrom 
2005). Instead, the mutations reduce the level of RNA co-immunoprecipitation with  IMPDH1 
(Mortimer and Hedstrom 2005) and disrupt polyribosome-association of the tested retinal 
IMPDH1 isoform (Mortimer et al. 2008). The latter finding suggests a role for mammalian 
IMPDH in regulation of translation (Mortimer et al. 2008). It should be noted, however, that 
IMPDH isoenzymes were not among the enriched proteins after poly(A)+ RNA affinity 
purification from immortalized human cell lines (Castello et al. 2012; Baltz et al. 2012), suggesting 
that ribosome-association might be specific for IMPDH1 retinal isoform. It remains to be 
determined whether the yeast Imd2, Imd3 and Imd4 are also associated with polyribosomes and 
what the functional role of this interaction could be. Imd2, Imd3 and Imd4 co-purification with 
mRNA under normal yeast growth conditions (our data) as well as upon glucose deprivation (S. 
F. Mitchell et al. 2013) suggests that the proteins may associate with both translationally active 
and inactive pools of mRNPs.  
Besides the possible role for Imd2, Imd3 and Imd4 in translation regulation (Mortimer et 
al. 2008), the secondary functions of the above-mentioned proteins have not been studied to our 
knowledge. However, the identification of 21 ribosome biogenesis factors among the poly(A)+ 
RNA co-purifying proteins in glucose deprived yeast cells (S. F. Mitchell et al. 2013) or the co-
purification of Ubp3 with >1000 transcripts (Tsvetanova et al. 2010) strongly suggests that some 
ribosomal biogenesis factors and Ubp3 have a jet unidentified role in mRNA life cycle. 
Importantly, this function seems to be evolutionarily conserved since most of the MS2L-tagged 
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RNA co-purifying ribosome biogenesis factors as well as Ubp3  have been found to co-purify 
with poly(A)+ RNA also in mammalian cells (Castello et al. 2012; Baltz et al. 2012).  
In addition to proteins with no well established role in mRNA regulation that co-purified 
with at least two of the analysed MS2L-tagged RNAs, many proteins previously not implicated in 
mRNA regulation were enriched also in single MS data sets. For instance, ENO2-6MS2L co-
purified with the mitochondrial RNA polymerase Rpo41 (Greenleaf, Kelly, and Lehman 1986) 
and with a component of mitochondrial nucleoid Mgm101 (Mbantenkhu et al. 2011). Both 
proteins were >9-fold enriched, suggesting a specific interaction with ENO2-6MS2L. Since 
Rpo41 and Mgm101 are mitochondrial proteins, this finding raises the questions of where and 
why the cytoplasmic mRNPs containing ENO2-6MS2L mRNA interact with these mitochondrial 
proteins. The functional role of ENO2-6MS2L interaction with Rpo41 and Mgm101 remains 
unknown. However, a possible cellular site of interaction could be the mitochondrial surface. A 
part of cellular enolase pool is associated with mitochondrial surface where the protein is a 
component of a large macromolecular complex containing additional glycolytic enzymes, 
mitochondrial membrane carriers and enzymes of the citric acid cycle (Entelis et al. 2006; 
Brandina et al. 2006). The formation of such a macromolecular complex might involve ENO2 
mRNA translation in the vicinity of mitochondria, where the mRNA or the nascent enolase 
peptide could come into contact with mitochondrial proteins awaiting import. Alternatively, the 
co-purification of Rpo41 and Mgm101 with ENO2-6MS2L might represent false-positive 
interactions that occur upon the release of mitochondrial proteins due to cell breakage. 
Considering the high enrichment level of Rpo41 and Mgm101 (>9-fold enrichment) the latter 
scenario seems unlikely. However, we cannot rule out that some non-specifically bound proteins 
have been classified as enriched. The low enrichment level (<2-fold enrichment) and 
classification as enriched only in a single MS data set raises the possibility that some cytoplasmic 
metabolic enzymes (Leu2, Zwf1, Aro1, His4, Ura3, Met6), mitochondrial proteins (Adh3, 
Mss116, Hsp60) and additional proteins with various functions (Sec16, Psp2, Bmh2) represent 
non-specific interactors. 
PGK1-6MS2L co-purified with four glycolytic enzymes – Pgk1, Hxk2, Pgi1 and Tdh3 
(Table 31). In addition, three glycolytic enzymes (Tpi1, Tdh2 and Eno2) only slightly failed to 
meet the set threshold criteria for enriched proteins. Co-purification of Pgk1 protein with PGK1-
6MS2L mRNA is easily explained by association between the PGK1-6MS2L mRNA, the 
ribosome and the Pgk1 nascent peptide. This chain of interactions might also contribute to the 
co-purification of the other glycolytic enzymes with PGK1-6MS2L. Namely, several lines of 
evidence suggest that glycolytic enzymes form a supramolecular complex (see Discussion, Part 1, 
“PGK1-6MS2L co-purifies with several glycolytic enzymes – co-translational formation of a 
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supramolecular glycolytic enzyme complex?” for references). Pgk1 nascent peptide might be co-
translationally recruited to such a complex, resulting in PGK1-6MS2L co-purification with not 
only Pgk1 nascent peptide but also with other glycolytic enzymes. It remains to be experimentally 
determined if the co-purification of glycolytic enzymes with PGK1-6MS2L represents biologically 
meaningful interactions or is a result of non-specific association of abundant cytoplasmic 
proteins with mRNPs upon cell breakage. The fact that 6MS2L-RNA did not co-purify with any 
of the glycolytic enzymes supports the notion that PGK1-6MS2L co-purification with glycolytic 
enzymes is biologically meaningful and represents the association of glycolytic enzymes into a 
supramolecular complex. 
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Table 1. The list of MS2L-tagged mRNA co-purifying proteins, which fulfilled the set threshold criteria to be 
classified as “enriched” (forward labelling experiment log2 (H/L) >0.5 and reverse labelling experiment log2 
(H/L) <–0.5). Each single row contains the group of proteins (proteinGroup) that could be assigned to a set of 
peptides that were identified by SILAC-based quantitative mass spectrometry. P – number of identified 
peptides; H/L – normalized SILAC ratio; log2 – log2 transformed normalized SILAC ratio; significance – 
significance B (if < 0.01, the corresponding proteinGroup is significantly up or down regulated). 
 
Boiled Beads unique (PGK1-6MS2L) Forward experiment Reverse experiment 
Protein ID Gene P H/L log2 Significance P H/L log2 Significance  
P09440 
Q06698 
P0CX47; P0CX48 
P53741 
P0CX82; P0CX83 
P05748; P54780 
P53952 
P14120 
P40212; Q12690 
P26321 
P05738 
P53297 
P0CX43; P0CX44 
P38811 
P32563 
P49626 
P25368 
P41805 
P33322 
P53254 
P42846 
P60010 
P25586 
P0C0T4 
P48415 
P15424 
P37838 
P02407; P14127 
P38786 
P0CX29; P0CX30 
P0CX35; P0CX36 
P40010 
P05756 
P41819 
 
MIS1 
YLR419W 
RPS11A; RPS11B 
BRE5 
RPL19A; RPL19B 
RPL15A; RPL15B 
YNL050C 
RPL30 
RPL13B; RPL13A 
RPL5 
RPL9A 
PBP1 
RPL1A; RPL1B 
TRA1 
VPH1 
RPL4B 
RRP7 
RPL10 
CBF5 
UTP22 
KRI1 
ACT1 
KRR1 
RPS25B 
SEC16 
MSS116 
NOP4 
RPS17A; RPS17B 
RPP1 
RPS23A; RPS23B 
RPS4B 
NUG1 
RPS13 
DIM1 
 
27 
15 
9 
12 
5 
3 
2 
4 
4 
6 
9 
9 
7 
12 
6 
9 
5 
2 
4 
12 
3 
6 
7 
6 
13 
9 
7 
6 
2 
8 
12 
7 
5 
6 
 
5.733 
5.309 
4.952 
4.640 
4.589 
4.381 
4.191 
4.013 
3.529 
3.298 
3.059 
2.935 
2.904 
2.655 
2.490 
2.488 
2.391 
2.391 
2.356 
2.098 
1.949 
1.820 
1.770 
1.718 
1.697 
1.676 
1.661 
1.636 
1.624 
1.609 
1.576 
1.474 
1.466 
1.429 
 
2.52 
2.41 
2.31 
2.21 
2.20 
2.13 
2.07 
2.00 
1.82 
1.72 
1.61 
1.55 
1.54 
1.41 
1.32 
1.32 
1.26 
1.26 
1.24 
1.07 
0.96 
0.86 
0.82 
0.78 
0.76 
0.74 
0.73 
0.71 
0.70 
0.69 
0.66 
0.56 
0.55 
0.51 
 
0.001493 
0.00229 
0.003327 
0.004657 
0.004922 
0.006205 
0.007696 
0.009449 
0.01687 
0.022462 
0.030435 
0.035751 
0.037233 
0.05182 
0.064808 
0.064998 
0.074247 
0.074249 
0.077964 
0.11182 
0.13818 
0.16624 
0.17855 
0.19254 
0.19855 
0.20465 
0.20904 
0.21669 
0.22043 
0.22521 
0.2362 
0.2738 
0.27689 
0.29207 
 
19 
7 
7 
8 
5 
4 
2 
5 
2 
4 
5 
7 
5 
2 
3 
9 
2 
4 
7 
4 
4 
4 
3 
7 
3 
7 
2 
8 
2 
7 
8 
5 
4 
2 
 
0.128 
0.158 
0.120 
0.171 
0.216 
0.267 
0.531 
0.354 
0.255 
0.541 
0.240 
0.249 
0.233 
0.475 
0.343 
0.257 
0.699 
0.275 
0.459 
0.495 
0.465 
0.183 
0.542 
0.691 
0.457 
0.510 
0.646 
0.188 
0.189 
0.129 
0.109 
0.593 
0.583 
0.441 
 
-2.96 
-2.67 
-3.06 
-2.55 
-2.21 
-1.91 
-0.91 
-1.50 
-1.97 
-0.89 
-2.06 
-2.00 
-2.10 
-1.07 
-1.55 
-1.96 
-0.52 
-1.86 
-1.12 
-1.01 
-1.10 
-2.45 
-0.88 
-0.53 
-1.13 
-0.97 
-0.63 
-2.41 
-2.40 
-2.95 
-3.20 
-0.75 
-0.78 
-1.18 
 
0.058185 
0.079027 
0.052032 
0.088563 
0.1216 
0.1581 
0.3201 
0.21699 
0.14966 
0.32554 
0.13936 
0.14565 
0.13403 
0.28984 
0.20958 
0.15112 
0.40006 
0.16409 
0.28084 
0.30096 
0.28443 
0.097472 
0.32597 
0.39652 
0.27988 
0.30894 
0.37647 
0.10163 
0.10192 
0.058713 
0.044872 
0.35141 
0.34648 
0.2705 
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RNase unique (PGK1-6MS2L) Forward experiment Reverse experiment 
Protein ID Gene P H/L log2 Significance P H/L log2 Significance  
P02400 
P25644 
Q02648 
P39998 
P33753 
P36102 
P53010 
P05750 
P0CX51; P0CX52 
P26783 
P34761 
P26786 
Q12517 
P38922 
P40070 
P40024 
P10081 
P40047 
P25567 
P0CX37; P0CX38 
P05317 
P53316 
Q04600 
P05694 
P32505 
P00359 
P35997;P38711 
P07246 
P12709 
P0CX84; P0CX85 
P48164 
P40561 
P04807 
P33399 
P04173 
P0C0V8; Q3E754 
P50094; O42831 
Q3E7Y3; P0C0W1 
P00330 
Q12499 
P05759; P0CG63 
P26785 
P10080 
P32588 
RPP2B 
PAT1 
TRM44 
EDC3 
TRM2 
PAN3 
PAN2 
RPS3 
RPS16A; RPS16B 
RPS5 
WHI3 
RPS7A 
DCP1 
HRB1 
LSM4 
ARB1 
TIF1 
ALD5 
SRO9 
RPS6A; RPS6B 
RPP0 
YGR250C 
TMA64 
MET6 
NAB2 
TDH3 
RPS27A; RPS27B 
ADH3 
PGI1 
RPL35A; RPL35B 
RPS7B 
SGN1 
HXK2 
LHP1 
LEU2 
RPS21A; RPS21B 
IMD4; YAR075W 
RPS22B; RPS22A 
ADH1 
NOP58 
RPS31; UBI4 
RPL16B 
SBP1 
PUB1 
2 
10 
14 
6 
9 
14 
4 
6 
6 
7 
4 
15 
5 
6 
4 
9 
4 
19 
9 
7 
6 
6 
5 
11 
10 
14 
3 
3 
7 
3 
13 
5 
8 
5 
8 
2 
9 
7 
10 
6 
5 
4 
6 
4 
14.164 
13.558 
13.080 
11.665 
11.031 
8.756 
8.492 
5.776 
5.179 
4.096 
4.040 
3.986 
3.759 
3.407 
3.016 
2.963 
2.632 
2.604 
2.455 
2.439 
2.426 
2.342 
2.311 
2.253 
2.240 
2.187 
2.164 
2.117 
2.076 
1.986 
1.947 
1.937 
1.915 
1.883 
1.773 
1.754 
1.753 
1.749 
1.702 
1.674 
1.671 
1.666 
1.585 
1.572 
3.82 
3.76 
3.71 
3.54 
3.46 
3.13 
3.09 
2.53 
2.37 
2.03 
2.01 
2.00 
1.91 
1.77 
1.59 
1.57 
1.40 
1.38 
1.30 
1.29 
1.28 
1.23 
1.21 
1.17 
1.16 
1.13 
1.11 
1.08 
1.05 
0.99 
0.96 
0.95 
0.94 
0.91 
0.83 
0.81 
0.81 
0.81 
0.77 
0.74 
0.74 
0.74 
0.66 
0.65 
6.41E-06 
8.92E-06 
1.17E-05 
2.67E-05 
3.95E-05 
0.000183 
0.000222 
0.002044 
0.003576 
0.010735 
0.011403 
0.012082 
0.015499 
0.023099 
0.036651 
0.039086 
0.058868 
0.060995 
0.073711 
0.075259 
0.076522 
0.085284 
0.088839 
0.095843 
0.097537 
0.10452 
0.10777 
0.11472 
0.12103 
0.13664 
0.14396 
0.14587 
0.15024 
0.15697 
0.18218 
0.18699 
0.18722 
0.18814 
0.2006 
0.20858 
0.20942 
0.21072 
0.23558 
0.23962 
2 
6 
6 
3 
5 
8 
6 
5 
1 
5 
2 
9 
2 
5 
3 
7 
5 
16 
5 
8 
5 
2 
3 
6 
5 
15 
2 
2 
4 
3 
11 
2 
3 
3 
4 
2 
5 
3 
14 
3 
4 
1 
3 
3 
0.342 
0.039 
0.033 
0.062 
0.089 
0.051 
0.068 
0.219 
0.512 
0.443 
0.194 
0.406 
0.204 
0.274 
0.341 
0.378 
0.688 
0.418 
0.309 
0.645 
0.355 
0.387 
0.315 
0.637 
0.420 
0.616 
0.457 
0.613 
0.280 
0.511 
0.398 
0.412 
0.352 
0.484 
0.690 
0.419 
0.390 
0.480 
0.686 
0.631 
0.439 
0.477 
0.531 
0.605 
-1.55 
-4.70 
-4.93 
-4.00 
-3.49 
-4.30 
-3.88 
-2.19 
-0.97 
-1.17 
-2.37 
-1.30 
-2.29 
-1.87 
-1.55 
-1.40 
-0.54 
-1.26 
-1.69 
-0.63 
-1.50 
-1.37 
-1.67 
-0.65 
-1.25 
-0.70 
-1.13 
-0.71 
-1.84 
-0.97 
-1.33 
-1.28 
-1.51 
-1.05 
-0.54 
-1.25 
-1.36 
-1.06 
-0.54 
-0.66 
-1.19 
-1.07 
-0.91 
-0.73 
0.11457 
7.19E-05 
3.30E-05 
0.000622 
0.002543 
0.000255 
0.000892 
0.041735 
0.23489 
0.18581 
0.030213 
0.15866 
0.034501 
0.071114 
0.11402 
0.13915 
0.35518 
0.16763 
0.092826 
0.32743 
0.12316 
0.14554 
0.096408 
0.32177 
0.16908 
0.30776 
0.19553 
0.30549 
0.074752 
0.23437 
0.15346 
0.16312 
0.12107 
0.21506 
0.35655 
0.16833 
0.14759 
0.21212 
0.35401 
0.31791 
0.1829 
0.21002 
0.24857 
0.30011 
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Boiled Beads unique (PGK1-6MS2L) Forward experiment Reverse experiment 
Protein ID Gene P H/L log2 Significance P H/L log2 Significance  
P50095 
P38701 
P19882 
P38199 
 
IMD3 
RPS20 
HSP60 
HEK2 
 
13 
11 
19 
5 
 
1.539 
1.486 
1.458 
1.455 
 
0.62 
0.57 
0.54 
0.54 
 
0.25081 
0.26979 
0.2804 
0.28139 
 
11 
9 
9 
2 
 
0.466 
0.665 
0.666 
0.589 
 
-1.10 
-0.59 
-0.59 
-0.76 
 
0.20208 
0.3407 
0.34132 
0.2889 
 
 
 
Shared (PGK1-6MS2L) Forward experiment Reverse experiment 
  P H/L log2 Significance P H/L log2 Significance  
P30771 
Q03466 
P53550 
P22147 
Q12000 
P38011 
P04147 
P39015 
P39729 
Q01477 
P40150 
P38934 
P14126 
P39936 
P16521; P53978 
P10664 
P25443 
P40850 
Q03862 
P39935 
P32527 
P05755 
P38788 
P0CX39; P0CX40 
P35732 
P06105 
P33442 
P00560 
P07281 
P23248 
 
UPF1 
EBS1 
DCP2 
XRN1 
TMA46 
ASC1 
PAB1 
STM1 
RBG1 
UBP3 
SSB2 
BFR1 
RPL3 
TIF4632 
YEF3; HEF3 
RPL4A 
RPS2 
MKT1 
ARX1 
TIF4631 
ZUO1 
RPS9B 
SSZ1 
RPS8A; RPS8B 
DEF1 
SCP160 
RPS1A 
PGK1 
RPS19B 
RPS1B 
 
16 
12 
15 
15 
8 
11 
29 
16 
6 
7 
21 
22 
2 
18 
22 
5 
5 
9 
10 
18 
15 
7 
18 
2 
17 
40 
6 
19 
6 
7 
 
60.681 
22.113 
19.375 
7.407 
6.489 
6.393 
5.960 
5.709 
5.636 
3.914 
3.711 
3.463 
3.415 
3.385 
2.864 
2.853 
2.647 
2.526 
2.411 
2.348 
2.150 
2.111 
2.110 
1.855 
1.853 
1.831 
1.704 
1.686 
1.676 
1.521 
 
5.92 
4.47 
4.28 
2.89 
2.70 
2.68 
2.58 
2.51 
2.49 
1.97 
1.89 
1.79 
1.77 
1.76 
1.52 
1.51 
1.40 
1.34 
1.27 
1.23 
1.10 
1.08 
1.08 
0.89 
0.89 
0.87 
0.77 
0.75 
0.75 
0.60 
 
5.90E-12 
1.66E-07 
5.20E-07 
0.00051 
0.001089 
0.001183 
0.00173 
0.002173 
0.002325 
0.013067 
0.016363 
0.02166 
0.022893 
0.023695 
0.044104 
0.044713 
0.057788 
0.067367 
0.078029 
0.084665 
0.10984 
0.11553 
0.11573 
0.16287 
0.1635 
0.16843 
0.20005 
0.20519 
0.20791 
0.25725 
 
9 
5 
6 
26 
3 
11 
28 
17 
4 
5 
19 
15 
3 
10 
17 
5 
3 
3 
6 
17 
10 
5 
11 
1 
7 
35 
7 
16 
5 
7 
 
0.015 
0.022 
0.058 
0.127 
0.105 
0.123 
0.097 
0.127 
0.119 
0.214 
0.300 
0.165 
0.297 
0.193 
0.384 
0.431 
0.549 
0.330 
0.355 
0.296 
0.387 
0.449 
0.372 
0.353 
0.563 
0.591 
0.511 
0.084 
0.659 
0.418 
 
-6.08 
-5.49 
-4.10 
-2.98 
-3.25 
-3.02 
-3.36 
-2.97 
-3.07 
-2.22 
-1.74 
-2.60 
-1.75 
-2.37 
-1.38 
-1.21 
-0.86 
-1.60 
-1.50 
-1.76 
-1.37 
-1.16 
-1.42 
-1.50 
-0.83 
-0.76 
-0.97 
-3.58 
-0.60 
-1.26 
 
3.88E-07 
4.19E-06 
0.000465 
0.00852 
0.004608 
0.007778 
0.003471 
0.008689 
0.007029 
0.039179 
0.087279 
0.019108 
0.084941 
0.02986 
0.1438 
0.17674 
0.2614 
0.10682 
0.12305 
0.084346 
0.14529 
0.18956 
0.13543 
0.12181 
0.27131 
0.29042 
0.23405 
0.002011 
0.33636 
0.1674 
 
 
 
 
APPENDIX 
 
230 
 
ENO2-6MS2L (RNase eluate) Forward experiment Reverse experiment 
Protein ID Gene P H/L log2 Significance P H/L log2 Significance  
Q03466 
Q02933 
P33753 
P0CX55; P0CX56 
P25644 
Q02648 
P37292 
P32787 
P0CX82; P0CX83 
P0CX35; P0CX36 
Q07362 
P40024 
P53550 
P13433 
P30771 
P22147 
P39998 
P36102 
P38922 
P53010 
Q06698 
P38934 
P26321 
P0CX47; P0CX48 
P14126 
P39729 
P38203 
P38788 
P05317 
P10664 
P07281 
P40047 
P0CX37; P0CX38 
P32527 
P53297 
P24000 
P04456 
P25443 
P39015 
P05755 
Q02753 
Q3E7Y3; P0C0W1 
P47017 
P48567 
EBS1 
RNY1 
TRM2 
RPS18A; RPS18B 
PAT1 
TRM44 
SHM1 
MGM101 
RPL19A; RPL19B 
RPS4A; RPS4B 
PBP4 
ARB1 
DCP2 
RPO41 
NAM7 
XRN1 
EDC3 
PAN3 
HRB1 
PAN2 
YLR419W 
BFR1 
RPL5 
RPS11A; RPS11B 
RPL3 
RBG1 
LSM2 
SSZ1 
RPP0 
RPL4A 
RPS19B 
ALD5 
RPS6A; RPS6B 
ZUO1 
PBP1 
RPL24B 
RPL25 
RPS2 
STM1 
RPS9B 
RPL21A 
RPS22B; RPS22A 
LSM1 
PUS4 
11 
2 
7 
3 
11 
5 
14 
2 
4 
4 
2 
8 
5 
9 
12 
24 
4 
7 
4 
8 
17 
26 
2 
2 
3 
8 
2 
16 
5 
6 
4 
19 
5 
10 
3 
2 
4 
6 
19 
5 
2 
6 
2 
2 
29.074 
19.370 
18.617 
18.299 
14.727 
13.519 
12.245 
11.898 
11.636 
9.977 
9.872 
9.581 
9.420 
9.110 
9.046 
8.919 
8.661 
8.600 
8.577 
8.546 
8.525 
8.306 
7.665 
7.602 
7.532 
7.306 
7.303 
7.117 
7.042 
7.010 
6.997 
6.920 
6.843 
6.719 
6.704 
6.645 
6.576 
6.141 
5.800 
5.603 
5.600 
5.525 
5.511 
5.419 
4.86 
4.28 
4.22 
4.19 
3.88 
3.76 
3.61 
3.57 
3.54 
3.32 
3.30 
3.26 
3.24 
3.19 
3.18 
3.16 
3.11 
3.10 
3.10 
3.10 
3.09 
3.05 
2.94 
2.93 
2.91 
2.87 
2.87 
2.83 
2.82 
2.81 
2.81 
2.79 
2.77 
2.75 
2.75 
2.73 
2.72 
2.62 
2.54 
2.49 
2.49 
2.47 
2.46 
2.44 
0.0085327 
0.020706 
0.02245 
0.023246 
0.035463 
0.041542 
0.049604 
0.052165 
0.05422 
0.07021 
0.071427 
0.074966 
0.077032 
0.081243 
0.082141 
0.08399 
0.087901 
0.08887 
0.089244 
0.089735 
0.090075 
0.093744 
0.1057 
0.107 
0.10846 
0.11336 
0.11343 
0.11771 
0.1195 
0.12027 
0.1206 
0.12249 
0.12444 
0.12767 
0.12806 
0.12965 
0.13154 
0.14437 
0.15573 
0.16286 
0.16297 
0.1658 
0.16634 
0.16997 
10 
2 
8 
3 
9 
8 
10 
2 
5 
7 
5 
5 
10 
4 
10 
23 
4 
5 
5 
3 
5 
17 
2 
6 
8 
7 
1 
11 
6 
5 
3 
21 
7 
10 
8 
3 
3 
2 
18 
5 
4 
4 
1 
6 
0.038 
0.034 
0.015 
0.088 
0.011 
0.009 
0.040 
0.013 
0.592 
0.527 
0.093 
0.092 
0.067 
0.047 
0.036 
0.059 
0.041 
0.054 
0.027 
0.046 
0.039 
0.046 
0.157 
0.150 
0.051 
0.108 
0.111 
0.074 
0.701 
0.140 
0.230 
0.056 
0.094 
0.079 
0.058 
0.408 
0.055 
0.293 
0.048 
0.227 
0.633 
0.207 
0.130 
0.038 
-4.72 
-4.88 
-6.11 
-3.50 
-6.48 
-6.77 
-4.65 
-6.27 
-0.76 
-0.92 
-3.43 
-3.44 
-3.90 
-4.42 
-4.78 
-4.08 
-4.60 
-4.22 
-5.22 
-4.45 
-4.70 
-4.43 
-2.67 
-2.74 
-4.28 
-3.21 
-3.17 
-3.75 
-0.51 
-2.84 
-2.12 
-4.16 
-3.42 
-3.65 
-4.12 
-1.29 
-4.19 
-1.77 
-4.39 
-2.14 
-0.66 
-2.27 
-2.94 
-4.71 
0.087438 
0.080276 
0.03748 
0.16303 
0.02903 
0.023716 
0.090891 
0.033636 
0.44422 
0.42409 
0.16885 
0.16793 
0.13481 
0.10319 
0.084911 
0.12295 
0.093604 
0.11465 
0.065687 
0.10142 
0.088747 
0.1026 
0.23324 
0.22754 
0.1109 
0.18623 
0.18901 
0.14509 
0.47409 
0.21793 
0.28865 
0.11841 
0.16962 
0.1519 
0.12098 
0.38021 
0.11629 
0.32603 
0.10514 
0.28625 
0.45615 
0.27294 
0.20872 
0.088203 
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ENO2-6MS2L (RNase eluate) Forward experiment Reverse experiment 
Protein ID Gene P H/L log2 Significance P H/L log2 Significance  
P48589 
P0C0V8; Q3E754 
P38011 
Q03862 
P0C2H8 
Q01477 
P38174 
P26786 
P50094; O42831 
P05740; P46990 
P40150 
P02407; P14127 
P04147 
P39730 
P12945 
P39936 
P29453 
P40850 
P53235 
P09440 
P50095; REV_P38882 
P41805 
P05738 
P46784; Q08745 
P07347 
P25567 
Q12129 
P05750 
P38697; P39567 
Q12517 
Q12211 
Q06106 
P38701 
P33322 
P20459 
Q02792 
P0CX43; P0CX44 
Q12186 
Q08208 
Q12000 
P48164 
P39517 
P32481 
Q02326 
RPS12 
RPS21A; RPS21B 
ASC1 
ARX1 
RPL31A 
UBP3 
MAP2 
RPS7A 
IMD4; YAR075W 
RPL17A; RPL17B 
SSB2 
RPS17A 
PAB1 
FUN12 
NAT1 
TIF4632 
RPL8B 
MKT1 
YGR054W 
MIS1 
IMD3; REV_UTP9 
RPL10 
RPL9A 
RPS10B; RPS10A 
ARD1 
SRO9 
NMD4 
RPS3 
IMD2; IMD1 
DCP1 
PUS1 
MRD1 
RPS20 
CBF5 
SUI2 
RAT1 
RPL1A; RPL1B 
MSL5 
NOP12 
TMA46 
RPS7B 
DHH1 
GCD11 
RPL6A 
5 
3 
16 
10 
4 
13 
3 
16 
8 
3 
20 
5 
25 
7 
8 
20 
10 
4 
8 
19 
12 
1 
12 
2 
2 
6 
5 
7 
10 
3 
2 
8 
7 
4 
4 
5 
13 
5 
5 
7 
15 
5 
5 
7 
5.343 
5.280 
5.228 
5.033 
4.979 
4.808 
4.756 
4.638 
4.462 
4.402 
4.362 
4.333 
4.332 
4.249 
4.233 
4.123 
4.091 
3.997 
3.848 
3.537 
3.499 
3.459 
3.453 
3.356 
3.192 
3.135 
3.135 
2.990 
2.927 
2.877 
2.804 
2.539 
2.412 
2.381 
2.376 
2.310 
2.206 
2.171 
2.105 
2.104 
2.081 
2.069 
2.022 
1.999 
2.42 
2.40 
2.39 
2.33 
2.32 
2.27 
2.25 
2.21 
2.16 
2.14 
2.13 
2.12 
2.12 
2.09 
2.08 
2.04 
2.03 
2.00 
1.94 
1.82 
1.81 
1.79 
1.79 
1.75 
1.67 
1.65 
1.65 
1.58 
1.55 
1.52 
1.49 
1.34 
1.27 
1.25 
1.25 
1.21 
1.14 
1.12 
1.07 
1.07 
1.06 
1.05 
1.02 
1.00 
0.17301 
0.17561 
0.17782 
0.18635 
0.18883 
0.197 
0.19955 
0.20562 
0.21509 
0.2185 
0.22078 
0.22251 
0.22253 
0.22747 
0.22843 
0.23531 
0.23738 
0.24348 
0.25376 
0.27732 
0.28036 
0.28369 
0.28419 
0.29251 
0.30732 
0.31273 
0.31274 
0.32715 
0.33374 
0.33903 
0.34717 
0.37881 
0.39554 
0.39985 
0.40047 
0.4098 
0.4251 
0.43048 
0.44086 
0.44092 
0.44465 
0.44656 
0.45431 
0.45827 
3 
1 
9 
5 
2 
9 
4 
13 
7 
3 
17 
4 
27 
5 
2 
14 
8 
8 
5 
12 
13 
2 
8 
2 
2 
5 
3 
6 
11 
4 
2 
5 
6 
2 
5 
3 
10 
5 
5 
7 
14 
6 
3 
4 
0.126 
0.100 
0.078 
0.064 
0.086 
0.064 
0.126 
0.117 
0.076 
0.075 
0.077 
0.139 
0.079 
0.094 
0.174 
0.077 
0.199 
0.129 
0.142 
0.065 
0.125 
0.270 
0.148 
0.098 
0.188 
0.077 
0.056 
0.043 
0.097 
0.153 
0.189 
0.165 
0.099 
0.244 
0.422 
0.350 
0.136 
0.670 
0.310 
0.110 
0.375 
0.197 
0.396 
0.156 
-2.99 
-3.32 
-3.68 
-3.97 
-3.54 
-3.96 
-2.99 
-3.09 
-3.72 
-3.74 
-3.70 
-2.84 
-3.66 
-3.41 
-2.52 
-3.70 
-2.33 
-2.95 
-2.82 
-3.95 
-3.00 
-1.89 
-2.76 
-3.35 
-2.41 
-3.69 
-4.17 
-4.54 
-3.37 
-2.71 
-2.40 
-2.60 
-3.34 
-2.03 
-1.25 
-1.52 
-2.88 
-0.58 
-1.69 
-3.19 
-1.42 
-2.34 
-1.34 
-2.68 
0.20474 
0.17754 
0.15031 
0.13 
0.15992 
0.13065 
0.20513 
0.19588 
0.1469 
0.14582 
0.14893 
0.21767 
0.15141 
0.1698 
0.24782 
0.14875 
0.26696 
0.20803 
0.22024 
0.13178 
0.20378 
0.3133 
0.22555 
0.17471 
0.25896 
0.14902 
0.11771 
0.09673 
0.17348 
0.22987 
0.25951 
0.24048 
0.17557 
0.29762 
0.38591 
0.35459 
0.21485 
0.46607 
0.33514 
0.18774 
0.36605 
0.26541 
0.37523 
0.23298 
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ENO2-6MS2L (RNase eluate) Forward experiment Reverse experiment 
Protein ID Gene P H/L log2 Significance P H/L log2 Significance  
P39935 
Q08647 
P26785 
Q06704 
P11412 
P26783 
P00925 
P35997; P38711 
P53883 
P35732 
P50109 
P08566 
P0C0W9; Q3E757 
P40070 
P38779 
 
TIF4631 
PUS7 
RPL16B 
IMH1 
ZWF1 
RPS5 
ENO2 
RPS27A; RPS27B 
NOP13 
DEF1 
PSP2 
ARO1 
RPL11A; RPL11B 
LSM4 
CIC1 
 
16 
5 
4 
9 
4 
6 
22 
3 
10 
2 
8 
4 
8 
3 
6 
 
1.898 
1.886 
1.852 
1.835 
1.823 
1.818 
1.737 
1.682 
1.617 
1.579 
1.575 
1.550 
1.550 
1.500 
1.444 
 
0.92 
0.91 
0.89 
0.88 
0.87 
0.86 
0.80 
0.75 
0.69 
0.66 
0.66 
0.63 
0.63 
0.58 
0.53 
 
0.47584 
0.47805 
0.48408 
0.48726 
0.48955 
0.4904 
0.49217 
0.47765 
0.4598 
0.44918 
0.44804 
0.44095 
0.44082 
0.4262 
0.40934 
 
14 
6 
5 
6 
3 
9 
19 
2 
4 
14 
9 
6 
6 
5 
2 
 
0.190 
0.259 
0.497 
0.295 
0.595 
0.121 
0.152 
0.097 
0.380 
0.184 
0.656 
0.655 
0.237 
0.567 
0.436 
 
-2.39 
-1.95 
-1.01 
-1.76 
-0.75 
-3.05 
-2.72 
-3.37 
-1.40 
-2.45 
-0.61 
-0.61 
-2.08 
-0.82 
-1.20 
 
0.26033 
0.30637 
0.414 
0.32723 
0.44521 
0.1993 
0.22881 
0.17344 
0.36837 
0.25534 
0.46239 
0.46197 
0.29261 
0.43678 
0.3916 
 
 
 
6MS2L-RNA (RNase eluate) Forward experiment Reverse experiment 
Protein ID Gene P H/L log2 Significance P H/L log2 Significance  
P36102 
P04147 
P39936 
P34160 
P38205 
Q08920 
P33753 
P53010 
Q12129 
P39935 
P30771 
P53316 
P40561 
P32380 
P32505 
P07260 
P10080 
Q07362 
P40850 
P40070 
P22147 
P48567 
P53297 
PAN3 
PAB1 
TIF4632 
STO1 
NCL1 
CBC2 
TRM2 
PAN2 
NMD4 
TIF4631 
NAM7 
YGR250C 
SGN1 
SPC110 
NAB2 
CDC33 
SBP1 
PBP4 
MKT1 
LSM4 
XRN1 
PUS4 
PBP1 
9 
29 
11 
9 
9 
3 
8 
8 
3 
14 
6 
4 
3 
10 
4 
9 
4 
2 
7 
4 
11 
7 
7 
58.517 
40.286 
39.738 
29.565 
27.439 
25.617 
24.868 
24.695 
23.554 
22.795 
21.883 
16.236 
15.179 
14.339 
13.960 
13.203 
11.406 
11.274 
10.773 
10.730 
10.461 
10.085 
9.366 
5.87 
5.33 
5.31 
4.89 
4.78 
4.68 
4.64 
4.63 
4.56 
4.51 
4.45 
4.02 
3.92 
3.84 
3.80 
3.72 
3.51 
3.49 
3.43 
3.42 
3.39 
3.33 
3.23 
0.00016 
0.00057 
0.00059 
0.00149 
0.00186 
0.00227 
0.00248 
0.00253 
0.00289 
0.00317 
0.00355 
0.00782 
0.00926 
0.01066 
0.01137 
0.013 
0.01824 
0.01873 
0.02073 
0.02092 
0.02213 
0.02397 
0.02808 
11 
28 
21 
13 
11 
3 
13 
13 
3 
20 
14 
5 
5 
2 
6 
9 
5 
5 
8 
4 
23 
6 
8 
0.037 
0.021 
0.018 
0.024 
0.053 
0.038 
0.013 
0.031 
0.120 
0.036 
0.059 
0.086 
0.104 
0.339 
0.074 
0.122 
0.245 
0.157 
0.136 
0.214 
0.165 
0.106 
0.126 
-4.74 
-5.58 
-5.76 
-5.38 
-4.24 
-4.74 
-6.24 
-4.99 
-3.06 
-4.78 
-4.08 
-3.53 
-3.27 
-1.56 
-3.75 
-3.03 
-2.03 
-2.67 
-2.88 
-2.23 
-2.60 
-3.24 
-2.99 
0.000934 
0.000119 
7.16E-05 
0.000196 
0.002804 
0.000948 
1.87E-05 
0.000521 
0.024294 
0.000857 
0.003887 
0.010985 
0.017253 
0.17003 
0.007407 
0.025588 
0.10136 
0.044024 
0.032266 
0.079971 
0.04875 
0.018093 
0.027155 
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6MS2L-RNA (RNase eluate) Forward experiment Reverse experiment 
Protein ID Gene P H/L log2 Significance P H/L log2 Significance  
P25644 
P38199 
P50094; O42831 
P32588 
P50095; REV_P38882 
P40047 
P26783 
P38011 
P38934 
Q08647 
P25443 
P0CX29; P0CX30 
P26786 
P38701 
P33442 
P0CX35; P0CX36 
P38697; P39567 
P0CX47; P0CX48 
P05750 
P48164 
P48589 
P0CX37; P0CX38 
P0CX43; P0CX44 
P05738 
P09440 
Q05022 
P05755 
P38889 
Q02326 
P05739 
P26785 
P10664 
P39015 
P0CX82; P0CX83 
P0C0W9; Q3E757 
P05737 
Q02753 
P29453 
P40150 
Q03690 
P40212; Q12690 
P05740; P46990 
P0CX49; P0CX50 
a
 
P0CX63 
b
 
PAT1 
HEK2 
IMD4; YAR075W 
PUB1 
IMD3; REV_UTP9 
ALD5 
RPS5 
ASC1 
BFR1 
PUS7 
RPS2 
RPS23A, RPS23B 
RPS7A 
RPS20 
RPS1A 
RPS4A, RPS4B 
IMD2 
RPS11A; RPS11B 
RPS3 
RPS7B 
RPS12 
RPS6A; RPS2B 
RPL1A; RPL1B 
RPL9A 
MIS1 
RRP5 
RPS9B 
SKN7 
RPL6A 
RPL6B 
RPL16B 
RPL4A 
STM1 
RPL19A; RPL19B 
RPL11A; RPL11B 
RPL7A 
RPL21A 
RPL8B 
SSB2 
CLU1 
RPL13B; RPL13A 
RPL17A; RPL17B 
RPL18A; RPL18B 
YGR161W-B 
6 
4 
7 
4 
12 
21 
4 
10 
16 
6 
2 
2 
9 
2 
7 
5 
9 
3 
4 
7 
2 
3 
9 
6 
3 
8 
3 
2 
4 
5 
3 
3 
8 
4 
5 
8 
4 
7 
15 
4 
3 
3 
2 
5 
9.124 
8.279 
7.720 
7.420 
6.892 
6.149 
6.018 
5.741 
5.707 
5.633 
4.682 
4.610 
4.569 
4.564 
4.563 
4.481 
4.475 
4.445 
4.346 
4.263 
4.253 
4.200 
4.012 
3.974 
3.914 
3.900 
3.877 
3.765 
3.740 
3.647 
3.637 
3.606 
3.535 
3.508 
3.496 
3.492 
3.337 
3.284 
3.201 
3.172 
3.166 
3.137 
3.077 
3.066 
3.19 
3.05 
2.95 
2.89 
2.78 
2.62 
2.59 
2.52 
2.51 
2.49 
2.23 
2.20 
2.19 
2.19 
2.19 
2.16 
2.16 
2.15 
2.12 
2.09 
2.09 
2.07 
2.00 
1.99 
1.97 
1.96 
1.95 
1.91 
1.90 
1.87 
1.86 
1.85 
1.82 
1.81 
1.81 
1.80 
1.74 
1.72 
1.68 
1.67 
1.66 
1.65 
1.62 
1.62 
0.02967 
0.03625 
0.04167 
0.04503 
0.05188 
0.06403 
0.06656 
0.07235 
0.07312 
0.0748 
0.10196 
0.10453 
0.10603 
0.10622 
0.10625 
0.10933 
0.10955 
0.11073 
0.11469 
0.11819 
0.11863 
0.12095 
0.12963 
0.1315 
0.13454 
0.13523 
0.13644 
0.14244 
0.14381 
0.14912 
0.1497 
0.15156 
0.1559 
0.1576 
0.15838 
0.15866 
0.169 
0.17269 
0.17881 
0.181 
0.18144 
0.18371 
0.18846 
0.18938 
7 
6 
12 
4 
15 
20 
5 
11 
15 
6 
3 
2 
10 
5 
8 
3 
12 
3 
4 
9 
4 
3 
12 
8 
6 
25 
4 
3 
5 
7 
2 
3 
14 
4 
7 
10 
5 
5 
19 
9 
3 
3 
2 
5 
0.114 
0.192 
0.188 
0.214 
0.259 
0.205 
0.393 
0.272 
0.315 
0.281 
0.548 
0.167 
0.446 
0.409 
0.358 
0.324 
0.279 
0.229 
0.383 
0.345 
0.340 
0.356 
0.520 
0.426 
0.364 
0.303 
0.234 
0.389 
0.363 
0.398 
0.282 
0.321 
0.373 
0.167 
0.385 
0.348 
0.267 
0.330 
0.355 
0.436 
0.329 
0.299 
0.248 
0.417 
-3.13 
-2.38 
-2.41 
-2.22 
-1.95 
-2.29 
-1.35 
-1.88 
-1.67 
-1.83 
-0.87 
-2.58 
-1.16 
-1.29 
-1.48 
-1.63 
-1.84 
-2.13 
-1.39 
-1.54 
-1.56 
-1.49 
-0.94 
-1.23 
-1.46 
-1.72 
-2.10 
-1.36 
-1.46 
-1.33 
-1.83 
-1.64 
-1.42 
-2.58 
-1.38 
-1.52 
-1.91 
-1.60 
-1.49 
-1.20 
-1.60 
-1.74 
-2.01 
-1.26 
0.021672 
0.065225 
0.062731 
0.080211 
0.11132 
0.074 
0.20909 
0.12083 
0.15247 
0.12736 
0.31352 
0.049618 
0.24621 
0.22022 
0.18395 
0.15863 
0.12632 
0.090389 
0.20154 
0.17396 
0.17075 
0.18228 
0.29549 
0.23238 
0.18822 
0.14387 
0.093922 
0.2059 
0.18736 
0.21267 
0.12792 
0.15686 
0.19473 
0.049946 
0.20328 
0.17633 
0.11728 
0.16357 
0.18141 
0.23893 
0.16287 
0.14043 
0.10362 
0.22616 
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6MS2L-RNA (RNase eluate) Forward experiment Reverse experiment 
Protein ID Gene P H/L log2 Significance P H/L log2 Significance  
P05759 
c
 
P39730 
P05317 
P06105 
P41805 
Q06106 
P35732 
P38249 
P37292 
Q04215 
d
 
P06634 
P38788 
Q06704 
P32527 
P47047 
P07281 
P38879 
P46655; REV_P50275 
P03962 
P04801 
P34730 
P46672 
P00815 
 
RPS31 
FUN12 
RPP0 
SCP160 
RPL10 
MRD1 
DEF1 
RPG1 
SHM1 
YMR046C 
DED1 
SSZ1 
IMH1 
ZUO1 
MTR4 
RPS19B 
EGD2 
GUS1; REV_ASE1 
URA3 
THS1 
BMH2 
ARC1 
HIS4 
 
2 
3 
5 
29 
2 
3 
8 
6 
8 
5 
4 
12 
2 
9 
4 
1 
3 
5 
2 
5 
6 
3 
2 
 
3.041 
3.036 
3.022 
2.807 
2.795 
2.416 
2.387 
2.335 
2.314 
2.234 
2.121 
2.113 
2.086 
2.021 
1.986 
1.742 
1.724 
1.683 
1.512 
1.508 
1.473 
1.457 
1.417 
 
1.60 
1.60 
1.60 
1.49 
1.48 
1.27 
1.25 
1.22 
1.21 
1.16 
1.09 
1.08 
1.06 
1.01 
0.99 
0.80 
0.79 
0.75 
0.60 
0.59 
0.56 
0.54 
0.50 
 
0.19145 
0.19186 
0.19299 
0.21221 
0.21338 
0.2545 
0.25811 
0.26466 
0.26745 
0.2782 
0.29439 
0.29564 
0.29971 
0.31006 
0.3157 
0.35985 
0.36344 
0.37186 
0.40961 
0.4106 
0.41905 
0.42295 
0.43304 
 
4 
6 
3 
41 
2 
8 
14 
4 
8 
4 
7 
14 
11 
12 
11 
2 
6 
7 
4 
9 
7 
3 
1 
 
0.342 
0.387 
0.483 
0.419 
0.595 
0.589 
0.652 
0.505 
0.484 
0.610 
0.641 
0.646 
0.688 
0.650 
0.662 
0.607 
0.697 
0.574 
0.476 
0.541 
0.627 
0.513 
0.630 
 
-1.55 
-1.37 
-1.05 
-1.25 
-0.75 
-0.76 
-0.62 
-0.99 
-1.05 
-0.71 
-0.64 
-0.63 
-0.54 
-0.62 
-0.60 
-0.72 
-0.52 
-0.80 
-1.07 
-0.89 
-0.67 
-0.96 
-0.67 
 
0.17168 
0.20483 
0.27155 
0.22742 
0.34297 
0.33898 
0.37596 
0.28573 
0.27227 
0.3516 
0.36965 
0.37271 
0.39626 
0.37505 
0.38175 
0.34995 
0.40135 
0.32974 
0.26668 
0.30925 
0.36144 
0.29132 
0.36371 
 
 
Additional protein IDs forming one proteinGroup:  
a 
P27809 
b
 P0CX64; P25384; Q12472; P0C2J3; Q03494; Q12113; Q12337; Q12501; Q12491; P0C2J5; P0C2J2; P0C2J4; P0C2J6; P0CX61; P0CX62; 
P25383; Q03483; Q12293; Q12392; Q12439; Q99303; Q12260 
c
 P0CG63; P0CH08; P0CH09 
d
 Q12266 
 
 
 
 
Table 2. RNase elution efficiency as assessed by the comparison of enriched proteins in RNase eluate and 
Boiled Beads sample. After PGK1-6MS2L affinity purification the beads were first treated with RNase and 
subsequently boiled in SDS sample buffer. The resulting protein samples – RNase eluate and Boiled Beads (BB) 
sample – were analysed by mass spectrometry. The enriched proteins were grouped into three categories 
(Unique, Possible Common, Common) depending if the protein classified as enriched in one MS data set, 
possibly in both or in both MS data sets. Table depicts the log2 (H/L) ratios of the enriched proteins. 
 
BB sample 
Gene 
Unique 
Gene 
Possible Common 
BB RNase BB RNase 
for rev for rev for rev for rev 
YLR419W 
RPL19A; RPL19B 
RPL15A; RPL15B 
YNL050C 
2.41 
2.20 
2.13 
2.07 
-2.67 
-2.21 
-1.91 
-0.91 
-3.30 
-0.15 
 
 
 
0.22 
 
 
MIS1 
RPS11A; RPS11B 
BRE5 
RPL30 
2.52 
2.31 
2.21 
2.00 
-2.96 
-3.06 
-2.55 
-1.50 
2.10 
0.63 
2.25 
 
 
-0.30 
 
-1.31 
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BB sample 
Gene 
Unique 
Gene 
Possible Common 
BB RNase BB RNase 
for rev for rev for rev for rev 
RPL13B; RPL13A 
TRA1 
VPH1 
RPL10 
RRP7 
UTP22 
KRI1 
ACT1 
KRR1 
SEC16 
MSS116 
NOP4 
RPP1 
NUG1 
 
1.82 
1.41 
1.32 
1.26 
1.26 
1.07 
0.96 
0.86 
0.82 
0.76 
0.74 
0.73 
0.70 
0.56 
 
-1.97 
-1.07 
-1.55 
-1.86 
-0.52 
-1.01 
-1.10 
-2.45 
-0.88 
-1.13 
-0.97 
-0.63 
-2.40 
-0.75 
 
-1.26 
 
 
-0.83 
 
 
 
-0.59 
 
1.47 
 
 
0.83 
 
 
 
-0.59 
 
RPL5 
RPL9A 
PBP1 
RPL1A; RPL1B 
RPL4B 
CBF5 
RPS25B 
RPS17A; RPS17B 
RPS23A; RPS23B 
RPS4A; RPS4B 
RPS13 
DIM1 
 
1.72 
1.61 
1.55 
1.54 
1.32 
1.24 
0.78 
0.71 
0.69 
0.66 
0.55 
0.51 
 
-0.89 
-2.06 
-2.00 
-2.10 
-1.96 
-1.12 
-0.53 
-2.41 
-2.95 
-3.20 
-0.78 
-1.18 
 
 
1.77 
1.30 
1.12 
 
0.89 
1.67 
0.45 
0.45 
0.61 
0.48 
1.39 
 
-0.84 
-0.43 
 
-0.05 
-1.61 
 
 
-0.51 
-0.42 
-0.39 
-0.34 
 
 
RNase eluate 
Gene 
Unique 
Gene 
Possible Common 
BB RNase BB RNase 
for rev for rev for rev for rev 
RPP2B 
TRM2 
PAN3 
PAN2 
RPS5 
WHI3 
DCP1 
HRB1 
LSM4 
ALD5 
SRO9 
RPP0 
TMA64 
MET6 
NAB2 
TDH3 
ADH3 
PGI1 
RPL35A; RPL35B 
HXK2 
LHP1 
IMD4; YAR075W 
ADH1 
RPS31; UBI4 
0.02 
 
 
 
-0.25 
 
 
 
 
 
 
-0.13 
 
-0.02 
 
-2.44 
 
0.06 
-0.03 
 
 
 
-1.85 
-0.12 
0.77 
 
 
 
-2.65 
 
 
 
 
 
 
-0.80 
 
 
 
1.47 
 
 
-1.44 
 
 
 
1.33 
-0.45 
3.82 
3.46 
3.13 
3.09 
2.03 
2.01 
1.91 
1.77 
1.59 
1.38 
1.30 
1.28 
1.21 
1.17 
1.16 
1.13 
1.08 
1.05 
0.99 
0.94 
0.91 
0.81 
0.77 
0.74 
-1.55 
-3.49 
-4.30 
-3.88 
-1.17 
-2.37 
-2.29 
-1.87 
-1.55 
-1.26 
-1.69 
-1.50 
-1.67 
-0.65 
-1.25 
-0.70 
-0.71 
-1.84 
-0.97 
-1.51 
-1.05 
-1.36 
-0.54 
-1.19 
PAT1 
TRM44 
EDC3 
RPS3 
RPS7A 
ARB1 
TIF1 
RPS6A;RPS6B 
YGR250C 
RPS27A; RPS27B 
RPS7B 
SGN1 
LEU2 
RPS21A; RPS21B 
RPS22B; RPS22A 
NOP58 
RPS16A; RPS16B 
SBP1 
RPS20 
HSP60 
RPS16A 
 
 
3.26 
 
0.32 
0.40 
0.43 
1.29 
0.49 
0.67 
 
0.49 
 
2.09 
 
0.47 
0.60 
0.00 
1.97 
0.53 
0.29 
0.63 
 
-3.82 
 
-4.04 
-3.06 
-2.68 
-0.40 
 
-2.76 
 
-1.14 
-2.48 
-1.07 
-0.30 
-0.31 
-0.24 
-0.26 
-1.90 
-0.39 
-0.15 
-0.28 
-0.23 
 
3.76 
3.71 
3.54 
2.53 
2.00 
1.57 
1.40 
1.29 
1.23 
1.11 
0.96 
0.95 
0.83 
0.81 
0.81 
0.74 
0.74 
0.66 
0.57 
0.54 
2.37 
 
-4.70 
-4.93 
-4.00 
-2.19 
-1.30 
-1.40 
-0.54 
-0.63 
-1.37 
-1.13 
-1.33 
-1.28 
-0.54 
-1.25 
-1.06 
-0.66 
-1.07 
-0.91 
-0.59 
-0.59 
-0.97 
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RNase eluate 
Gene 
Unique 
Gene 
Possible Common 
BB RNase BB RNase 
for rev for rev for rev for rev 
PUB1 
IMD3 
HEK2 
 
 
 
 
 
 
 
 
 
0.65 
0.62 
0.54 
 
-0.73 
-1.10 
-0.76 
 
 
BB sample and RNase eluate Common 
Gene 
BB RNase 
Gene 
BB RNase 
for rev for rev for rev for rev 
NAM7 
EBS1 
DCP2 
XRN1 
TMA46 
ASC1 
PAB1 
STM1 
RBG1 
UBP3 
SSB2 
BFR1 
RPL3 
TIF4632 
YEF3; HEF3 
 
6.78 
4.99 
4.38 
2.99 
4.05 
0.90 
2.46 
2.50 
3.95 
2.30 
1.08 
2.01 
3.17 
1.78 
0.73 
 
-7.41 
-5.20 
-5.01 
-3.42 
-2.96 
-2.61 
-3.26 
-2.76 
-2.76 
-2.57 
-1.55 
-2.61 
-1.96 
-2.34 
-0.82 
 
5.92 
4.47 
4.28 
2.89 
2.70 
2.68 
2.58 
2.51 
2.49 
1.97 
1.89 
1.79 
1.77 
1.76 
1.52 
 
-6.08 
-5.49 
-4.10 
-2.98 
-3.25 
-3.02 
-3.36 
-2.97 
-3.07 
-2.22 
-1.74 
-2.60 
-1.75 
-2.37 
-1.38 
 
RPL4A 
RPS2 
MKT1 
ARX1 
TIF4631 
ZUO1 
RPS9B 
SSZ1 
RPS8A; RPS8B 
DEF1 
SCP160 
RPS1A 
PGK1 
RPS19B 
RPS1B 
 
1.25 
1.48 
1.49 
1.28 
1.42 
0.75 
2.02 
0.90 
2.93 
1.14 
0.79 
0.62 
1.68 
0.73 
0.56 
 
-1.81 
-2.60 
-1.67 
-1.44 
-2.08 
-1.45 
-3.14 
-0.89 
-3.13 
-1.02 
-1.18 
-3.03 
-5.09 
-0.58 
-2.64 
 
1.51 
1.40 
1.34 
1.27 
1.23 
1.10 
1.08 
1.08 
0.89 
0.89 
0.87 
0.77 
0.75 
0.75 
0.60 
 
-1.21 
-0.86 
-1.60 
-1.50 
-1.76 
-1.37 
-1.16 
-1.42 
-1.50 
-0.83 
-0.76 
-0.97 
-3.58 
-0.60 
-1.26 
 
 
 
 
 
Table 3. Literature-based analysis of MS2L-tagged RNA co-purifying proteins (>1.41-fold enriched) to identify 
their previously known target RNAs and function. Comparison of  our data set of enriched proteins to RBPs 
identified in yeast (S. F. Mitchell et al. 2013) or in mammalian cells (Castello et al. 2012; Baltz et al. 2012). 
  
PGK1-6MS2L       
Gene mRNA Target Function
a
 
Mitchell 
et al. 
Homologue/Related 
Human Proteinb 
Castello 
et al. 
Baltz et 
al. 
ACT1 
ADH1 
ADH3 
ALD5 
ARB1 
ARX1 
ASC1 
BFR1 
BRE5 
CBF5 
DCP1 
DCP2 
none 
none 
none 
none 
rRNA 
rRNA 
rRNA 
mRNA (Hogan et al. 2008a) 
mRNA 
snoRNA, rRNA 
mRNA 
mRNA 
Other 
Metabolism 
Metabolism 
Metabolism 
Rs Biogenesis 
Rs Biogenesis 
Translation 
Translation 
Other 
Rs Biogenesis 
Decay 
Decay 
no 
no 
no 
no 
no 
no 
no 
yes 
yes 
yes 
no 
no 
ACTG1 
ADH1A 
Opisthokonta 
ALDH2 
ABCF2 
EBP1  
GNB2L1 
MDR1  
Saccharomycetaceae 
DKC1 
DCP1A 
DCP2 
no 
no 
 
no 
cand 
no 
yes 
no 
 
yes 
no 
no 
no 
no 
 
no 
no 
no 
yes 
no 
 
no 
no 
no 
APPENDIX 
 
237 
 
PGK1-6MS2L       
Gene mRNA Target Function
a
 
Mitchell 
et al. 
Homologue/Related 
Human Proteinb 
Castello 
et al. 
Baltz et 
al. 
DEF1 
DIM1 
EBS1 
EDC3 
HRB1 
HSP60 
HXK2 
IMD3; REV_UTP9 
IMD4; YAR075W 
KHD1 
KRI1 
KRR1 
LEU2 
LHP1 
LSM4 
MET6 
MIS1 
MKT1 
MSS116 
NAB2 
NOP4 
NOP58 
NUG1 
PAB1 
PAN2 
PAN3 
PAT1 
PBP1 
PGI1 
PGK1 
PUB1 
RBG1 
RPL10 
RPL13B; RPL13A 
RPL15A; RPL15B 
RPL16B 
RPL19A; RPL19B 
RPL1A; RPL1B 
RPL3 
RPL30 
RPL35A; RPL35B 
RPL4A 
RPL4B 
RPL5 
none 
rRNA 
mRNA (Luke et al. 2007) 
mRNA 
mRNA 
none 
none 
none 
none 
mRNA 
rRNA 
rRNA 
none 
tRNA, snRNA 
mRNA 
none 
none 
none 
mRNA 
mRNA 
rRNA 
snoRNA 
rRNA 
mRNA 
mRNA 
mRNA 
mRNA 
mRNA 
none 
none/mRNA (Castello et al. 2012) 
mRNA 
none 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
Other 
Rs Biogenesis 
Decay 
Decay 
Export 
Other 
Metabolism 
Metabolism 
Metabolism 
Localization 
Rs Biogenesis 
Rs Biogenesis 
Metabolism 
Other 
Decay 
Metabolism 
Metabolism 
Unknown 
Splicing 
Export 
Rs Biogenesis 
Rs Biogenesis 
Rs Biogenesis 
Translation 
Decay 
Decay 
Decay 
Decay 
Metabolism 
Metabolism 
Decay 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
no 
no 
no 
no 
yes 
no 
no 
yes 
yes 
yes 
no 
no 
no 
no 
no 
no 
no 
no 
yes 
yes 
yes 
yes 
yes 
yes 
no 
no 
yes 
yes 
no 
no 
yes 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
N/A 
DIMT1L 
SMG7  
EDC3 
MYEF2 
HSPD1 
HK1 
IMPDH3 
IMPDH4 
PCBP3 
KRI1 
KRR1 
Eukaryota 
Saccharomycetaceae 
LSM4 
 Eukaryota 
 Ascomycota 
 Ascomycota 
Saccharomycetaceae 
ZC3H14 
RBM28 
NOP58 
GNL3L 
PABPC1 
PAN2 
PAN3 
PATL1 
ATXN2 
GPI 
PGK1 
TIA1 
DRG1 
RPL10 
RPL13 
RPL15 
RPL13A 
RPL19 
RPL10A 
RPL3 
RPL30 
RPL35 
RPL4 
RPL4 
RPL5 
 
yes 
no 
no 
no 
yes 
no 
no 
no 
yes 
yes 
yes 
 
 
yes 
 
 
 
 
yes 
yes 
yes 
yes 
yes 
no 
no 
yes 
yes 
no 
cand 
yes 
cand 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
 
yes 
no 
no 
yes 
no 
no 
no 
no 
no 
no 
yes 
 
 
yes 
 
 
 
 
yes 
yes 
yes 
no 
yes 
no 
no 
yes 
yes 
no 
no 
yes 
no 
yes 
no 
yes 
no 
no 
yes 
yes 
yes 
no 
yes 
yes 
yes 
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PGK1-6MS2L       
Gene mRNA Target Function
a
 
Mitchell 
et al. 
Homologue/Related 
Human Proteinb 
Castello 
et al. 
Baltz et 
al. 
RPL9A 
RPP0 
RPP1 
RPP2B 
RPS11A; RPS11B 
RPS13 
RPS16A; RPS16B 
RPS17A; RPS17B 
RPS19B 
RPS1A 
RPS1B 
RPS2 
RPS20 
RPS21A; RPS21B 
RPS22B; RPS22A 
RPS23A; RPS23B 
RPS25B 
RPS27A; RPS27B 
RPS3 
RPS31 
RPS4A; RPS4B 
RPS5 
RPS6A; RPS6B 
RPS7A 
RPS7B 
RPS8A; RPS8B 
RPS9B 
RRP7 
SBP1 
SCP160 
SEC16 
SGN1 
SRO9 
SSB2 
SSZ1 
STM1 
ZUO1 
TDH3 
TIF1 
TIF4631 
TIF4632 
TMA46 
TMA64 
TRA1 
rRNA 
rRNA 
rRNA, tRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
mRNA 
mRNA 
none 
mRNA (Winstall et al. 2000) 
mRNA 
unknown 
none 
mRNA (Hogan et al. 2008a) 
rRNA 
none 
mRNA 
mRNA 
mRNA 
unknown 
none 
none 
Translation 
Translation 
Rs Biogenesis 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Rs Biogenesis 
TL Repression 
Translation 
Other 
Unknown 
Translation 
Co-TL NP Mat 
Co-TL NP Mat 
TL Repression 
Co-TL NP Mat 
Metabolism 
Translation 
Translation 
Translation 
Translation 
Unknown 
Transcription 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
yes 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
yes 
yes 
no 
no 
yes 
no 
no 
no 
no 
no 
no 
yes 
yes 
yes 
no 
no 
RPL9 
RPLP0 
RPP30 
Saccharomycetaceae 
RPS11 
RPS13 
RPS16 
RPS17 
RPS19 
RPS3A 
RPS3A 
RPS2 
RPS20 
RPS21 
RPS15A 
RPS23 
 Saccharomycetaceae 
RPS27A 
RPS3 
RPS27A 
RPS4X 
RPS5 
RPS6 
RPS7 
RPS7 
RPS8 
RPS9 
RRP7A 
Saccharomycetaceae 
HDLBP 
SEC16A; SEC16B 
ASCL3 
Saccharomycetaceae 
N/A 
HSP70L1 
Saccharomycetaceae 
MPP11 
GAPDH 
EIF4A1 
EIF4G1 
EIF4G2 
ZC3H15 
Saccharomycetaceae 
TRRAP 
cand 
yes 
yes 
 
yes 
cand 
no ev 
no 
no ev 
yes 
yes 
yes 
yes 
yes 
yes 
cand 
 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
 
yes 
no 
no 
 
 
no 
 
no 
cand 
yes 
yes 
yes 
yes 
 
no 
no 
yes 
no 
 
no 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
no 
yes 
yes 
 
yes 
yes 
yes 
yes 
yes 
no 
yes 
yes 
yes 
no 
no 
 
yes 
no 
no 
 
 
no 
 
no 
no 
yes 
yes 
yes 
yes 
 
no 
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PGK1-6MS2L       
Gene mRNA Target Function
a
 
Mitchell 
et al. 
Homologue/Related 
Human Proteinb 
Castello 
et al. 
Baltz et 
al. 
TRM2 
TRM44 
UBP3 
UPF1 
UTP22 
WHI3 
VPH1 
XRN1 
YEF3; HEF3 
YGR250C 
YLR419W 
YNL050C 
 
tRNA 
tRNA 
mRNA 
mRNA 
rRNA 
mRNA 
none 
mRNA 
mRNA 
unknown 
unknown 
unknown (Scherrer et al. 2010) 
 
tRNA Mod 
tRNA Mod 
Other 
Decay 
Rs Biogenesis 
Unknown 
Other 
Decay 
Translation 
Unknown 
Unknown 
Unknown 
 
no 
no 
yes 
yes 
no 
no 
no 
yes 
no 
yes 
yes 
no 
 
TRMT2A; TRMTB 
TRMT44 
USP10 
UPF1 
NOL6 
N/A 
ATP6V0A1 
XRN1 
Ascomycota 
CELF1 
DHX36 
Saccharomycetaceae 
 
yes 
no 
yes 
yes 
yes 
 
no 
yes 
 
yes 
yes 
 
 
no 
no 
yes 
yes 
no 
 
no 
yes 
 
yes 
yes 
 
 
 
 
ENO2-6MS2L 
Gene mRNA Target Functiona 
Mitchell 
et al. 
Homologue/Related 
Human Proteinb 
Castello 
et al. 
Baltz et 
al. 
ALD5 
ARB1 
ARD1 
ARO1 
ARX1 
ASC1 
BFR1 
CBF5 
CIC1 
DCP1 
DCP2 
DEF1 
DHH1 
EBS1 
EDC3 
ENO2 
FUN12 
GCD11 
HRB1 
IMD2; IMD1 
IMD3; REV_UTP9 
IMD4; YAR075W 
IMH1 
LSM1 
LSM2 
LSM4 
MAP2 
none 
rRNA 
none 
none 
rRNA 
rRNA 
mRNA (Hogan et al. 2008) 
snoRNA, rRNA 
none 
mRNA 
mRNA 
none 
mRNA 
mRNA (Luke et al. 2007) 
mRNA 
none 
mRNA 
mRNA 
mRNA 
none 
none 
none 
none 
mRNA 
mRNA 
mRNA 
none 
Metabolism 
Rs Biogenesis 
Co-TL NP Mat 
Metabolism 
Rs Biogenesis 
Translation 
Translation 
Rs Biogenesis 
Unknown 
Decay 
Decay 
Other 
Decay 
Decay 
Decay 
Metabolism 
Translation 
Translation 
Export 
Metabolism 
Metabolism 
Metabolism 
Other 
Decay 
Decay 
Decay 
Co-TL NP Mat 
no 
no 
no 
no 
no 
no 
yes 
yes 
no 
no 
no 
no 
yes 
no 
no 
no 
no 
no 
yes 
yes 
yes 
yes 
no 
no 
no 
no 
no 
ALDH2 
ABCF2 
NAA11 
Eukaryota 
EBP1  
GNB2L1 
MDR1 
DKC1 
Saccharomycetaceae 
DCP1A 
DCP2 
N/A 
DDX6 
SMG7  
EDC3 
ENO2 
Ascomycota 
Eukaryota 
MYEF2 
IMPDH1 
IMPDH3 
IMPDH4 
saccharomyceta 
LSM1 
LSM2 
LSM4 
METAP2 
no 
cand 
no 
 
no 
yes 
no 
yes 
 
no 
no 
 
yes 
no 
no 
no 
 
 
no 
no 
no 
no 
 
yes 
yes 
yes 
yes 
no 
no 
no 
 
no 
yes 
no 
no 
 
no 
no 
 
yes 
no 
no 
no 
 
 
yes 
no 
no 
no 
 
yes 
yes 
yes 
no 
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ENO2-6MS2L 
Gene mRNA Target Functiona 
Mitchell 
et al. 
Homologue/Related 
Human Proteinb 
Castello 
et al. 
Baltz et 
al. 
MGM101 
MIS1 
MKT1 
MRD1 
MSL5 
NAT1 
NMD4 
NOP12 
NOP13 
PAB1 
PAN2 
PAN3 
PAT1 
PBP1 
PBP4 
PSP2 
PUS1 
PUS4 
PUS7 
RAT1 
RBG1 
RNY1 
RPL10 
RPL11A; RPL11B 
RPL16B 
RPL17A; RPL17B 
RPL19A; RPL19B 
RPL1A; RPL1B 
RPL21A 
RPL24B 
RPL25 
RPL3 
RPL31A 
RPL4A 
RPL5 
RPL6A 
RPL8B 
RPL9A 
RPO41 
RPP0 
RPS10B; RPS10A 
RPS11A; RPS11B 
RPS12 
RPS17A; RPS17B 
mRNA 
none 
none 
rRNA 
mRNA 
unknown 
unknown 
rRNA 
rRNA 
mRNA 
mRNA 
mRNA 
mRNA 
mRNA 
none 
unknown (Castello et al. 2012) 
tRNA, snRNA 
tRNA 
tRNA, rRNA, snRNA 
mRNA and others 
none 
tRNA, rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
unknown 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
Splicing 
Metabolism 
Unknown 
Rs Biogenesis 
Splicing 
Co-TL NP Mat 
Unknown 
Rs Biogenesis 
Rs Biogenesis 
Translation 
Decay 
Decay 
Decay 
Decay 
Unknown 
Unknown 
tRNA Mod 
tRNA Mod 
tRNA Mod 
Decay 
Translation 
Decay 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Transcription 
Translation 
Translation 
Translation 
Translation 
Translation 
no 
no 
no 
no 
no 
no 
no 
no 
no 
yes 
no 
no 
yes 
yes 
no 
yes 
yes 
no 
no 
yes 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
saccharomyceta 
Ascomycota 
 Ascomycota 
RBM19 
Ascomycota 
NAA15 
Saccharomycetaceae 
Ascomycota 
Ascomycota 
PABPC1 
PAN2 
PAN3 
PATL1 
ATXN2 
N/A 
N/A 
PUS1 
Ascomycota 
PUS7 
XRN2 
DRG1 
Saccharomyceta 
RPL10 
RPL11 
RPL13A 
RPL17 
RPL19 
RPL10A 
RPL21 
RPL24 
RPL23A 
RPL3 
RPL31 
RPL4 
RPL5 
Opisthokonta 
RPL7A 
RPL9 
Eukaryota 
RPLP0 
RPS10 
RPS11 
RPS12 
RPS17 
 
 
 
yes 
 
yes 
 
 
 
yes 
no 
no 
yes 
yes 
 
 
yes 
 
yes 
yes 
cand 
 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
 
yes 
cand 
 
yes 
yes 
yes 
yes 
no 
 
 
 
yes 
 
no 
 
 
 
yes 
no 
no 
yes 
yes 
 
 
yes 
 
yes 
yes 
no 
 
yes 
yes 
no 
yes 
no 
yes 
yes 
yes 
yes 
yes 
no 
yes 
yes 
 
yes 
no 
 
yes 
yes 
no 
yes 
yes 
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ENO2-6MS2L 
Gene mRNA Target Functiona 
Mitchell 
et al. 
Homologue/Related 
Human Proteinb 
Castello 
et al. 
Baltz et 
al. 
RPS18A; RPS18B 
RPS19B 
RPS2 
RPS20 
RPS21A; RPS21B 
RPS22B; RPS22A 
RPS27A; RPS27B 
RPS3 
RPS4A; RPS4B 
RPS5 
RPS6A; RPS6B 
RPS7A 
RPS7B 
RPS9B 
SHM1 
SRO9 
SSB2 
SSZ1 
STM1 
SUI2 
ZUO1 
ZWF1 
TIF4631 
TIF4632 
TMA46 
TRM2 
TRM44 
UBP3 
UPF1 
XRN1 
YGR054W 
YLR419W 
 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
none 
mRNA 
unknown 
none 
mRNA (Hogan et al. 2008) 
mRNA 
rRNA 
none 
mRNA 
mRNA 
unknown 
tRNA 
tRNA 
mRNA 
mRNA 
mRNA 
rRNA 
unknown 
 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Metabolism 
Translation 
Co-TL NP Mat 
Co-TL NP Mat 
TL Repression 
Translation 
Co-TL NP Mat 
Metabolism 
Translation 
Translation 
Translation 
tRNA Mod 
tRNA Mod 
Other 
Decay 
Decay 
Translation 
Unknown 
 
no 
no 
no 
yes 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
yes 
no 
no 
no 
no 
no 
no 
yes 
yes 
yes 
no 
no 
yes 
yes 
yes 
yes 
yes 
 
RPS18 
RPS19 
RPS2 
RPS20 
RPS21 
RPS15A 
RPS27A 
RPS3 
RPS4X 
RPS5 
RPS6 
RPS7 
RPS7 
RPS9 
SHMT2 
Saccharomycetaceae 
N/A 
HSP70L1 
Saccharomycetaceae 
EIF2S1 
MPP11 
G6PD 
EIF4G1 
EIF4G2 
ZC3H15 
TRMT2A; TRMTB 
TRMT44 
USP10 
UPF1 
XRN1 
EIF2A 
DHX36 
 
no 
no ev 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
cand 
 
 
no 
 
yes 
no 
no 
yes 
yes 
yes 
yes 
no 
yes 
yes 
yes 
cand 
yes 
 
yes 
yes 
yes 
yes 
no 
yes 
yes 
yes 
yes 
yes 
no 
yes 
yes 
no 
no 
 
 
no 
 
yes 
no 
no 
yes 
yes 
yes 
no 
no 
yes 
yes 
yes 
no 
yes 
 
 
 
6MS2L-RNA 
Gene mRNA Target Functiona 
Mitchell 
et al. 
Homologue/Related 
Human Proteinb 
Castello 
et al. 
Baltz et 
al. 
ALD5 
ARC1 
ASC1 
BFR1 
BMH2 
CBC2 
CDC33 
none 
none 
rRNA 
mRNA (Hogan et al. 2008) 
none 
mRNA 
mRNA 
Metabolism 
tRNA Aminoacy 
Translation 
Translation 
Other 
Nuc Processing 
Translation 
no 
no 
no 
yes 
no 
no 
no 
ALDH2 
Ascomycota 
GNB2L1 
MDR1  
YWHAE 
NCBP2 
EIF4E 
no 
 
yes 
no 
yes 
yes 
no ev 
no 
 
yes 
no 
no 
yes 
yes 
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6MS2L-RNA 
Gene mRNA Target Functiona 
Mitchell 
et al. 
Homologue/Related 
Human Proteinb 
Castello 
et al. 
Baltz et 
al. 
CLU1 
DED1 
DEF1 
EGD2 
FUN12 
GUS1; REV_ASE1 
HIS4 
IMD2; IMD1 
IMD3; REV_UTP9 
IMD4; YAR075W 
IMH1 
KHD1 
LSM4 
MIS1 
MKT1 
MRD1 
MTR4 
NAB2 
NCL1 
NMD4 
PAB1 
PAN2 
PAN3 
PAT1 
PBP1 
PBP4 
PUB1 
PUS4 
PUS7 
RPG1 
RPL10 
RPL11A; RPL11B 
RPL13B; RPL13A 
RPL16B 
RPL17A; RPL17B 
RPL18A; RPL18B 
RPL19A; RPL19B 
RPL1A; RPL1B 
RPL21A 
RPL4A 
RPL6A 
RPL6B 
RPL7A 
RPL8B 
unknown 
mRNA 
none 
none 
mRNA 
tRNA 
none 
none 
none 
none 
none 
mRNA 
mRNA 
none 
none 
rRNA 
multiple RNA types 
mRNA 
tRNA 
unknown 
mRNA 
mRNA 
mRNA 
mRNA 
mRNA 
none 
mRNA 
tRNA 
tRNA, rRNA, snRNA 
mRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
Unknown 
Translation 
Other 
Co-TL NP Mat 
Translation 
tRNA Aminoacy 
Metabolism 
Metabolism 
Metabolism 
Metabolism 
Other 
Localization 
Decay 
Metabolism 
Unknown 
Rs Biogenesis 
Nuc Processing 
Export 
tRNA Mod 
Unknown 
Translation 
Decay 
Decay 
Decay 
Decay 
Unknown 
Decay 
tRNA Mod 
tRNA Mod 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
yes 
yes 
no 
no 
no 
yes 
no 
yes 
yes 
yes 
no 
yes 
no 
no 
no 
no 
yes 
yes 
no 
no 
yes 
no 
no 
yes 
yes 
no 
yes 
no 
no 
yes 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
no 
Saccharomycetaceae 
DDX3Y 
N/A 
NACA 
Ascomycota 
EPRS 
Eukaryota 
IMPDH1 
IMPDH3 
IMPDH4 
saccharomyceta 
PCBP3 
LSM4 
Ascomycota 
 Ascomycota 
RBM19 
SKIV2L2 
ZC3H14 
NSUN2 
Saccharomycetaceae 
PABPC1 
PAN2 
PAN3 
PATL1 
ATXN2 
N/A 
TIA1 
Ascomycota 
PUS7 
EIF3A 
RPL10 
RPL11 
RPL13 
RPL13A 
RPL17 
RPL18 
RPL19 
RPL10A 
RPL21 
RPL4 
Opisthokonta 
Opisthokonta 
RPL7 
RPL7A 
 
no 
 
no ev 
 
no ev 
 
no 
no 
no 
 
yes 
yes 
 
 
yes 
yes 
yes 
yes 
 
yes 
no 
no 
yes 
yes 
 
yes 
 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
no ev 
yes 
yes 
yes 
yes 
 
 
yes 
yes 
 
no 
 
no 
 
no 
 
no 
no 
no 
 
no 
yes 
 
 
yes 
no 
yes 
yes 
 
yes 
no 
no 
yes 
yes 
 
yes 
 
yes 
yes 
yes 
yes 
no 
no 
yes 
no 
no 
yes 
yes 
yes 
 
 
yes 
yes 
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6MS2L-RNA 
Gene mRNA Target Functiona 
Mitchell 
et al. 
Homologue/Related 
Human Proteinb 
Castello 
et al. 
Baltz et 
al. 
RPL9A 
RPP0 
RPS11A; RPS11B 
RPS12 
RPS19B 
RPS1A 
RPS2 
RPS20 
RPS23A; RPS23B 
RPS3 
RPS31 
RPS4A; RPS4B 
RPS5 
RPS6A; RPS6B 
RPS7A 
RPS7B 
RPS9B 
RRP5 
SBP1 
SCP160 
SGN1 
SHM1 
SKN7 
SPC110 
SSB2 
SSZ1 
STM1 
STO1 
ZUO1 
THS1 
TIF4631 
TIF4632 
TRM2 
UPF1 
URA3 
XRN1 
YGR161W-B 
YGR250C 
YMR046C 
 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
rRNA 
mRNA 
mRNA 
mRNA (Winstall et al. 2000) 
none 
none 
none 
unknown 
none 
mRNA (Hogan et al. 2008) 
mRNA 
rRNA 
tRNA 
mRNA 
mRNA 
tRNA 
mRNA 
none 
mRNA 
none 
unknown 
none 
 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Translation 
Rs Biogenesis 
TL Repression 
Translation 
Unknown 
Metabolism 
Transcription 
Other 
Co-TL NP Mat 
Co-TL NP Mat 
TL Repression 
Nuc Processing 
Co-TL NP Mat 
tRNA Aminoacy 
Translation 
Translation 
tRNA Mod 
Decay 
Metabolism 
Decay 
Other 
Unknown 
Other 
 
no 
no 
no 
no 
no 
no 
no 
yes 
no 
no 
no 
no 
no 
no 
no 
no 
no 
yes 
yes 
yes 
no 
no 
no 
no 
no 
no 
no 
yes 
no 
no 
yes 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
 
RPL9 
RPLP0 
RPS11 
RPS12 
RPS19 
RPS3A 
RPS2 
RPS20 
RPS23 
RPS3 
RPS27A 
RPS4X 
RPS5 
RPS6 
RPS7 
RPS7 
RPS9 
PDCD11 
Saccharomycetaceae 
HDLBP 
ASCL3 
SHMT2 
Saccharomycetaceae 
Saccharomycetaceae 
N/A 
HSP70L1 
Saccharomycetaceae 
NCBP1 
MPP11 
TARS 
EIF4G1 
EIF4G2 
TRMT2A; TRMTB 
UPF1 
Ascomycota 
XRN1 
N/A 
CELF1 
N/A 
 
cand 
yes 
yes 
yes 
no ev 
yes 
yes 
yes 
cand 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
 
yes 
no 
cand 
 
 
 
no 
 
cand 
no 
cand 
yes 
yes 
yes 
yes 
 
yes 
 
yes 
 
 
no 
yes 
no 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
yes 
no 
yes 
yes 
no 
no 
 
yes 
no 
no 
 
 
 
no 
 
yes 
no 
no 
yes 
yes 
no 
yes 
 
yes 
 
yes 
 
 
a
 Abbreviations: Co-TL NP Mat – Co-translational Nascent Peptide Maturation; Rs Biogenesis – Ribosome Biogenesis; TL Repression – 
Translation Repression; tRNA Mod – tRNA Modification; tRNA Aminoacy – tRNA Aminoacylation; Nuc Processing – Nuclear Processing; cand 
– candidate RBP; no ev – no evidence, N/A – no answer 
b
 Homologues of the MS2L-tagged RNA co-purifying proteins were retreived from (S. F. Mitchell et al. 2013). To find human homologues to 
the remaing proteins, HomoloGene tool of the National Center for Biotechnology Information (NCBI) was used. If HomoloGene could not 
detect a human homolog of the yeast gene, the table shows the division of the eukaryotic kingdom where homologous genes were 
detected (read: Conserved in Saccharomycetacea). ARX1, BFR1 and EBS1 homologs are according to the literature EBP1 (Hung and Johnson 
2006), MDR1 (Wilkinson and Millar 1998) and SMG7 (Luke et al. 2007), respectively.   
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Table 4. Literature-based classification (Appendix, Table 3) of the enriched proteins according to the type of 
RNA bound by the protein. Table depicts percent of proteins known to bind a certain type of RNA. Note that 
some proteins classified under multiple categories. Proteins containing putative RNA-binding domains or 
known to be involved in mRNA biology but for whom the RNA target has not been identified, we classified 
under category “undefined RNA”. snoRNA – small nucleolar RNA; snRNA – small nuclear RNA. 
 
MS2L-tagged 
RNA 
log2
a
 mRNA rRNA tRNA snoRNA snRNA 
undefined 
RNA 
no known 
RNA target 
PGK1 
0.5 27 43 3 2 1 4 19 
1 35 38 3 1 0 8 18 
ENO2 
0.5 26 43 6 1 2 7 17 
1 29 42 6 1 1 7 14 
6MS2L 
0.5 27 39 7 0 1 4 22 
1 32 41 6 0 1 6 15 
a
 log2 0.5 corresponds to threshold log2 (H/L) >0.5 or <-0.5; log2 1 corresponds to threshold log2 (H/L) >1 or <-1. 
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